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ABSTRACT 
The central nervous system is a potential site of action for the Fusarium mycotoxin Fumonisin B I 
(FB I), and is exemplified in horses by the disease equine leukoencephalomalacia. Structurally 
resembling sphingoid bases, FB I inhibits ceramide synthase, an enzyme involved in sphingolipid 
metabolism, leading to accumulation of free sphinganine (Sa) and sphingosine (So). This 
investigation focused on FBI, Sa, So and the Fusarium mycotoxins fusaric acid (FA), 
moniliformin (MaN), zearalenone (ZEA), deoxynivalenol (DON), and T-2 toxin (T2). 
Effects of the Fusarium mycotoxins and sphingoid bases on the N2a neuroblastoma cell line 
were assessed using the methylthiazol tetrazolium (MIT) and ApoGlow™ assays. The MIT 
assay revealed significant differences between the viability of N2a control cells and the cytotoxic 
effects of FBI (p=O.OOl), So (p=1.1 xlO-6), Sa (p=1.9xlO-6), MaN (p=0.002), DON (p=0.04) 
and ZEA (p=0.003) on N2a cells between S-250flM. The cytotoxic effects of FA did not differ 
significantly from controls (p=O.l). The ApoGlow™ assay revealed that in N2a cells, FBI at 
8flgmrl, FA at 128flg.mr l , and (FBI+FA) combined induced growth arrest at 2 and 4flg·mr ' . 
Assessment of the effects of FBI and FA on the Iurkat leukaemic suspension cell line revealed 
that FBI induced apoptosis at 1.56,12.5 and 50flg.m1-I, growth arrest at 100, 200 and 800flg.mrl 
and proliferation at 400flg.mrI Fusaric acid induced proliferation at 1. 56flg.mrl, apoptosis at 
3.15flg.mrl, growth arrest at 100 and 200flg.mrl, and necrosis at 800flg.mrl. Combined, 
(FBI+FA) induced apoptosis at 1.56, 3.15,12.5 and 800flg.mrI 
Flow cytometry and fluorescence microscopy revealed that mycotoxins, Sa and So induced 
varying levels of apoptosis and necrosis in N2a cells. Acridine orange and ethidium bromide 
staining facilitated discrimination between viable, apoptotic and necrotic cells . Transition of the 
mitochondrial transmembrane potential was measured using Rhodamine 123 with propidium 
iodide, and the dual emission potential sensitive stain IC-1. Changes in mitochondrial membrane 
potential and plasma membrane integrity were expressed as increases or decreases in 
fluorescence intensity. An increase in mycotoxin concentration from 50 to 200flM was usualJy 
paralleled by a decrease in I-aggregate formation, suggesting a decrease in the ~\!fm. Staining 
with Rh 123IPI indicated at specific concentrations whether N2a cells were either Jate apoptotic 
or necrotic reflected by the levels of PI uptake. No dose dependant mechanism of cell death was 
established using either method, as fluctuations were evident. 
Inununolocalisation of T2, ZEA and FBI within cellular organelles that exhibited ultrastructural 
pathology provided correlation between mycotoxin exposure and effects. Multinucleate giant cells 
and retraction of cellular processes were observed. At the electron microscope (EM) level, FBI 
was immunolocalised within microsegregated and peripherally condensed nucleoli, the 
nucleoplasm, distorted mitochondria and dilated endoplasmic reticulum (ER). The capacity of 
cells to incorporate mycotoxins and effect cytological changes represents a major factor in the potential 
for initiation of malignant transformation. 
Exposure of N2a cells to FBI for 72 hours increased intracellular free Sa and depleted complex 
sphingolipids. Using High Performance Liquid chromatography (HPLC), acid hydrolysis 
revealed reduction in Sa from a level of O.6±0.12flM in control cells, to 02±0.lflM in cells 
exposed to 50flM and lOOflM FBI. Base hydrolyses revealed increase in free Sa: So ratios from 
0.52±0.2 in control cells, to 1.14±0.2 and 1A±0.3 in cells exposed to 50 and lOOflM FBI 
respectively. The Sa: So ratio in the complete culture media (CCM) increased from 1. 7±0. 3 for 
control cells to 2.0±0.2 and 2.50±OA for cells exposed to 50 and lOOflM FBI respectively. 
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Correlation coefficients between Sa: So ratios to FBI exposure in CCM (R=0.75) and within 
cells (R=0.85), imply that the free Sa: So ratio within cells appears to be a better biomarker for 
FBI-induced disruption of sphingolipid metabolism in vitro, than the Sa: So ratio in CCM. 
Optimisation of HPLC analytical procedures improved recovery of FB I from spiked human sera 
to 95.8% (n=15) and detection limits to ~5ng.ml-1 at a signal to noise ratio of 5:1. Optimisation 
of methods for recovery of Sa and So from spiked sera, led to recoveries of 77.9% and 85.0%, 
for So and Sa respectively at levels of spiking with lOng per 500)..l1 of serum. Matched sera 
Sa:So ratios and FBI levels in brain cancer and non-cancer subjects in KwaZulu-Natal were 
determined using these optimised methods. Fumonisin B I was detected in sera of non-cancer 
(76.7±62.2nM) and brain cancer subjects (l07.38±116nM). Mean serum Sa:So ratios of 21 
non-cancer subjects was 1.7±0.7. There was no correlation (R=0.26) between these variables in 
non-cancer subjects. The mean serum FBI level in brain cancer subjects was 107.4±116nM 
(range 10.5-298nM) (n=50) and the mean Sa:So ratio (n=50) was 1.9±1.7 (range 0.40-8.16). 
No correlation was found between these variables in the brain cancer subjects either (R = -0.23). 
Fumonisin BI was irnmunolocalised in 49 of 76 brain tumour tissue samples analysed using 
immunohistochemistry (ffiC). Thirty-eight of the 76 specimens had matched serum FBI levels 
and Sa: So ratios, and 23 of these were positive for FB I presence. Although not significantly 
different (p=O.ll), the FBI sera levels in the cancer group with FBI within the tumour tissue had 
higher levels of FBI in sera than the ffiC FBI negative group. Fumonisin BI was localised within 
irregular profiles of nuclei, elongated and swollen mitochondria and ER. Immunolocalisation of 
FBI within organelles in the brain showing ultrastructural cellular pathology suggests FBI may 
be implicated in the aetiology of human brain carcinogenesis. 
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Figure 6. 24: 
Light micrograph of 50 /-lM T-2 toxin treated N2cx. cells with DAB chromagen 197 
within giant cells (G) and in the cell cytoplasm. Cellular debris (D) and remnants 
of dead cells are also shown (Haematoxylin, Magn. X 400) . 
Light micrograph ofN2cx. cells treated with 50/-lM T-2 toxin, immunolabelled with 197 
DAB within the focus (F) of cells. There is a predominance of cytoplasmic 
staining, and absence of toxin incorporation within the nuclei (Haematoxylin, 
Magn. X 400). 
Light micrograph of 50/-lM T -2 toxin treated N2cx. cell with DAB-labelled T -2 198 
toxin inununolocalised within the cytoplasm of a cell showing loss of cell 
membrane integrity, and a concentration of T2 around the nuclear membrane. 
Multiple nuclei and peripheral condensation of chromatin (arrows) were also 
features of treated cells (Haematoxylin, Magn. X 1000) . 
Light micrograph of 100 /-lM T -2 toxin treated N2cx. cells with DAB-labelled T2 198 
localised within giant cells (G), in the cytoplasm, as well as in rounded-up dead 
cells. Fragmented DAB stained cellular debris was also evident (Haematoxylin, 
Magn. X 400). 
Light micrograph of 100 /-lM T-2 toxin treated N2cx. cells with DAB-labelled T2 199 
inununolocalised in the cytoplasm of a cell showing cytoplasmic swelling or lysis 
(arrows) and within the nucleus in association with features of peripheral 
condensation of chromatin. (Haematoxylin, Magn. X 1000). 
Light micrograph of 200/-lM T -2 toxin treated N2cx. cells with DAB-labelled T2 199 
inununolocalised in the cytoplasm of giant cells and the fragments of cells lysed by 
exposure to T-2 toxin (Haematoxylin, Magn. X 400). 
Light micrograph of 200/-lM T-2 toxin treated N2cx. cells with DAB labelled T2 200 
localised within cells with lysed membranes and cellular debris. Empty spaces 
between cells are indicative of the level of cell death induced (Haematoxylin, 
Magn. X 400) . 
Transmission electron micrograph of a control N2cx. cell containing a prominent 200 
single centralised nucleolus . The area above the cell is the flask to which the cell 
was attached, and the area below, is the araldite resin in which the cell was 
impregnated and embedded in (Magn. X 4000) . 
Transmission electron micrograph of a 50/-lM FBI-treated N2cx. cell with 201 
peripherally condensation of nuclear chromatin, and swelling within the cytoplasm 
of what appears to be the Golgi complexes (?G) (Magn. X 6 000) . 
Transmission electron micrographs of a 50/-lM FBI-treated N2cx. cell with 202 
peripheral condensation of nuclear chromatin (NC) [a] (Magn. X 6 000) with FB I 
inununolocalised within the same nucleolus (Nu) and cellular processes (P) (gold 
probes circled) [b](Magn. X 25000). 
Transmission electron micrograph of 50/-lM FBI-treated N2cx. cell with peripheral 203 
condensation of nuclear chromatin and distinct nuclear pores (arrows) In 
association with inununolabelled FBI (gold probes circled) (Magn. X 25 000) . 
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Figure 6. 25: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with 203 
gold-labelled FBI (gold probes circled) localised within the nucleoplasm and 
cytoplasm (Magn. X 30 000). 
Figure 6.26: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with gold- 204 
labelled FBI localised in association with the discontinuous nuclear membrane 
(arrow) and the nucleoplasm of the N2a cells (Magn. X 60 000). 
Figure 6.27: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with 204 
gold-labelled FBI (gold probes circled) localised in association with a 
mitochondrion (M) (Magn. X 60 000). 
Figure 6.28: Transmission electron micrograph of 100f,lM FBI-treated N2a cell within a myelin 205 
figure (arrow) in association with immunolocalised FBI (gold probes circled). Also 
note the swollen cellular processes (P) (Magn. X 25 000). 
Figure 6.29: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with swollen 205 
mitochondria with mitochondrial matrix (M) clearing (arrow), disruption of the 
outer mitochondrial membrane, and swollen cellular processes (P) 
(Magn. X 30 000). 
Figure 6.30: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with swollen 206 
mitochondria showing clearing of the mitochondrial matrix and rearrangement of 
the cristae (arrows) (Magn. X 35 000). 
Figure 6.31: Transmission electron micrograph of 100f,lM FBI-treated N2a cell with swollen 206 
mitochondria showing clearing of the mjtochondrial matrix (M) and areas of 
cytoplasmic lysis (Magn. X 25 000). 
Figure 6.32: Transmission electron micrograph of 50f,lM FBI-treated N2a cell with short 207 
profiles of ER (arrows) seen in association with swollen mitochondria (M) where 
the cristae are not clearly visible (Magn. X 30 000). 
Figure 6.33: Transmission electron micrograph of 100f,lM FBI-treated N2a cells with profiles 207 
of swollen ER seen in association with areas of cytoplasmic matrix clearing 
(arrows) and immunolocalised FBI (gold probes are circled) (Magn. X 30 000). 
Figure 6.34: Transmission electron micrograph of 100f,lM FBI-treated N2a cells with profiles 208 
of swollen ER seen in association with areas of cytoplasmic matrix clearing and 
imrnunolocalised FBI (Magn. X 40000). 
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Figure 7.1: Optimised method for Fumonisin BI extraction from the serum 213 
Figure 7.2: High performance liquid chromatograms of three injections of FBI (70ng.ml- l ) 217 
showing reproducibility of the retention times. 
Figure 7.3a: Spiking of serum samples at selected steps for optimisation of extraction of 220 
Fumonisin BI 
Figure 7.3b: High performance liquid chromatograms of serum samples spiked with Fumonisin 221 















High performance liquid chromatograms of spiked serum samples showing a 223 
compound with a retention time of 3.2min. eluting very close to Fumonisin BI. 
High performance liquid chromatograms of spiked serum samples indicating 225 
improved recoveries of Fumonisin BI following dilution and boiling of the serum 
samples. 
High performance liquid chromatograms of varying levels of Fumonisin BI 229 
isolated from the sera of non-cancer subjects (N6, N20 and N 14; blue, red and 
green traces respectively) . Also shown by the uppermost blue trace blue is the FBI 
standard at a concentration of SOOng. 
Isolation of sphinganine and sphingosine from serum according to Shephard and 237 
van der Westhuizen (1998). 
High performance liquid chromatograms of sphinganine and sphingosine isolated 242 
from the spiked sera of a non-cancer subjects (NSa 79 and 84, blue and red traces 
respectively) seen in association with the Sa and So standards (green trace). 
High performance liquid chromatograms of sera of a non-cancer subject spiked 248 
with increasing concentrations of recovered Sa and So standards. The traces 
shown are NSa 189 (blue), NSa 190 (red); Nsa 195(green), Nsa 194 (blue) and 
NSa 192(pink) from the bottom up. 
High performance liquid chromatograms showing FBI retrieved from the culture media 261 
after N2a. cells were exposed to 50)lM FBI for 72 hours. The traces shown are AH4, 
AH5 and AH6, and are green, red and blue respectively. 
High performance liquid chromatograms showing FBI retrieved from the culture media 262 
after N2a. cells were exposed to 100)lM FBI for 72 hours. The traces shown are AH 10, 
AH12 and AHll and are illustrated in blue, green and pink respectively. 
High performance liquid chromatograms of Sa and So obtained following acid 265 
hydrolysis of the isolated control (blue AHC6 trace) and FBI-treated (pink AH12 
and light blue AH4 trace) N2a cells relative to a 500ng Sa and So standard (green 
SaS0500 trace). 
High performance liquid chromatograms of Sa and So obtained following base 268 
hydrolysis of the isolated control (light blue BHC 1 trace) and FBI-treated (pink 
BHl and dark blue BH7 trace) N2a cells relative to a 125ng Sa and So standard 
(green 125 SaSo trace) 
High performance liquid chromatograms of Sa and So obtained following analyses 272 
of the culture media of the control (green MEDAHC6 trace) and FBI-treated 
(MED BH3, BHlO and AHIO traces) N2a cells in relation to the SaSo standard 
(SaSo 125 dark blue trace). 
Correlation between concentrations of FBI exposure and intra and extracellular Sa: 275 



















High performance liquid chromatograms showing the variable levels FBI retrieved 283 
from the sera of three non-cancer volunteers, as well as a 500ng.mr l FBI standard . 
High performance liquid chromatograms showing the Sa and So bases retrieved 284 
from the serum analyses of three non-cancer volunteers (norm S10, SI and S5, 
red, blue and purple traces), as well as a 150 ng.mr l Sa and So standard (green 
trace). 
Correlation between Fumonisin BI and the Sa: So ratio in non-cancer subjects . 286 
High performance liquid chromatograms showing the levels FBI retrieved from the 290 
sera of two cancer volunteers (green B82 and pink B88 traces), as well as a 
200ng.mr l FBI standard (dark blue trace). 
Correlation between FBI levels and Sa: So ratios in sera of brain cancer subjects. 291 
High performance liquid chromatograms showing the Sa and So bases retrieved by 294 
serum analyses of four brain cancer subjects, as well as a chromatogram of the 
250ng.mr l Sa and So standard (purple trace). 
Correlation between age of cancer subjects and serum FBI levels. 295 
Correlation between serum Fumonisin BI levels and Sa:So ratios in meningioma 296 
patients . 
Correlation between serum FBI and Sa levels in meningioma patients. 296 
Correlation between serum FBI and So levels in meningioma patients. 297 
Correlation between serum FBI and Sa levels in the 50 brain cancer patients. 297 
Gallery showing processing of images for analysis where (a) is the light 
microscope image, (b) is the conversion to grey image, (c) is the binary image 
showing segmentation of immuno-reactive regions, and (d) is the binary image 
after deletion on the Kontron 300 image analysis system. 
Computed light micrograph to show the areas measured. A mask image overlay 
(different colours) surrounds the cell with the stain. The mask image serves as the 
region validation check. Each colour in the overlay depicts varying intensity 
values. Intensity values are expressed on a grey scale. 
Light micrograph of the choroid plexus showing a mass of capillaries projecting 





Figure 1O .3a: Light micrograph of the cerebellar cortex of the normal brain showing a deeply 337 
convoluted fold. The outer molecular layer (ML) contains relatively fev\' neurons 
and large numbers of unmyelinated fibres , and the ilmer granular cell layer (GL) is 
extremely cellular. Between the two is a layer of huge neurons called Purkinje cells 
(P) (H&E, Magn. X 100). 
Figure 10.3b: Light micrograph of the Purkinje (P) cells that have very large cell bodies, and 337 
relatively fine axon extending down through the granular cell layer (H&E, 
Magn. X 1000). 
Figure 10.4: Light micrograph of a transitional meningioma consisting of diffuse sheets of 338 
spindle cells . Two rudimentary whorls (W) are shown with the cells arranged 
circumferentially around a central vascular space (H&E, Magn. X 400) . 
Figure 10.5: Light micrograph of an anaplastic astrocytoma showing glioblastomatous 338 
transformation . One part of the tumour is a poorly differentiated fibrillary 
astrocytoma (A). The blood vessel in the centre is showing endothelial cell 
proliferation (E). There is also a band of necrosis (N') (H&E, Magn. X 400) . 
Figure 10.6: Light micrograph of a medulloblastoma from the posterior fossa with ovoid (0) or 339 
elongated cells. The stroma is sparse and consists largely of small blood vessels 
(BV) (H&E, Magn. X 240). 
Figure 10.7: Light micrograph of an adenoma of the choroid plexus consisting of numerous 339 
papillae (P), the surface of which is covered with a single layer of columnar 
epithelial cells (H&E, Magn. X 100). 
Figure 10.8: Light micrograph of the renal medulla of a FBI-treated rat kidney used as a 340 
negative control in the IHe method, where the primary antibody was omitted. 
Absence of immunoreactivity indicates the antibody specificity (Magn. X 100). 
Figure 10.9: Light micrograph of a treated rat kidney where the secondary antibody was 340 
omitted during the mc method application . Absence of immunoreactivity indicates 
the antibody specificity (Magn. X 400). 
Figure 10.10: Light micrograph of FBI-treated Fischer 344 rat kidney tissue showing luminal 341 
distribution of FBI within distal convoluted tubules and within the lumen of the 
proximal convoluted tubules (peT) (Magn. X 200). 
Figure 10 .1I: Light micrograph of the non-cancer cerebellar cortex showing absence of non- 341 
immunological FBI staining (Magn. X 100) . 
Figure 10 .12 : Light micrograph of the method control where the primary antibody was omitted 342 
showing absence of immunoreactivity in the tumour tissue (Magn. X 40) 
Figure 10 .13a: Light micrograph of a meningothelial meningioma showing red AEC chromagen 342 
immunoprecipitation in cells within the tumour tissue (Magn. X 100). 
Figure 10 . l3b: Light micrograph of the meningothelial meningioma showing FBI 343 
immunoreactivity indicated by the red AEC chromagen within tumour tissue 
(Magn. X 400). 
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Figure 10.13c: Light micrograph of a meningioma showing varying intensities of the AEC 343 
chromagen staining within neoplastic cells with enlarged nuclei in the tumour 
tissue (Magn. X 1000). 
Figure 10.14: Light micrograph ofa brain tumour specimen with FBI immuno-precipitation in a 344 
few cells (red AEC chromagen) (Magn. X 1000). 
Figure 10.15 : Electron micrograph of a meningioma showing variation of cell size and pyknotic 344 
Figure 10.16: 
Figure 10.17: 










Figure AU : 
Figure A1.2 : 
enlarged nuclei (Nu) (Magn. X 2000). 
Electron micrograph of a tumour specimen with pleomorphic nuclei (Nu), 
scattered desmosomes (D) and evidence of keratinisation (K) in the cytoplasm 
(Magn. X 2000). 
Electron micrograph showing a nucleus (Nu) within a tumour specimen with a 
crenated border and FBI immunolocalised on the nuclear membrane and in the 
cytoplasm (in circles) (Magn. X 25 000) . 
Electron micrographs of brain tumour specimens showing nuclei (Nu) with FBI 
immunolocalised on the nuclear envelop and within the nucleoplasm (a) (Magn. X 
12 000), on the nuclear membrane and in the tumour cell cytoplasm in association 
with dilated ER (b). Note the gold probes are circled for identification. (Magn. X 
25000). 
Electron micrograph of a medulloblastoma showing a pyknotic nucleus with gold-
labelled FBI (gold probes circled) found in association with heterochromatin 
condensat.ion along the periphery of the nucleus and with granules interspersed 
within the euchromatin (Magn. X 20 000) . 
Electron micrograph of brain tumour tissue showing FB I immunolocalised within a 
mitochondrion (M) that is closely associated with ER and the nucleus . Note the 
gold probes are circled. (Magn. X 40 000). 
Electron micrograph showing immunolabelled FBI within myelin figures (My), 
mitochondria (M), cytoplasm and in disrupted ER (Magn. X 40000). 
Electron micrograph showing FBI immunolabelled within elongated mitochondria 








Electron micrograph showing immunolabelled FBI within swollen disrupted ER 349 
(Magn. X 60 000) . 
Electron micrograph showing immunolabelled FB I within strands of broken ER 349 
and the cytoplasm (Cyt) ofa tumour cell (Magn. X 60 000) . 
Electron micrograph showing immunolabelled FBI in association with swollen ER 350 
and areas of cytoplasmic lysis (Magn. X 80 000). 
Frequency of Histologically diagnosed brain and central nervous system cancer in 397 
South Africa (1993-1995) (Sitas et at., 1998). 
Age specific brain and central nervous system cancer rates per 100 000 398 
(1993-1995) (Sitas et at., 1998). 
x'Viii 



















Sununary statistics for cancer in the brain and central nervous system in South 
Africa, 1993-1995 (Sitas et at., 1998). 
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1.1 THE DIET-CANCER RELATIONSHIP 
Food is one of the ultimate complex mixtures to which man is exposed. Research indicates 
that dietary variables, anti-carcinogenic substances, and exposure to carcinogens that occur 
in foods or are induced during its' preparation, are relevant determinants in the diet-cancer 
relationship (Institute of Food Technologists, 1993). Given the popular misconception that 
the natural human diet is "safe", and that such risks are due to contamination by pesticides, 
xenobiotics and other "chemical" residues, there is a need for continual evaluation of the 
avenues open to investigators to reduce disease incidence. Well-structured studies would 
ultimately wield meaningful results enabling medical and scientifically based advice to be 
given to the public with regard to improving dietary habits . 
Numerous hypotheses on cancer causation exist. Their diversity and variety often reflect 
the paucity or conflicting, often over-abundance of experimental and epidemiological 
evidence on which they are based. Correlation is not necessarily causation, and hypotheses, 
however plausible, require unbiased evaluation. Although the complete web of cancer is 
complex, medical science is concerned with effective action, and this firstly requires no 
more than the identification of the relevant proximate influence, which, if removed, would 
lead to a substantial reduction in the risk of disease. On this empirical basis, what is 
diagnosed as a causal relation may turn out to be a predisposing, carcinogenic or 
co-carcinogenic factor. These factors may be several degrees away from those immediately 
responsible for carcinogenesis, but their discovery would help disclose the chain of 
causality, whose precise links could then be ascertained (Oettle', 1965). 
1.2 MYCOTOXINS 
Food-borne illnesses are of global importance. Among the factors that may induce these 
illnesses, mycotoxins that are defined as secondary metabolites synthesised by fungi under 
certain environmental conditions, have received considerable attention 
(International Agency for Research on Cancer, 1993a). Mycotoxins are potentially 
carcinogenic compounds produced by fungi mainly in the genera Aspergillus, Penicillium 
and Fusarium. 
Mycotoxlns of importance in human health include the aflatoxins, ochratoxin A, 
fumonisins, trichothecenes and zearalenone (Pitt et aI., 2000). The interest they generate 
stems from their high toxicity and potency in producing tumours in laboratory animals 
(Institute of Food Technologists, 1993). Consumers of foods contaminated by fungi are 
vulnerable to acute toxicity and to chronic long-term mutagenic and immunosuppressive 
effects of mycotoxins, which exacerbate primary infections or interact with inter-current 
diseases . The present study focuses on the Fusarium mycotoxins fusaric acid (FA), 
moniliformin (MON), zearalenone (ZEA), deoxynivalenol (DON), and T -2 toxin (T2), 
with specific emphasis being placed on Fumonisin BI (FBI). 
1.3 EXPOSURE TO Fusarium FUNGI AND FUMONISINS IN SOUTH AFRICA 
Exposure to FBI and other Fusarium metabolites is a public health hazard where mass food 
production and improper storage conditions are conducive to mould spoilage and 
subsequent mycotoxin production. Between 1984 to 1993, over 1600 samples of 
agricultural commodities comprising maize, compound animal feeds, oil seeds, soy bean, 
fish meal and forage in KwaZulu-Natal (KZN), South Africa (SA) were examined using a 
multi-mycotoxin screen. Aflatoxin had the highest incidence with over 14% of all samples 
examined followed by trichothecenes at 10%, and ZEA at 4%. Since 1989, selected maize 
samples with high levels of Fusarium species were examined for FBI and of these (n=20), 
90% were positive in 1993. As a consequence of these results and high incidence of 
Fusarium species (32%) in maize and maize containing feeds, which was higher than either 
Aspergillus species (27%) or Penicillium species (12%), concern was expressed with 
regard to the potential presence and exposure to fumonisin in the South African food chain 
(Dutton and Kinsey, 1996). 
As the potential for daily dietary exposure to these compounds via the ingestion of 
contaminated foods and feeds exists, their importance in food safety and as causes of 
human illness has increased. The diseases produced as a result of the consumption of 
contaminated foods however, remains poorly understood at the clinical level. 
Fusarium fungi have been implicated in haemorrhagic, oestrogenic, emetic, and feed 
refusal syndromes in animals. There is considerable evidence that the central nervous 
system (eNS) is a potential site of action for FBI and is exemplified in horses by the 
disease equine leukoencephalomalacia (ELEM). This disease is characterised by marked 
neurotoxicity and liquefactive necrotic lesions in the white matter of the cerebral 
hemispheres of the brain of horses and other equine species (Marasas et al., 1988a; 
Kellerman et al., 1990; Wilson et al., 1992; Ross et al., 1993). 
Studies on the pathophysiology of fumonisin toxicoses are essential in disease diagnosis, 
establishment of safety parameters, and development of control and prevention procedures. 
As the potential for dietary exposure to Fusarium mycotoxins exists, the human eNS is at 
risk of exposure to their biochemical effects and potential carcinogenicity. The data that 
exists on the adverse health effects of fumonisins in animals serves as the basis for concern 
for their effects on human health. However difficulty is inherent in the extrapolation of risk 
from animals to humans, and in the determination of what a significant biological exposure 
constitutes, due to differences in species-specific responses to a compound. 
Fusarium mycotoxins have been implicated in alimentary toxic aleukia, Drov or 
Kashin-Beck disease, Akakabi-byo or scabby grain intoxication, and oesophageal cancer in 
humans (Marasas et al., 1979a; 1988b; Rheeder et al., 1992). However, these published 
studies demonstrate inconclusive associations of fumonisins with human disease. In 
addition, minimal work has been channelled into investigating directly the possible 
implication of Fusarium mycotoxins, especially FBI, in the aetiology of human brain 
cancer, or in relation to isolated cells of the eNS and their lesions. 
The selection of a single agent for investigation does not deny the complex aetiology of 
cancer, nor does it exclude the possibility of other factors contributing to disease causation. 
Over simplification in an effort to shed clarity of understanding to a problem for proper 
elucidation is sometimes considered better than taking the dichotomous route of 
complication beyond recognition. This holds true especially if the latter were to become no 
more than a bewildered acknowledgment of complexity that explains away anomalies and 
effectively hinders logical analysis. 
1.4 BRAIN CANCER IN SOUTH AFRICA 
The National Cancer Registry (NCR) collates information on cancer diagnosed via a 
network of private and public pathology laboratories in SA. The most recent available 
report by Sitas et al. (1998), provides statistics for the time-frame between 1993 to 1995, 
that includes frequencies by population, sex, age-group, cancer site, age standardized, 
cumulative incidence rates and lifetime risks of developing cancer. These statistics 
(Table 1) indicate that a total of 387 females and 494 males were diagnosed with brain or 
CNS tumours between 1993 and 1995 . The Asian and White race groups seemed more 
susceptible to development of tumours as indicated by the calculated lifetime risk of 
getting these tumours, with males across all race groups at greater risk than women 
(Table 1). Figures Al.l and Al.2 (Appendix 1) graphically illustrate the frequency of 
histologically diagnosed brain and CNS cancer, and the age specific cancer rates per 




























Summary statistics for cancer in the brain and central nervous system 
in South Africa, 1993-1995 (Sitas et a/., 1998). 
94 95 93 % No of cases/ Age Cumulative Lifetime 
to of population, standardised incidence risk of 
95 all Per incidence rate developing 
cancers 100000 rate per (0-74 yrs) a cancer 
100000 
135 98 387 0.57 0.72 0.85 0.09 1111 
142 160 494 0.69 0.94 1.1923 0.11 909 
7 3 20 1.21 1.75 1.58 0.12 833 
5 11 22 1. 91 2.03 2.34 0.24 417 
31 29 105 0.51 0.29 0.31 0.03 3333 
28 38 129 0.69 0.38 0.43 0.04 2500 
7 3 20 0.86 0.53 0.56 0.04 2500 
6 5 19 0.90 0.53 0.79 0.07 1429 
58 38 165 0.56 7.80 2.62 0.26 385 
62 65 214 0.61 3.78 3.57 0.34 294 
32 25 67 
41 41 110 
The increased incidence of brain cancer in adults and children is suspected of having a 
strong environmental influence (Curan and Jones, 1991). The cancers most prevalent 
amongst South African children follows a worldwide trend, according to the Cancer 
Association of South Africa (CANSA) with brain cancer ranking second amongst the most 
common cancers, and accounting for 21% of all cancers diagnosed. Neuroblastomas, a 
cancer of the sympathetic nervous system, also ranked fifth amongst most common 
childhood cancers (Cancer Information Services, 1998). 
On the basis of racial classification, South Africans were previously subject to 
environments that determined their lifestyle, diet, socio-economic condition, residence, 
type of work and access to health care (Sitas and Pacella, 1994). These differences 
influenced reported cancer patterns observed among population groups. However, major 
socio-economic changes have occurred in SA over the past ten years that have impacted on 
these aspects. Were more recent statistics available, it would provide a more accurate 
representation of current cancer incidence across the racial groups due to increased 
reporting and increased access to health care for all races. The statistics presented by 
~itas et al. (1998) are representative of cases reported within only the 1993 -1995 
timeframe. At that time, in socially impoverished communities, limited access to medical 
facilities and treatment, lack of money and knowledge on disease treatment, may have 
prevented people from seeking and securing help. Nevertheless, this information was 
helpful in providing insight into past trends of reported cancer incidence in SA. 
1.5 POTENTIAL FOR FUNGAL ASSOCIATION IN NEUROLOGICAL 
DISEASES 
The overall goal of neurotoxicological investigations is to develop and validate quantitative 
biomarkers of neurotoxicity and to utilize these to elucidate toxicity mechanisms. This 
would increase the certainty of assumptions underlying risk assessment for neurotoxicants. 
Advances in medical science have revolutionized understanding of brain tumours and 
shown that abnormal proliferation, inability of the cells to die and their potential to modify 
their tissue environment, result from accumulation of genetic aberrations. Understanding 
the potential initiators and chain of events responsible for brain tumour growth is a 
prerequisite for the development of effective therapeutic modalities leading to improved 
prognosis and cures. 
In order to develop and implement methods of preventing intoxication and managIng 
symptoms of poisoning by Fusarium mycotoxins known to potentially affect the CNS, 
identification and understanding the mechanisms whereby these toxicants exert their 
effects is imperative. The selection of Fusarium toxins for study was on the basis of their 
incidence in analytical surveys of commercially available SA food and feeds 
(Dutton and Kinsey, 1995; 1996), as well as on the requirement for further research into 
their potential role in CNS-associated human disease. The significant contribution of maize 
and maize-based foods to the diet, and therefore their potential diet-toxicity interaction, 
warranted the present study to ascertain whether selected Fusarium mycotoxins may be 
associated with the pathophysiology of brain cancer in the population of KwaZulu-Natal, 
South Africa. 
Diagnosis of neurological diseases caused by fungi can be difficult as clinical signs are 
often ambiguous or similar to those found in other diseases, and histological lesions may 
be non-specific or absent. Therefore, the diagnosis of diseases caused by neurotoxic 
mycotoxins depends not only on history, clinical signs or finding the mycotoxin in the 
appropriate food and feed material (Plumlee and Galey, 1994), but also on finding the 
specific mycotoxin directly within lesions, in infected tissues, and/or in physiological 
fluids. 
1.6 OBJECTIVES 
This study comprised of an in vitro experimental, as well as a in vivo clinical component. The 
objectives of the in vitro component were to assess the: -
• potential for selected Fusarium mycotoxins to induce cytotoxicity, apoptosis, growth 
arrest or necrosis in the N2a. mouse neuroblastoma cell line; 
• structural and ultrastructural changes that occur as a result of exposure to Fusarium 
mycotoxins in N2a. mouse neuroblastoma cells using immunochemical techniques; and 
• in vitro effects of FBI on sphinganine (Sa) and sphingosine (So) metabolism in the N2a. 
cells. 
The objectives of the clinical component of this study were to: -
• analyse sera obtained from non-cancer subjects and brain tumour patients for levels of 
FBI, Sa, So and Sa:So ratios in order to establish whether any correlation exists 
between these variables, and 
• immunolocalise FBI within brain tumour tissues. 
CHAPTER 2 
Literature Review 
2.1 STRUCTURE OF THE NERVOUS SYSTEM 
The nervous system is divided into the CNS that consists of the brain contained within the 
cranium and spinal cord lodged in the vertebral canal, and the peripheral nervous system 
(PNS), made up of ganglia and peripheral nerves that lie outside the brain and spinal cord. 
Further subdivisions of the CNS, PNS and the associated functions are shown in 
Appendix 2. For the purpose of this study, discussion will specifically focus on some of the 
functions and parts of the brain. 
2.2 STRUCTURE OF THE BRAIN 
2.2.1 The meninges 
The meninges are three layers of tissue made up of the dura mater, arachnoid mater, and 
pia mater that cover and protect the brain and spinal cord. The dura mater is made up of 
two layers of whitish, inelastic film or membrane. The outer layer, the periosteum and an 
inner layer, the dura, lines the inside of the skull and creates folds or compartments in 
which parts of the brain are neatly protected and secured. The second layer of the 
meninges, the arachnoid layer is a thin and delicate membrane made up of delicate, elastic 
tissue and blood vessels of different sizes, and covers the entire brain. The space between 
the dura and the arachnoid membranes is the subdural space. The layer of meninges closest 
to the surface of the brain, the pia mater, has many blood vessels that reach deep into the 
surface of the brain. The pia that covers the entire surface of the brain follows the folds of 
the brain. The major arteries supplying the brain provide the pia with its blood vessels. The 
space that separates the arachnoid and the pia is called the subarachnoid space and it is here 
that cerebrospinal fluid (CSF) flows. Cerebrospinal fluid is found within the brain and 
surrounds the brain and spinal cord . It is within hollow channels in the brain, called 
ventricles, where the fluid is produced. The choroid plexus is responsible for the majority 
of CSF production. 
2.2.2 The cerebrum 
The brain protected by the rigid, bony skull consists of the cerebrum, the cerebellum and 
the brain stem (Figure 2.1). The cerebrum consists of two cerebral hemispheres that are 
incompletely separated by the longitudinal cerebral fissure. The hemispheres consist of the 
cerebral cortex, which refers to the grey matter covering the cortex, the white matter under 
the cortex, and three deeply located nuclei. These are the basal ganglia, the hippocampal 
formation and the amygdala. The cerebral hemispheres are divided by the hemispheric 
fissure and are thought to be concerned with perception, cognition, emotion, memory and 
higher motor functions. 
ita! 
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Figure 2.1: Structure of the brain (Burkitt et al., 1993). 
The corpus callosum connects the two halves of the brain and allows for communication 
between the hemispheres. The surface of the cerebrum contains billions of neurons and glia 
that together form the cerebral cortex. The cerebral cortex appears greyish brown in colour 
and is called the "grey matter". The cerebral cortex has small grooves (sulci), larger 
grooves (fissures) and bulges between the grooves called gyri. Beneath the cerebral cortex 
or surface of the brain, connecting fibres between neurons form the "white matter". The 
cerebral hemispheres have several distinct fissures. The brain can effectively be divided 
into pairs oflobes; namely the frontal, temporal, parietal and occipital lobes (Figure 2.1). 
2.2.3 The cerebellum 
Like the cerebrum, the cerebellum (Figure 2.1) is divided into two hemispheres and is 
composed of white and grey matter. The cerebellum, located at the back of the brain 
beneath the occipital lobes, is separated from the cerebrum by the tentorium (fold of dura). 
8 
The cerebellum fine-tunes motor activity or movement and controls balance and 
co-ordination . 
2.2.4 The brain stem 
The brain stem consists of the midbrain, pons and medulla oblongata (Figure 2.1) and 
extends from the base of the cerebrum and merges into the top of the spinal cord . 
Neurological functions located in the brainstem include those necessary for breathing, 
digestion, heart rate, blood pressure, for being awake and alert . It serves as a relay station, 
passing messages back and forth between various parts of the body and cerebral cortex. 
The midbrain is the smallest part of the brain. The midbrain is an important centre for 
ocular motion, while the pons is involved with coordinating the eye and facial movements, 
facial sensation, hearing and balance. The medulla oblongata is the most caudal part of the 
brain stem, composed of the midbrain, pons and medulla. It controls breathing, blood 
pressure, heart rhythms and swallowing. 
2.3 THE BLOOD BRAIN BARRIER 
The blood brain barrier (BBB) (Figure 2.2) is created by the tight apposition of endothelial 
cells lining blood vessels in the brain, forming a barrier between the circulation and the 
brain parenchyma (e.g., astrocytes, microglia). Blood-borne immune cells such as 
lymphocytes, monocytes and neutrophils cannot penetrate this barrier. A thin basement 
membrane, comprising lamin, fibronectin and other proteins, surrounds the endothelial 
cells and associated pericytes, and provides both mechanical support and a barrier function. 
Thus, the BBB is crucial for preventing infiltration of pathogens and restricting antibody-
mediated immune responses in the eNS, as well as for preventing disorganization of the 
fragile neural network. This, together with a generally muted immune environment within 
the brain itself, protects the fragile neuronal network from the risk of damage that could 
ensue from a full-blown immune response. On rare occasions, pathogens (e .g., viruses, 
fungi and prions) and autoreactive T cells breach the endothelial barrier and enter the brain. 
A local innate immune response is mounted in order to limit the infectious challenge, and 
pathogens are destroyed and cell debris is removed, a vital process that must precede tissue 
repair (Francis et aI., 2003). 
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Figure 2.2: The blood brain barrier (Francis et al., 2003). 
The barrier is a differentially penneable structure that is partially ascribable to the presence 
of specialised CNS capillaries and the envelopment of capillaries by astroglial foot 
processes. Specialized capillaries have tight junctions between endothelial cells and a 
lower rate of pinocytosis than visceral capillaries. The cerebral capillary endothelial cell 
displays some peculiar morphologic characteristics that fonn the anatomic basis of the 
BBB. It differs from the peripheral capillary endothelial cell (referring to all non-CNS 
sites) in that it is not fenestrated. Cells are joined by tight junctions composed of six to 
eight pentalaminar structures, and actively block protein movements, hydrophilic transfer 
and even ionic diffusion (Burkitt et ai., 1993). Thus, there is very little movement of 
compounds between endothelial cells from the blood to the CNS. 
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The cerebral vascular endothelial cell possesses a transcellular lipophilic pathway, 
allowing diffusion of small lipophilic compounds. In addition to this route, specific 
receptor-mediated transport systems are present for molecules, like insulin, transferrin, 
glucose, purines and amino acids. The CNS endothelial cell displays a net negative charge 
at its endoluminal side and at the basement membrane. This provides an additional 
selective mechanism by impeding anionic molecules to cross the membrane. The cerebral 
endothelial cell has very few pinocytic vesicles, and these vesicles are not involved in any 
transport function (Burkitt et aI., 1993). 
The BBB provides neurons with a relatively constant biochemical and metabolic 
environment, protection against endogenous and exogenous toxins and infective agents and 
insulates the neurons from circulating neurotransmitters and other humoural agents. The 
capillaries of the choroid plexus, the pituitary gland and pineal glands and the vomiting 
centre of the hypothalamus are, however, devoid of this barrier as befits their various 
functions. By virtue of this selective barrier, the CNS can preferentially regulate the 
extracellular concentration of certain solutes, growth factors and neurotransmitters, keep 
certain molecules in the CNS and isolate itself from some others, and further isolate itself 
from sudden systemic homeostatic changes. It is therefore an integral component of the 
mechanisms involved in the tight regulation of the extra-cellular homeostasis necessary to 
the normal CNS function (Burkitt et aI., 1993). 
2.4 WHA T IS BRAIN CANCER? 
Cancer development is a multistage process in which the summation of the steps of genetic 
change, clonal expansion of initiated cells and malignant conversion is required to produce 
a malignant tumour. Conversion from a pre-malignant phenotype to a malignant cell type is 
the major time-dependent stage of cancer pathogenesis, whereas tumour heterogeneity; 
associated with the acquisition of metastatic potential, is a relatively rapid event 
(Yuspa, 2000). 
Tumours in the CNS resulting in an overgrowth of cells in the brain or spinal cord are 
potentially harmful because of the solid framework of the skull and vertebrae. The growing 
tumour presses against other structures in this non-expanding space, eventually causing 
symptoms. Various cell types make up the brain and spinal cord, and each type of cell can 
give rise to a different type of tumour. Benign brain tumours can cause problems by 
pressmg on and damaging the surrounding brain tissue, however, they can often be 
successfully removed. Malignant brain tumours, or brain cancers, vary widely both in the 
way they grow and the way they respond to treatment. In addition, both benign and 
malignant tumours may cause the brain tissue around them to swell. Many malignant 
tumours in the brain are secondary cancers that arise as a result of metastasis of a tumour 
from another region of the body. 
There is no known cause of primary tumours of the brain and spinal cord. In certain 
individuals, primary tumours of the eNS may result from specific genetic diseases such as 
neurofibromatosis and tuberous sclerosis, or exposure to radiation or cancer-causing 
chemicals. Although smoking, alcohol consumption and certain dietary habits are 
associated with some types of cancers, they have not been linked to primary brain and 
spinal cord tumours. Some of the possible causes under investigation include viruses, 
defective genes, xenobiotics and chemicals. Studies are now investigating whether or not 
there is a link between dietary factors and eNS tumours. 
Studying the epidemiology of eNS tumours will ensure elucidation of factors responsible 
for the formation of different tumours, and determination of whether certain tumours are 
more prevalent at certain ages or in certain people. This information may reveal 
environmental factors that are linked to tumours, connections between tumours and other 
disorders, or patterns of tumour occurrence. Analytical epidemiological studies have 
revealed an increased risk of human brain tumour development in association with certain 
occupations but, with the exception of therapeutic X-ray irradiation, attempts to identify a 
specific exposure or causative environmental agent have so far been unsuccessful. 
2.5 NEUROTOXICOLOGY 
The nervous system differs from most other body systems in the degree of selective 
vulnerability of its subdivisions. Neurotoxins act by affecting the basic components of the 
nervous system producing various clinical syndromes. Neurotoxins may be highly specific, 
affecting limited numbers of specialised neurons . While vulnerability to toxins can be 
highly specific, neurotoxins are rarely mono-specific. Differences in vulnerability are due 
to anatomical, physiological, and pharmacological and biochemical specializations of 
neurons, their processes and supporting structures. 
2.6 TYPES OF BRAIN TUMOURS 
2.6.1 Gliomas 
Within the brain, gliomas, tumours arising from glial cells, usually occur in the cerebral 
hemispheres but may also strike the optic nerve, the brain stem, and particularly among 
children, the cerebellum. Gliomas are classified into several groups. The types of graded 
astrocytomas include well differentiated, anaplastic and glioblastoma multiforme. 
Sometimes astrocytomas are graded on a scale of I to Ill; grade III being the most 
malignant. Gliobastoma multiforme (sometimes called high-grade or grade IV 
astrocytomas), grow rapidly, invade nearby tissue, and contain cells that are very 
malignant. Brain stem gliomas are tumours located in the bottom part of the brain that 
connects to the spinal cord (the brain stem). Mixed gliomas are brain tumours that occur in 
more than one type of brain cell, including cells of astrocytes, ependymal cells and 
oligodendrocytes. 
2.6.2 Ependymomas 
Ependymal tumours begin in the ependyma, the cells that line the passageways in the brain 
where CSF is made and stored. About 50% of them expand deep into the cerebellum or 
cerebrum, the rest are found in the spinal cord. Ependymomas usually affect children and 
develop from cells that line both the hollow cavities of the brain and the canal containing 
the spinal cord. 
2.6.3 Oligodendrogliomas 
Oligodendroglial tumours develop from oligodendroglia; cells that make myelin to insulate 
nerve fibres. Oligodendroglia also provide support and nourishment for the cells that 
transmit nerve impulses. Oligodendrogliomas usually develop slowly in the cerebrum, and 
occur most often within the brain's cerebral hemispheres in young adults. 
2.6.4 Ganglioneuromas 
Ganglioneuromas contain both glial cells and mature neurons . Mixed gliomas contain more 
than one type of glial cell, usually astrocytes and other glial cell types. Brain stem gliomas 
are named by their location at the base of the brain, rather than the cells they contain. Optic 
nerve gliomas are found on the optic nerve and are particularly common in individuals who 
have neurofibromatosis. 
2.6.5 Meningiomas 
Meningiomas are tumours that develop from the meninges (described in section 2.2.1). 
Meningiomas generally do not invade surrounding normal tissue and rarely spread to other 
parts of the CNS or body. Malignant meningioma is a rare tumour that grows more quickly 
than other meningiomas. Meningeal carcinomatosis strikes when individual cells from 
cancer outside the CNS enter the CSF. These cells travel with the CSF and can form 
colonies or small tumours in many places, including the roots of nerves, the surface of the 
brain, the brain stem, and the spinal cord. 
2.6.6 Pineal tumours 
Pineal parenchymal tumours and pineal region tumours are found in or around the brain 
(the pineal gland) . The tumours can be slow growing (pineocytomas) or fast growing 
(pineoblastomas). Astrocytomas may also start here . The three most common types of 
pineal region tumours are gliomas, germ cell tumours, and primitive neuroectodermal 
tumours (PNETs) . Primitive neuroectodermal tumours are usually very malignant, growing 
rapidly and spreading easily within the brain and spinal cord . In rare cases they spread 
outside the CNS. Primitive neuroectodermal tumours include neuroblastomas, 
pineoblastomas, medulloepitheliomas, ependymoblastomas, and polar spongioblastomas. 
2.6.7 Pituitary Adenomas 
The pituitary gland releases hormones that help control the body's other glands and 
influences growth, metabolism, and maturation. Pituitary adenomas are classified into two 
groups, secreting and non-secreting. Secreting tumours release unusually high levels of 
pituitary hormones triggering a constellation of symptoms, which can include impotence, 
amenorrhoea, abnormal body growth, Cushing's syndrome, or hyperthyroidism, depending 
on which hormone is involved. 
2.6.8 Medulloblastomas 
Medulloblastoma is a rapidly growing tumour that develops in the cerebellum. This type of 
cancer may spread from the brain to the spine. It accounts for about 20% of the brain 
tumours found in children less than 15 years, and may also develop in adults. Cells from 
this type of tumour can travel through the CSF to start new tumours in other parts of the 
brain and spinal cord . 
2.6.9 Choroid plexus tumours 
The choroid plexus is located in the spaces inside the brain ventricles and makes the fluid 
that fills the ventricles and surrounds the brain and spinal cord. Tumours of the choroid 
plexus can grow slowly (choroid plexus papilloma) or rapidly (anaplastic choroid plexus 
papilloma). The rapidly growing tumours are more likely to spread to other places in the 
brain and spinal cord. The choroid plexus tumour is a rare, benign tumour most common 
in children under the age of 12. Choroid plexus papillomas grow slowly and eventually 
block the flow of CSF. This causes hydrocephalus and increased intracranial pressure. 
Choroid plexus carcinoma is the rare inoperable or malignant form of this tumour. 
2.7 ENVIRONMENTAL TOXICOLOGY 
Various environmental toxicants are known to affect the CNS, and in order to facilitate 
development of methods of preventing intoxication and managing symptoms of poisoning, 
it is imperative to understand their mechanisms of action. These mechanisms can be 
discussed at the level of the action on organs and tissues, on cells and membranes, and at 
the molecular level. Documentation of pathways for metabolic activation and 
detoxification of carcinogens explain the specificity of carcinogen-macromolecule 
interactions, illuminate important genetic determinants of cancer risk, and lead to the 
development of methods to detect carcinogen-macromolecule adducts in human 
populations. Marked variability in animal species focus attention on the search for 
susceptibility determinants in human populations. These insights and methods help to 
explain organ specificity to certain carcinogens. 
2.8 HYPOTHESES AND THEORIES OF CANCER INDUCTION 
In the evaluation of human health risks, sound human data, whenever available, are 
preferred to animal data. Animal and in vitro studies however do provide support, and are 
used to supply evidence missing from human studies. When epidemiological studies 
indicate that environmental factors are major causes of human cancer, research expands 
into a more mechanistic era. Cancer research has played a critical supporting role in 
validating hypotheses developed from population studies. Experimental studies have been 
predictive of cancer risks. The modifying influence of nutrition on cancer induction and the 
identification of environmental contaminants that contribute to cancer incidences, are 
examples of hazards identified through model systems designed to study chemical 
carcinogenesis (Yuspa, 2000). 
Human cancers do not result from a single mutation, but develop through stages reflecting 
the accumulation of several genetic changes. Given the involvement of several rather than 
one genetic event in many, if not all cancers, epidemiologice efforts to identify human 
dietary carcinogens may succeed under the following limited circumstances: -
• there may be some cancers that require a single, rate-limiting event, or 
• the cancer may involve multiple events, but all (or most) can be elevated by a single 
aetiological agent to which the high incidence population is chronically exposed; or 
• the final progressive event (e.g., the p53 mutation) for a cancer can be traced to a recent 
carcInogen exposure, or 
• the high- and low-incidence populations must not be differentially exposed to an 
unknown and hence uncontrolled chemo-protective agent. 
When further considering the multi-step nature and mechanisms involved in cancer 
development, it becomes clear that genetic changes, cellular adaptive reactions and 
responses and/or dynamic interaction between cells and tissues are important factors that 
underline the entire system (Farber et aI., 1989; 1990). The latter considerations form part 
of the epigenetic way of cancer development, an aspect that is largely ignored when the 
mechanism of cancer induction by chemicals is considered. Furthermore, recent 
investigations indicate that an increasing number of non-genotoxic chemicals in the 
spectrum of chemical carcinogenesis remain an open one. In this context, it has to be 
realized that the chemical and/or biological basis of cancer induction, whether via 
genotoxic or non-genotoxic systems still remains unknown. 
2.9 MYCOTOXINS 
Mycotoxins are a diverse group of compounds produced by a taxonomically wide range of 
filamentous fungi that contaminate foods and feeds. On exposure to animals or man via 
inhalation, ingestion or skin contact; mycotoxins may initiate both acute (short-term) and 
chronic (medium/long-term) toxicities ranging from death to chronic interferences with the 
function of the CNS, cardiovascular and pulmonary systems, and the alimentary tract 
(Smith and Moss, 1985; Bennet, 1987). 
Mycotoxins are produced for a variety of reasons that include facilitating entry or attack of 
hosts by helping to dissolve cell membranes, or as protective measures against encroaching 
organisms. Structurally diverse, mycotoxins are capable of reacting with molecular 
receptors including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), functional 
proteins, enzyme co-factors and membrane constituents. Toxicological action depends on 
the nature of the mycotoxin, dose, entrance route, time of exposure, and species 
susceptibility (Pitt et aI., 2000). The relative significance of a molecular receptor of a 
mycotoxin is determined by its affinity to the active form of the toxin, its role in vital 
biochemical processes, the persistence of the lesion it bears, and the severity of the 
consequence of the lesion (Hsieh, 1987). 
When considering the above arguments concernmg the mechanisms of cancer 
developments, this review will focus on fumonisin related biological effects that could 
provide information on the possible mechanism involved in the toxic and carcinogenic 
effects of these apparently non-genotoxic compounds. 
2.10 Fusarium SPECIES OF FUNGI AND THEIR ASSOCIATED MYCOTOXINS 
Individual Fusarium species are known to produce several mycotoxins of which the 
fumonisins, ZEA, DON, FA, nivalenol, HT -2 toxin, and T2 are considered among the most 
important. In order to develop methods of preventing intoxication and managing symptoms 
of poisoning by Fusarium mycotoxins known to potentially or adversely affect the CNS; 
identification of, and understanding the general mechanisms whereby these toxicants exert 
their effects is essential. The International Agency for Research on Cancer (IARC) 
reviewed the toxicity of Fusarium moniliforme derived toxins, and classified FB I and 
fumonisin B2 (FB2) as "possible" human carcinogens (Group 2B) (lARC, 1993b). It was 
concluded that there was inadequate evidence in humans for carcinogenicity, whereas there 
was limited evidence (FBI) or inadequate evidence (FB2) for carcinogenicity in 
experimental animals. In addition, !ARC (1993b) found that FBI was neither mutagenic 
nor genotoxic. 
Studies available were considered largely inconclusive, and quantitative data enabling a 
risk assessment on human studies were unavailable. Numerous studies have focussed on 
aspects of the possible role of FBI in cancer. 
These studies include the mechanism of action of FB I in cultured human cells, in vivo 
rodent studies, and the tumorigenicity of FBI in rats and mice. To determine the overall 
human cancer risk from exposure to a particular mycotoxin, one needs to understand the 
exposure, bioavailability and mechanism(s) of action. This must occur prior to reviewing 
the carcinogenic potential of this compound in representative animal bioassays or cell 
culture models, and epidemiological studies that show the potential for implication of this 
mycotoxin in the aetiology of cancer. 
2.11 FUMONISINS 
2. 11. 1 Occurrence and production of fumonisins 
Fusarium moniliforme is a soil and seed-borne fungal pathogen of maize (Zea mays) 
(Figure 2.3) (Nelson et aI., 1991; Bacon et ai., 1992; Munkvold, 1996). 
Figure 2.3: Typical Fusarium ear rot (Munkvold, 1996). 
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Infection of the maize plant and kernel varies depending on the point(s) of entry by the 
fungus into the developing maize plant (Bacon and Nelson, 1994; Munkvold et aI., 1997). 
In addition, the extent of fumonisin contamination varies with geographical location, 
agricultural practices, and the maize genotype, which determines the susceptibility of the 
plants to fungal invasion. Fumonisin production is further influenced by temperature, 
humidity, drought stress, rainfall during the pre-harvest and harvesting periods, as well as 
by the storage of the maize kernels under improper moisture conditions 
(Bacon and Nelson, 1994). 
The fumonisins are a class of polar metabolites, originally isolated from Fusarium 
moniliforme [now known as F. verticil/ioides} (Bezuidenhout et aI., 1988) and later, from 
F. proliferatum, F nygamai, and F. napiforme. The worldwide occurrence of fumonisins in 
maize and maize-based products has been well documented and reviewed 
(Doko and Visconti, 1994; Pohland, 1994; Marasas, 1996; Bullerman, 1996; 
Shephard et al., 1996a; Patel et al., 1997; Castelo et al., 1998; de NUs, 1998; 
de Nijs et aI., 1998a; 1998b). Also reported are the sporadic natural occurrence of 
fumonisins in sorghum, rice and navy beans (Tseng et aI., 1995; Patel et aI., 1996; 
Munibazi and Bullerman, 1996; Bhat et aI., 1997). 
The polarity of the fumonisin molecule (Figure 2.4) determines its level of carcinogenicity 
(Gelderblom et aI., 1993), i.e., the more polar a molecule, the greater the cytotoxic 
response. In addition to polarity, the presence of a free amino group and the location of the 
hydroxyl group could also affect the biological activity of these compounds. Thus, both the 
amino group and the intact molecule play an important role in the toxic and cancer 
promoting activity of fumonisins. This would explain the associations of FBI with soluble 
and insoluble portions of cells (Cawood et aI., 1994). 
Feed-derived fumonisins are poorly absorbed by farm animals therefore fumonisin residues 
in milk (Scott et aI., 1994; Maragos and Richard, 1994; Becker et aI., 1995; Richard et al., 
1996), eggs (Vudathala et aI., 1994), and meat (Prelusky et al., 1994; Prelusky et aI., 1996; 
Smith and Thakur, 1996) are either undetectable or detected at extremely low levels. Due 
to the heat stability (Dupuy et aI., 1993; Howard et aI., 1998), light stability (I ARC , 
1993b), water solubility (United States National Toxicology Program, 1999), poor 
absorption and metabolism, as well as rapid excretion by animals, most fumonisin will 
eventually be recycled into the environment in a manner that will concentrate its spatial 
distribution. 
2.11.2 Structure, physical and chemical properties of fumonisins 
Fumonisin BI (FBI) has the empirical fonnula C34HS9NOJS and is the diester of propane-
1 ,2,3-tricarboxy lic acid and 2-amino-12, 16-dimethy 1-3,5,10,14, 15-pentahydroxyeicosane 
(relative molecular mass: 721) (Figure 2.4). It is the most prevalent of fumonisins, a family 
of toxins with at least 15 identified members. The pure substance is a white hygroscopic 
powder, which is soluble in water, acetonitrile-water or methanol, is stable in acetonitrile-
water (1 : 1), at food processing temperature and in light, but is unstable in methanol. The 15 
fumonisins reported have been grouped into four main categories (Plattner, 1995; 
Musser and Plattner, 1997; Abbas et at., 1998): 
• fumonisin Al (F AI), fumonisin A2 (F A2), fumonisin A3 (F A3), fumonisin AKI 
(FAKI); 
• FBI, FB2, fumonisin B3 (FB3), fumonisin B4 (FB4); 
• fumonisin CI (FC I), fumonisin C2 (FC2), fumonisin C3 (FC3), fumonisin C4 (FC4); 
and 
• fumonisin PI (FPJ), fumonisin P2 (FP2) and fumonisin P3 (FP3). 
Fumonisin B2, FB3 and FB4 differ from FBI in that they lack hydroxyl groups present in 
FBI; FAI, FA2 and FA3 are like FBI, FB2and FB3, but are N-acetylated; FAKI is like FAI 
but is IS-keto functionalised; the fumonisin 'C's are like the fumonisin 'B's but lack the 
methyl group adjacent to the amino group; and the fumonisin 'P's have a 
3-hydroxypyridium group instead of the amine group in the fumonisin 'B's 
(Gelderblom et aI., 1992; Plattner eta!., 1992; Branham and Plattner, 1993). 
Figure 2.4: 
CooH 
Fumoni in 51 
min p ntol P I) 
The Chemical structure of Fumonisin B\ and aminopentol (Merrill, 2002). 
The "B" series are believed to be the most abundant and toxic naturally occurring 
analogues (Sydenham et aI., 1992; Thiel et aI., 1992). Because of the four free carboxyl 
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groups and the amine group, the compounds are water soluble, but insoluble in non-polar 
organic solvents. Three dimensional minimum energy confonnation for FBI, FBz, FB3 and 
FB4 were calculated (Beier et al., 1995), and it was found that the amine and carboxylic 
acid groups are spatially related, suggesting that they have chelating properties, and hence, 
could cause membrane ion leakage (Abbas et at., 1992). 
2.11.3 Fumonisins and sphingolipids 
Fumonisins bear structural resemblance to Sa (Figure 2.5), an intermediate in the 
biosynthesis of complex sphingolipids (Sweeley, 1991; Bell et al., 1993). This structural 
similarity led to the hypotheses that the mechanism of action of these mycotoxins might be 
via disruption of sphingolipid metabolism; via interaction with enzyme(s) of sphingolipid 
metabolism, or a combination of both these factors (Merrill et al., 1996a; 1996b). The 
fumonisins have been shown to inhibit ceramide (CER) synthase, the key enzyme in 
sphingolipid biosynthesis. Since sphingolipids play critical roles in the regulation of cell 
growth, cell differentiation and transformation (Merrill, 1991), disruption of the 
metabolism of these bioactive molecules may be the mechanism for toxicity and 
carcinogenicity of these mycotoxins (Y 00 et at., 1992; Merrill et at., 1993a; 1993b; 1993c). 
The implication that several human and animal diseases arise from defects in sphingolipid 













Structure and occurrence of sphingolipids 
Sphingolipids are components of the plasma membrane of eukaryotic cells. These 
compounds are the most structurally diverse class of membrane lipids, being composed of 
over 70 long-chain (sphingoid) bases, dozens of amide-linked fatty acids, and more than 
300 head groups (Merrill and Sweeley, 1996). 
Sphingolipids are composed ofa long chain sphingoid base, an amide linked fatty acid and 
a polar head group at the I-position (Figure 2.5). Sphingolipids contain a CER backbone, 
which anchors them in the outer leaflet of the lipid bilayer. The CER backbone can be 
modified by attachment of phosphorylcholine to form sphingomyelin (SM), or by 
attachment of one or more sugar residues to form glycosphingolipids (GSLs). Except for 
CER, which has a hydroxyl at the I-position, and for SM, which has a phosphorylcholine 
head group; all other sphingolipids contain carbohydrate head groups and hence are 
designated GSLs (Rannun and Bell, 1989). 
The first classes of sphingolipids were named according to the tissue from which they were 
isolated (e.g., SM, cerebrosides, psychosine) (Figure 2.5) leaving the false impression that 
these compounds are unique to neuronal tissues. Sphingolipids are present in all eukaryotic 
cells where they primarily occur in cell membranes and related intracellular membranes, 
such as Golgi and lysosomal membranes, as well as in some prokaryotic organisms 
(Merrill et aI., 1997). In addition to biosynthesis, catabolism of sphingolipids also occurs. 
In the intestines, SM and other complex GSLs are digested, and the gut cells absorb CER 
and So. 
There have been a few analyses of the amounts and types of sphingolipids in foods 
(Ohnishi and Fujino, 1982; Blank et a/., 1992; Jensen and Newburg, 1995); and as a result 
relatively little is known about the role that these components of the diet may contribute to, 
or protect against disease. 
2.12.2 Fate and significance of sphingolipids 
Sphingolipids serve as structural molecules in membranes (Rannun and Bell, 1989; 
Rakomori, 1990; Merrill, 1991) and as regulators of cell growth, differentiation and 
neoplastic transformation through participation in cell-cell communication, cell receptors 
and signalling systems, and endothelial cell permeability (Merrill, 1991; 
Wang et aI., 1991). Ceramides derived from sphingolipid metabolism affect DNA 
synthesis. The role of CER as an intracellular second messenger for tumour necrosis 
factor -a (TNF-a), interleukin P (IL-P) and other cytokines; as well as So, So-I-phosphate 
among other sphingolipid metabolites, have been demonstrated to modulate cellular 
calcium homeostasis, cell cycle progression and apoptosis. Carcinogens and toxins may act 
via unscheduled initiation or inhibition of these pathways leading to disruption of 
metabolism of these molecules, and leading, ultimately, to the toxicity and carcinogenicity 
of these mycotoxins (Yoo et aI., 1992; Merrill et aI., 1993b). 
2.13 SPHINGOLIPIDS AND THEJR METABOLISM 
Sphingosine is a component of complex sphingolipids. The maintenance of a low 
concentration of free So and free Sa is important because these compounds have intrinsic 
biological activity (Hannun and Bell, 1989; Merrill and Stevens, 1989; Merrill, 1991; 
Riley et aI., 1994a). The regulated metabolism of complex sphingolipids result in the 
formation of lipid "second messengers" (honnones being the "first messengers") 
(Merrill and Jones, 1990; Ballou, 1992) that modulate cellular processes, including 
expression of genes and activation or inactivation of specific proteins (Ballou, 1992). 
The major toxic effects of fumonisins are based on their disruptive effects on sphingolipid 
biosynthesis and accumulation of sphingoid bases leading to cell membrane damage 
(Wang et aI. , 1996). Since long-chain sphingoid bases may be growth inhibitory, cytotoxic, 
induce apoptosis (Merrill, 1983; Stevens et aI., 1990; Nakamura et al., 1996; 
Sweeney et al., 1996; Yoo et aI., 1996) but can stimulate growth under certain conditions 
(Zhang et aI., 1990; 1991; Schroeder et aI., 1994); the accumulation of Sa and So might 
account for the aforementioned effects offumonisins. 
2.13.1 Biochemical pathways and compartmentalization of de novo sphingolipid 
biosynthesis 
Essential to the understanding of how disruption of sphingolipid metabolism contributes to 
the diseases associated with consumption of fumonisins, is the understanding of 
sphingolipid biosynthesis. Studies on the kinetics of de novo sphingolipid biosynthesis are 
usually conducted by following the incorporation of radiolabelled serine or fatty acids into 
long chain base components of complex sphingolipids such as SM and GSLs. The earliest 
effect of fumonisin on sphingolipid metabolism in vitro is the decrease in serine 
incorporation into CER (Figure 2.6), followed by an increase in free Sa concentration (Y 00 
et at., 1992). Large increases in free Sa concentration in cells are observed within a few 
hours after exposure to fumonisins. Some of the Sa is metabolised to other bioactive 
intermediates, and some released from cells. In animals, free Sa accumulates in tissues and 
appears in blood and urine, with a concentration dependent decrease in more complex 
sphingolipids (Y 00 et at., 1996). 
+ [. 
=~CIl:Oli 
J·K ( • 




phln .lui 1 
' IJ~ >. 
hin~.\nin 







H ( 'H: . 
H 
.,. H~ ( 
o 
- _II~I"­
/If II •• C11~""""''''l 
PIllI, .. j'lt:' ti/lll • 
\ I,\TI' ) 
II ) 
I'w/~" 




De novo biosynthetic pathway for sphingoid bases and complex sphingolipids. 
The colour coding distinguishes the biosynthetic enzymes (with common 
names in red and green arrows for the reactions catalysed) and intermediates 
in blue) from additional reactions that occur with these intermediates (in 
black) ( Merrill, 2002). 
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De novo biosynthesis ofGSLs is coupled to intracellular vesicular transport of the growing 
molecules through the cisternae of the Golgi apparatus and to the plasma membrane, 
Typically, de novo sphingolipid biosynthesis (Figure 2,6) proceeds via the following 
reactions (Merrill and Jones, 1990; Sweeley, 1991; Bell et aI., 1993): -
• The condensation of the amino acid L-serine with a fatty acyl-coenzyme A, usually 
palmitoyl-coenzyme A (palmitoyl-coA), to 3-ketoSa is catalysed by the enzyme serine 
palmitoyltransferase (SPT), a pyridoxyl 5' -phosphate-dependent enzyme, 
• In the following reduced nicotinamide adenine dinucleotide phosphate (NADPH)-
dependent reaction, 3-ketoSa is reduced to D-erythro-Sa by the enzyme 3-keto Sa 
reductase, 
• Sphinganine is acylated to dihydroceramide (N-acyl Sa) by the CER synthase using 
various fatty acyl CoAs, 
• Head-groups are subsequently added to the I-hydroxyl group. 
• The 4,5-trans-double bond of the So backbone is added after acylation of the amino 
group of Sa by the enzyme dihydroceramide desaturase (Merrill and Wang, 1986; 
Michel et aI., 1997). 
• Both dihydroceramide and dihydrosphingomyelin are substrates for the enzyme. Thus, 
free sphingosine is not an intermediate of de novo sphingolipid biosynthesis 
(Merrill, 1991; Rother et al., 1992). 
The endoplasmic reticulum (ER) (and possibly the Golgi, mitochondrial associated 
membranes, and the nuclear membrane) is the primary site of de novo synthesis of CER, 
and several lines of evidence point to roles for this CER in mediating apoptosis, At the 
organelle level in animal cells, the initial steps from the condensation of serine and 
palmitoyl-CoA, through to the formation of CER takes place in the ER (Figure 2,7), 
Subsequent biosynthesis of GSLs and SM takes place in the Golgi apparatus. Cerami de is 
processed in the Golgi apparatus, and complex sphingolipids are packaged, sorted and 
transported to aU cell membranes (Simons and van Meer, 1988; Schwarzmann and 
Sandhoff, 1990). The catabolism of complex sphingolipids occurs in the lysosomes, 
endosomes and the plasma membrane. 
Sphingolipid turnover involves the hydrolysis of complex sphingolipids to cerami des, then 
to So. Free So released as a consequence of either regulated turnover or catabolism is 
quickly reacylated to CER (Wilson et aI., 1988) or is phosphorylated in the cytosol 
and cleaved to a fatty aldehyde and ethanolamine phosphate In the ER 
(Van Veldhoven and Mannaerts, 1991), which is incorporated into 
phosphotidylethanolamine. The fatty aldehyde and ethanolamine phosphate can be 
redirected into the biosynthesis of glycerophospholipids and other fats with degradation of 
free sphingoid bases occurring in the cytosol. 
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Figure 2.7: Compartmentalization of ceramide metabolism and function. Shown are several 
distinct compartments of ceramide metabolism and function. Abbreviations in the 
figure are Cer, ceramide; DHS, dihydrosphingosine, Cath D, cathepsin D, Sph, 
sphingosine, Sph-K, sphingosine kinase, Alk, alkaline, PaICoA, palmitoyl-CoA, 
SR, sarcoplasmic reticulum; dhCer, dihydroceramide, CerS, ceramide synthase, 
de Sat, desaturase, PC, phosphotidylcholine, SMS, SM synthase 
(Hannun and Obeid, 2002). 
2.13.2 Functions of sphingolipids and their breakdown products in cellular 
regulation 
The maintenance of a low level of free sphingoid bases in tissues is important, as these 
compounds are biologically active and cytotoxic in high concentrations. Elevation of 
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intracellular free sphingoid bases disrupts the regulatory mechanisms within cells. 
Complex sphingolipids such as gangliosides, interact with growth factor receptors, the 
extracellular matrix, and neighbouring cells, whereas the backbones, So and other 
sphingoid bases, cerami des, and sphingosine-I-phosphate (So-I-phosphate); activate or 
inhibit protein kinases and phosphatases, ion transporters, and other regulatory machinery. 
Tumour necrosis factor a, ll..,-~ and nerve growth factor (NGF), for example, induce SM 
hydrolysis to CER. Other agonists, such as platelet-derived growth factor (PDGF), trigger 
further hydrolysis of CER to So, and activate So kinase to form So-I-phosphate. These 
metabolites either stimulate or inhibit growth, and may be cytotoxic in some cases via 
induction of apoptosis, depending on which products are formed or added exogenously, the 
cellular levels, intracellular localization, and the cell type. Ceramide and So-1 phosphate 
are second messengers with opposing roles in mammalian cell growth arrest and survival, 
their relative cellular level being proposed to be a rheostat that determines the fate of cells 
(Mandala et ai, 1998). Therefore, fumonisin disruption of sphingolipid metabolism and 
deregulation of lipid biosynthesis might impact many of these processes, and will likely 
have a variety of effects depending on cell type and other factors . 
2.14 THE SPHINGOMYELIN PATHWAY, APOPTOSIS AND CERAMIDE 
The SM pathway is a ubiquitous signalling system that links specific cell surface receptors 
and environmental stresses through to the nucleus (Hannun, 1994). Enzymes of CER 
metabolism show distinct subcellular localization. The plasma membrane (Figure 2.7) 
harbours a fraction of acid sphingomyelinase (SMase) and possibly a caveolar-associated 
neutral SMase (Andrieu-Abadie et ai, 2001), and generation of CER at the plasma 
membrane exerts distinct and specific functions, such as inhibition of protein kinase C 
(PKC) translocation, and aggregation of the Fas receptor (Hannun et ai, 2001; 
Paris et ai, 2001), but not other effects mediated by endogenous CER (apoptosis and cell 
cycle arrest (Hannun et aI., 2001). Activation of the apoptotic pathway by TNF-a, Fas and 
ionising radiation was mediated through the SM signal transduction pathway 
(Obeid et aI., 1993; Jarvis et aI., 1994; Cifone et aI., 1995) that is initiated by hydrolysis of 
SM by SMases to generate CER. The specificity of CER as a second messenger for 
apoptosis was demonstrated when cell permeable CER analogues were able to recapitulate 
the effects of TNF-a, Fas and ionising radiation and induce apoptosis directly 
(Obeidetal., 1993; Jarvisetal., 1994;Cifoneetal., 1995). 
2.14.1 Ceramide in Apoptosis 
Apoptosis is an inducible pre-programmed pathway of sequential biochemical events 
leading to activation of calcium and magnesium dependent endonucleases that cleave the 
nuclear chromatin at selective inter-nucleosomal linker sites (Wyllie, 1980; Vaux, 1993). 
Bose et al. (1995) demonstrated that CER synthase activity can be regulated in eukaryotes 
and constitutes definitive evidence for a requirement for CER elevation in the induction of 
apoptosis. Signals generated at the membrane of affected cells activate neighbouring intact 
cells and infiltrating macrophages to phagocytose dying cells and disintegrating nuclei 
(Duvall et al., 1985). 
The biosynthesis of sphingomyelin is approximately 10-fold more sensitive to inhibition by 
FB 1 than that of GSLs. This is also the case for other inhibitors of CER synthesis, such as 
13-fluoroalanine (Medlock and Merrill, 1988; Merrill et al., 1993b). Although excessive 
amounts of CER are often toxic and resul ts in apoptosis of many cell types 
(Jarvis and Grant, 1998), a basal level of this messenger is required for cell proliferation 
and differentiation. Decreasing the steady-state CER leads to growth arrest and loss of 
differentiation (Spiegel and Merrill, 1996; Merrill et al. , 1997). Therefore, a delicate 
balance in CER levels is needed for maintenance of proper cell function. 
2.14.2 Ceramide metabolism and disease 
Deregulation in intracellular CER levels also has been implicated in diabetes, Acquired 
Immune Deficiency Syndrome (AIDS) and autoimmunity (Mathias et al., 1998; 
Sandhoff et aI., 1998). Increasing evidence points to the roles of disruption of these 
pathways in disease pathogenesis. For example, the primary mutation responsible for 
hereditary neuropathy has been mapped to the LCB 1 subunit of SPT, and it has been 
suggested to induce apoptosis of susceptible sensory neurons (Bejaoui et aI., 2001; 
Dawkins et aI., 2001). Ceramide levels have been shown to be elevated in a number of 
neurodegenerative disorders such as Batten's disorder, and two of the genes responsible for 
subtypes of this disorder, CLN3 and protein palmitoyl thioesterase, have been shown to 
attenuate ceramide levels in response to apoptotic stimuli, suggesting a role for the CER 
pathway in mediating cell dysfunction and death in these disorders (Puranam et al., 1999; 
Cho et aI., 2000). 
The absence of CER in specialized areas of the brain like the nigro-striatal neurons is 
believed to result in the death of these neurons leading to Parkinson's disease 
(France-Lanord et aI., 1997; Hunot et al., 1997; Larocca et al., 1997). C2-ceramide has 
been shown to protect hippocampal neurons from death induced by amyloid b-peptide, 
suggesting that a basal level of CER is required for the delay of Alzheimer's disease 
(Goodman and Mattson, 1996; Mattson et aI., 1997). Increases in CER are therefore 
notably beneficial for delaying the onset ofneurodegenerative diseases. 
This increase in CER may be manipulated to assist in limiting uncontrolled cell growth. 
High amounts of CER usually lead to apoptosis, and this property can be used as a 
powerful weapon for killing tumour cells. Cerami de has potential for eliminating aberrant 
cells in circumstances when they are not desired. Given the pleotropic functions of CER in 
a plethora of signalling systems and its involvement in the aetiology of many diseases, it is 
possible that new approaches to treat diseases could be initiated by modulating CER levels, 
either through reduction in de novo CER synthesis or CER release through blockade of 
neutral SMase and acidic SMase activity (Spiegel and Merrill, 1996; Merrill et aI., 1997). 
2.14.3 Ceramide synthase and fumonisins 
All fumonisins of the "B" senes inhibit CER synthase at low or submicromolar 
concentrations (Wang et aI., 1991; Merrill et aI., 1993b; 1993c; 1996b). In assays ofFAl, 
less than 2% inhibition ofCER synthase at 10~M was found. Acetylation therefore appears 
to reduce the potency by more than 50 fold. Removal of the tricarballylic acid (TCA) side 
chains (Figure 2.4) reduces the potency in vitro by approximately ten fold 
(Merrill et aI., 1993c). 
In order to determine whether fumonisins inhibit other enzymes aside from CER synthase, 
that interact with either long chain bases or fatty acyl-CoA's, FBI was tested with So 
kinase (the enzyme initiating sphingoid base disposal) and SPI (the regulatory enzyme for 
sphingoid base synthesis) (Wang et aI., 1991). Neither enzyme was inhibited by the levels 
of fumonisins that result In complete inhibition of CER synthase 
(Merrill et aI., 1993b; 1996b). 
Norred et at. (1997) assessed the relative potency of analogues of FBI to inhibit CER 
synthase. Fumonisin B I, FB2, FB3, FB4, FC4 , and TA toxin (a structurally similar 
mycotoxin produced by the tomato pathogen, Alternaria alternata f sp. lycopersici) were 
approximately equipotent inhibitors. Hydrolysed FBI, FB2 and FB3 were only 30-40% as 
potent as the parent toxins . Fumonisin Al did not block CER synthase, suggesting that F Al 
is non-toxic. Inhibition of CER synthase by fumonisin analogues did not appear to be 
related to the Jipophilicity of the compounds. The ability of relatively high doses of other 
mycotoxins that bear no structural similarity to fumonisins, including aflatoxin B I, 
cyclopiazonic acid, beauvericin, T2, sterigmatocystin, luteoskyrin, verrucarin A, 
scirpentriol, and ZEA to block CER synthase was also determined . All of the toxins tested 
were negative in the bioassay with the exception of fumonisins, indicating that disruption 
of sphingolipid metabolism is a specific cytotoxic response (Norred et at., 1997). 
Fumonisin BI inhibits CER synthase with either Sa or So as the substrate, and with a 
variety of fatty acyl-coenzyme As as the co-substrate (Wang et aI., 1991; 
Merrill et aI., 1993b; 1993c). The inhibition is competitive with both sphingoid bases and 
fatty acyl-CoA (Merrill et aI., 1993c) which indicates that fumonisin may inhibit CER 
synthase by interacting with both the binding site for Sa or So, and the site for the fatty 
acyl-CoAs (Merrill et aI., 1996b). Ceramides also affect DNA synthesis . The inhibition of 
CER synthase by fumonisins causes Sa to accumulate, and at least a portion of Sa 
undergoes phosphorylation and cleavage (Merrill et aI., 1993c). 
2.15 FUMONISIN INDUCED DISRUPTION OF SPHINGOLIPID METABOLISM 
The term "fumonisin-induced disruption of sphingolipid metabolism" includes the 
inhibition of So and CER biosynthesis, depletion of more complex sphingolipids, increase 
in free Sa, decrease in reacylation of So derived from complex sphingolipid turnover and 
degradation of dietary sphingolipids, increase in sphingoid base degradation products (i .e., 
So-I-phosphate, Sa-I-phosphate, ethanolamine phosphate and fatty aldehydes), and 
increase in lipid products derived from the increase in the sphingoid base degradation 
products (Merrill et at., 1996b). 
2.15.1 Fumonisin-induced disruption of sphingolipid metabolism in cell systems 
To fully understand the ways that disruption of sphingolipid metabolism could account for 
the cell damage caused by fumonisins, it is necessary to consider: -
• the multitude of functions of complex sphingolipids (Bell et aI., 1993), 
• the potent bioactivity of Sa and its metabolites (Merrill et al.,1993a), and 
• the parallel or branch metabolic pathways that can be affected by disruption of 
sphingolipid metabolism (Riley et aI., 1996; Merrill et aI., 1997). 
Sphingolipids have been associated with many facets of cellular regulation 
(Merrill et aI., 1993a; Bell et al., 1993; Ballou et aI., 1996; Merrill et aI., 1997; 
Kolesnick and Krenke, 1998; Perry and Hannun, 1998). Such associations could contribute 
to or modify the expression of fumonisin-associated diseases. Based on existing knowledge 
about some of the systems regulated by sphingolipids, mechanisms can be proposed 
whereby disruption of sphingolipid metabolism by fumonisins could account for the 
toxicity and carcinogenicity of these mycotoxins (Bose et aI., 1995; Strum et aI., 1995; 
Witty et aI., 1996; Suzuki et aI., 1997). 
Ceramide signalling is mediated by SM hydrolysis via enzymes that are not inhibited by 
fumonisin (Perry and Hannun, 1998). When fumonisins are added to cells for the purpose ' 
of inhibiting de novo CER generation, there is potential for accumulation of free sphingoid 
bases and their downstream sphingoid base-I-phosphates. Considerable data supports the 
hypothesis that fumonisin-induced disruption of sphingolipid metabolism is an important 
event in the cascade of events leading to cellular deregulation (Table 2.1). Several 
biochemical modes of action have been proposed to explain all, or some, of the fumonisin-
induced animal diseases. Some invoke disruption of sphingolipid metabolism as the initial 
site of action, and there are also studies that hypothesize fumonisin-induced changes in key 
enzymes involved in cell cycle regulation, differentiation and/or apoptosis as initial or 
secondary sites of action (Merrill et al., 1995; 1996b; Riley et aI., 1996; Norred et aI., 1996; 
Merrill et aI., 1997; Norred et aI., 1998; Wang et aI., 1999). Fumonisins may effect/affect 
carcinogenesis by altering sphingolipid metabolism. Cellular regulatory processes 
modulated by sphingolipids are known to be important in the control of normal cell 
growth, differentiation, apoptosis and immune response (Table 2.1). Fumonisins impact 
many of these processes and have a variety of effects depending on cell type and other 
factors. 
The two most likely explanations for the increased cell death after inhibition of 
sphingolipid biosynthesis by fumonisins are that the accumulation free Sa (or a Sa 
degradation product) are growth inhibitory and cytotoxic for the cells (Stevens et aI., 1990; 
Hannun et ai., 1991; Sweeney et aI., 1996), that complex sphingolipids are required for cell 
survival and growth, and loss of complex sphingolipid biosynthesis would be expected to 
alter cell behaviour, and lead to cell death. These hypotheses are based on findings with 
mutants of SPT, the initial enzyme of sphingolipid biosynthesis (Hanada et al., 1990; 1992; 
Riley et al., 1999) and in studies with specific inhibitors of GSL biosynthesis (Radin, 1994; 
Nakamura et al., 1996) . 
Table 2.1: Mechanisms for cell behaviour changes, growth inhibition and 
cytotoxicity induced by fumonisin via disruption of sphingolipid 
metabolism. 
Repression of expression of PKC, stimulation of a cyelic adenosine Huang et al., 1995 
monophosphate (AMP) response element in CV-I African green monkey 
kidney cells (l-10flM FBI, 3 to 16 hours) 
Decreased phorbol dibutyrate binding, increased cytosolic PKC activity, with Smith eta!., 1997 
both exogenous Sa and FBI to J774A1 cells 
Inhibition ofphorbol dibutyrate binding in short-term incubations using crude Yeung et al., 1996 
cerebrocortical membrane preparation and both FBI and exogenous So 
Activation of the mitogen-activated protein kinase (MAPK) in Swiss 3T3 Wattenberg et a!., 1996 
cells with FB I 
Over-expression of nuelear cyclin D 1 and increased cyelin-dependent kinase Ramljak et al., 2000 
(CDK) 4 activity in rat livers obtained from a long-term feeding study and a 
21-day feeding study with FB I 
Dephosphorylation of the retinoblastoma protein, repression of CDK 2, and Ciacci-Zanella et al., 
induction of two CDK inhibitors in CV-1 cells with FBI 1998 
Apoptosis inhibitor and protease inhibitor protection of CV-1 cells and Ciacci-Zanella and Jones, 
primary human cells from FBI-induced apoptosis 1999 
Increased TNF secretion in lipopolysaccharide-activated intra-peritoneal Dugyala et a!., 1998 
macrophages from FBI-treated mice 
Glutathione depletion and lipid peroxidation in cultured cells Kang and Alexander, 
1996; Lim et al., 1996; 
Abado-Becognee et a!., 
1998; Abel and 
Gelderblom, 1998; Sahu 
et al., 1998; Yin et al., 
1998 
2. 15.2 Mutagenicity of fumonisin Bl and related end-points 
Fumonisin B 1, FB2 and FB3 were shown to be non-mutagenic in the Salmonella assay 
against the tester strains TA 97a, TA 98, TA 100 and TA 102, either in presence or absence 
I 
of the S9 microsomal preparation at a range of concentrations from 0 to 10 mg/plate 
(Gelderblom and Snyman, 1991). The non-mutagenicity of FB J to Salmonella tester strain 
TAIOO at concentrations up to 100mg per plate was supported by Park et at. (1992). 
Similar negative results were reported in gene mutation assays with FB J in Salmonella 
T A98 and TAl 00, as well as in SOS chromotest in Escherichia coli strain PQ37 (5, 16, 50, 
166, 500~g/assay) in the presence and absence of metabolic activation, and differential 
DNA repair assays with E. coli K12 strains (343/753 , uvrB/recA and 343/765, uvr+ rec+) 
(Knasmuller et at., 1997). 
In contrast, Sun and Stahr (1993), using a commercial bioluminescent bacterial (Vibrio 
fischeri) genotoxicity test, claimed that FBI showed genotoxic activity without the 
metabolic activation of S9 fraction at a range of 5-20 ~g/m1. Fumonisin BJ and FB2 were 
non-genotoxic in an in vitro rat hepatocyte DNA repair assay at concentrations of 0.04-
80~Mlplate (and FB2 at 0 . 04-40~MI plate), as well as in vivo at 100 mg.kg- J of FBI or FB2 
(Gelderblom et al., 1989; 1992). The finding that FBI does not induce unscheduled DNA 
synthesis was confirmed in an in vitro assay in primary hepatocytes at concentrations from 
0 . 5-200~M (Norred et at., 1990; 1992a; 1992b). 
Gelderblom et al. (1988a; 1988b) found that fumonisins are complete carcinogens capable 
of inducing gamma-glutamyl-transpeptidase positive (GGTP) foci in the livers of both non-
initiated and diethylnitrosamine (DEN) initiated rats. At low doses in rats, fumonisins 
appear to act primarily as tumour promoters (Gelderblom et at. , 1995a) and induce 
increased apoptosis (Tolleson et al., 1996a). Single gavage doses of 50, 100 and 200 mg 
FBl/kg body weight significantly (p=0.05) inhibited hepatocyte proliferation in partially 
hepatectomized male Fischer rats (Gelderblom et al. , 1995a). Inhibition of hepatocyte 
proliferation was also observed after dietary exposure to FBI (>50mg/kg diet) 
(Gelderblom et at. , 1996a). However, when evaluating the genotoxicity of several toxins to 
rat, FBI also inhibited DNA synthesis induced by epidermal growth factor (EGF) in 
primary rat hepatocytes (Gelderblom et at. , 1995a; 1995b). 
Norred et at. (1992a) found FBI at 0.5-250 ~M, to have no effect on unscheduled DNA 
synthesis. Sheu et at. (1996) on the basis of results in studies of FB I (1 0-1 OOO~g/ml) in 
BALB/3 T3 A31-1-1 mouse embryo cells concluded that FB I lacks in vitro transforming 
activity. In these cells, FBI treatment produced transforming activity at 500 jlglml, but not 
at lower or higher concentrations. 
Intraperitoneal injection of FBI induced an increased frequency of micronuclei in mouse 
bone marrow polychromatic erythrocytes at 25 and 100 mg.kg-I (Aranda et aI., 2000) . 
Micronuclei form when chromosomal fragments behave independently of remaining 
chromosomes during the division of cells damaged by genotoxic agents, and the frequency 
of micronuclei is considered to reflect genotoxic damage to cells. It was concluded that 
FB I induces in vivo genotoxicity in the absence of in vitro mutagenicity in Salmonella 
(Aranda et aI., 2000). Sahu et al. (1998) showed that FBI induced DNA strand breaks in 
isolated rat liver nuclei. 
On the basis of negative genotoxicity data from experiments covering several endpoints 
using the Ames test and in vitro and in vivo assays (Gelderblom et al., 1989; 1992; 1995a; 
Norred et al., 1990; 1992a; Gelderblom and Snyman, 1991; Park et al. ,1992) and positive 
results in a non-validated type of bacteria test (Sun and Stahr, 1993), the overall conclusion 
is that there is inadequate evidence that FBI is genotoxic. 
More recently however, Bever et al. (2000) reported that the incubation of methanolic 
extracts of Fusarium cultures with DNA in the presence of rat liver S9 proteins resulted in 
the formation of DN A adducts. The chromatographic characteristics of these unidentified 
DNA adducts suggest they are hydrophobic. Therefore, the possibility exists that 
compounds present in Fusarium fungi might alkylate DNA and participate in the induction 
of Fusarium induced tumours (Bever et aI., 2000; Howard et aI., 2001). 
2.15.3 Lipid peroxidation 
Lipid peroxidation normally occurs at low levels in all cells and tissues, whereby free 
oxygen radicals attack the double bonds of polyunsaturated fatty acid side chains in 
phospholipid membranes. These fatty acids are then converted to lipid peroxides. Lipid 
peroxides and oxygen free radicals stimulate peroxidation reactions that are toxic to cells 
and membranes (Walsh, 1994). Some of their effects include endothelial cell injury and 
dysfunction, increased uptake of low-density lipoproteins into vessel walls 
(Hennig et aI., 1984), alterations in membrane fluidity (Halliwell and Gutteridge, 1990), 
altered membrane permeability to ions and proteins, stimulation of mitogens and growth 
factors, modification and destruction of proteins (Rice-Evans and Burbon, 1993), 
decreased protein synthesis (Machlin and Bendich, 1987), DNA strand breakage 
(Floyd, 1990) and inactivation of enzymes, increased production of toxic aldehydes, 
increased intracellular calcium leading to activation of calcium dependent enzymes, such 
as proteases and phospholipases (Walsh, 1994). 
The effects of FB I on lipid peroxidation were studied in Vero monkey kidney cells. 
Fumonisin BI was found to be a potent inducer of malondialdehyde, a secondary product 
formed during lipid peroxidation (Abado-Becognee et aI., 1998). Fumonisin BI also 
induced lipid peroxidation and DNA strand breaks in isolated rat liver nuclei at 
concentrations ranging from 40 to 300 ~M (Sahu et aI., 1998). Fumonisin treatment has 
also been shown to increase the extent of lipid peroxidation in Fischer-344 rat primary 
hepatocytes, and in liver in vivo in a concentration and dose-dependent manner 
(Abel and Gelderblom, 1998). 
2.15.4 Endothelial cell damage 
Healthy endothelial cells maintain vascular integrity, prevent adhesion and influence the 
tone of underlying vascular smooth muscle (Flavahan and Vanhoutte, 1995). This interface 
between intra and extra-vascular compartments simultaneously allows transport of 
nutrients, waste products, regulatory molecules, and phagocytic cells across basement 
membranes (Jaffe, 1987). Damaged endothelial cells are unable to function, leading to 
increased capillary permeability, platelet thrombosis and increased vascular tone 
(Flavahan and Vanhoutte, 1995). Increased permeability of endothelial cell membranes in 
the systemic circulation to proteins could explain oedema. 
Ramasamy et al. (1995) established that FBI alters sphingolipid metabolism in endothelial 
cells from porcine pulmonary arteries, and that FBI and D-erythro Sa interfere with their 
permeability barrier function. Ramasamy et al. (1995) showed that FBI increased the rate 
of albumin transfer across endothelial cell monolayers derived from pulmonary artery, and 
elevated Sa levels, the latter possibly explaining the loss of endothelial barrier function. By 
24 hours, incubation of endothelial cells with 50~M FBI resulted in the Sa:So ratio, which 
is a frequently used indicator of exposure to this mycotoxin, increasing significantly from 
approximately 0.19 to 6.8 (Ramasamy et aI., 1995).The blockage of de novo sphingolipid 
synthesis might therefore have weakened intercellular interactions, making the barrier 
"leaky". In addition, complex sphingolipids, as well as So and Sa, affect numerous signal 
transduction pathways, some of which have been implicated in the control of endothelial 
permeability (Hoek, 1992). Identification of the process/es that are affected could be 
complex, because there is evidence for both transcellular and paracellular pathways for 
macromolecule transport. 
A simple explanation for the reduction in the permeability barrier may be that the FBI 
(and/or the Sa that accumulates) killed a substantial portion of the cells. Yoo et al. (1992) 
showed that in the LLC-PKI pig renal epithelial cell line, there was a close association 
between the inhibition of sphingolipid biosynthesis by FBI and growth inhibition and 
toxicity. However, Ramasamy et al. (1995) found no evidence of cytotoxicity based on 
using trypan blue exclusion and morphology in the porcine pulrnonary artery endothelial 
cells at any of the concentrations of FBI tested. Therefore, cytotoxicity does not appear to 
account for the increase in albumin transfer in this cell model. Studies with fatty acids 
(Hennig et aI., 1984; Ramasamy et al., 1991) also showed increased albumin transfer 
without significant loss of cell viability (Ramasamy et aI., 1995). 
Accumulation of Sa may playa role in the disruption of barrier function by FBI, but this is 
unlikely to account for all of the effects of this mycotoxin. The concentrations of FBI that 
affected the endothelial cells were similar to the amounts toxic to the pig renal epithelial 
line LLC-PK\ (Yoo et al., 1992), and that were mitogenic for Swiss 3T3 cells 
(Schroeder et aI., 1994). They are much lower than the concentration that was toxic for 
cultured hepatocytes (>1 OOJ.lM) (Gelderblom et at., 1995b). Since fumonisins are 
nephrotoxic and hepatotoxic in vivo (Riley et al., 1994b), this implies that vascular 
endothelium may be as sensitive as these known target organs. Effects offumonisin (and/or 
Sa) on endothelial cells (Ramasamy et aI., 1995), might contribute to the pathogenesis of 
diseases caused by these mycotoxins. A disrupted or damaged endothelium will allow 
increased penetration of plasma components into underlying tissues. Based on these 
findings regarding the ability of FBI to affect the endothelial cells in culture, the possibility 
exists that this mycotoxin may affect vascular function in vivo. 
2.15.5 The role of fumonisins in mitogenesis 
At low doses, fumonisins appear to be mainly tumour promoters (Gelderblom et aI., 
1988a). Tumour promoters are often mitogens, which is intriguing since Spiegel et al. 
(1993) have shown that So and So I-phosphate can induce DNA synthesis in growth 
arrested Swiss 3T3 cells (Zhang et aI., 1990; Zhang et aI., 1991). The amount of free Sa 
that accumulates in cells is a function of the extent of inhibition of CER synthase, 
concentration of essential precursors (serine, palmitoyl-CoA), and growth rate of cells, the 
rate of Sa degradation, and the rate of elimination from cells. 
Using Swiss 3T3 cells, Schroeder et al. (1994) demonstrated that addition of FBI to cells 
elevated Sa and induced an increase in eH] thymidine incorporation into DNA. 
Furthermore, fumonisin-induced accumulation of free Sa was blocked by addition of an 
inhibitor of SPT, 0-fluoroalanine, which blocks the initial step of sphingolipid 
biosynthesis. 0-fluoroalanine which reduces the fumonisin induced accumulation of free 
Sa, but not the inhibition of complex sphingolipid biosynthesis, prevented the 
fumonisin-induced stimulation of DNA synthesis, but had no effect on mitogenesis when 
added alone. This indicates that FB 1 did not cause accumulation of Sa I-phosphate, and 
that sphingoid bases per se can stimulate DNA synthesis. Schroeder et al. (1994) suggest 
that disruption of sphingolipid metabolism by fumonisins might cause cancer due to the 
mitogenic potential of these compounds, and hypothesised that fumonisin might induce 
DNA synthesis via the accumulation of Sa. 
2.16 MOLECULAR MECHANISM OF ACTION OF FUMONISINS, SIGNAL 
TRANSDUCTION PATHWAYS, SPHINGOLIPIDS AND FUMONISIN Bl 
Fumonisins cause compositional or oxidative damage to cellular lipids, which in turn cause 
molecular events culminating in oxidative damage to DNA and other critical 
macromolecules (Gelderblom et aI., 1996b; 1997; Abado-Becognee et aI., 1998; Abel and 
Gelderblom, 1998; Sahu et aI., 1998; Yin et aI., 1998). Wang et al. (1991) discovered that 
fumonisins inhibit CER synthase leading to disruption of de novo sphingolipid 
biosynthesis. The immediate consequences are accumulation of Sa and So, an increase in 
the Sa:So ratio, and depletion of complex sphingolipids. Recognizing the importance of 
sphingolipids in cell regulatory processes, including those related to proliferation and 
apoptosis, investigators proposed that the critical mechanistic step in fumonisin toxicity 
was inhibition of CER synthase, starting a cascade of molecular events leading to 
cytotoxicity or neoplasia (Merrill, 1991; Riley et aI. , 1994a; Hannun and Obeid, 1995; 
Merrill et aI., 1997),. 
Different hypotheses on the ability of FBI to alter signal transduction pathways and its 
potential role in carcinogenesis exist. Protein kinase C is a pivotal enzyme in cell 
regulation and signal transduction. Sphingosine is a potent and reversible inhibitor ofPKC. 
Based on the ability of free sphingoid bases to inhibit PKC, it is possible that fumonisin 
repression of PKC activity is secondary to fumonisin-disruption of sphingolipid 
metabolism. Huang et al. (1995) treated green monkey kidney cells with FB I and found 
that fumonisin represses expression ofPKC and AP-1 dependent transcription. In contrast, 
fumonisin stimulated a simple promoter containing a single cyclic AMP response element. 
Since fumonisin did not alter protein kinase A (PKA) activity, it appears that cyclic AMP 
response element activation was independent of PKA. Huang et al. (1995) concluded that 
altered signal transduction pathways played a role in the carcinogenesis of fumonisins. 
Similar results were found for baby hamster kidney cells treated with FBJ 
(Abeywickrama and Bean, 1992). 
The activation of MAPK results in the modulation of transcription and activation of 
enzymes involved in signal transduction such as cytoplasmic phospholipase A2 (cPLA2), 
which releases arachidonic acid (AA) from membrane phopholipids. Arachidonic acid is 
the precursor of prostaglandins and leukotrienes, two inflammatory mediators that regulate 
gene expression and protein kinase activity among other effects. Fumonisin B I increases 
PKC translocation and stimulates MAPK. Pinelli et al. (1999) in an investigation on effects 
of FBI on the AA cascade in the W126 VA human bronchial epithelial cell line, found that 
FBI stimulated cPLA2 activity and increased AA release by a mechanism independent of 
PKC activation. The activation of cPLA2 was found to be a two-step process: the first 
being its phosphorylation by MAPK, and the second was a consequence of the increase in 
So inside and outside the cells after two hours, which is known to induce a rise in 
intracellular free calcium. Overall, this suggests that the effect of FBI on cells is partially 
dependent on the action of FBI on the enzymes involved in the cell cycle, such as MAPK 
and PKA, and on bioactive fatty acids, such as the prostaglandins and leukotrienes, and on 
disruption of sphingolipid metabolism (Pinelli et at., 1999). 
In a study by Ramljak et al. (2000), which suggested the mechanism by which FBI acts as 
a carcinogen, the over-expression of cyclin Dl protein was shown in both pre-neoplastic 
and neoplastic liver specimens obtained from a long-term feeding study of FBI in rats. In 
rats fed FBI short-term, cyclin Dl protein levels in liver were increased up to five-fold in a 
dose-responsive manner. Northern blot analysis demonstrated no increase in messenger 
ribonucleic acid (mRNA) levels of cyclin Dl. Two-dimensional electrophoresis of cyclin 
D 1 protein in FB I-treated samples showed a distinct pattern of migration (presence of less 
negatively charged form of the protein) that differed from controls. Recently, it has been 
shown that phosphorylation of cyclin D1 by glycogen synthase kinase 3 ~ (GSK-3~) on a 
single threonine residue (Thr-286) positively regulates proteosomal degradation of cyclin 
D 1. In FB dreated samples, GSK-3 ~ phosphorylated on serine 9 was detected. Activated 
protein kinase B (aPKB) appeared to be responsible for this inhibitory phosphorylation. 
These findings suggest that over-expression of cyclin D 1 results from stabilization due to a 
lack of phosphorylation mediated by GSK-3~. An increase in CDK4 complexes with 
cyclin D 1 in FB I-treated samples was also observed. This study showed that the activation 
of aPKB leads to increased survival, inhibition of GSK-3~ activity and post-translational 
stabilization of cyclin D1, all events responsible for disruption of the cell cycle GIIS 
restriction point in hepatocytes (Ramljak et aI., 2000). 
2.17 APOPTOSIS BY FUMONISlNS 
2.17.1 In vivo studies with rodents 
Fumonisin BI administered to different animal species increased apoptosis in vanous 
tissues (Lim et aI., 1996; Tolleson et aI., 1996a; Voss et aI., 1996a; Sharma et aI., 1997; 
Bucci et aI., 1998; Haschek-Hock et aZ.; 1998; Ciacci-Zanella and Jones, 1999; 
Lemmer et aI., 1999; United States National Toxicology Program, 1999). Increased 
apoptosis seems to playa role in toxic effects including tumour induction by FBI. In most 
studies, apoptosis is one of the observations on which the no-observed-adverse-effect level 
(NOAEL) is based. The dose level causing apoptosis depends on the duration of exposure, 
and can vary in rodents from 0.9 to 12mg FBdkg body weight (respectively in long-term 
and short-term experiments). Oxidative damage has also been indicated in the aetiology of 
toxic effects (Abel and Gelderblom, 1998). 
Studies with rats have shown fumonisin-induced apoptosis in both liver and kidney. Male 
and female F344 rats were fed FBI (99, 163, 234, and 484 parts per million (ppm)) for 28 
days and the organs examined histologically. Apoptosis was seen in hepatocytes at the 
lowest dose level, and the prevalence and severity increased with increasing dose. There 
was a dose dependent decrease in liver and kidney weights in the rats. The liver weight loss 
was accompanied by the induction of apoptosis and hepatocellular and bile duct 
hyperplasia in both sexes, with the female rats being more responsive at lower doses. The 
induction of tubular epithelial cell apoptosis was the primary response of the kidneys to 
dietary FB I. Apoptosis was present at all doses in the kidneys of male rats, and occurred in 
females only at 163, 234 and 484ppm FBI (Tolleson et aI. , 1996a). 
In a study on Fischer rats and B6C3F1 mice, FBI caused renal carcinomas in male rats and 
liver cancer in female mice. In male BD-IX rats, FBI caused hepatic toxicity and 
hepatocellular carcinomas. An early effect of FB I exposure in these target organs was 
apoptosis. However, there was also some evidence of oncotic necrosis following FBI 
administration, especially in the liver. Induction of apoptosis may be a consequence of 
CER synthase inhibition and disruption of sphingolipid metabolism by FBI . 
Dragan et al. (2001) hypothesise that FB I may be the first example of an apparently 
non-genotoxic agent producing tumours through a mode of action involving apoptotic 
necrosis, atrophy, and consequent regeneration. 
Sharma et al. (1997) administered subcutaneous injections (0 to 6.25 mg.kg-I) of FBI daily 
for five days to male BALB/c mice. Their liver and kidneys were sampled one day after the 
last injection, and a decrease in kidney weight was observed . An evaluation of stained 
sections revealed dose-dependent FBI-associated hepatic and renal lesions in all groups. 
Terminal uridine triphosphate (DTP) nick-end labelling (TUNEL) in liver and kidney 
sections confirmed the presence of dose-related apoptotic cells, at all treatment levels. 
Thus, FBI produced apoptosis after a brief exposure to relatively low doses. The toxicity of 
FBI was greater than previously found in studies on oral toxicity (Sharma et aI., 1997) . 
2.17.2 Apoptosis in in vitro models 
Increased apoptosis has been reported following in vitro exposure to FBI in turkey 
lymphocytes (Dombrink-Kurtzman et al., 1994), human keratinocytes, fibroblasts, 
A 
oesophageal cells and hepatoma cells (Tolleson et al., 1996b), and CV -1 monkey kidney 
cells (Wang et aI. , 1996). Tolleson et al. (1996b) found that FBI inhibited incorporation of 
eH] thymidine by cultured neonatal human keratinocytes and HepG2 human 
hepatocarcinoma cells at 10-7 and 1O-4M, respectively. Fumonisin BI also inhibited clonal 
expansion of normal human keratinocytes and HET -1 A human oesophageal epithelial cells 
at 10-5M and growth in mass culture of normal human fibroblasts at 10-7M . The 
clonogenicity of normal human keratinocytes decreased to 45 .5% of controls after 
exposure to 1 O-~ FB I for two days. However, no differences in the cell cycle distribution 
of cultured keratinocytes were noted after exposure to 1O-5M FBI for 40 hours. The 
viability of normal human keratinocytes and HET -1 A cells decreased as a result of FBI 
treatment, as determined by a fluorescein diacetate and propidium iodide (PI) flow 
cytometric cell viability assay. Fumonisin BI treated keratinocytes released nucleosomal 
DNA fragments into the medium 2-3 days after exposure to 1O-4M FBI and more DNA 
strand breaks were detected in attached keratinocytes exposed to 0-10-4M FB I using a 
terminal deoxynucleotidyl transferase-based immunochemical assay system. Furthermore, 
FB I-treated keratinocytes and HET -1 A cells developed morphological features consistent 
with apoptosis, shown by phase contrast microscopy, fluorescent microscopy of acridine 
orange (AcO) stained cells, and electron microscopy (EM) (Tolleson et aI., 1996b). 
Tolleson et at. (1999) further examined the role of sphingolipid changes in FBI-stimulated 
apoptosis. Sphinganine accumulated rapidly, So levels remained unchanged, and CER 
decreased during FB I exposure. Increased DNA fragmentation, decreased viability, and 
apoptotic morphology were observed in cells exposed to FBI, Sa or N-acetyl So. 
Co-exposure to N-acetyl So or ~-chloroalanine, which blocks Sa accumulation, partially 
protected cells from FB I-induced apoptosis . These results illustrate three sphingolipid-
dependent mechanisms for inducing apoptosis; accumulation of excess CER, accumulation 
of excess Sa, and depletion of CER or complex sphingolipids derived from CER. 
Incubation of human colonic HT29 cells, with FBI or the aminopentol (API) caused a 
significant reduction in cell number. The API was less potent with 50).lM API causing the 
same reduction in cell number (-30% after 24 hr) as 10).lM FBI. The reduction in cell 
number reflected increases in DNA fragmentation, and the percentage of apoptotic cells. 
Both FBI and API caused the accumulation of Sa (25 and 35-fold by 10).lM FBI and 50).lM 
API, respectively); thus, concentrations of FBI and API that caused comparable reductions 
in cell number were also similar with respect to elevation of Sa, which is growth inhibitory 
and cytotoxic. Inhibition of the first step of sphingolipid biosynthesis with myriocin 
(ISP-l) prevented the elevation in Sa, DNA fragmentation, and apoptosis induced by FBI. 
Therefore, these effects of FBI on HT29 cells can be attributed to the accumulation of Sa 
(Schmelz et aI., 1998). 
Wang et al. (1996) established that FBI-induced apoptosis, or cell cycle arrest, in CVl 
Mrican green monkey kidney fibroblasts, by assessing the appearance of apoptosis, cell 
cycle regulation, and putative components of signal transduction pathways involved in 
apoptosis. The addition of FBI to CVl cells induced formation of DNA ladders, 
compaction of nuclear DNA, and appearance of apoptotic bodies. Fumonisin BI also 
induced cell cycle arrest in the G 1 phase in CVl cells (Wang et aI., 1996). 
In a subsequent study, Jones et al. (2001) identified genes that inhibit FBI-induced 
apoptosis in CVl cells and two mouse embryo fibroblast (MEF) lines. A baculovirus gene 
p53 , and inhibitor of apoptosis, CpIAP, protected these cells from apoptosis. CpIAP blocks 
apoptosis induced by the tumour necrosis factor (TNF) pathway, as well as via other 
mechanisms. Further support for the involvement of the TNF signal transduction pathway 
in FBI induced apoptosis, was the cleavage of caspase 8. Inhibition of caspases by the 
baculovirus gene p35 also inhibited FBI-induced apoptosis. The tumour suppressor gene 
p53 was not required for FBI induced apoptosis because p53-/- MEF undergoes apoptosis 
following FBI treatment. Furthermore, BcI-2 was not an effective inhibitor of FBI-induced 
apoptosis in CVl cells or p53+/+ MEF. These results provide information to understanding 
the mechanism by which FBI induces apoptosis (Jones et al., 2001). 
2.18 APOPTOSIS BY SPHINGOID BASES 
Sphingosine induces apoptosis in neutrophils (Ohta et al., 1994). Jarvis et al. (1996) also 
documented the ability of sphingoid bases to induce apoptosis in 1ll.,60 and U937 cells. 
Exposure to either So or Sa for six hours promoted apoptotic degradation of genomic 
DNA. The DNA damage correlated directly with reduced cloning efficiency, and was 
associated with the appearance of apoptotic cytoarchitectural traits. At sub-lethal 
concentrations (::;750nM), however, sphingoid bases synergistically augmented the 
apoptotic capacity of CER (1 O~M), producing both a leftward shift in the CER 
concentration-response profile and a pronounced increase in the response to maximally 
effective levels of CER. Thus, So and Sa increased both the potency and efficacy of CER 
(Jarvis et al. , 1996). 
Sweeney et al. (1996) reported that So and its methylated derivative N,N,-dimethyl So 
(DMS) induced apoptosis in cancer cells of both haematopoietic and carcinoma origin. In 
human leukaemic cell lines CMK-7, HL60 and U937, treatment with 20~M So for six 
hours caused apoptosis in up to 90% of cells . Human colonic carcinoma cells HT29, 
HRTI8, MKN74 and COL0205 were shown to be more susceptible to apoptosis upon 
addition ofDMS (>50%) than of So «50%), yet were weakly or not sensitive to N, N, N-
trimethyl So (TMS). Under the same conditions in the presence of serum, neither So-I-
phosphate nor CER analogues C2-, C6- or C8-CER were able to induce apoptosis in any 
cell lines. However, in the absence of serum, CER analogues induced apoptosis in 
leukaemic cell lines after 18 hours, yet much less so than So or DMS . Furthermore, 
apoptosis induced by So or DMS could not be inhibited by FBI. Apoptosis was not induced 
by sphingolipids in primary culture cells, such as HUVEC or rat mesangial cells, but was 
apparent in transformed rat mesangial cells. Additionally, apoptosis induced by So, DMS 
or C2-CER were inhibited by protease inhibitors. These data support evidence that the 
catabolic pathway of SM involving So and other metabolites is an integral part of the 
apoptosis pathway (Sweeney et al. , 1996). 
Gennero et at. (2002) studied the apoptotic effect of So-I-phosphate and increased 
So-I-phosphate hydrolysis on mesangial cells, and found that So-I-phosphate stimulated 
proliferation of rat mesangial cells and phosphorylation of MAPKs at sub-confluent cell 
density. Mesangial cells expressed several So-I-phosphate receptors of the endothelial 
differentiation gene (EDG) family: EDG-I, -3 , -5, and -8. Conversely, So-I-phosphate 
induced apoptosis at low cell density (2x104cells/cm2), which was demonstrated by flow 
cytometry and Hoechst staining. Apoptosis was observed also in quiescent or growing 
cells. Incubation with e 3p] So-I-phosphate, eH] So-I-phosphate and CH] SO 
demonstrated increased So-I-phosphate hydrolysis, resulting in enhanced intracellular So 
levels and decreased So-I-phosphate levels. Therefore, Gennero et at. (2002) suggested 
that So and decreased So- I-phosphate are primarily responsible for So-I-phosphate-
induced apoptosis, and that incubation of low density mesangial cells with So-I-phosphate 
results in apoptosis, presumably due to increased So-I-phosphate hydrolysis . 
2.19 INHmITION OF DE NOVO SPHINGOLIPID BIOSYNTHESIS IN 
CULTURED CELLS 
Theoretically, the balance between the intracellular concentration of effectors that protect 
cells from apoptosis, and those that induce apoptosis, determine cellular responses. As the 
balance between the rates of apoptosis and proliferation are important in tumorigenesis, 
cells sensitive to the proliferative effect of decreased CER and increased So-I-phosphate 
may be selected to survive and proliferate when free sphingoid base concentration is not 
growth inhibitory. Conversely, when the increase in free sphingoid bases exceeds a cell's 
ability to convert Sa:So to dihydroceramide/CER, or their sphingoid base I-phosphate, 
then free sphingoid bases will accumulate. In this case, cells that are sensitive to sphingoid 
base-induced growth arrest will die, and non-sensitive cells will survive. If the cells 
selected to die are of normal phenotypes, and the cells selected to survive are abnormal, 
then cancer risk will increase (Riley et al., 2001). 
The potential for fumonisins to inhibit de novo sphingolipid biosynthesis was examined in 
cultures of hepatocytes obtained from male Sprague-Dawley rats and in rat liver 
microsomes. Fumonisin Bl caused almost complete inhibition of [14C] So formation by 
hepatocytes. Similar inhibition occurred when [14C] serine and FBI were added together for 
2 or 16 hours, and when the cells were incubated for 16 hours with FBI before addition of 
e4C] serine. Fumonisin Bz produced a comparable degree of inhibition. Wang et al. (1991) 
speculated that similarities between the fumonisins and sphingoid bases allowed their 
recognition as substrate (or transition state or product) analogues of CER synthase. It was 
further speculated that the absence of a hydroxyl group at carbon 1 may have altered their 
orientation in the active site of the enzyme and precluded acylation or, if acy lated, resulted 
in an inhibitory CER that could not be removed by addition of a sphingolipid headgroup at 
that position. 
Wang et at. (1991) conducted further in vitro assays of So N-acyltransferase using rat liver 
microsomes, and followed the conversion of eH] So to eH]CER by rat hepatocytes. 
Results showed that O.I!lM of FBI caused 50% inhibition in So N-acyltransferase activity. 
When rat hepatocytes were incubated with I!lM FB I and 1 !lCi of eH] So for one hour, the 
conversion of eH] So to CER was significantly inhibited (p<0.05) compared to that of 
untreated control cultures, with an approximate concentration giving 50% inhibition of cell 
proliferation (IC50) of 0.1 !lM. These results provide identification of a biochemical target 
for the action of fumonisins and imply that inhibition of de novo sphingolipid biosynthesis 
in vitro may underlie the hepatotoxicity and hepatocarcinogenicity of this mycotoxin 
in vivo (Wang et at., 1991). 
Cytotoxicity studies in primary rat hepatocytes and binding studies using subcellular 
fractions indicate that e4C] FBI binds tightly to hepatocytes and microsomal and plasma 
membrane fractions (Cawood et at., 1994). 
Investigations on pig kidney epithelial cells showed that the fumonisins were potent 
inhibitors of sphingolipid biosynthesis in the cells, killing the renal cells after three days at 
70~M of FBI (Yoo et al., 1992). Fumonisin BI and FB2 between 10 and 35~M inhibited 
cell proliferation in the LLC-PKI cells, whereas higher concentrations (>35~M) killed 
cells. Inhibition of cell proliferation and cell death were preceded by a lag period of at least 
24 hours during which cells appeared to be functioning normally. Inhibition of de novo 
sphingolipid biosynthesis occurred before inhibition of cell proliferation or cytotoxicity, 
and the dose response for decrease in eH] So:eH] Sa ratio at seven hours closely 
paralleled the dose response for effects on proliferation and cytotoxicity at three-five days. 
In addition, the level of free Sa and to a lesser extent So, increased in fumonisin treated-
cells in a dose dependent manner. The fact that Sa accumulated to a much greater extent 
than So, suggested that the de novo pathway was the primary target for inhibition, and as a 
result of this differential inhibition, the Sa:So ratio increased after exposure to fumonisin. 
These increases occurred long before any indication of cytotoxicity. These results support 
the hypothesis that inhibition of de novo sphingolipid biosynthesis is an early event in the 
toxicity of fumonisins to LLC-PK 1 cells (Yoo et al., 1992). 
Other consequences of fumonisin inhibition of CER synthase include increase in 
degradation products from catabolism of free sphingoid bases (Merrill et at., 1993a;1993b), 
increase in lipid products derived from increases in sphingoid base degradation products 
(Smith and Merrill, 1993), and increase in free So presumably from inhibition of 
reacylation of So derived from either the diet or catabolism of complex sphingolipids 
(Yoo et al., 1992; Merrill et al., 1993b). 
Fumonisin B I stimulates Sa-dependent DNA synthesis in Swiss 3T3 cells, but is 
mitoinhibitory and growth inhibitory 10 many cell systems (Merrill, 1983; 
Stevens et aI., 1990; Zhang et aI. , 1990) Schroeder et at. (1994) found that free sphingoid 
bases can act as mitogens, however that the critical concentration of cellular sphingoid 
bases necessary to stimulate mitogenesis is within a range and the effects were cell-type 
specific. Fumonisins that cause sphingoid base accumulation can therefore be regarded as 
tumour promoters, possibly by stimulating cell proliferation. The exogenous addition of So 
and So-I-phosphate to Swiss 3T3 cells was also shown to stimulate DNA synthesis 
(Zhang et al., 1990; Spiegel et aI., 1993). In contrast, other studies indicate that 
accumulation of sphingoid bases and depletion of complex sphingolipids were contributing 
factors to growth inhibition and increased cell death (Spiegel and Merrill, 1996). 
While So has little difficulty in crossing cell membranes (Hannun et al., 1991), the half-life 
of Sa inside LLC-PKI cells is much longer than that of FBI in LLC-PKI cells 
(Riley et al., 1998), which suggests either that the inhibition of Sa N-acyltransferase is 
persistent, that Sa does not easily diffuse out of cells, or that Sa degradation is slow relative 
to its biosynthesis. Studies with LLC-PKI cells also indicate that a low, but persistent pool 
of [14C] labelled material is retained inside cells long after the rapidly diffusible pool of 
[14C] fumonisin has exited the cells (Riley et aI., 1998). This retained pool appears to be 
capable of maintaining the elevation of cellular free sphingoid base concentration, a 
biomarker of fumonisin exposure (Solfrizzo et al., 1997; Riley et aI., 1998; 
Wang et aI., 1999). Riley et al. (1999) using the same cell system showed that fumonisin 
inhibition of cell proliferation and increased cell death (apoptosis) are prevented by >90% 
using the SPT specific inhibitor, ISP 1 (Riley et aI., 1999). Similar results were obtained 
with the HT29 human colonic cell line (Schmelz et aI., 1998). 
Fumonisin BI elevated intracellular free Sa levels in both LLC-PK1 and Chinese hamster 
ovary fibroblast (CHO) cells (Yu et aI. , 2001). However, CHO cells were resistant to 
fumonisin cytotoxicity at 50~M, while LLC-PK1 cells were sensitive at concentrations 
>35~M Adding exogenous Sa to the CHO cells along with 50~M FBI treatment for 
72 hours caused both necrosis and apoptosis . It was concluded that elevated endogenous Sa 
acts as a contributing factor to fumonisin-induced cell death (Yu et aI., 2001). 
2. 20 THE EFFECT OF FUMONISIN Bl ON OXYGEN TRANSPORT 
Yin et at. (1996a) used electron spin resonance (ESR) spin label oximetry to study the 
effect of FBI on oxygen transport in phosphotidylcholine bilayers. Moreover, the use of 
spin label attached to different carbons of fatty acids facilitated structural and oximetric 
determinations with the same test sample. The incorporation of 10 mol %FB I increased the 
oxygen transport properties of both saturated and unsaturated membranes at 37°C by 
approximately 30% and decreased the ordering of the hydrocarbon chains near the surface 
of the membranes. Concomitantly, oxygen transport near the centre of bilayers was 
diminished slightly, and the relative oxygen diffusion-concentration product profile curves 
were markedly flattened. 
Yin et at. (1996b) used ESR spectroscopy and spin label techniques further to study the 
effects of FBI and APJ on the structural and dynamic properties of phosphatidylcholine 
membranes at the molecular level. Multilamellar liposomes consisting of 
dimyristoylphosphatidyl-choline (DMPC) and egg yolk phosphatidylcholine (EYPC) were 
used. In the fluid phase membrane, FBI significantly increased the fluidities of 
n-doxylstearic acid spin labels attached to carbons 5 and 7, which disordered the alkyl 
chains and perturbed the surface region of the bilayer. By comparison, minimal effects 
were detected near the middle of the bilayer. In the gel phase, FBI and API decreased 
membrane fluidity, which further enlarged the change in ordering on the phase transition. 
Fumonisin BI also restricted the mobility of the rigid cholestane spin ]abel. A reduction in 
mobility of the temp-stearate spin label suggests that the TCA moieties of FBI might 
mimic the structure of polar head groups in phospholipids. These results that show 
fumonisins disturbed the ordering of membranes, provide additional mechanisms to 
elucidate toxicological activities of fumonisins . 
Subsequently Yin et at. (1998) studied the effects of FBI on lipid peroxidation in 
membranes. In this study of the interaction between FBI and lipid bilayers, fumonisins 
disturbed the ordering of membranes, enhanced oxygen transport in membranes, and also 
increased membrane permeability. The results provided the first evidence that fumonisin 
appears to increase the rate of oxidation, promote free radical intermediate production and 
accelerate the chain reactions associated with lipid peroxidation. The disruption of 
membrane structure, enlargement of relative oxygen diffusion-concentration products, and 
enhancement effects on membrane permeability, provide additional insights into potential 
mechanisms by which fumonisins could enhance oxidative stress and cell damage. 
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2.21 FUMONISIN-INDUCED DISRUPTION OF SPHINGOLIPID 
METABOLISM IN VIVO 
Free So and Sa are present in tissues and cells in trace amounts (Merrill et aI., 1988). Free 
Sa is a metabolic intermediate of the sphingolipid biosynthetic pathway, and free So is 
generated primarily as a consequence of sphingolipid turnover or degradation. Thus, 
neither should accumulate under normal conditions (Merrill, 1991; Rother et al., 1992; 
Michel et aI., 1997). The hypothesis was that if fumonisin inhibition of CER synthase 
in vivo resulted in accumulation of free Sa in the liver, at least some of the Sa that 
accumulates in cells treated with fumonisins would leave the cells and appear in blood, and 
if the kidney was affected, some would leave in the urine (Wang et aI., 1992; 
Merrill et aI., 1996b). This was reasonable since Sa is a hydrophobic compound that can 
enter and presumably cross cell membranes. It was hypothesised that disruption of 
sphingolipid biosynthesis in liver (or other organs) of animals consuming fumonisins or 
fumonisin-contaminated feeds could be detected by an increase in free Sa concentration, 
and an increase in the free Sa:So ratio in serum (Riley et al., 1994a). This hypothesis was 
tested by a number of retrospective studies using serum and tissue obtained from feeding 
studies with ponies, pigs, chickens and rats. 
2.21.1 Tissue and species specificity 
Fumonisin B 1 has low acute oral toxicity in several animal species (Eriksen and Alexander, 
1998). There are several sub-acute toxicity studies performed with animal species (poultry, 
rabbits, hamsters, non-human primates, lamb, mink, cattle) not directly useful for 
quantitative dose response assessment. Many of these studies were performed with 
contaminated feed, rather than pure fumonisin (Bryden et al., 1987; Weibking et aI., 1993; 
Javed et aI., 1995; Kuiper-Goodman et aI., 1996; Norred et aI., 1996). Differences in tissue 
and species specificity may be due to varying susceptibility to the cellular effects of 
disrupted sphingolipid metabolism (Voss et aI., 1996b). Fumonisin induced free sphingoid 
bases or their metabolites in serum may affect the function of the vasculature, and thus 
indirectly affect tissues that are not directly affected by fumonisin inhibition of CER 
synthase (Ramasamy et al., 1995; Smith et aI., 1996). 
2.21.2 Fumonisins as cancer initiators and promoters in rats, mice and rabbits 
Fumonisin BI appears to be non-genotoxic based on in vitro assays 
(Gelderblom and Snyman, 1991; Norred et aI., 1992a), and is a complete carcinogen 
(Gelderblom et aI., 1991) in that it effects the different stages of cancer development in rat 
liver, including cancer initiation, promotion and progression. Studies with other 
carcinogens have uncovered a basic pattern that is characteristic for initiation and 
promotion in rat liver. This pattern represents induction of rare "resistant" hepatocytes 
(resistant to negative regulation or sensitive to growth stimuli), the outgrowth of which can 
be selectively stimulated during the process of cancer promotion, to generate hepatocyte 
nodules. A subset of nodules, the persistent or late nodules, is one site of origin for 
hepatocellular carcinoma (Farber and Sarma, 1987; Farber et aI., 1989). 
Fumonisins are slow initiators because prolonged exposure (up to 14 days) at a relatively 
high dosage is required to effect cancer initiation (Gelderblom et al., 1992; 1994). Creation 
of an environment conducive to expansion of initiated cells by inhibition of normal 
hepatocyte proliferation IS often observed with genotoxic hepatocarcinogens 
(Farber, 1990). Selective proliferation of resistant hepatocytes results in clonal expansion 
of these initiated cells. It is not known whether the characteristic enzyme phenotype 
induced by genotoxic carcinogens is also induced by fumonisins (Roomi et aI., 1985; 
Riley et aI., 1994a; 1994b). 
Gelderblom et al. (1994) showed that prolonged exposure of rats to FBI or even a single 
gavage dosage, inhibited compensatory hepatocyte proliferation following partial 
hepatectomy. In this regard, FBI resembles many other carcinogens that are potent 
inhibitors of normal proliferation, as typically seen even after hepatectomy and chemically 
induced necrosis, is sometimes a pre-requisite for cancer initiation (Cayama et aI., 1978). 
The inhibitory effect of FBI could explain why FBI is a slow cancer initiator 
(Gelderblom et aI., 1992; 1994). It can also be reasoned that a threshold level for cancer 
initiation by fumonisins exists in rat liver which, as a function of time, will be determined 
by the dosage used, induced effects, and inhibitory effects on the resultant compensatory 
cell proliferation (Gelderblom et aI., 1994). The rate-limiting step for cancer induction may 
be the induction of cell death and resultant compensatory cell proliferation. Superimposed 
on this is the inhibitory effect on cell proliferation, which could further delay or inhibit 
cancer initiation, and therefore the apparent carcinogenic potential of this mycotoxin 
(Riley et al., 1994a; 1994b). 
Fumonisins also serve as promoters. The cancer promoting activity by F. moniliforme 
culture material and pure FBI in DEN-initiated rats is associated with its hepatotoxic 
effects (Gelderblom et al., 1988a; 1988b; 1994). Long-term feeding studies have indicated 
that hepatotoxicity of FB I plays a determining role in carcinogenicity of this mycotoxin in 
rat liver. In the absence of a promoting regimen, FBI is a promoter and is continuously 
present during long term feeding studies (Gelderblom et al., 1992). When considering 
these properties of FBI, it would appear that cancer promotion by this mycotoxin proceeds 
via the induction of a growth differential because it has the potential to serve both to 
increase the growth rate of abnormal (pre-cancerous) cells and arrest growth (and be toxic) 
for normal cells. This data suggests that the fumonisins are complete carcinogens because 
they are potent selecting agents. 
2.21.3 Fumonisin-induced disruption of sphingolipid metabolism and cancer 
Given the close correlation between the elevation in free sphingoid bases and the severity 
and extent of liver and kidney ultrastructural alterations in rats fed pure FBI for four weeks 
(Riley et al., 1994b), it seems likely that disruption of sphingolipid metabolism occurred in 
animals fed fumonisins for longer periods to produce cancer. In vivo, fumonisin acting as a 
mitogen could increase the probability, or irreversibly lock in a spontaneous genomic error. 
Mitogenesis increases cancer risk by increasing the probability of DNA damage being 
converted to mutations, making DNA more sensitive to being damaged, increasing gross 
chromosomal alterations, and increasing the expression of oncogenes 
(Ames and Gold, 1990). Cancer is a proliferative disorder, thus the fact that different cell 
types might respond in a differential fashion to elevated intracellular free sphingoid bases 
is not consistent with either the multistage model of carcinogenesis or the genotoxic/non-
genotoxic classification scheme of Cohen and Ellwein (1990) . Cohen and Ellwein (1990) 
hypothesised that non-genotoxic carcinogens act by increasing cell proliferation by direct 
mitogenic stimuli, toxicity and consequent regeneration, or through interruption of 
physiological processes. 
Livers from rats fed F. moniliforme culture material containing fumonisins at 
concentrations which caused focal necrosis and hepatocellular hyperplasia, also contained 
free sphingoid bases and elevated free Sa:So ratios (Voss et aI., 1990). Focal necrosis and 
hepatocellular hyperplasia is indicative of ongoing repair and regeneration. The 
observation of mitotic figures in these tissues indicate that the presence of high 
concentrations of free sphingoid bases in these livers do not preclude cell division, and thus 
tissue repair processes may have been suppressed. Alternatively, clonal selection may have 
selected for cells sensitive to the mitogenic effects of elevated free sphingoid bases. 
Changes in pool size of specific sphingolipids (e.g., SM and CER) that are associated with 
cellular signalling systems could alter the way extracellular messages are transduced. 
Systems which are important control points for cellular growth and differentiation could be 
disrupted during the interval when repair processes and thus mitogenesis are rapidly 
proceeding. The mitogenic, cytostatic and cytotoxic potential of fumonisin induced 
disruption of sphingolipid metabolism, may all play some role in the increased cancer risk 
in rats (Riley et aI., 1994a; 1994b). 
In short-term studies with rats, rabbits and mice, disruption of sphingolipid metabolism 
occurred at, or below the fumonisin dosages that cause liver or kidney lesions 
(Riley et aI., 1994b; Martinova and Merrill, 1995; LaBorde et aI., 1997; 
Tsunoda et al., 1998; Voss et al., 1998). In rats and rabbits, the fumonisin concentration 
that causes nephrotoxicity and an increase in kidney free Sa concentration is lower than the 
fumonisin dose that causes hepatotoxicity (Voss et aI., 1993; 1996b; 1998; 
Gumprecht et al., 1995; LaBorde et aI., 1997). 
2.21.4 Short and long term cancer initiation studies 
Short-term studies in a cancer initiation/promotion model in rat liver provide important 
information about the possible mechanisms involved during the initial stages of cancer 
development by this apparently non-genotoxic mycotoxin. The short-term assays have 
mainly used rat liver nodules as the end-point, assessed either using microscopy or 
histochemical analysis of different enzyme activities such as gamma-glutamyl transferase 
(GGT) or placental glutathione S-transferase (PGST). In these assays, different stages of 
the multistage carcinogenesis model were investigated by combining FBI treatment with 
classical promotion assays. In these studies, FBI or a Fusarium extract was administered 
alone, before a promoting treatment, or after an initiating treatment . These studies 
indicated that a cytotoxic/proliferative response is required for cancer induction, and that a 
no-effect threshold exists for cancer induction. The mechanisms proposed for cancer 
induction include the possible role of oxidative damage during initiation, the disruption of 
lipid metabolism, integrity of cellular membranes, and altered growth-regulatory responses 
as important events during promotion (Gelderblom et al. , 2001) . 
Short term in vivo studies have shown that FBI mimics genotoxic carcinogens with respect 
to the induction of resistant hepatocytes in rat liver (Gelderblom et al., 1992; 1994). This 
was substantiated by observations that FBI induces GGT and PGST, which are accepted 
histological markers for putative pre-neoplastic lesions initiated by genotoxic carcinogens. 
It is unclear whether the characteristic enzyme phenotype that is associated with the 
fumonisins in rats indicated an increase in cell proliferation is also likely to playa role in 
the induction of the "resistant phenotype" as hepatotoxicity, and resultant regenerative cell 
proliferation is a prerequisite for initiation (Gelderblom et al., 1994). The only difference 
noticed thus far in the induction of the resistant phenotype between the fumonisins and 
other genotoxic carcinogens, lies in the kinetics of the cancer initiation step . 
2.22 ANIMAL DISEASES ASSOCIA TED WITH CONSUMPTION OF 
FUMONISIN Bl 
2.22.1 Equidae 
Fumonisin BI and FB2 are causative agents of ELEM. The name is somewhat misleading 
since the grey matter may also be involved (Marasas et aI., 1988a). The disease has been 
recognised as 'mouldy corn poisoning' and has been experimentally reproduced by feeding 
horses with corn naturally contaminated with fumonisins (Wilson et aI., 1992), as well as 
by the administration of purified FBI (Kellerman et aI., 1990). Wilson and 
Maronpot (1971) succeeded in establishing the causative agent when they isolated 
F. verticil/ioides as the predominant contaminant of mouldy maize that had caused cases of 
ELEM in Egypt, and reproduced ELEM by feeding culture material of the fungus on maize 
to two donkeys. Subsequently, investigators in SA confirmed the ability of 
F. verticil/ioides C~1RC 826) culture material to induce the characteristic clinical signs and 
pathological changes of ELEM, as well as hepatosis in horses and donkeys 
(Kellerman et al., 1972; Marasas et al., 1976; Kriek et aI., 1981; Marasas et aI., 1988a). 
The horse appears to be the species most sensitive to fumonisins, and ELEM is the most 
frequently encountered disease associated with F. moniliforme and F. proliferatum 
(Kellerman et al., 1990; Wilson et al., 1992; Ross et al., 1993). Equine 
leukoencephalomalacia is characterised by liquefactive necrosis of the cerebral 
hemispheres, causing damage to vascular endothelium of the eNS and, in some cases, 
hepatocellular necrosis and vacuolisation. The clinical signs associated with the neurologic 
form of ELEM in horses include apathy, lethargy, head pressing, drowsiness, pharyngeal 
paralysis, blindness, staggering, hyper-excitability, seizures and eventual recumbency. 
Once animals show the neurological signs, death usually occurs within 48-72 hours. If an 
animal survives the acute syndrome, neurological deficits are observed . The signs 
associated with the hepatic form include petechial or ecchymotic haemorrhages of the 
mucous membranes, icterus, oedema of the head and neck, decreased appetite, depression, 
lingual paralysis, clonic convulsions, and coma. On post-mortem examination, the classic 
finding is grey to brown areas of malacia and cavitation of the white matter of the cerebral 
hemisphere. It is usually unilateral, but may be asymmetrically bilateral. Histologically, 
there is marked, multi focal, liquefactive necrosis, multifocal vascular congestion, and 
perivascular haemorrhage throughout the white matter of the cerebrum. 
Equine leukoencephalomalacia concurrent with significant liver disease was observed in 
horses and ponies fed feeds naturally contaminated with fumonisins at low concentrations 
(Wilson et al., 1992; Ross et aI., 1993). The development of brain lesions in the absence of 
major liver lesions does not preclude biochemical dysfunction in non-brain tissue from 
contributing to the brain lesions. The length of exposure, levels of contamination, 
individual animal differences, previous exposure, or pre-existing liver impairment 
contribute to incidence of clinical disease (Ross et al., 1993). Elevated serum enzyme 
levels indicative of liver damage (Wilson et al., 1992) are preceded by elevation in the 
serum Sa: So ratio (Wang et al., 1992; Riley et al., 1997). Serum enzyme levels often 
return to near normal concentrations, but usually increase markedly immediately prior to, 
or at the onset of behavioural changes (Kellerman et al., 1990; Wang et al., 1992; Wilson 
et al., 1992; Ross et al., 1993; Riley et al., 1997). Marasas et al. (1988a) have suggested 
that high dosage levels of fumonisins induce fatal hepatotoxicity with mild brain lesions, 
whereas low dosage levels cause mild hepatotoxicity and severe brain lesions. 
The causes ofELEM after FBI dose may be divided into direct and indirect effects. Direct 
action may be mediated by the presence of Sa in brain. An indirect effect of FB I is also 
possible because FBI-induced hepatotoxicity and nephrotoxicity in rats, disruption of 
barrier function of cultured endothelial cells, and damage to the cerebral blood vessels have 
been reported. Alteration of blood vessels in the CNS and/or disruption of the BBB may 
have effects on the transfer of FBI or Sa in brain tissue (Kwon et al., 1997a). 
Leukoencephalomalacia was induced in two horses by the oral administration of FB I. A 
filly received 59.5 mg.kg-I of a 50% preparation of FBI isolated from corn cultures of 
F moniliforme MRC 826, administered in 21 doses of 1.25-4 mg.kg- I over 33 days 
(the other 50% was inorganic matter that co-eluted during purification), and a colt received 
44.3 mg.kg-1 of95% pure FBI in 20 doses of 1-4 mg.kg-1 in 29 days. Gross necropsy of the 
filly revealed a sunken area (2cm in diameter) in the lateral part of the anterior frontal lobe 
of the left cerebral hemisphere. The white matter on the cut section of this focus was softer 
than normal and reddish-brown. Microscopic examination revealed necrosis of the white 
matter, numerous macrophages, aggregates of mineralisation, and small haemorrhages. At 
the periphery of the necrotic area, the blood vessels showed hypertrophy and hyperplasia of 
endothelial cells, fibrinoid changes of their cell walls, and perivascular mononuclear cell 
infiltration. The white matter close to the focal lesion had mild status spongiosis and mild 
to moderate proliferation of astrocytes. Necropsy of the colt showed swelling of the 
cerebral hemisphere and flattening of the gyri. A yellowish-brown focus was seen in the 
subcortical white matter of the left dorsal frontal lobe, and extended posteriorly to the 
occipital lobe. A smaller, gelatinous focus was found in the white matter of the right 
occipital lobe. Microscopic examination of the lesions revealed partial loss of cellular 
detail of the white matter, swelling and proliferation of astrocytes, infiltration of 
macrophages, and swelling ofaxons. The blood vessels around the foci had hyperplasia 
and hypertrophy of endothelial cells, as well as perivascular oedema. The white and grey 
matter of the rest of the left side of the brain showed moderate oedema, and the right side 
showed only a mild oedema. These authors concluded that these results unequivocally 
prove that FBI can induce LEM in horses (Kellerman et al., 1990). There is no specific 
therapy for ELEM. By the time clinical signs are noted, it is usually too late in the course 
of the disease. Removal of the contaminated feed from susceptible animals is very 
important and avoidance is the only way to prevent the disease. 
2.22.2 Porcine pulmonary oedema syndrome 
Kriek et al. (1981) were the first to report porcine pulmonary oedema (PPO) syndrome. 
When culture material of F. verticillioides (MRC 826) was fed to horses, pigs, sheep, rats 
and baboons; lung oedema occurred only in pigs. Clinical signs ofPPO typically occur two 
to seven days after pigs consume diets containing large amounts of fumonisins over a short 
period of time. Clinical signs include dyspnoea, weakness, cyanosis and death 
(Kriek et aI., 1981; Osweiler et aI., 1992; Casteel et aI., 1993; 1994; Diaz and Boermans, 
1994; Rotter et al., 1996; Fazekas et aI., 1998; Gumprecht et aI., 1998). At necropsy, the 
animals exhibit varying degrees of interstitial and interlobular oedema, with pulmonary 
oedema and hydrothorax (Colvin and Harrison, 1992; Colvin et aI., 1993). It has been 
hypothesised that cardiovascular alterations are a consequence of sphingoid base induced 
inhibition of L-type calcium channels (Smith et aI., 1996), and that cardiovascular 
dysfunction in pigs, subsequent to increased free sphingoid base concentration in the heart, 
is the cause of PPO (Haschek et aI., 1995; Smith et aI., 1996; 1999; 
Haschek-Hock et aI., 1998). 
2.22.3 Vervet monkeys 
Riley et al. (1996) recommended that quantitative detection of high concentrations of free 
Sa in urine, serum or tissues be used in conjunction with other clinical tools in situations 
where toxicity to animals resulting from exposure to fumonisins is suspected. 
Shephard et al. (1996b) studied the Sa:So ratio in serum of Vervet monkeys over 60 weeks. 
These animals consumed diets such that their total daily fumonisin intake was -0.3 and 
0.8 mg. kg-l bodyweight per day of F. moniliforme culture material. Serum Sa levels in the 
experimental groups (mean of 219nM and 325nM, respectively) were significantly 
elevated above the levels in controls (mean 46nM; p=O.02). The Sa:So ratio was 
significantly elevated from a mean of 0.43 in the control group to 1.72 and 2.57 in the 
experimental groups, respectively (p=0.003). Hence, the disruption of sphingolipid 
biosynthesis in vervet monkeys induced by fumonisins in their diet, can effectively be 
monitored in the serum as an elevation of the Sa: So ratio (Shephard et aI., 1996b). 
2.23 HUMAN STUDIES 
Studies have suggested potential developmental effects, such as neural tube defects (NTD), 
could be associated with exposure to fumonisins (Flynn et al., 1996; 1997; 
Collins et al., 1997). By what mechanism could fumonisin induce NTDs? Folate is needed 
for biochemical reactions involving one carbon metabolism, such as the biosynthesis of 
purines and thymidine, the regeneration of methionine from homocysteine and histidine 
metabolism. The folate receptor is found in membrane domains enriched in cholesterol and 
sphingolipid, and IS a glycosylphosphatidylinositol (GPI) anchored protein 
(Lacey et aI., 1989). This receptor is responsible for transport of folate into cells with 
elevated folate requirements, such as placenta, kidney and breast. By the time of 
organogenesis, the foetus is dependent on maternally derived folic acid . This continuous 
requirement for folic acid is not usually a problem because the placenta concentrates this 
water-soluble vitamin 3: 1 in favour of the foetus (Henderson et aI., 1995). It has been 
shown that treatment of Caco-2 cells with FB I inhibits folate receptor mediated transport of 
5-methyltetrahydrofolate in both a time and concentration dependent fashion 
(Stevens and Tang, 1997). It is not unreasonable to assume that blocking the placental 
uptake of this water-soluble vitamin for a few critical days might induce a NTD. 
Coumi (2000) dealt with the possible role of FBI in pre-eclampsia, and immunolocalised 
FBI in placental tissue obtained from normotensive and pre-eclamptic patients. Image 
analysis indicated that the intensity of staining for FBI was higher in the pre-eclamptic 
group than in the normotensive group. Serum obtained from both maternal and cord blood 
samples taken from the same patients as the placental samples were analysed for FBI 
presence using high performance liquid chromatography (HPLC). Fumonisin BI was 
detected in the maternal and cord blood serum samples of the pre-eclamptic group. 
Fumonisin BI was also detected in three normotensive maternal serum samples, but was 
not detected in any of the cord serum samples of those pregnancies. In utero exposure to 
FBI is suggested by the presence of this mycotoxin in the placental samples, and in the 
maternal and cord serum samples obtained from pre-eclamptic pregnancies (Coumi, 2000). 
Chelule et al. (2000) analysed 20 stool samples of rural school children of Vulamehlo in 
SA for FBI, as well as 23 urban control stool samples obtained from various households 
within the Durban metropolitan area. The rural (35%) and urban samples (9%) showed the 
presence of FB I ranging from 790 to 19 560ng per gram of freeze dried stool. Clearly, the 
rural population have greater exposure as they consume locally produced maize that is 
often contaminated with FBI . Considering the losses due to degradation during digestion, 
recovery, dilution effects and the time interval to when food was consumed, the quantities 
detected might be equivalent to considerable amounts offumonisins in food. Children from 
rural areas, who were not regarded as suffering from any disease, are clearly routinely 
exposed to FBI which is resident in their gastrointestinal tract (GIT) for considerable 
periods of time, depending upon personal habits. If positive results were found, it was 
initially predicted these would be from the rural population where maize is the staple food. 
However, two volunteers from Durban were positive at levels in the higher range of 
contamination (3.5 and 16.2 mg.g- I respectively). Fischer's exact test showed that the rural 
population was six times more at risk to FBI exposure than the urban group. It is usual 
however for urbanized black people to eat maize products, presumably from urban stores, 
and therefore may be complacent about its quality (Chelule et al., 2000) . 
Subsequently, Chelule et al. (2001) surveyed households in rural (in villages of Mphise 
and Ngcolisis) and urban (Durban Metro) areas of KZN, SA. Analysing stored maize, plate 
ready food and faeces enabled assessment of the exposure of the inhabitants to FB I. 
Of the 50 rural maize samples examined 32% had levels of FBI ranging from 0.1-22.2 
mg. kg-I , whereas 29% of the 28 cooked maize (phutu) samples contained FBI ranging from 
0.1-0.4 mg.kg- I. The incidence and levels of FBI in faeces were 33% and 0.5-39 mg. kg-I 
respectively. Of the 49 urban maize samples analysed, 6.1% had a range of 0.2-0.5 mg.kg- I 
FBI, whereas 3 of 44 faecal samples (6%) ranged between 0.6-16.2mg.kg- l . No FBI was 
detected in urban phutu samples. Because these levels are lower than those published from 
regions in SA with high incidence of oesophageal cancer (OC), it may be concluded that 
the risk ofOC from FBI exposure is lower in the KZN region (Chelule et al., 2001). 
Several possibilities present themselves; either FB I is highly potent or its absorption is 
aided by other dietary factors such as alcohol or fat . Previous data indicates that it is 
improbable that in the digestive tract toxin is modified into a more accessible form e.g., by 
esterification, or that there are transport systems that assist in passage, either present in an 
active or latent form. An alternative approach is to measure Sa and So levels, which are 
elevated, however, hold out some hope for exposure studies. However detailed work will 
be needed to correlate exposure levels with dose and time periods. 
2.24 HUMAN EXPOSURE ESTIMATES 
2.24.1 Environmental levels and human exposure 
The occurrence of FB I in maize intended for human consumption is common worldwide. 
Considerable differences are evident in the extent of human exposure between maize-
growing regions in the developed and developing countries. For example, although FBI can 
occur in maize products in the United States of America (USA), Canada and Western 
Europe, human consumption of those products is modest. In parts of Africa, South-Central 
America and Asia where FBI contamination may be high, some populations consume a 
high percentage of their calories as maize meal. Maize contaminated naturally by FBI can 
be simultaneously contaminated with F verticillioides or F. proliferatum toxins, or with 
other mycotoxins including DON, ZEA, aflatoxin and ochratoxin. 
Human exposure estimates have been made for fumonisins in Canada, SA, USA and the 
Netherlands (Kuiper-Goodman et al., 1996; Humphreys et al., 1997; Marasas, 1997; 
de Nijs, 1998). For Canada during the period 1991 to early 1995, human exposure 
estimates of 0.017-0.089 Ilg.kg-I bodyweight per day were reported (Kuiper-Goodman et 
aI., 1996). In the Netherlands, the exposure estimates ranged from 0.006 to 7.1 Ilg.kg-I 
bodyweight per day (based on the daily average intakes of maize and maize products of 3g 
(general popUlation average), 42g (regular maize product eaters) and 162g (individuals 
with gluten intolerance) in the Netherlands, the respective population groups had an 
estimated daily intake of 4, 57 and 220 Ilg FBI per person respectively, based on a mean 
FBI content of 1.36 mg.ki l maize produced (de Nijs et aI., 1998a; 1998b). 
Thiel et al. (1992) estimated that human exposures in the Transkei region in SA are 14 and 
440~g FBI per kilogram body weight per day for healthy and mouldy corn respectively. 
More recent estimates of the probable daily intake (PDI) of South Africans are summarized 
in Table 2.2. These vary from 1.2-to 355 Ilg.kg-I bodyweight per day in rural blacks in 
Transkei (Marasas, 1997). These exposure estimates vary considerably according to the 
source and extent of maize in the diet, as well as the extent of Fusarium kernel rot 
prevalent in the harvested crop. 
Table 2.2: Probable daily intake of fumonisin in South Africa (Maras as, 1997). 
Product Country Number of Mean Probable daily intake 





Commercial maize SA a 68 400 2.6 1.6 
Commercial maize SA • 209 300 2.0 1.2 
Maize meal SA • 52 200 1.3 0.8 
Home-grown maize SA b 18 7100 46.6 28.0 
Home-grown maize SA C 18 54000 354.9 212.9 
Imported maize USA a 1682 1100 7.2 4.3 
Maize consumption 
gramJ70 kg body 460 276 
weight per day 
a From: Marasas (1997) 
b Transkei, from individual fanus in high OC area, healthy maize 
c Transkei, from individual fanus in high OC area, mouldy maize 
d Imported in 1993 
Maize examined by Dutton et at. (1993) was found to have a 50% incidence of FBI 
contamination. During the period 1984-1993, just over 1600 samples of agricultural 
commodities comprising maize, compound animal feeds, oil seeds, soybean, fish meal and 
forage were examined in KZN in SA for fungi and over 20 mycotoxins using a multi screen 
augmented with individual assays (Dutton and Kinsey, 1996). Aflatoxin occurred most 
commonly at over 14% of all samples examined followed by trichothecenes at 10%, and 
then zearalenone at 4%. Since 1989, selected maize samples with high levels of Fusarium 
species have been examined for FBI and of these (n=20) in 1993, 90% were positive. 
Because of this result and high incidence of Fusarium species (32%) in maize and maize 
containing feeds that were higher than either Aspergillus species (27%) or Penicillium 
species (12%), concern was expressed with regard to the potential presence offumonisin in 
the SA food chain (Dutton and Kinsey, 1996). 
In 1994, 417 samples of agricultural commodities, comprising maize, compound animal 
feeds, oil seeds, soybean, fish meal and forage were examined in KZN in SA for fungi and 
over 20 mycotoxins, using a multi screen augmented with individual assays. The majority 
of samples examined were maize (198; 47.9%) reflecting the agricultural importance of 
this cereal in SA. Feeds were the next most important, as this cereal was the usual energy 
source in them. Trichothecenes occurred most commonly of over 19% in all samples 
received and zearalenone at 3%. Selected samples (73) were analysed for FBI and of these 
69 (94%) were found to be positive. Because of this result and high incidence of Fusarium 
species (over 70% in maize and maize containing feeds, attention was drawn to the actual 
and potential presence of fumonisin in the food chain in SA (Dutton and Kinsey, 1995). 
2.25 OESOPHAGEAL CANCER IN HUMANS 
2.25.1 Transkei, South Africa 
The high incidence of OC among the black population of Transkei, SA has been reported 
in several surveys (Jaskiewicz et al., 1987; Makaula et aI., 1996), and reviewed by IARe. 
The only studies available were correlation studies, most of which indicated some 
relationship between OC rates and occurrence of F. verticillioides (IARC, 1993a; 1993b). 
Contamination of homegrown maize in Transkei by a number of toxigenic Fusarium 
species, particularly F. verticillioides, has been observed since the early 1970' s (Marasas et 
aI., 1979a; 1979b; 1981; 1984; 1988a; 1988b; 1993; Marasas, 1993; 1994; 1996; 1997). 
Another Fusarium species associated with maize in Transkei is F. graminearum, and the 
mycotoxins DON and ZEA produced by this fungus occur in homegrown maize intended 
for human consumption (Maras as et aI., 1979a). 
In rural communities in SA, the chief component of the staple diet is maize. An association 
has been suggested between high levels of fumonisin-producing moulds on maize used to 
make alcoholic beverages and OC in human subgroups in Transkei. Transkeians 
deliberately favour and frequently use visibly mouldy maize in the making of home brewed 
beer because of the unique flavour the mould imparts (Norred, 1993). This maize has been 
found to contain up to 118 mg.kg·1 fumonisins (Rheeder et al., 1992). Based on 
experiments conducted on beer made from wort containing added FBI 
(Scott and Lawrence, 1995), such beers could contain fumonisin concentrations of 
30mgllitre beer. 
The incidence of OC was higher in both sexes in the south (Butterworth and Kentani 
Districts) compared to the northern parts of the Transkei region (Bizana and Lusikisiki 
Districts). Both areas depend on homegrown maize for around 50-100% of the year's 
supply, the remaining being purchased from commercial sources or imports. Maize 
porridge is the staple diet (up to 100% of calories). The occurrence of F. gramineantm in 
maize kernels was found to be greater in low-risk than in high-risk areas for OC in later 
studies (Marasas et aI., 1981 ; 1988b). Sydenham et al. (1990a) confirmed that DON and 
ZEA levels were significantly higher in homegrown maize from areas with low rates of OC 
than from those with high rates. In contrast, the occurrence of F. verticillioides in maize 
kernels was significantly correlated to OC rates . However, the rules for selection of 
families were different between the two populations. The prevalence of F. verticillioides 
was greater in homegrown maize collected in 12 households in the high-incidence area 
compared to a similar collection in a low-incidence area. Households in the high-incidence 
area were selected on the basis of cytological examination of cells collected from the 
oesophagus (Marasas et al., 1988b). Subsequent studies conducted after the chemical 
characterization of the fumonisins in 1988, also found significantly higher levels of 
F. verticillioides and fumonisins (20 times higher) in areas with high rates of OC in 
Transkei than In areas with low rates (Sydenham et al., 1990a; 1990b; 
Rheeder et al., 1992). 
The fungi F. verticillioides and F. graminearum cause maize ear disease under different 
ecological conditions. The environmental conditions that prevail in the areas in the 
Transkei with high rates of OC clearly favour colonization of maize ears by 
F. verticillioides. Significant fumonisin accumulation in maize occurs periodically in all 
such environments examined so far, primarily in relation to drought and other 
environmental stresses. Taking this into account, SA studies have shown that the level of 
fumonisin in home-grown maize has been consistently high in the areas in the Transkei 
with high rates of Oc. Cancer registry data have shown these areas to have consistently 
high rates of OC since 1955 (Jaskiewicz et al., 1987; Makaula et al., 1996). However, 
these studies were limited by the lack of controlled conditions, particularly for established 
confounding risk factors (e.g., alcohol consumption), and therefore do not allow any 
definitive conclusions to be made about cancer causation in humans. 
The incidence of OC in the Transkei region averages about 50 per 100 000, but can be as 
high as 200 per 100 000 compared with less than five per 100 000 in most parts of the 
world . Other parts of the world with high OC include the Linxian region of China 
(100-150/100000) and North Eastern Iran (>100/100000) (Nair, 1998). 
2.25.2 China 
Maize is also consumed as a staple in a number of areas in China, including Linxian and 
Cixian counties in Henan province (Chu and Li, 1994; Yoshizawa et at., 1994). Mortality 
rates for males in the high-risk areas ranged from 26 to 36 per 100 000 in the low-risk 
counties and from 76 to 161 per 100 000 in the high-risk counties. The incidence of 
F. verticillioides has been reported to be higher in maize in high- than low-risk areas. 
Maize samples from Linxian and Cixian counties were analysed for FB, by 
Chu and Li (1994). All 31 samples contained FBI at levels ranging from 18 to 155 mg.kg- 1 
2.25.3 Charleston, South Carolina 
Both FBI and FB2 were detected in commercial maize-based samples obtained from 
Charleston, South Carolina in 1989. This city has one of the highest incidences and 
mortality rates of OC in the USA. The mean levels of FBI (detected in 7/7 samples) and 
FB2 (detected in 6/7 samples) were 635 and 182 ng.g-', respectively. Even though these 
levels were lower than those determined in homegrown maize samples from the Transkei, 
Sydenham et at. (1991) stated that the presence of these mycotoxins in commercial 
foodstuffs is cause for further investigation of the role offumonisins in OC aetiology. 
2.26 EFFECTS OF FUMONISINS ON THE BRAIN AND BRAIN CELLS 
Long-term exposure to low levels or non-cytotoxic concentrations of certain environmental 
pollutants may lead to neurodegeneration through specific patterns of neural cell reactivity. 
This section of the literature review deals with data relating to the potential effects of 
fumonisins on the brain and brain cells. 
2.26.1 Effects of fumonisins on the brains of animals 
The developing nervous system in rats is vulnerable to perturbations by environmental 
toxicants (Spyker, 1975; Vorhees, 1992). In the rat, the rate of the brain is most rapid 
during post-natal development day (PND) 7 (Dobbing and Sands, 1979). The immature 
brain has a greater passive permeability of lipid soluble molecules between blood and brain 
tissue or CSF than does the mature brain (Saunders and Mollgard, 1984). In rat cerebral 
cortex, the maximal proliferation of capillary cells occurs between PND 5 to 9 
(Robertson et aI., 1985), and some drugs (e.g ., phenobarbital, phenytoin) can permeate the 
neonatal brain more readily than the adult (Cornford et aI., 1983). Therefore, it appears that 
the developing rat may be a more sensitive model to study FBI effects than is the adult rat, 
because FBI is a hydrophilic, lipid soluble compound possessing a relatively large 
molecular weight (721.8 daltons). 
The question of toxicity to the neonate is of concern since neonates may be more sensitive 
to fumonisins than adults . K won et al. (1997b) indicated that subcutaneous injection of FB I 
in neonatal rats caused elevation in the Sa:So ratio in brain tissue and reduced myelin 
deposition. K won et al. (1 997b ) further demonstrated that FB I treatment altered Sa levels 
and significantly increased Sa: So ratios in two regions of the brain, namely in the 
forebrain and brainstem. In the same regions of the CNS, rats with limited nutrition did not 
demonstrate altered Sa levels or Sa: So ratios. These data suggest that sphingolipid 
metabolism in the CNS of developing rats is vulnerable to FBI exposure. The elevated Sa 
level was the result of a direct effect on the neonate brain, indicating that FB I can cross the 
BBB (Kwon et aI., 1997a). When toxicity to the dam was minimal, evidence of toxicity to 
the rat neonate was minimal or absent (Ferguson et aI., 1997). 
Since FBI exposure IS associated with alteration of sphingolipid metabolism, 
K won et al. (1997 a) investigated the effects of FB I treatment on BBB transfer in 
developing rats in order to elucidate whether blood Sa levels affect brain Sa levels. 
Sphinganine and So levels in brain tissue and plasma were analysed by HPLC. Area under 
the curve (AUC) 0-24hour ratios of brain Sa to plasma Sa levels were about 40 after a single 
0.8 to 8 mg.kg-I subcutaneous dose of FBI . The AUC 0-12 hour ratio of brain FBI to plasma 
was 0.02 . Sphinganine levels in brain and plasma show dose dependent increases, and 
brain Sa AUCO-24 hour was higher than plasma Sa AUCO-24hour at both the 0.8 and 8 mg.kg- I 
dose. These data indicate that small amounts of FBI entered brain tissue and increased Sa 
levels in the developing rats. This was supported by HPLC detection of FB I in the brain 
tissue. The data also suggest that plasma Sa elevation due to FBI exposure probably did not 
contribute to the elevation of brain Sa levels. Fumonisin BI effects on increasing Sa levels 
continued to 24 hours in both brain and plasma after the 8 mg.kg- I dose. However, in the 
0 .8 mg. kg-I dose, the alteration of brain Sa levels was transient and plasma Sa levels were 
not elevated. The fact that FBI alters brain Sa levels and Sa: So ratios indicates that 
sphingolipid metabolism in the CNS of developing rats is vulnerable to FBI exposure 
(Kwon et aI., 1997a). These data suggest that even low levels of FBI in brain were 
sufficient to increase endogenous Sa levels in the brain. It seems that the accumulation of 
Sa was due to a direct effect of FBI on brain tissue rather than passive accumulation of 
peripheral Sa into the brain from the blood (Kwon et aI., 1997a). This data supports the 
hypothesis that alterations of the brain Sa levels are related to the direct action of FB I on 
the brain rather than the transport of peripheral Sa to the brain. 
Kwon et al. (1997b) further determined whether FBI alters Sa levels and myelin synthesis 
in the CNS of developing rats . Fumonisin B I administration (subcutaneous 0.4 or 
0.8 mg.kg- I per day) from PND3 to PND12 resulted in a significant reduction of body 
weight and decreased survival rates . Both Sa levels and Sa:So ratios were significantly 
increased in the brain ofrats given 0.8 mg FBI/kg/day or treated by limited nutrition when 
compared to those in saline controls. Sphinganine levels and Sa:So ratios were 
significantly higher in the 0.8 mg FBI/kg/day treated, but were not altered in the limited 
nutrition group. Myelin deposition in the corpus collosum and 2' , 3' -oyclic nucleotide-3'-
phosphorylase (CNP) activities were decreased significantly in both nutritionally limited 
and FBI exposed rats (Kwon et aI., 1997b). This data indicates that sphingolipid 
metabolism in the CNS of developing rats is vulnerable to FBI exposure, and that the 
hypomyelination associated with FBI treatment may be mediated by limited nutrition. 
Alterations of sphingolipid metabolism and myelin synthesis in the CNS may be caused by 
FBI exposure and the direct disruption of brain enzyme activity involved in sphingolipid 
synthesis and/or damage to myelinating cells. In support of this theory it has been reported 
that 35% of the myelin lipid in both rat and human brain are GSLs (cerebrosides and 
sulphatide) and SM, key components in the myelination ofaxons in the brain and spinal 
cord. In addition, sphingolipid biosynthesis and axonal growth in cultured hippocampal 
neurons are inhibited by FBI (Harel and Futerman, 1993). 
The transfer of FBI into rat brain may become one of the principal factors involved with 
the assumption of direct action of FBI on brain. However, bioavailability of FBI in brain 
tissue was not high according to kinetic data of K won et al. (1997b) . The low transfer of 
FBI to the brain was probably due to the low lipid solubility and a large molecular weight 
of FB I. Alteration of blood vessels in the CNS and/or disruption of the BBB, may have 
effects on the transfer of FBI or Sa in brain tissue (Kwon et aI., 1997b). 
Goel et al. (1995) reported that brain Sa levels, but not Sa: So ratios, were significantly 
elevated in horses that developed ELEM. Fumonisin BI elevates free sphingoid levels in 
developing rats as does the phenomena of Niemann-Pick disease (type A) in the human 
foetus (gestational ages, 16-20 weeks). The latter condition, however, causes much more 
accumulation of So that Sa In cerebral cortex, liver and spleen 
(Rodriguez-Lafrasse et aI., 1994), while the former increased Sa in the brain of developing 
rats without affecting So levels (Goel et aI., 1995). This suggests that alterations of brain 
sphingolipid metabolism may be related to the outcome of human or animal diseases. 
Disruption of sphingolipid metabolism by FBI in liver and kidneys may directly cause 
tissue damage, whereas the damage in the brain and lung may be indirect due to disruption 
of endothelial functions (Gumprecht et aI., 1995; Ramasamy et aI., 1995; 
Riley et aI., 1996; Eriksen and Alexander, 1998; Tsunoda et aI., 1998). 
Two of five pregnant rabbits gavaged with purified FBI at 1.75 mg.kg-I/day died, one after 
nine doses and the other after 13 doses. Microscopic examination revealed focal small 
haemorrhages in cerebral white matter in both animals, with malacia and haemorrhage also 
present in the hippocampus of one. The lesions were bilateral. Haemorrhage and 
degeneration were also present in the choroid plexus of the lateral ventricle, with 
perivascular oedema in the temporal cerebral cortex. Haemorrhagic and leukomalacic 
lesions similar to those associated with fumonisin exposure in equidae were observed 
(Bucci et at., 1996). 
2.26.2 Effects of fumonisins on myelin synthesis 
Since sphingolipids are major constituents of myelin, and activators of PKC are known to 
induce demyelination (Pouly et aI., 1997), effects on myelin formation and integrity may 
be expected as a consequence of FBI exposure. Recent reports support such a hypothesis. 
Pre-natal treatment ofrats with FBI alter the functional development of the nervous system 
(Ferguson et aI., 1997), while myelin synthesis was reduced in pups treated post-natally 
with this mycotoxin (Kwon et aI., 1997a; Kwon et aI., 1997b). These authors' indicate that 
mUltiple subcutaneous dosing of developing rats with FBI significantly reduces body and 
brain weights, and also causes hypomyelination accompanied by altered sphingolipid 
metabolism in the CNS. Kwon et al. (1997b) showed that a single injection of FBI 
(8mg.kg"l) resulted in FBI concentrations in the brain equivalent to 0.42f..LM at 
30 minutes (min.) and 0.06~M at 12 hours after injection, whereas plasma concentrations 
were 58 .61JM and 0.3~M respectively. 
2.26.3 Effects of fumonisin Bl on tissue slices 
Protein kinase C consists of a family of isozymes that are differentially localized in various 
cells (Nishizuka, 1988; Nishizuka et ai., 1991). Among these, y-PKC exists at high 
concentrations in various brain regions (Tanaka and Saito, 1992). Yeung et ai. (1996) 
evaluated whether FBI affects PKC activation, and its redistribution in response to FBI 
exposure in rat cerebrocortical slices. Similar to the tumour promoting phorbol ester, 
phorbol 12 myristate-13 acetate (PMA) , PKC is also catalytically activated by FBI. 
Cytosolic and membranous PKC activities were determined by histone phosphorylation in 
the presence of [y_32p ] adenosine triphosphate (ATP), phosphotidyl-L-serine, PMA., and 
calcium ions. Distribution of y-PKC isozyme in the presence of FB I was assessed by 
immunoblotting using affinity purified anti-peptide antibodies . Similar to PMA, FBI added 
to rat cerebrocortical slices facilitated PKC translocation from cytosol to membrane in a 
concentration dependent manner. This FBI-induced PKC translocation was inhibited by 
incubation with the inactive 4a.-phorbol-12,13-didecanoate. The effects of FB land PMA 
were neither additive nor synergistic. In addition, PMA and FBl-induced PKC enzyme 
redistribution were inhibited by pre-treating tissues with So. A concentration-related FBl 
attenuation of specific phorbol dibutyrate (PDBu), [3H] PDBu, binding was also observed 
when cortical membranes were incubated with either PMA or So (Yeung et ai., 1996). This 
was the first report of FBl-induced PKC translocation via a direct action on the 
diacylglycerol site that also binds phorbol esters. Because phorbol esters are well-known 
tumour promoters, this study provides a plausible mechanism to explain the 
carcinogenicity of FB I. 
Interference with sphingolipid metabolism in response to sustained FBl exposure is a 
plausible mechanism by which these mycotoxins induce mitogenesis (Yoo et ai., 1992; 
Merrill et ai., 1993a; 1993b; Schroeder et ai., 1994). Given the differences in duration of 
FBI exposure that are required to activate PKC and inhibit sphingolipid metabolism, it is 
possible that mycotoxin-induced mitogenesis involves two phases. Thus, upon chronic 
exposure to FB l, PKC activation seems to be a dominant mechanism in the early stage, 
followed by FBl-mediated disruption of sphingolipid biosynthesis and accumulation of 
sphingoid bases or their metabolites (Wang et aI., 1991; Riley et aI., 1994b). In the later 
phase, profound reductions in PKC activation may be due to the additive actions of FB I-
induced translocation followed by proteolytic degradation of the translocated enzyme, as 
well as inhibition of enzyme activation by the sphingoid bases or their metabolites 
(Hannun et aI., 1986; Vaccarino et aI., 1987; Kharlamov et aI., 1993). The mechanism FBI 
uses to elicit its mitogenic activity are complex and these findings provide an additional 
cellular mechanism to further define the effects. 
2.26.4 Fumonisin Bl in isolated brain cells 
2.26.4.1 Fumonisin Bl inhibits ceramide synthase and de novo sphingolipid 
biosynthesis in cultured neurons in situ 
van Echten et al. (1990) and Mandon et al. (1991) showed that the addition of So to 
cultured mouse cerebellar neurons caused a decrease in the incorporation of e4C] serine 
into sphingolipids, apparently due to the down regulation of SPT. Since FBI caused 
cellular Sa to accumulate, it was thought that FBI might induce a secondary inhibition of 
the first step of the pathway, as well as at CER synthase. However, in experiments in 
which cells were treated overnight with 25~M FBI and the microsomes were isolated and 
assayed for SPT activity, the activity of the fumonisin treated cells was not significantly 
different from controls. This effect was further studied in neuroblastoma cells 
(Rother et al., 1992), where it was shown that FB I specifically inhibited the conversion of 
Sa to dihydroceramides. 
Incorporation of[14C] serine into SM and GSLs was examined to evaluate how this affects 
the distribution of newly synthesised CER, among different complex sphingolipids in 
cultured mouse cerebellar neurons (Merrill et aI., 1993b). Fumonisin B I inhibited CER 
synthase in mouse brain microsomes with a competitive-like kinetic behaviour with respect 
to both Sa and stearoyl-CoA This suggests that CER synthase recognizes both the amino 
group (sphingoid binding domain) and the TCA side-chains (fatty acyl-CoA domain) of 
FBI (Merrill et al., 1996b). The reduced inhibition by the hydrolysed derivatives of the 
fumonisin B series (Norred et aI., 1997; van der Westhuizen et ai., 1998) supports this 
hypothesis. Humpf et ai. (1998) have shown that CER synthase acylates hydrolysed FB I, 
API, to form N-palmitoyl-AP I. The product was found to be an inhibitor ofCER synthase, 
and to be 10 times more toxic than FBI in the HT29 human colonic cell line. 
Fumonisin BI inhibited sphingolipid biosynthesis in the cultured cerebellar neurons and 
this was reflected by accumulation of free Sa, a reduction in the mass of total 
sphingolipids, reductions in the incorporation of [14C] serine into glucosylceramide, 
lactosylceramide, SM and gangliosides (GMI , GD3 , Gola, Golb, Grlb, GQlb), and inhibition 
of the incorporation of ['4C] galactose and eH] Sa into complex sphingolipids 
(Merrill et aI., 1993b). Dose response studies revealed that the labelling of SM 
(ICso of 0.7IJ.M) was more sensitive to inhibition by FBI than was glycolipid formation 
(ICso of -7IJ.M) in these cells. A similar effect was seen when ~- fluoroalanine was added to 
inhibit the activity of SPT, the first enzyme of the pathway. The inhibition of complex 
sphingolipid synthesis was reversible, and nearly normal labelling products were obtained 
48 hours after removing the mycotoxin. These studies establish that FB I inhibits de novo 
sphingolipid biosynthesis by neuronal celis, and moreover, that limiting CER synthesis 
differentially affects the formation of SM versus GSLs. 
Fumonisin BI had a more potent effect on SM formation than on glycolipid biosynthesis 
Merrill et al. (1993 b). This was considered due to a greater sensitivity of SM synthesis to a 
reduction in CER formation, because it was also seen with another inhibitor of de novo 
CER biosynthesis W-fluoroalanine). Such selectivity may be due to a number of causes:-
• The Michaelis-Menten constant (Km) for CER of glucosylceramide synthase may be 
lower than that of SM synthase, thus a decrease in CER synthesis will not affect GSL 
formation until the CER concentration decreases to below the Km. 
• The intracellular localisation of SM and GSL biosynthesis (Hoekstra and Kok, 1992) 
might account for these differences. For example, GSL synthesis may begin in a 
cellular compartment that is more proximal to the site of CER synthesis; therefore these 
enzymes would have first access to CER. This explanation agrees with evidence that 
CER synthesis is on the cytoplasmic surface of the ER (Mandon et aI., 1992) whereas 
SM synthase is thought to be on the luminal side of the cis-Golgi (Jeckel et al., 1990; 
1992), although some cells appear to have more than one intracellular site for SM 
synthesis. 
• The inhibitors (FBI and ~-fluoroalanine) may inhibit a CER "flipase" that moves this 
substrate from the cytosolic to the luminal side of the Golgi membrane. 
• The inhibitors may affect SM synthase and glycosyltransferase(s) directly but more 
potently inactivate the former. 
Merrill et al. (1993b) however further postulated that similar findings with two very 
structurally different compounds, FBI and ~-f1uoroalanine, make these last two 
explanations less likely. Thus, the greater sensitivity of SM synthesis is probably due to the 
differences in the Km and/or subcellular localisation of the pertinent enzymes 
(Merrill et aI., 1993b). This study demonstrated that FBI blocks sphingolipid formation 
from [14C] serine, eH] galactose, and eH] Sa in neuronal cells, that Sa accumulates in 
cells treated with this mycotoxin, and that SM biosynthesis from e4C] serine is 
differentially affected at fumonisin concentrations that only partially inhibit CER synthesis. 
These studies establish FBI inhibits de novo sphingolipid biosynthesis by neuronal cells 
and moreover, that limiting CER synthesis differentially affects the formation of SM 
versus sphingolipids. 
Fumonisin BI may have two modes of interaction with CER synthase. The 'Sa-like' 
domain may interact with the Sa binding-site, and the negatively charged TCA groups may 
interact with the fatty acyl-CoA binding site by mimicking the polyanionic phosphate 
groups of the CoA. The latter interaction is probably not the most important, because FBI 
does not inhibit another CoA-dependent enzyme (i.e., SPT) or labelling of glycerolipids 
(Wang et aI., 1991), and removal of the TCA groups increases the lC50 only about lO-fold 
(Merrill et aI., 1993b). The ability of FBI to interact with both the binding sites however 
might account for its potency. 
Sphingolipid biosynthesis was studied In cultured munne cerebellar neurons 
(van Echten et aI., 1990) in the absence or presence of exogenous So homologues with 
different alkyl chain lengths (12,18,24 carbon atoms). Labelling of cells with C4C] serine 
for 24 hours indicated that endogenous So biosynthesis with incorporation of radiolabelled 
serine was inhibited by these long chain bases (0.5-50~M) in a concentration-dependent 
manner. The inhibition was fully reversible after removal of the long chain bases from the 
culture medium. Metabolic labelling of neurons with [14C] galactose provided strong 
evidence that the cells were able to use the exogenous So homologues, irrespective of their 
alkyl chain length, as substrates for the biosynthesis of GSLs. When the biosynthetically 
inert sphingoid, azidosphingosine (5-S0IlM) was fed to the cells, de novo So and GSL 
biosynthesis were both strongly inhibited (van Echten et aI., 1990). 
EI Bawab et al. (2001) characterised the reverse activity of a purified rat brain membrane 
bound ceramidase. Fumonisin BI was shown to inhibit the CoA dependent CER synthase 
activity in rat brain microsomes, and was also found to not inhibit the reverse ceramidase 
activity purified from rat brain. These results clearly indicate that the two activities 
represent different enzymes and further attest to the specificity of FB I. 
2.26.4.2 Fumonisin Bl impairs myelin formation in aggregating brain cell culture 
The effects of subchronical applications of FB I were analysed in vitro, using cultures of rat 
telecephalon as a model. As cells in the aggregates develop from an immature state to a 
highly differentiated state with synapse and compact myelin formation, it is possible to 
study the effects of FBI at different developmental stages. The results showed that FBI did 
not cause cell loss and it had no effect on neurons . At all developmental stages tested, FBI 
caused neither cell death nor apoptosis. It also did not induce microglial reaction, which is 
considered an early marker of neurotoxicity (Monnet-Tschudi et aI., 1995; 1996). 
Fumonisin BI delayed oligodendrocyte maturation, as suggested by the slight decrease of 
the differentiation marker galactocerebroside (Gal C), without affecting the number of 
myelinating cells, since no change in the enzymatic marker CNP was found 
(Espinosa de los Monteros et al., 1988). Since the myelin basic protein (MBP) content was 
not significantly decreased in highly differentiated cultures, mature myelin appeared to be 
more resistant to FBI treatment. However, at 40 ~ FBI, the MBP immunoreactivity was 
decreased in myelinating, as well as in highly differentiating cultures. These data indicate 
that at high concentrations, FBI may affect both the synthesis and the deposition of MBP. 
Furthermore, FB I may also interfere with the compaction of the myelin sheath in 
differentiated cultures, since the myelin oligodendrocytes glycoprotein (MOG) was 
decreased in differentiated cultures. This marker, localized essentially at the external 
surface of the myelin sheath, appears late in the compacting myelin sheaths 
(Brunner et al., 1989). This could explain why no effect on MOG was detected earlier in 
development. 
The other effect observed after FBI treatment in differentiated cultures, was a loss of the 
astrocytic marker, glial fibrillary acidic protein (GF AP), while the enzymatic marker 
glutamine synthetase was not modified. These data indicate that FBI did not interfere with 
maturation of astrocytes or with their viability. It is known that sphingolipids bind to 
cytoskeletal proteins leading to stabilization of the cytoskeleton. Therefore a deficit of 
sphingolipids due to a block on CER synthase by FBI could explain this loss of GF AP . 
Since GF AP is largely distributed in astrocytic foot processes, FBI could disrupt their 
structural organisation. The content of GF AP was decreased in differential astrocytes 
exclusively, while neurons were not affected by 40~M of FBI applied continuously for 
10 days . In summary, FBI selectively affected glial cells while neurons were spared . In 
particular, FBI delayed oligodendrocyte development and impaired myelin formation and 
deposition. At high concentrations, FBI affected mature compact myelin . The relevance of 
this data to humans, and the relationship between the observations and the known actions 
of FBI require further investigation (Monnet-Tschudi et aI., 1999). 
2.26.4.3 Effects of fumonisins on myelin synthesis 
Kwon et al. (2000) assessed short-term consequences of direct FBI exposure on astrocytes 
and oligodendrocytes in primary cultures of rat cerebrum, to determine the effects of FBI 
on myelin and sphingolipid metabolism. Beginning at five days in vitro (DIV), the cultures 
were exposed to FBI at five concentrations (between 0.S-7S ~M). The cultures were 
evaluated after exposure to the toxin for five (10 DIV) and ten days (IS DIV) respectively. 
The levels of the sphingolipid associated constituents So and Sa were determined with 
HPLC. Relative to untreated cultures, exposure to FBI diminished the levels of So at 
IS DIV, whereas FBI exposed cultures showed significantly increased Sa levels and Sa:So 
ratios. In addition, FBI exposed cultures exhibited a two fold increase in the number of 
process bearing cells by IS DIY. Also the activity of CNP was increased in FBI-treated 
cultures. Overt cytotoxicity to FBI was not observed in this study. Even at the highest FBI 
concentration (7S~M), exposure of glial cultures continuously for 10 DIV did not result in 
FBI-associated changes in protein or DNA. This finding is consistent with previous reports 
that FBI did not change protein content or cell number in cultured hippocampal neurons or 
aggregating brain cell cultures (Hare I and Futerman, 1993; Monnet-Tschudi et aI., 1999). 
However, Kwon et al. (2000) reported that protein and DNA content were inconsistently 
increased after exposure to FB I for IS DIY. Previous cell culture studies have yielded 
seemingly divergent results perhaps due to differences in cell type or metabolic status. 
For instance, FBI and Sa are cytotoxic to proliferating cultured CHO cells 
(Stevens et aI., 1990) and a line of kidney cells (Yoo et aI., 1992). In contrast, FBI or Sa 
stimulates DNA synthesis in fibroblasts (Schroeder et al., 1994). The saturating effects of 
FB I on the Sa levels may be due to either the inhibitory action of FB I on target enzymes or 
saturating of FBI transport across cell membranes. When administered experimentally, FBI 
exposure results in reduced brain growth, hypomyelination and changes in sphingolipid 
metabolism that are evident from increases in both the Sa level and the Sa: So ratio of brain 
tissue (Kwon et al., 1997a). 
Fumonisin BI exposure for a long period may result in decreased So levels due to the 
reduction of sphingolipids. Kwon et al. (2000) reported that Sa levels were significantly 
increased at both 10 DIY and 15 DIY in FBI-treated cultures. Kwon et al. (2000) 
concluded that there was indication that the direct cellular exposure to FB I does not inhibit 
cell growth as assessed by DNA or protein content. Furthermore, the FBI related increases 
in both CNP activity and number of process bearing cells suggests that FBI may be 
mitogenic for cells in the oligodendrocytes/astrocyte lineage as it is for cultured fibroblasts. 
Thus, the white matter defects in animals exposed to FBI may not result directly from glial 
cytotoxicity. However, because the changes observed in the Sa levels and Sa:So ratios of 
FB I exposed cultures quantitatively resemble those previously found in vivo 
(Kwon et al., 1997a; 1997b), subtle FBI related changes in sphingolipid metabolism may 
impair oligodendrocytes differentiation and the formation of myelin. The study of 
Kwon et al. (2000) suggests that short-term exposure to FBI may modify the proliferation 
of glial cells. 
2.26.4.4 Effects of fumonisin Bl on glycosphingolipids and gangliosides 
Sialic-acid containing GSLs, gangliosides, are principal constituents of cell membranes and 
enriched in mature neurons. Sphingolipids are strong candidates as regulators of growth 
since they are enriched in neurons, and their levels and types, particularly gangliosides 
change significantly during development and differentiation. Furuya et al. (1995) observed 
an aberrant growth of dendrites of Purkinje cells depleted of membrane GSLs by FBI 
treatment. Fumonisin B I treatment resulted in less complex patterns of dendritic 
arborisation, suggesting a role of GSLs in neurite branching. Endogenous sphingolipids are 
required for the normal growth of cultured cerebellar Purkinje neurons and SM is present 
abundantly in the somatodendritic region of these cells. Furuya et al. (1998) in a 
subsequent study investigated the effects of depletion of sphingolipids on the phenotypic 
growth and survival of immature Purkinje cells and the ability of CER or other 
sphingoli pids to antagonize these effects. Inhibition of CER synthesis by ISP-1, decreased 
cellular levels of sphingolipids, decreased cell survival accompanied by an induction of 
apoptotic cell death, and aberrant dendritic differentiation of Purkinje cells with no 
detectable changes in other cerebellar neurons (Furuya et at., 1998). These observations 
suggest that CER is a requisite for survival and dendritic differentiation ofPurkinje cells. 
SHSY5Y lrk-A neuroblastoma cells are a cell clone transfected with NGF-receptor gene 
p140trk-A Addition of FBI (30-50~M) to SHSY5Ytrk-A human neuroblastoma cells resulted 
in a 40% decrease of the ganglioside content, and in a reduction of NGF-induced 
outgrowth of neuritic processes within four days. A comparable effect of FBI was found in 
a neuronal tissue culture system, resulting in a dose dependent inhibition of neurite 
outgrowth from embryonic chicken spinal cord explants. The effective concentrations were 
in the range of 20-50~M FBI. Similar concentrations have been reported to reduce axon 
elongation and branching of rat hippocampal neurons during a defined period of cell 
culture (Harel and Futerman, 1993; Schwarz et aI., 1995), as well as serum 
deprivation-induced neurite outgrowth of murine neuroblastoma cell lines. 
Since FBI did not impair neurite growth, newly synthesised GSLs are not essential for 
axonal growth. This finding is in accordance with the study by Schwarz et at. (1995), in 
which incubation of cultured hippocampal neurons with FBI dramatically reduced the 
amount of cell surface gangliosides, as early as 24 hours after the initiation of treatment. 
Schwarz et at. (1995) analysed the relationship between neuronal growth and sphingolipid 
metabolism by analysing the effect of FBI on neuronal development. Inhibition of GSL 
synthesis did not affect the formation of the parent axon during its emergence from the cell 
body. In hippocampal neurons, the most significant effect of inhibition of GSL synthesis 
was impairment of formation or stabilization of collateral axonal branches. Inhibition of 
sphingolipid synthesis results in a decrease in the number of axonal branch points/cell, 
whereas inhibition of sphingolipid degradation results in an increase in the number of 
axonal branch points (Schwarz et aI., 1995). 
Schwarz and Futerman (1998) demonstrated that dendritic growth in hippocampal neurons 
also requires ongoing sphingolipid synthesis. With continuous incubation with FBI, 
dendritic growth rates were -25% slower than control cells, resulting in neurons with 
shorter dendritic arbors and less dendritic branch points per cell, and readily apparent 
differences in morphology compared to control cells after 10-14 days in culture. In 
contrast, FBI had no effect on the initial growth of minor processes, which were destined to 
become dendrites, even in cells in which FBI affected the rate of axon growth. These data 
demonstrate that normal dendrite growth in hippocampal neurons requires sphingolipid 
biosynthesis, although the molecular requirements for sphingolipid synthesis may differ 
from those in axons. 
de Chaves et at. (1997) presented evidence that FBI inhibits GSL synthesis in cultured 
primary rat sympathetic neurons by showing that FBI inhibited incorporation of 
CH] palmitate into several gangliosides in rat sympathetic neurons indicating that it 
inhibits GSL synthesis. The findings also indicate that newly synthesized GSLs are not 
essential for neurite growth, but that the lipid second messenger CER negatively regulates 
neurite growth. 
2.26.4.5 Effect of fumonisin Bl on cell viability, protein synthesis and cell cycle 
The involvement of lipid peroxidation on FBI induced cytotoxicity was investigated in the 
C6 glioma cell line to establish any relationship between cell viability, genotoxicity and 
cell division (Mobio et at., 2000). The study showed that FBI induced a reduction in cell 
viability, which was prevented by the antioxidant vitamin E, thus confirming the 
involvement of lipid peroxidation in the cytotoxicity induced by this toxin. Rat C6 glioma 
cell viability was not affected significantly up to 5-6J...1.M of FBI, then decreased to 60-65% 
with 9-30 J...I.M FBI. Viability was never lower than 50% even with higher concentrations of 
30-50 J...I.M FBI . The reduction in C6 glioma cells viability induced by FBI was prevented by 
vitamin E at 25J...1.M when cells were pre-treated before the addition of the toxin (p=0.01). 
Protein synthesis as determined by the incorporation of eH] leucine in C6 glioma cells was 
inhibited in a dose dependent manner by FBI after 24hour incubation. The inhibition was 
strong and linear (r=0.987) up to lO).lM. The IC50 concentration was 6J...1.M. For higher 
concentrations of FBI, the percentage of inhibition reached a plateau at about 75-80%. 
After 48hour incubation, FBI inhibited DNA synthesis exactly as after 24hour incubation. 
A residu~l DNA synthesis was still going on. Protein synthesis was slightly less inhibited 
after 48 hours, as compared to percentage inhibition after 24 hours . This applied also to the 
C6 cells viability. 
Using flow cytometry, the distribution of cells within the different cell cycle phases in 
control C6 cells was 36±2% for the Go/GI phase, 18.5±3% for S phase and 46±0.5% in 
G2iM phase When C6 glioma cells were incubated with FBI, the distribution of cells into 
the different cell cycle phases was modified. The number of cells in S phase decreased 
significantly, (p ::; 0.05), but not in a dose-dependent manner, from six up to 18~M FBI. 
The number of cells in G2iM phase increased significantly (p ::; 0.05), but not in a 
dose-dependent manner from 3~ of FBI. The reason for this lack of dose dependency is 
not clear, however it is striking that low concentrations of FBI that are not highly cytotoxic 
are capable of inducing the cell cycle arrest. This effect could be closely related to 
genotoxicity or some epigenetic effects. This suggests that even low concentrations of FB I 
that do not affect cell viability are already capable of inducing cell cycle arrest in the G2iM 
phase (Mobio et at., 2000). 
The synthesis of DNA as determined by CH] thymidine incorporation in C6 glioma cells 
was not significantly inhibited up to 5~M. With 10, 20 and 50~M of FBI, the inhibition of 
the DNA synthesis was of 27±4%, 37±4% and 27±0.5% respectively. Concerning the 
epigenetic effects, the results of Mobio et al. (2000) show that FB I induces significant 
hypermethylation in the DNA of C6 glioma cells in the concentration range of 9 to 18~M. 
The lack of hypermethylation with FBI concentrations above 18~M could be related to an 
extreme cytotoxicity and also as a consequence of DNA damage. The extent of DNA 
damage induced by concentrations of FBI in the range of 6-18~M could favour the 
hypermethylation of DNA. In addition, methylated CpG sites can bind specific nuclear 
proteins such as MeCp 1 and MeCp2 (Nan et aI., 1993), which could conceivably block or 
modify the repair process (Tornaletti and Pfeifer, 1995). 
The apparent discrepancy between the percentage of FBI-induced inhibition of DNA 
synthesis and protein synthesis in the C6 glioma cells, as related to the concentrations of 
the mycotoxin, could tentatively be explained by assuming that protein synthesis is the first 
target of FBI, thus confirming previous results (Abado-Becognee et aI., 1998). This could 
consequently decrease the intracellular level of DNA synthesis with the 48-hour incubation 
time. C6 cell viability was not modified while the protein synthesis inhibition was slightly 
lower. All these results reflect consequences of the residual DNA synthesis, and may allow 
cell multiplication to a new generation, which at its turn is being inhibited by FBI. Such a 
pathway could generate mutated cell types due to possible DNA base modification induced 
by FB I in the previous cell generation. 
2.26.4.6 Effects of fumonisin Bl on neuron extension and synapse formation 
Neuronal growth is regulated by both extracellular and cellular determinants and proceeds 
by the addition of new membrane material at the growth cone. To determine whether lipid 
synthesis is necessary to maintain neuronal growth, Harel and Futerman (1993) examined 
the effect of FBI on the development of cultured hippocampal neurons . Ganglioside 
synthesis and content was reduced after FB I treatment, ganglioside GD 1 b was not 
detectable at the cell surface by immunofluorescence, and in fumonisin-treated cells no 
increase in axon length was observed. Addition of a fluorescent derivative of CER together 
with FBI reversed the effect, confirming that FBI acts via inhibition of CER synthase. 
Normal axonal growth was restored by addition of exogenous CER derivative suggesting 
that depletion of GSLs directly caused the reduced axonal growth. The ability to restore 
normal function by CER replacement shows that these effects of fumonisins are due to loss 
of biosynthesis of a key sphingolipid (or sphingolipids). However, fumonisin induced 
disruption of sphingolipid metabolism causes numerous biochemical changes that could 
affect cellular regulation. It is difficult therefore to clearly demonstrate that a single 
biochemical perturbation could account for any specific effect on cell behaviour. This 
study showed that sphingolipid synthesis is necessary to maintain neuronal growth by 
demonstrating that in hippocampal neurons, inhibition of CER synthesis by FBI disrupted 
axonal outgrowth. 
Using primary cultures of hippocampal neurons in a study on the regulatory roles for 
sphingolipids in the growth of polarised neurons, Futerman et al. (1998) found that 
sphingolipids play at least three distinct roles in regulating neuronal development. These 
are namely that CER enhances the formation of minor neuronal processes from 
lamellipodia, that glucosyiceramide synthesis is required for both normal and accelerated 
axon growth, and that at both of these stages of development, CER induces apoptotic cell 
death at high concentrations. These observations are consistent with the possibility that 
minor process formation and apoptosis are both regulated by CER-dependent signalling 
pathways, whereas axonal growth may require glucosylceramide synthesis to support an 
intracellular transport pathway (Futerman et aI., 1998). 
Meivar-Levy and Futerman (1999) demonstrated that inhibition of CER synthesis by FBI 
for five days, resulted in up-regulation of the activities of three enzymes in the pathway of 
Gb3 synthesis; namely glucosylceramide, lactosylceramide and Gb3 synthases. Up 
regulation of the activities is due to an increase in maximal velocity (V max), with no change 
in Km values. 
Aggregating brain cell cultures exposed to FB I (3-40 llM) for 10 days show decreases in 
both the total content of MBP and immunoreactivity of the oligodendrocyte membrane 
marker Gal C in the absence of general cytotoxicity (Monnet-Tschudi et aI., 1999). 
2.26.4.7 Effects of ceramide, sphinganine and sphingosine on neuronal cells 
The effect of six structurally modified So analogues on biosynthesis of sphingolipids was 
studied in primary cultured murine cerebellar neurons. Treatment of cells with 
eis-4-methylsphingosine at micromolar levels resulted in a markedly decreased 
sphingolipid biosynthesis, whereas the other compounds examined; trans-4-methyl-So, 
eis-5-methyl-So, trans-5-methyl-So, cis-So, and I-deoxy-So inhibited sphingolipid 
biosynthesis less efficiently. The inhibition of sphingolipid biosynthesis by the various 
compounds was paralleled by a decrease of SPT activity in situ. The activity of other 
enzymes of sphingolipid biosynthesis, as well as phospholipid and protein biosynthesis 
was not affected. Except for I-deoxysphingosine, the other five So analogues were shown 
to be substrates for So kinase in vitro. The inhibitory effect of the So analogues on SPT 
was mediated by their respective I-phosphate derivatives and the pronounced effect of 
eisA-methyl-So was caused by a high intracellular concentration of eisA-methyl-
So I-phosphate. eis-4-methyl-So, in addition, caused drastic changes in cell morphology of 
primary cerebellar neurons, which were not observed when these cells were treated with 
one of the other So analogues examined (van Echten-Deckert et aI., 1997). 
Sphingosine has been found to inhibit neutrite outgrowth in PC-12 cells in response to 
NGF (Hall et al., 1988). I-Methylthiodihydroceramide (1011M) decreased de novo CER 
biosynthesis by about 90% in primary cultured cerebellar neurons. Accordingly, de novo 
formation of SM and of GSLs, all of which contain CER in their backbone, was reduced in 
a time and concentration-dependent manner by up to 80%. Complex sphingolipid synthesis 
was restored upon addition of dihydroceramide or CER, in micromolar concentrations, to 
the culture medium, · suggesting that none of the glycosyltransferases involved in GSL 
biosynthesis is inhibited by this analogue (van Echten-Deckert et al., 1998). 
Riboni et al. (1995) showed that CER plays a mediator role in the regulation of cell 
differentiation in N2a neuroblastoma cell line. Fumonisin BI blocked So-induced 
differentiation, which established that conversion of So to CER is required. Fumonisin BI 
also diminished retinoic acid induced differentiation, showing that de novo CER synthesis 
is important in differentiation of this cell line. 
2.26.4.8 DNA damage in astrocytes exposed to fumonisin Bl 
Galvano et al. (2002) exposed rat astrocytes to FBI with the aim of evaluating the 
involvement of oxygen free radicals and some other biochemical pathways such as 
caspase-3 activity and DNA damage. Their results indicated that FBI treatment (48 hours, 
72 hours and 6 DIY, and 10, 50, and 1001lM) does not affect cell viability . Conversely, 
after 72 hours of treatment, 50 and 100~M FBI induced DNA damage and enhancement of 
caspase-3 activity compared to controls. The authors conclude that the DNA damage of 
apoptotic type in rat astrocytes is caused by FBI, and that the genotoxic potential of FBI 
should be reconsidered as it has probably been underestimated. 
2.27 OTHER Fusarium MYCOTOXINS 
Included in the in vitro component of the work in this study are the mycotoxins FA, ZEA, 
T2, and DON. Brief summarises of their characteristics are listed below. 
2.27.1 Zearalenone 
Zearalenone is a non-steroidal oestrogenic mycotoxin produced by several Fusarium 
species (Figure 2 .8). It is a stable compound, both during storage/milling and the 
processing/cooking of food, and does not degrade at high temperatures. Zearalenone has 
been implicated in numerous mycotoxicoses in farm animals, especially in pigs 
(European Commission, 2000a). 
HO 
Figure 2.8: Chemical structure of zearalenone. 
Consumption of ZEA by swine at more than 0.1 to 5ppm causes an oestrogenic syndrome, 
characterised in females by a swollen vulva with enlarged mammary glands, and in young 
males by a shrinking of the testes. Oestrogenism in swine is usually more prevalent in the 
early spring because, once the fungus is established in the grain, it generally requires a 
period of relatively low temperatures to produce significant amounts of ZEA 
(Jacobsen et al., 1993). 
Zearalenone has shown a DNA damaging effect in recombination tests with Bacillus 
cereus, and further experiments revealed DNA adduct formation in the kidney, ovaries and 
livers of female mice. In contrast, DNA adducts were not observed in rats after treatment 
with ZEA. Zearalenone was not carcinogenic to rats of either sex but was carcinogenic in 
mice, as observed by the increased proportion of male and female mice with pituitary 
adenomas and by the increased proportion of female mice with hepatocellular adenomas 
after feeding these animals ZEA (United States National Toxicology Program. 1982). 
Further research is also needed with regard to human toxicity. Zearalenone was suspected 
to be the causative agent in an epidemic of pubertal changes in young children in Puerto 
Rico between 1978 and 1981 and it has been suggested that zearalenone may have a 
possible involvement in human cervical cancer. Currently, IARC classifies zearalenone as 
a Class 2A carcinogen, the highest possible classification when categorical human 
epidemiology is absent (Leatherhead Food Research Association, 2002). 
2.27.2 T-2 TOXIN 
T-2 toxin belongs to the trichothecenes type A group that are produced by Fusarium 
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species of fungi (Figure 2.9). The trichothecenes share a tricyclic nucleus and usually 
contain an epoxide at C-12 and C-13. This epoxide is essential for toxicity. Trichothecenes 
are in general very stable compounds, both during storage/milling and the 
processing/cooking of food and do not degrade at high temperatures (Desjardins, 1993). 
Figure 2.9: Chemical structure of T -2 toxin. 
Trichothecenes are sesquiterpene epoxides that inhibit eukaryotic protein synthesis and 
thereby impair human and animal health (Desjardins et ai., 1993). T -2 toxin has been 
implicated in two outbreaks of acute human mycotoxicoses. The first occurred in Siberia, 
during the Second World War, producing a disease known as "alimentary toxic aleukia" 
(A T A) where thousands of people, who were forced to eat grain that had over-wintered in 
the field were affected. The symptoms of AT A included fever, vomiting, and acute 
inflammation of the alimentary tract, anaemia, circulatory failure and convulsions. T-2 
toxin poisoning also occurred in Kashmir in India in 1987, and was attributed to the 
consumption of bread made from mouldy flour from which T2 was isolated. 
The major symptom was abdominal pain together with inflammation of the throat, 
diarrhoea, bloody stools and vomiting. This mycotoxin has also been implicated with the 
occurrence of haemorrhagic toxicoses in farm animals, especially in poultry. T -2 toxin is a 
potent skin-damaging agent and is absorbed slowly (12-24 hours) via intact skin, but 
rapidly through abraded skin. The rapid appearance of symptoms after respiratory exposure 
in humans, along with the results of animal inhalation studies, indicates rapid absorption 
and high retention of aerosolised T2, with the respiratory tree retaining small amounts 
(Augers on, 2000). The many mechanisms by which T2 produces toxicity are varied and 
their relative importance in producing illness is not fully understood. These mechanisms 
include inhibition of protein, DNA and mitochondrial protein synthesis, as well as 
induction of single strand breaks in DNA (European Commission, 2000b). 
Dietary levels ofT-2 toxin as low as O.Sppm were found to cause a reduction in feed intake 
in pigs (Rafai et aI., 1995). T -2 toxicoses are due to elevation of tryptophan in the brain. 
Tryptophan is a precursor of serotonin, a mediator of appetite (Smith and Seddon, 1998). 
The relative toxicities of the type A (isovaleryl, hydrogen or hydroxyl at the C8 position, 
(e.g., T2, Figure 2.9) and the type B (carbonyl group at the C8 position e.g., DON, 
Figure 2.10) trichothecenes have been studied in a number of cell and animal systems. 
While the ranking of toxicity is similar, the range of toxicity varies dramatically with the 
system used . The difference in toxicities between the most (T2 toxin) and the least 
(3-acetyl DON) toxic trichothecenes was 1300-fold for Vero cells 
(Thompson and Wannemacher, 1986), 23 000 fold for MIN-GL 1 cells, 2000 fold for KS62 
cells (Visconti et aI., 1991), and lS00 for BHK-21 cells (Rotter et aI. , 1993). 
Holt and Deloach (1988) found that bovine cells were the most sensitive to T2 
(SO% inhibition at 2.2ng.mr1) while hamster cells were the least sensitive (SO% inhibition 
at 26.2ng.mr1). Murine cells exhibited intermediate sensitivity (SO% inhibition at 
109ng.mr1). Lymphocytes were three fold more sensitive to T2 inhibition than comparable 
tissue culture cell lines. Mirocha et al. (1992) found that T -2 toxin was toxic to five rat 
hepatoma cell lines (H4TG, H4-II-E, H4-II-E-C3 , Fao and MH1C1) and one dog kidney 
cell line (MDCK) . The IC50 values for T2 were between 1.S-Sng.mr
1 for the rat hepatoma 
lines and O.Sng.mr l for the dog kidney cell line. 
2.27.3 Deoxyn ivalenol 
Deoxynivalenol is produced by F. culmorum and F. graminearum, which are abundant in 
cereal crops (wheat, maize, barley, oats, and rye) and processed grains (malt, beer and 
bread) (Figure 2.10). Chemically, it belongs to the class of tricothecenes. In contaminated 
cereals 3- and IS-acetyl DON can occur in significant amounts (10-20%) concomitantly 
with DON. Deoxynivalenol is a very stable compound, both during storage/milling and the 
processing/cooking of food (Rotter et aI., 1996; Ehling et aI., 1997; Eriksen and Alexander, 
1998). 
· · · OH 
H ••• OH 
Figure 2.10: Chemical structure of 4-deoxynivalenol (DON; vomitoxin, dehydronivalenol, 
RD-toxin). 
The IARC (1993a) classified DON in Category 3, i.e., not classifiable as to its 
carcinogenicity to humans. At that time however, the negative chronic study in mice was 
not available (Iverson et al., 1995). Deoxynivalenol inhibits the synthesis of DNA and 
RNA and protein synthesis at the ribosomal level, and has a haemolytic effect. An acute 
dose of DON can induce vomiting in pigs, whereas at lower concentrations in the diet it 
reduces growth and feed consumption. Both effects, which are also seen with other 
trichothecene toxins, are possibly mediated by modifYing the serotonergic activity in the 
CNS or via peripheral actions on serotonin receptors (Rotter et al., 1996; 
Eriksen and Alexander, 1998). 
Deoxynivalenol showed neither mutagenic activity III Ames tests with Salmonella 
typhimurium, both with and without S-9 activation systems, nor in an in vitro unscheduled 
DNA synthesis test using rat primary hepatocytes. Deoxynivalenol enhanced cell 
transformation in mouse embryo cells in vitro, and induced clastogenic effects and 
inhibited gap-junctional intercellular communication in Chinese hamster V79 cells. 
Deoxynivalenol inhibited the protein synthesis in CHO cells in vitro in the same dose range 
as that inducing clastogenic effects. There are indications for a suppression of humoral and 
cellular immunity, resulting in an increased susceptibility for infectious diseases 
(Hsia et al., 1988; IARC, 1993a; 1993b; Leatherman and Middlebrook, 1993; 
Eriksen and Alexander, 1998). Regarding this increased susceptibility for infectious 
diseases, a NOAEL of 0.25 mg.kg-1 body weight per day (Tryphonas et al., 1986) and a 
lowest-effect level of 0.22 mg.kg-1 body weight per day were reported in studies with male 
Swiss-Webster and male Balb/C mice, respectively (Baars et al., 1999). Studies are needed 
to cover the trichothecenes group as a whole, to confmn that there are no neurotoxic effects 
at doses below those causing effects on growth and body weight, focusing on the known 
target for tricothecenes, the CNS serotonergic system. 
2.27.4 Fusaric acid 
Fusaric acid (5-butylpicolinic acid, FA) (Figure 2.11) is a phytotoxin produced mainly by 
F. moniliforme. Fusaric acid selectively inhibits the enzyme dopamine ~-hydroxylase, both 
in vitro and in vivo (Nagatsu et al., 1970) leading to an increased concentration of 
dopamine (DA) and its metabolites with concomitant reduction in brain noradrenalin (NA) 
concentrations. Dopamine-~ hydroxylase catalyses the final step in the biosynthesis of 
norepinephrine. Fusaric acid does not influence the activity of tyrosine hydroxylase, 
monoamine oxidase or aldehyde dehydrogenase (Nagatsu et al., 1970) nor does it affect the 
release or uptake of catecholamines. In man, FA was shown to increase CSF DA 
metabolites, while reducing NA metabolites (Sack and Goodwin, 1974). Disease symptoms 
observed includes loss of appetite, vomiting, gastrointestinal lesions, lethargy, 
immunosuppression and loss of muscle co-ordination. 
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Figure 2.11 : Chemical structure of fusaric acid (5-butylpicolinic acid, FA). 
Fusaric acid is mildly toxic to mice and has several important pharmacological properties 
in that both brain and pineal neurotransmitters and metabolites are affected 
(Porter et al., 1995). Fusaric acid was growth inhibitory and cytotoxic in vitro 
(Fernandez-Pol et al., 1993; Vesonder et al., 1993) and inhibited DNA synthesis in WI-38 
fibroblasts (Fernandez-Pol et al., 1993). It is a hypotensive agent and by inhibiting 
~-hydroxylases (Hidaka et al., 1969), alters tissue levels of catecholamines and 
indolamines in rats (Porter et ai., 1995; Rimando and Porter, 1997). Fusaric acid was not 
overtly toxic to rats (Voss et al., 1999) and enhanced vomiting and feed refusal in pigs 
given trichothecenes (Smith and MacDonald, 1991; Smith et al., 1997). Bacon et al. (1995) 
found enhanced toxicity when F A and FB, were administered simultaneously to 
developing chicks in ovo, providing direct evidence of FA and FBI synergism. 
83 
Swine are particularly sensitive to the presence of Fusarium mycotoxins In feed stuffs_ 
Deoxynivalenol and FA act in a synergistic manner to reduce growth rates and production 
efficiency in swine, Fusarium mycotoxicoses are known to affect appetite regulation in 
swine, with suppression of appetite being an economically significant factor. It has been 
proposed that the loss of appetite is associated with elevated brain tryptophan 
concentrations, Large doses of tryptophan can cause vomiting in swine, Fusaric acid has a 
relatively low toxicity in animals, however it has been demonstrated that acute doses of FA 
administered to rats can elevate brain tryptophan and serotonin levels, Seddon et al. (1997) 
have shown that orally dosing swine with FA can trigger vomiting and lethargy with 
accompanying increases in brain tryptophan and serotonin. Deoxynivalenol triggers similar 
responses in swine. The ability of tryptophan to be taken up by the brain across the BBB is 
a limiting factor in determining brain tryptophan concentrations. Large neutral amino acids 
such as leucine, isoleucine, valine, phenylalanine and tyrosine compete with tryptophan for 
uptake into the brain. Therefore, dietary supplementation of these amino acids or the 
feeding of feedstuffs rich in these amino acids might overcome the feed refusal due to . 
Fusarium mycotoxins and would facilitate increased use with Fusarium-contaminated 
grains in swine production, 
2.27.5 Moniliformin 
Moniliformin is formed in cereals by a number of Fusarium specles that include 
F. avenaceum, F. subgiutinans, and F. proliferatum and occurs as the sodium or potassium 
salt of I-hydroxycyc1obut-l-ene-3, 4-dione. 
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Figure 2.12: Chemical structure of moniliformin. 
There is a limited amount of data on the effects ofMON on mammalian species. It is a 
potent inhibitor of mitochondrial pyruvate and ketoglutarate oxidation. In a few studies 
MON caused chromosomal aberrations, In humans, MON has been linked to Keshan 
disease which is endemic to certain areas of China. 
2.28 CONCLUSION 
Research on the occurrence, toxicity, and mechanism of action of Fusarium mycotoxins 
has provided information essential to establishing the degree of exposure of humans and 
animals to these toxins, and the extent to which they pose a threat to human and animal 
health. Further studies on the human pathophysiology of fumonisin toxicoses are essential 
in diagnosis of the disease, establishment of safety parameters and development of control 
and prevention procedures. Currently, the available information on human health effects 
associated with fumonisins is inconclusive. However, based on the information on the 
animal health effects associated with fumonisins, human health risks associated with 
fumonisins are possible and require investigation. Unless systems other than sphingolipid 
metabolism are discovered affected by fumonisins, the inhibition of CER synthase would 
be considered the initial step in the toxicity and carcinogenicity of these mycotoxins. This 
represents only the starting point for understanding the pathology of these compounds. 
More must be learned about the cellular consequences of elevations in Sa and various Sa 
metabolites, and the reductions in key complex sphingolipids caused by fumonisins. Such 
investigations should provide insight into, not only the mechanism of diseases caused by 
fumonisins, but also into the biological role of sphingolipids. 
This review has highlighted that a vast amount of work has been directed into in vitro and 
in vivo analyses of the effects of fumonisins. Due to interspecies differences between 
structure and cell composition in the CNS of humans and animals, the consequent varying 
cytotoxic effects of fumonisin are not easy to extrapolate to the human situation. Althqugh 
research has been directed into the effects of fumonisins on selected cells in the human 
CNS, no direct links have been established between fumonisins and human brain cancer. 
This study aims to address this gap in knowledge by screening brain tumour tissue and 
matched serum samples using immunohistochemical techniques and HPLC to establish 
whether FB 1 is associated with the pathogenesis of human brain cancer. 
CHAPTER 3 
Cytotoxicity of selected Fusarium mycotoxins and sphingoid 
bases on the N2a mouse neuroblastoma cell line 
3.1 INTRODUCTION 
The development of ideal in vitro models contribute significantly to the knowledge of 
cytotoxic and genotoxic mechanisms of chemical procarcinogens. Although the complexity 
of a whole organism can never be represented or mimicked in vitro, there are a number of 
toxicological questions that may be addressed in these systems. For the understanding of 
basal mechanistic aspects, and for the screening of compounds for specific toxic effects, 
such simplified systems are often preferable, facilitating reduction in the number of 
compounding variables (Horbach and De Groene, 1995). Furthermore, due to the 
advantages of in vitro cytotoxicity assays in tenns of convenience, direct detection of 
toxicity, cost and duration, these assays may well be suited for risk assessment in general. 
Toxic compounds may present a potential risk to neuronal function by directly or indirectly 
affecting the nervous system via interference with biochemical processes. Neuronal cell 
lines represent homogenous cell populations that may be maintained indefinitely in culture, 
providing experimental systems with relatively constant characteristics 
(Walum et al., 1990; Bonsi et aI., 1996). Furthennore, different cell lines express specific 
neuronal phenotypes. Such experimental models would permit the identification of specific 
cellular targets of toxins within the nervous system, and facilitate the study of the 
mechanism of their cytotoxic action (Bonsi et al., 1996). 
The N2a cell line is a transformed cell line derived from a mouse neuroblastoma tumour of 
the PNS and arises from cells of the neuroectoderm. In vivo, this tumour subtype arises 
from neuroblasts forming the adrenergic component of the sympathetic nervous system, so 
the most common sites of presentation are the adrenal medulla and sympathetic ganglia 
running along the spinal cord from the neck to the abdomen (Kemshead, 1985). 
Rapid and accurate assessment of viable cell number and cell proliferation are important 
requirements in experiments involving in vitro studies. Microculture tetrazolium assays 
(MTAs) are used to measure cell proliferation, and in cytotoxicity assays; to probe the 
relationships between cell survival, cytotoxicity and viability, as well as investigate 
associations between compromised cell metabolism, oxidative stress, and programmed cell 
death. Slater et al. (1963) described the staining reactions of four tetrazolium salts caused 
by the intact respiratory chains of rat liver mitochondria, the main point being the 
applicability of these observations for measuring the mitochondrial activity of living cells. 
Mossman (1983) further described a colorimetric cell culture assay based on this study, 
using the tetrazolium salt 3-{4,5-dimethyl thiazol-2-yl}-2,5-diphenyltetrazolium bromide 
(MTT) to measure cell proliferation and survival. This assay depends upon the reduction of 
the yellow-coloured MTT salt to purple formazan crystals by the succinate tetrazolium 
reductase system that belongs to the respiratory chain of mitochondria in viable cells 
(Altmann, 1976; Slater et al., 1963). Berridge et al. (1996) showed that the reduction is 
intracellular, and is catalysed predominantly by microsomal enzymes that require reduced 
nicotinamide nucleotides, and that succinate can also act as an electron donor in MTT 
reduction, through mitochondrial succinate dehydrogenase. This reduction through 
mitochondrial succinate dehydrogenase is slow however, and contributes little to total 
cellular MTT reduction. Both cell viability and cell proliferation may be monitored by this 
colorimetric assay. Increased total enzymatic activity, including that for mitochondrial 
dehydrogenases, accompanies cell proliferation. 
Based on these principles, MTT assays have been used for numerous medical, 
microbiological and toxicological tests (Cole, 1986; Gerlier and Thomasset, 1986; 
Hanelt et al., 1994). Reubel et al. (1987) and Reubel et al. (1989) reported the suitability of 
the MTT assay for the cytotoxic evaluation of the mycotoxins DON, ZEA and ochratoxin 
A using mono layers, as well as floating cells. Similar studies were carried out by 
Holt et al. (1988), Holt and Deloach (1988) and Holt et al. (1989) studying the cellular 
effects of T2 on different cell lines. The MTT assay has also been used for testing other 
Fusarium mycotoxins on many cell lines (Visconti et al., 1991). 
The objective of the present investigation was to assess the cytotoxicity of selected water-
soluble (FBI, MaN and FA) and ethanol soluble (ZEA, T2 and DON) Fusarium mycotoxins 
on the N2a mouse neuroblastoma cell line. In addition, the cytotoxic effects of the 
exogenously added sphingoid bases, Sa and So, were also assessed. 
3.2 MA TERIALS AND METHODS 
3.2.1 Materials 
Cell culture materials, media, antibiotics, and sterile disposable consumables were 
purchased from Adcock Ingram (SA) unless otherwise indicated . Pre-sterilised Corning 
plastic tissue culture flasks (7Scm2) were used as culture vessels, and sterile 96-well 
microtitre plates were used for the cytotoxicity assays . All mycotoxins were obtained from 
the Mycotoxin Research Group at the University of KwaZulu-Natal (UKZN). The MTT 
salt, DL-erythro-dihydrosphingosine (sphinganine) and D-sphingosine (sphingosine) were 
purchased from Sigma Aldrich Chemical Company (SA). 
The N2a. mouse neuroblastoma cell line was purchased from Highveld Biologicals, SA. A 
strict aseptic protocol was adhered to with regard to the culture environment and apparatus 
used . 
3.2.1.1 Cell culture media 
Dulbecco's Modified Essential Medium (DlV.lEM) (pH 7.2-7.4) balanced salt solution 
(without L-glutamine and with a combination of inorganic salts, glucose, amino acids and 
vitamins) was purchased pre-sterilized for cell culture. L-glutamine (200mM) (lOml) was 
added to DMEM (SOO ml). Foetal calf serum (FCS) was used as an additional nutrient 
source. Pre-sterilised, heat- inactivated filtered FCS was aliquoted into sterile vials (2Sml) 
and stored at -20°C until use. Foetal calf serum was added (10%) (volume per volume 
(v/v» to DMEM (SOOml) to make complete culture medium (CCM) required for growing 
cells . The CCM (SOOml) was also supplemented with sodium pyruvate (lOOmM) (S ml). 
The antibiotic Penstrep-Fungizone (Sml) was added to CCM (SOOml) routinely. Hank's 
Balanced Salt solution (HBSS) (2ml) was used routinely to wash and remove dead cells 
and cell debris prior to supplementing cells with fresh CCM (Sml) . Ethylenediamine 
tetraacetic acid [(EDT A), 0.1 % in distilled water] was used for trypsinising the N2a. cells. 
Dimethylsulphoxide (DMSO) was used at concentrations of S%-10% (v/v) in 10%CCM as 
the freezing medium for cells stored at -70°C. High FCS concentrations are used in 
freezing because FCS does not crystallise, and surrounds cells preventing water from 
entering and crystallising within the cells. 
3.2.2 Methods 
Descriptions of all cell culture techniques employed, including environment, trypsinisation, 
cell counting, viability assessment, storage, and preservation of cells were applied as 
previously documented in Palanee (1998) . 
3.2.2.1 Preparation of the mycotoxins, sphingoid base stock solutions, and MTT 
salt 
Fumonisin Bl, FA, and MON (1 mg per mycotoxin) were dissolved directly in CCM (l ml), 
with CCM as the comparative control for this set of mycotoxins. Zearalenone, T2, DON, 
Sa, and So (I mg each) were dissolved in ethanol (100 j.ll) and CCM (900 j.ll) to a stock 
solution of 1 mg.mrl. The control was made up of EtOH (lOOj.lI) and CCM (900j.l1). All 
stock solutions were vortexed thoroughly to ensure complete dissolution of the toxins . 
Each stock solution was then used in the preparation of a range of concentrations 
(5, 10,25, 50, 100, 150,200 and 250 j.lM) in CCM. 
The MTT salt (5 mg) was dissolved in HBSS (lml) to a concentration of 5mg.mr l. This 
suspension was filtered through a 0.45j.lm filter to remove insoluble residues of the MTT salt. 
The sterile stock solution was prepared immediately before use and stored in the dark at room 
temperature (RT) until required. 
3.2.2.2 The MTT bioassay 
The MTT bioassays on the N2a cell line were carried out according to Hanelt et at. (1994). 
Briefly, a culture flask (75 cm2) of confluent N2a cells was trypsinised and the cells 
resuspended in CCM to give a cell number of 4 x 106 cells.mrl. Aliquots of the cell 
suspension (10j.l1) were dispensed in each of the 96 wells of the microtitre plate to give a final 
cell count of 40 000 cells/well. 
The diluted mycotoxins and sphingoid bases were mixed thoroughly and an aliquot (200 j.ll) 
of the test compound at each of the above-mentioned concentrations was transferred to 
individual wells of the microtitre plate. There were five replicates at each test concentration 
for each compound and the respective controls. Following the assays 48 hour incubation 
period, all test compounds and media were aspirated from the wells, and the cells in the wells 
were supplemented with fresh CCM (100 ~l) and MTT salt solution (10 ~l of a 5 mg.mr1 
MTT salt solution in HBSS), followed by a further four hour incubation period at 37°C in the 
dark. The media and MTT salt solution were then aspirated, and the formazan crystals 
solubilised with DMSO (1 00 ~l) for 1 hour at 37°C. The optical density (OD) of the cells 
was measured spectrophotometrically, at a dual wavelength of 595nm and 610nm, on a 
Bio-Rad Microplate Reader. Dose response graphs were drawn using the mean absorbance 
values obtained in relation to increasing mycotoxin or sphingoid base concentration 
(Figures 3.1; 3.2 and 3.3). 
3.2.3 Statistical analyses 
All data were presented as means±standard deviation (SD). The results of the cytotoxicity 
assay were analysed using the paired 2-tailed Student's t test. A p value <0.05 was considered 
statistically significant. Mean absorbance values of cells treated with each 
mycotoxinfsphingoid base at each concentration in the range was used to determine the 
percentage cell viability in comparison to the control cells at each concentration (Equation 1). 
Equation 1: 
Cell viability (%) = mean absorbance of toxin treated cells x 100 
mean absorbance of control cells 
p Values <0.05 were taken as an indication of significant difference from controls. 
p<0.05=t, p<O.Ol =., P <0.001· indicating significant difference from controls are 
illustrated on Figures 3.1; 3.2 and 3.3. 
3.3 RESULTS AND DISCUSSION 
3.3.1 The MTT cytotoxicity assays 
The MTT assays were performed to monitor cell viability by measuring the conversion of 
tetrazolium salts to yield formazan, the amount of which was considered proportional to 
the number of living cells. 
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Figure 3.1: Dose response graphs of the effects of Fumonisin Bh Moniliformin and Fusaric acid on the N2a. cell line. p 
values <0.05 were taken as an indication of significant difference from the controls. p<O.05=·, p<0.01 = ., 
P <0.001= • ,using Student's t-test are illustrated. 
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The results of the MTT cytotoxicity assays and the comparative effects of FBI, MON and 
F A on the N2a neuroblastoma cell line, are shown in Figure 3.1. The effects of the 
sphingoid bases Sa and So, as well as ZEA, DON, T2 on the same cell line are illustrated 
in Figures 3.2 and 3.3, respectively. 
The exposure time of 48 hours was selected for the MTT assays on the basis of a dose 
response curve carried out over several time intervals. This helped determine a reasonable 
length oftime that N2a cells could be cultured in the microtitre plates with minimal levels 
of control cell death, taking into account the standard doubling rate of these cells in the 
volume of media per well . Support for selection of the 48 hour exposure time, comes from 
studies of Yoo et al. (1992) who showed that FBI inhibited cell proliferation (between 10 
and 35IlM), and cytotoxicity (>35~M FBI) in LLC-PKI cells was preceded by a lag period 
of at least 24 hours during which cells appeared to be functioning normally. Although it is 
acknowledged that cytotoxicity is cell-type specific, in this study the 48-hour exposure 
period was considered appropriate for the MTT assays on the N2a neuroblastoma cell line. 
To remove any bias in interpretation, all treated cells were assessed in parallel to their 
respective controls. 
Most mycotoxins are difficult to dissolve in CCM, and in order to obtain a homogenous 
test solution, organic solvents are usually added to the media. Many studies have used FBI 
dissolved in methanol and/or acetonitrile: water (1 : 1) for in vitro studies. However, based on 
the data of the United States National Toxicology Program (1999) that FBI is soluble in 
water to at least 20 mg.mr l , FBI was resuspended directly in the CCM in this study to 
ensure that all effects seen were the direct result of exposure to this mycotoxin, and not by 
exposure to the organic solvent. 
Statistical analyses of the MTT bioassay results using Student's t-test indicate that there 
were significant differences between the overall effects of FBI (p=0.00095) in comparison 
to untreated N2a control cells across the concentration range (Figure 3.1; Table 3.1). 
Statistically significant differences (p<0.01) were also noted specifically at 5, 50, 150, 200 
and 250llM FBI in comparison to controls. The FBI trend line in Figure 3.1 indicates that 
there is a decrease in N2a cell viability with increasing FB I concentration (Figure 3.1). 
Cell viability decreased from 75 .7% at 5~M to 42 .1% at 250llM FBI (Table 3.1). This 
decrease however was not strictly dose-dependent (Table 3.1). These results are supported 
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by studies by Norred et al. (1991), Shier et al. (1991) and Yoo et al. (1992) who have 
shown that FBI inhibits cell proliferation and is cytotoxic to many cell types. Inhibition of 
cell proliferation by FB I exposure usually occurs at concentrations that are lower than 












Mean percentage of N2a. cell viabilities (p value) following 48 hours 
exposure to fumonisin BI, fusaric acid and moniliformin in comparison 
to untreated N2a. control cells t • 
% Cell viability (p value) 
FBI FA MON 
75.7 (0.01) 108.4 (0.48) 106.9 (0.5) 
36.7 (0.006) 88.9 (0.25) 83.9 (0 .09) 
85.6 (0.3) 134.1 (0.0009) 77.3 (0.13) 
72 .8 (0.028) 42.1 (0.006) 69.4 (0 .04) 
79.9 (0.06) 41.1 (0 .004) 69.5 (0.02) 
86.3 (0.11) 91.4 (0.3) 61.4 (0.002) 
71.6 (0.003) 5l.6 (0.0004) 87.2 (0.14) 
29.8(0.0001) 115.4(0.13) 68 .7 (0.013) 
42.1(0.0001) 33.2 (0.0003) 86.6 (0.08) 
I Statistical analyses were done with comparison to matched controls. p values<0.05 were taken as an 
indication of significant difference from controls. p values < 0.05=·, p<O.O I = ., P <0.00 I • are indicated in 
Figure 3.1. 
In an earlier study, Riboni et at. (1995) showed that FB I blocked So-induced differentiation 
of the N2a. neuroblastoma cell line. These authors established that conversion of So to 
CER was required and that de novo CER synthesis was important, as CER played a 
mediator role in the regulation of differentiation in these cultured cells. The structural 
similarity of the polyhydric alcohol moiety of FBI to So and Sa (Figures 2.4 and 2.5), 
allow FB I to be recognised as a substrate for CER synthase (Merrill et at., 1996b). 
Merrill et al. (1993b) using microsomal preparations from cultured mouse cerebellar 
neurons showed that FBI was competitive with both sphingoid base and fatty acyl-CoA for 
CER synthase. Merrill and Sweeley (1996) further suggested that CER synthase recognized 
both the amino group (sphingoid binding domain) and the TCA side-chains 
(fatty acyl-CoA domain) of FBI. Spiegel and Merrill (996) also showed that inhibition of 
the enzyme induced a consequent intracellular accumulation of biologically active 
sphingoid bases and depletion of complex sphingolipids. These factors require 
consideration in the present study as compounding variables that may have initiated or 
exacerbated impairment of cellular transduction processes, cell differentiation, growth 
inhibition, cell mortality and/or mitogenicity of FBI on the N2a. cells. 
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In this study, -63% cytotoxicity was induced in the N2a cells at 10 IlM FBI (Figure 3.1), 
and at 200IlM, FBI induced - 70% cell death following the 48 hour exposure period 
(Table 3.1). It is likely that the levels of cytotoxicity of FBI indicated by the MTT assay 
are related to the FB I-induced inhibition of So-induced differentiation of the N2a cells in 
culture. Tolleson et al. (1996b) found that the growth of keratinocytes and epithelial cells 
were inhibited by 42% when exposed to 1OJ.!M FBI . More recently, Mobio et al. (2000) 
reported that in the C6 glioma cells, FBI induced 10 ± 2% and 47 ± 4% cell death 
following 24-hour incubation period with 3~M and 541lM FBI respectively. In contrast, 
Galvano et al. (2002) exposed rat astrocytes to FBI, and found that FBI-treatment 
(48 hours, 72 hours and six days in vitro, at 10, 50 and 100llM FB 1) did not affect cell 
viability. These results highlight that the cytotoxic effects of FBI vary with cell type and 
duration of exposure and there are variable cellular responses. 
Variable toxin susceptibility and the cytotoxic responses of cell types to FBI may be 
explained by the following . Although glial cells, astrocytes and neuroblasts are 
components of the CNS, the variability in cytotoxic response after exposure to FBI by the 
N2a neuroblastoma cdl line in comparison to glioma cells and astrocytes are potentially 
due to cellular, structural and biochemical differences. Reubel et al. (1987), 
Von Milczewskis (1987) and Holt et al. (1988) suggest that the varying cytotoxic 
responses of different cell types to particular mycotoxins may be due to the different 
metabolic activity of the target cells. The three most commonly encountered explanations 
for cell to cell variability in toxin sensitivity are differences in the amounts of target 
enzymes or other cellular functions which interacts with the toxin, the amounts of 
metabolic enzymes which activate a non-toxic precursor molecule into a metabolite with 
non-specific toxicity, and the efficiency of detoxification mechanisms that protects the 
cells and tissues that are less susceptible to toxic agent (Shier et al. , 1991). 
Thompson and Wannemacher (1984) suggest that the cytotoxic effects of a mycotoxin may 
also be influenced by the ability of a mycotoxin to bind to cellular receptors and/or 
penetrate cell membranes. This is dependent on the size, structural conformation of the 
toxin molecule, and its polarity. Furthermore, the relative significance of a molecular 
receptor of a mycotoxin is determined by its affinity to the active form of the toxin, its role 
in vital biochemical processes, the persistence of the lesion it bears, and the severity of the 
consequence of the lesion. 
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Inhibition of CER synthase by FBI causes the intracellular Sa levels to increase 
(Wang et al., 1991 ; Yoo et aI., 1992). The two most likely explanations for the increased 
cell death after inhibition of sphingolipid biosynthesis by fumonisins are that the 
accumulating free Sa (or a Sa degradation product) is growth inhibitory and cytotoxic to 
the cells (Stevens et aI., 1990; Hannun et aI. , 1991; Sweeney et aI. , 1996), and/or that more 
complex sphingolipids are required for cell survival and growth (Hanada et aI., 1992; 
Radin, 1994; Nakamura ef aI., 1996). There is therefore the potential for misinterpretation 
of results of experiments using fumonisins as an inhibitor of CER biosynthesis, unless the 
effects of these sphingoid bases are also considered. 
Ethanol was used as the solvent vehicle for Sa and So in combination with CCM in the 
MTT assays. Figures 3.2 and 3.3 show that although the viability of the N2a 
neuroblastoma cells decreased with exposure to the ethanol containing control serial 
dilutions, no significant differences were detected between any of the ' test concentrations. 
This is indicated in Figure 3.2 by the control trend line, which indicates a gradual decrease 
in cell viability, with an increase in the percentage of ethanol in the CCM. To illustrate that 
the amount of ethanol used (100 ~l) to dissolve the mycotoxins did not induce an acute 
cytotoxic response in these cells, an ethanol-free control was run against the ethanol-
containing CCM treated cells . The lack of a significant difference between the control and 
(control plus ethanol) treatment (p=0 .99) indicate that the cytotoxicity induced by the 
ethanol solvent was negligible on this cell line. 
Elevations of sphingoid bases disrupt normal regulatory mechanisms within cells, and are 
cytotoxic as indicated by exposure of the N2a cells to exogenous Sa and So (Figure 3.2) . 
The results of the MTT assay indicate that Sa and So were extremely cytotoxic at all the 
concentrations tested on the N2a cell line (Figure 3.2) . Statistical analyses and comparison 
of So and Sa against their ethanol containing controls across the entire range, indicate 
statistically significant differences with p=1 .1 x10-6 and p=1.9 x10-6 for So and Sa 
respectively. Comparison of the effects of Sa to So revealed that they did not differ 
significantly (p=O. 51) . At each concentration tested however, statistically significant 
differences were noted (p<0.01) in comparison to the controls within the range. In addition, 
at all test concentrations cell viabilities were below 50% of the controls (Table 3.2) . 
97 
Table 3.2: Mean percentage of N2a viabilities (p value) following 48 hours of 
exposure to sphinganine and sphingosine in comparison to ethanol 
treated N2a controls2• 
Concentration (~M) % N2a. cell viability (p valuet 
Sa So 
5 32.3 (0.003 42 .6 (0.0009) 
10 38.7 (0.002) 36.2 (0 .002) 
25 27.4 (0.004) 30 .7 (0.0012) 
50 29.5 (0.0003) 29.3 (0.0007) 
75 36.0 (0.001) 31.27 (0.0007) 
100 45.8 (0.0l3) 40.72 (0.014) 
150 34.8 (0.003) 29.26(0 .0008) 
200 49.1 (0.001) 46.45 (0.004) 
250 45.5 (0.002) 40.22 (0.003) 
2 Statistical analyses were done with comparison to controls run in parallel. p values <0.05 were taken as an 
indication of significant difference from controls. p values < 0.05=·, p<O.Ol = ., p <0.001· are indicated in 
Figure 3.2. 
These results are supported by findings of previous studies on the N2a cell line by 
Hall et a!. (1988) and Riboni et al. (1995), who reported that addition of exogenous So 
rapidly elevated cellular CER levels in the N2a cells, suggesting that some effects of So 
may be mediated by its conversion to CER. The role of CER as an intracellular second 
messenger for TNF-a, IL-P and other cytokines; So, So-I-phosphate among other 
sphingolipid metabolites, has been demonstrated to modulate cellular calcium homeostasis, 
cell cycle progression and apoptosis (Yoo et al., 1992; Merrill et al., I993b) . Elevated So 
and Sa in the N2a cells may therefore have acted via unscheduled initiation or inhibition of 
these pathways leading to disruption of metabolism of these endogenous molecules, 
leading to cytotoxicity and cell death. The maintenance of a low level of free sphingoid 
bases in cells is important because these compounds have considerable intrinsic biological 
activity and can be cytotoxic in high concentrations. 
Another potential mechanism of action leading to decreased cell viability in the N2a cells 
exposed to Sa and So, may be via a mechanism similar to that proposed by 
van Echten et a!. (1990) and Mandon et a!. (1991) . These authors showed that adding So to 
cultured mouse cerebellar neurons caused a decreased incorporation of [14C] serine into 
sphingolipids, apparently due to a down regulation of SPT in a time-and concentration 
dependent manner. A maximum decrease of 80% in this enzymes activity was achieved 
with doses as high as 50llM So homologues (Mandon et a!., 1991). At this concentration of 
Sa and So added to the N2a cell line in the present study on the N2a cells, approximately 
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70% cell cytotoxicity was induced following the 48-hour exposure period (Figure 3.2 and 
Table 3.2). 
Chapter 8 in this dissertation documents the quantitative HPLC analyses of intra and 
extracellular levels of Sa and So in the N2a cells prior to and following exposure to FBI, 
and provides an indication of baseline levels of these sphingoid bases. In vitro and in vivo 
Sa and So levels are usually in the nanomolar range whereas in this MTT assay, they were 
tested at levels multifold higher; hence this level of cytotoxicity was not unexpected. 
However, concentrations below 51lM Sa and So were not tested on the N2a cell line as this 
was a comparative study with the effects of the mycotoxins, and the dilution range to 
which the cells were exposed was standardised for both mycotoxins and sphingoid bases. 
Future studies on these cells however will endeavour to establish the effects of exposure to 
exogenous Sa and So at concentrations below 5).lM. 
Given that FBI inhibits CER synthase resulting in an increase in free Sa and So, and that 
the toxicity of FB I may be exacerbated via accumulation of these endogenous sphingoid 
bases, a point of interest in this study was that the equivalent amount of cell cytotoxicity 
was induced at 250llM FBI (Figure 3.1) and 5).lM So (~42%) (Figure 3.2). In addition, 32% 
cell viability was noted with 51lM Sa. This is relevant, in that FBI may have induced 
inhibition of sphingolipid metabolism in these cells over the 48 hours leading to an 
increase in Sa and So, resulting in FBI initiating indirectly the equivalent levels of cell 
cytotoxicity. This hypothesis is supported by Gelderblom et al. (l995b; 1996b) where in 
fumonisin-treated primary rat hepatocytes, Sa: So ratios were maximally elevated at 111M 
FBI, whereas cytotoxicity was observed at >250).lM FBI. 
Exposure to FA (Figure 2.11) at a concentration of 25 11M, induced proliferation of the N2a 
cells with viabilities of 134% being detected, i.e., viabilities 34% above controls 
(Figure 3.1). Fusaric acid may act on cytosolic copper ionlzinc ion (Cu2+/Zn2+) and/or 
mitochondrial manganese ion (Mn2+) - containing superoxide dismutase (SOD) enzymes 
that may be important for growth and survival of cancerous cells 
(Fernanadez-Pol et aI., 1982) or it may act by binding zinc which is a structural component 
of certain zinc finger DNA binding proteins that are involved in cell proliferation (Johnson 
and McKnight, 1989; Fernandez-Pol, 1991; Fernandez-Pol, 1992). Enhanced levels of 
formazan may therefore be interpreted as increased metabolic activity (Hanelt et aI., 1994) 
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and proliferation as observed with the N2a cells treated with FA. This hypothesis is 
supported by elevated cell viabilities of 108% and 134.1% detected at 5~M and 25~M FA 
in this study respectively (Table 3.1, Figure 3.1). 
At higher concentrations of FA exposure (50,75, 150 and 250~M; p<O.OOl), higher levels 
of cell death were recorded, e.g., 41.1 % viability at 75 ~M FA and 33.2% viability at 
250~M FA. However, using Student's t-test, when assessed across the entire range of 
concentrations, the effects ofF A on the N2a cells were not significantly different to that of 
control cells (p=O.l), or to cells treated with MON (p=0.9) (Figure 3.1). 
Fernandez-Pol et at. (1993) reported similar findings with the human colon 
adenocarcinoma Lo Vo cells. In that study, within 24 hours of exposure to 500~M FA, 
most of the cells were blocked at random in the cell cycle and approximately 80% of the 
cells were dead after 30 hours. Vesonder et al. (1993) also found that FA was cytotoxic to 
the MDCK dog kidney fibroblast cell line, McCoy mouse fibroblast cells (MM), rat 
hepatoma tumour (RH) and CHO cell lines. Three human colorectal adenocarcinoma cell 
lines, SW 48, SW 480 and SW 742 were also sensitive to the inhibitory and cytotoxic 
effects of FA. 
The cytotoxicity of F A may be attributed to the 5-butyt side chain (Figure 2.11), which 
because of its lipid solubility may allow better cellular penetrability of this mycotoxin. At 
50~M and 200~M FA, 42.1% and 33.2% cell viability was detected in the N2a cell line 
respectively, following the 48hour exposure period. Telles-Pupulin et at. (1998) showed 
that FA affects mitochondrial energy metabolism by at least three modes of action, namely 
inhibition of succinate dehydrogenase, inhibition of oxidative phosphorylation, and 
inhibition of a-ketoglutarate dehydrogenase. The inhibition of oxidative phosphorylation 
seems to be the result of a direct action on the ATP synthase/adenosine triphosphatase 
(ATPase) without significant inhibition of the ATP/adenosine diphosphate (ADP) 
exchange. In isolated perfused rat liver, FA inhibits oxygen uptake and gluconeogeneis 
from pyruvate, the latter being strictly dependent on intra-mitochondrially generated ATP. 
In the present study, cell viability is partially reflected by conversion of the MTT salt by 
succinate dehydrogenase enzymes of mitochondria of viable N2a cells. Lower cell 
viabilities may have been as a consequence of the inhibition of these enzymes by FA. 
In this study, statistically significant differences were noted between MON-treated 
(p=0.002) and control N2a cells across the range of the mycotoxin test concentrations. Cell 
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viabilities were between 61% and 69 .5% with exposures between 50-200~M MON 
(Figure 3.1). Similar levels of cytotoxicity were noted in the RH, CHO and MDCK cell 
lines (Vesonder et aI., 1993). 
Thiel (1978) reported that the principal mechanism of action of MON is believed to 
involve selective inhibition of mitochondrial pyruvate dehydrogenase (PDH) and 
a-ketoglutarate dehydrogenase. Thiel (1978) reported that a 5 ~M concentration of MON 
caused a 50% inhibition of oxygen uptake by rat liver mitochondria with pyruvate as the 
substrate. Burka et at. (1982) showed that MON binds to PDH preventing entry of 
pyruvate into the TCA cycle, therefore decreasing mitochondrial respiration. Support for 
direct binding ofMON to PDH was also provided by Burka et at. (1982), who showed that 
rat brain transketolase and pyruvate dehydrogenase were inhibited by 59% by 1 OO~M 
MON. More recently, decreased protein synthesis and induction of oxidative damage have 
also been ascribed to MON (Norred et al., 1990). 
The MTT assay uses reduced nicotinamide adenine dinucleotide (NADH) as a marker of 
cell viability. There are two main sources of NADH in cells catabolising carbohydrates; 
namely glycolysis and the TCA cycle. The former is in the cytosol and the latter in 
mitochondria. Of these, the TCA cycle produces 10 times more NADH, so essentially the 
MTT assay measures this. If MON blocks the entry of pyruvate into the TCA cycle, it 
decreases mitochondrial respiration and therefore NADH production, and this would be 
reflected by decreased cell viabilities using the MTT assay. Following 48hour exposure to 
50 ~ and 1 00 ~M MON, viabilities of 69.4% and 61.4% were noted for the mycotoxin 
treated N2a cells respectively. 
In this study, sodium pyruvate supplementation of the CCM was essential to ensure N2a 
cell proliferation and survival; cells grown in CCM without sodium pyruvate ceased 
growing. This was considered significant in that it is possible that MON and the pyruvate 
supplement may have competed for the binding site on PDH. By adding high levels of 
MON as a suicide substrate of PDH, it may have potentially blocked or decreased 
mitochondrial respiration causing cell death. The data in the present study concur with 
earlier findings by Gathercole et al. (1986) who showed that pyruvate supplementation 
resulted in decreased MON-induced inhibition of PDH function. However in the present 
study, sodium pyruvate was added to the CCM for the N2 a cells at a concentration of 
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2mM. The higher concentration of pyruvate than MON in the CCM may be the reason why 
cell viability never dropped below 61 % in these cells. At the lowest concentrations of 5 I-lM 
and 10I-lM MON, viabilities of 106 % and 83% were determined respectively which 
indicated the potential negligible proliferative capacity of 51-lM MON, and ~20% cytotoxic 
capacity at 10l-lM MON. Even at the highest concentration of 250l-lM MON, 86.6% cell 
viability was noted which indicates that the levels of sodium pyruvate in the CCM may 
have protected N2a cells from the toxic effects of this water-soluble mycotoxin. 
Statistically significant differences were noted for N2a cells treated with DON (p=0.04) 
and lEA (p=0.003) when the entire range of mycotoxin test concentrations were compared 
to their controls (Figure 3.3, Table 3.3). With the cytotoxicity ofT-2 toxin on the N2a cells 
there was a tendency towards significance (p=0.07). The entire range of concentrations of 
lEA when assessed against that of DON (p=0.09), were not significantly different from 
each other either, nor were there significant differences between the effects of DON and T2 
(p=OA). However, the effects of lEA compared to that of T2 toxin did differ significantly 
(p=0.04). 
In the T2-treated N2a cells, viability increased with increasing toxin concentration from 
45 .5% viability at 51-lM, to 80.2% viability at 200!-lM T2. A similar trend was noted in cells 
treated with DON, with cell viabilities increasing from 42.6% at 51-lM DON to 104.8% at 
250 I-lM. Deoxynivalenol and T2 either induced growth arrest or minimal mitogenic effects 
at the higher levels of the exposure (e.g., at 200 !-lM), in contrast to the levels of 
cytotoxicity induced at lower concentrations (e.g., at 10 I-lM, Table 3.3, Figure 3.3), as 
indicated by the higher percentage of viable cells in both sets of treated N2a cells. At the 
lower range of concentrations (i .e., 5 and 50!-lM), lEA induced between 40-60% 
cell-death. At the 200l-lM lEA however, 56.1% cell viability was indicated. For these 
mycotoxins, a distinct dose-dependent effect for cytotoxicity was not established. 
The trichothecenes are directly toxic without activation. T -2 toxin is an amphipathic 
molecule that can enter the cell membrane, disrupt membrane function 
(Khachatourians, 1990), and induce cell membrane injury via a free-radical mechanism 
(Coulombe, 1993). In this study on the N2a cells, >50% cell death was induced between 5 
and 10l-lM T2 after the 48 hours, but cell viabilities were close to controls at the higher 
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range of concentrations. Beasley (1989) reported that trichothecenes inhibit the 
peptidyltransferase reaction by binding to the 60S ribosomal subunit in eukaryotic 
ribosomes and their anti-proliferative activity has been presumed to be a consequence of 
inhibition of protein synthesis in the initiation phase. This concurs with findings in this 
study on the N2a neuroblastoma cells, where at concentrations of 100 and 200~M, DON 
seemed to have induced proliferative effects in the N2a cells with cell viabilities of 113% 
and 104% in comparison to controls (100%). This hypothesis was further supported by lack 












Mean percentage of N2a cell viabilities (p value) following 48 hours of 
exposure to zearalenone, deoxynivalenol and T-2 toxin in comparison to 
ethanol treated N2a controls3• 
% Cell viability (p value) 
ZEA DON T2 
60.5 (0.06) 42.6 (0.0007) 45.5 (0.02) 
68.2 (0.05) 70.2 (0.001) 44.9 (0.02) 
40.5 (0.002) 48 .8 (0.004) 61.02 (0.07) 
45 .3 (0.01) 44.7 (0.004) 65.1 (0.4) 
60.3 (0.02) 74.2 (0 .04) 93.0 (0.02) 
80.0 (0.4) 113.0 (0.7) 65.6 (0.3) 
47.0 (0.007) 77.9 (0.09) 94 .5 (0.06) 
56 .1 (0.04) 104.8 (0.9) 80.2 (0.8) 
3Statistical analyses were carried out with comparison to controls using Student's t-test. p values <0.05 were 
taken an indication of significant difference from controls. p values < 0.05=·, p<O.OI = ., P <0.001 • are 
indicated in Figure 3.3 . 
Holt and Deloach (1988) have shown using the toxin sensitive MDCK canine kidney cell 
line and in toxin-resistant CHO cells, that T -2 toxin mediates a number of effects on the 
cell membrane, on protein synthesis, and probably mitochondrial reduction ofMTT. Using 
the MTT assay, Holt et at. (1988) further showed that the inhibitory effects of T -2 toxin on 
MTT cleavage in L929 cells was comparable to that observed for protein and DNA 
synthesis (50% inhibition at 6-8ng. mr!). T -2 toxin also inhib its the mitochondrial electron 
transport system by inhibiting succinate dehydrogenase (Khachatourians, 1990) and 
inhibits gap-junctional intercellular communication in Chinese Hamster V79 cells 
(IARC, 1993a). 
It is possible in the N2a cell line, that at the lower range of concentrations, T2 may have 
inhibited succinate dehydrogenase in these cells. As was suggested for the effects of FA, 
cell viability is partially reflected by the conversion of the MTT salt by the succinate 
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dehydrogenase enzymes of the mitochondria of viable N2a cells. Lower cell viabilities 
may have been detected as a result of the inhibition of this enzyme by T2 in the N2a cell 
line. In contrast, using this system to analyse the lethal effects of T2 on cells from various 
animal species (Holt and Deloach, 1988), it was found that the concentrations that induced 
50% cell death were much lower than those used in this study on the N2a cells, 
highlighting further that a mycotoxins effects are cell type specific. 
The N2a cells treated with DON followed a similar trend to the T2-treated cells, with 
viabilities increasing from 42.6% at 5~M DON to 104.8% at 200~M . Similar findings were 
reported by Abbas et al. (1984), Visconti et al.(1991) and Rotter et al.(1993), where DON 
was found to be cytotoxic to a variety of cells including fibroblasts and lymphocytes. 
Effective concentrations ranged from 0.1 to 2~g. mrl (5-1 0 ~M) DON. At the cellular level, 
the key toxic event was related to inhibition of protein synthesis at the ribosomal level 
during the elongation-termination step (Ueno, 1983). Mekhancha-Dahel et al. (1990) 
showed that DON inhibited the synthesis of DNA, RNA and protein synthesis at the 
ribosomal level, as well as inhibited DNA synthesis in murine splenic lymphocytes and 
human peripheral blood lymphocytes. 
At 25, 50~M and 200~M ZEA, 40.5 , 45.4 and 56.1% cell viabilities were reported 
respectively for the N2a cells following the 48-hour exposure period. Abeywickrama and 
Bean (1992) studied the cytotoxic effects of ZEA on the baby hamster kidney cell line 
(BHK)-21 , and on the human epidermoid cell line HEP-2. Zearalenone was highly 
cytotoxic to BHK-21 cells at 2~g.~rl , and HEP-2 cells were less susceptible even at a level 
of 1 ~g. ~r' . The concentrations of ZEA to which Abeywickrama and Bean (1992) exposed 
the cells, were equivalent to the millimolar range. This may be considered extremely high 
since micromolar concentrations were used in this study on the N2a cells, and although 
significantly lower concentrations of mycotoxin were tested, high percentages of cell death 
were reported in this study (Table 3.3). 
Reubel et al. (1987) evaluated the effect of DON and ZEA on the human erythroleukaemia 
cell line K562, and on porcine lymphocytes and granulocytes. After 24-hour exposure, 
concentrations of DON as low as 4~g.mrl (2-5~) were found to inhibit significantly the 
cleavage activity of K562. Cytotoxicity in lymphocytes and granulocytes were observed at 
concentrations of0.4-0.8~g . mrl (- 1-3~M) DON. Reubel et al. (1987) reported that 25 to 
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12.5~g.mrl (-50-75~M) ZEA inhibited mitochondrial cleavage activity of lymphocytes 
and K562 cells significantly, whereas in granulocytes none of the concentrations tested 
were toxic. Shelby et at. (1995) reported that when using the brine shrimp bioassay, the 
concentration of ZEA that caused 50% mortality was -75 ~M. These results are similar to 
that of the present study, where following 48-hour exposure to 75~M ZEA, 60% cell 
mortality was noted in the N2a cell line. 
3.4 CONCLUSION 
The MTT assay was efficient in providing an indication of the levels of cytotoxicity or 
mitogenicity induced by the Fusarium mycotoxins FBI, FA, MON, DON, T2 and ZEA, as 
well as the sphingoid bases, Sa and So in the N2a neuroblastoma cells at the range of 
concentrations comparatively assessed after the 48 hour exposure period. Dead cells were 
unable to metabolise various tetrazolium saIts, and this factor facilitated the use of the 
colorimetric assay to measure cell survival. 
Different levels of susceptibility were determined and indicate that the test compounds 
were able to traverse or interact biochemically with cellular organelles or cell membranes 
and induce toxicity due to often negligible differences in their molecular structures (e.g., 
DON and T2; and FBI, Sa and So) that effected differences in bioactivity and the cellular 
responses. At the concentrations tested, the sphingoid bases were clearly more cytotoxic to 
this cell line than any of the mycotoxins tested, with viabilities as low as 29% being 
reported. Based on studies presented later on in this dissertation (i.e., in Chapter 8), it is 
clear (in retrospect) that the levels of Sa and So added to the cells were muItifold higher 
than those that a cell would normally be exposed to, and therefore these levels of cell death 
were natural. Sphingoid bases are endogenous compounds found in cells, unlike the 
xenobiotic mycotoxins, and are known to play important roles in cell regulatory processes. 
This factor highlights further the importance of the regulation of levels of free sphingoid 
bases in celis, and the need for intervention with regards to exposure to compounds such as 
FB I that disrupt biochemical pathways that regulate levels of sphingoid bases in cells . 
Findings that neuronal function may be impaired by the presence of Fusarium mycotoxins 
and elevated Sa and So, even if at a negligible level, require consideration in vivo. The use 
of the MTT assay can only provide information on the cytotoxic properties that are 
105 
characteristic of certain, but not all compounds. This colorimetric assay possibly 
underestimates cellular damage, and detects cell death only at the later stages of apoptosis 
when the metabolic activity of the cells is reduced. Regardless of this disadvantage, this 
colorimetric assay was useful for quantifying factor-induced cytotoxicity within a 24 to 
48 hour period of cell culture, and opened avenues to pursue further more comprehensive 
analyses of the effects of these compounds on the N2a neuroblastoma cell line. 
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CHAPTER 4 
Bioluminescent determination of apoptosis and necrosis using 
adenylate nucleotide measurenlents to analyse the effects of 
fumonisin Bl and fusaric acid on the N2a neuroblastoma and 
Jurkat cell lines 
4.1 INTRODUCTION 
Apoptosis and necrosis are conceptually and morphologically distinct forms of cell death 
(Wyllie et at., 1980). However, these two types of cell demise can occur simultaneously in 
tissues and cultured cells exposed to the same stimulus (Ankarcrona et at., 1995; 
Shimizu et at., 1996a). Often the intensity of the initial insult decides the prevalence of 
either apoptosis or necrosis (Bonfoco et aI., 1995). This suggests that while some early 
events may be common to both forms of cell death, a downstream controller may be 
required to direct cells towards the organized execution of apoptosis (Leist et at., 1997). 
Numerous pathways of apoptosis have been identified, the activation of which ultimately 
has an effect upon the cells' mitochondria. The mitochondrion consists of the outer 
membrane, intermembrane space, inner membrane, and matrix (Figure 4.1). Oxidative 
phosphorylation occurs across the inner mitochondrial membrane and results in the 
synthesis of ATP. Energy is released as electrons flow through the complexes of the inner 
mitochondrial membrane, and fall to a lower energy state, where the release of energy 
actively transports hydrogen ions from the matrix to the intermembrane space, thus making 
the matrix negatively charged, and the intermembrane space positively charged. This 
distribution of protons across the inner membrane generates the mitochondrial 
transmembrane potential (,1\Vm) (Figure 4.1). The transient opening of the megachannels 
or permeability transition (PT) pores, which span the inner to the outer mitochondrial 
membrane is necessary for the equilibration of essential ions between the cytosol and 
mitochondrial matrix. These PT pores open irreversibly during apoptosis. This disruption 
in PT is believed to be the cause of the collapse in the transmembrane potential, and brings 
about the release of cytochrome c from the inner mitochondrial membrane to the cytosol 
(Simmons, 1999; Bradbury et at., 2000). It has recently been suggested that not all 
mitochondria are responsible for the release of cytochrome c, and that a proportion 
maintain the transmembrane potential and ATP production continues 
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(Lemasters et ai., 1998; Bradbury et ai., 2000). The loss of the transmembrane potential is 
also thought to precede the exposure of phosphotidylserine (PS) residues on the outer 
plasma membrane leaflet, which is usually confined to the inner leaflet of the plasma 
membrane in healthy cells. 
Figure 4.1: 
Mltochondrll Inner Structure 
Mechanism of distribution of essential ions between inner and outer 
mitochondrial membranes (with modification of Simmons, 1999). 
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4.1.1 Determination of Apoptosis by cellular ADP:ATP ratios 
Observations have been made regarding depletion of intracellular ATP during apoptosis, 
with various ATP depleting chemotherapeutic agents causing tumour regression. This led 
to a hypothesis that ATP depletion is a significant factor, making it a worthy therapeutic 
marker (LumiTech™, 1999). Exposure of different cell lines to apoptosis-inducing drugs 
causes cells to halt their normal proliferative cycle, and this can be detected as a drop in 
measured ATP in cell populations. When cells go into growth arrest, they maintain the 
same ATP levels, but when measured against a proliferating sample, there are obviously 
less cells to measure and thus, the overall amount of ATP per sample size is less. When the 
cell starts to undergo apoptosis, the ATP levels drop as the cell uses energy to organize the 
process, and in this case the drop of ATP levels is due to less ATP contributed per cell. 
Early events in apoptosis are initiated in those cells sensitive to the agent. These cells show 
an increase in cellular ADP, without an appreciable drop in ATP. On exposure to either 
higher concentrations or longer incubation with a drug, ADP levels continue to rise and 
ATP levels continue to drop. The result being that in a population of cells exposed to death 
inducing conditions, the ratio of ADP to ATP increases as the cells become more 
compromised (Bradbury et aI., 2000). As ATP levels fall to a point where the cell can no 
longer perform basic metabolic functions, the cell will die. In necrosis, ATP levels fall 
rapidly, as a result of exposure to high concentrations of toxic agents (secondary necrosis) 
or mechanical damage/lyses (primary necrosis). These changes in the ATP levels brought 
about by apoptosis may be early indicators of apoptotic changes within cells. 
4.1.2 The ApoGlowTM assay 
Bioluminescent measurements of ATP have been used to assess cell proliferation and 
cytotoxicity since all cells have an absolute requirement for ATP to maintain viability 
(Crouch et aI., 1993). Measurement of ATP is an established method to test the 
chemosensitivity of cell lines and tumours, and to determine tumour growth inhibition by 
cytotoxic agents In pnmary cultures of ovanan and breast cancer cells 
(Andreotti et aI., 1995; Cree et ai., 1995; Kravtsov et aI., 1998; Kurbacher et aI., 1998). 
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Until recently, it has been difficult to measure relatively small amounts of ADP in the 
presence of larger quantities of ATP (Bradbury et at., 2000). The ApoGlowTM Kit was 
designed to detect these subtle changes in adenylate nucleotide levels in cells cultured in 96 
well microtitre plates. The assay facilitates the sequential measurement of A TP and ADP in 
each well of the microplate leading to the generation of an ADP: A TP ratio. This ratio 
correlates with apoptosis and necrosis, and a division can be seen between apoptosis and 
necrosis. By comparison of data from untreated control wells, it is also possible to 
determine if an agent induces death by either mechanism, or promotes cell proliferation. 
Proliferation results in an increase in the A TP readings, as cell numbers increase, while the 
ratios remain constant. From a single test, it is therefore possible to determine all possible 
outcomes resulting from cell viability modifying treatments. 
4.1.2.1 Principles of the ApoGlowTM assay 
Bioluminescent detection of adenylate nucleotides is extremely sensitive, with a detection 
limit of 100 cells per microwell. The ApoGlowTM kit uses bioluminescence catalysed by 
the enzyme luciferase to measure these intracellular nucleotides in a stepwise reaction, to 
give a rapid detection of cell death or proliferation that results in the emission of light at 
562nm, according to the following scheme: 
luciferase 
A TP + Luciferin + 02 • Oxyluciferin + AMP + PPi + C02 
(Higashi et at., 1985). 
A change in the ratio of ADP to A TP occurs when mitochondrial function becomes 
compromised in apoptosis, and that specifically cells in the early stages of apoptosis show 
an increase in ADP without an appreciable drop in A TP. When all components of the 
reaction remain constant, the emitted light intensity is linearly related to the A TP 
concentration and is measured using a luminometer. The ADP is measured by its 
conversion to A TP, and the ADP:A TP ratio is then calculated, and used to differentiate 
between the different modes of cell death. The ApoGlowTM kit uses patented technology to 
allow for easy ADP detection in microplates (Bradbury et at., 2000). 
Ceramide plays a pivotal role in neural cell death and development (Merrill et at., 1997). 
Monnet-Tschudi et at. (1999) have demonstrated that FB I selectively affected glial cells, 
110 
interfered with oligodendrocytes development, and impaired myelin formation and 
deposition. Another effect observed after FB I treatment in astrocyte-differentiated cultures 
was a loss of the astrocyte cytoskeletal marker GF AP due to deficit of sphingolipids by the 
inhibition of CER synthase (Monnet-Tschudi et aI., 1999). In this latter case, FBI could 
even act as a protective agent by inhibiting CER synthesis, given that in particularly 
stressed conditions, such as in hypoxia-injured LLC-PK 1 cells, increased CER synthesis 
induces DNA fragmentation and apoptosis (Ciacci-Zanella et aI., 1998). Analogous results 
have been observation with chicken embryo astrocytes (Mangoura and Dawson, 1998). 
Since numerous studies have demonstrated that, besides inhibition of CER synthesis, FBI 
causes DNA damage and membrane lipid peroxidation (Sahu et aI., 1998), the aim of this 
study was to determine using the ApoGlow ™ assay, the potential for FB I and FA, 
individually and in combination, to induce apoptosis, necrosis, growth arrest, or 
proliferation in the adherent N2a neuroblastoma, as well as the Jurkat suspension cell line. 
The Jurkat cell line, a human acute T-Iymphoblastic leukaemic suspension cell line is 
CD95+ and has a mutated p53 gene. The Jurkat cell line was included in this study, as it 
would provide some insight into the effects these mycotoxins may have on circulating 
white blood cells in vivo. 
4.2 MA TERIALS AND METHODS 
The experimental work presented in this chapter was carried out at Nottingham Trent 
University (NTU), Faculty of Health Sciences, United Kingdom (UK), with supervision 
and guidance from Mrs Anne Cox, Dr Claire Scholfield and Professor Martin Griffin 
(July-September 1999) in collaboration with LumiTech™ at the Nottingham City Hospital. 
Financial support was kindly provided by the National Research Foundation (NRF), SA. 
Only the effects of FB I and FA were assessed in this international collaborative study, the 
reason being that this work was part of the initial experiments carried out and the other 
mycotoxins included in the assessments in Chapters 3, 5, and 6 were added in later in the 
time line of work presented in this dissertation. 
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4.2.1 Materials 
Cell culture materials, media, antibiotics and sterile disposable consumables were 
purchased from Sigma Chemical Company (UK). Pre-sterilised Corning tissue culture 
flasks (75cm2) were used as culture vessels, sterile clear 96-well microtitre plates (CoStar) 
and 96 well white-walled clear-bottomed luminometer plates (Wallac) were used for the 
assays. Aseptic protocols were adhered to. The N2a cell line was obtained from the cell 
culture facility at NTU, and the Jurkat cell line from the cell culture facility at Leicester 
University, UK. A Lucy 1 Anthos Luminoskan Labsystems microplate luminometer 
equipped with reagent dispensers capable of injecting 20I-.t1 volumes was used, enabling full 
automation of the assay. 
The Jurkat cell line was cultured in RPMI-1640 cell culture media containing 10% FCS, 
2mM L-glutamine, 2% Penstrep and 2mg.mr i gentamicin sulphate. The N2a cell line was 
cultured in DMEM supplemented with 10% FCS (v/v), 2mM L-glutamine, 2mM sodium 
pyruvate and 2% (v/v) penicillin streptomycin . 
4.2.2 Methods 
4.2.2.1 The ApoGlowTM assay 
ATP contamination can be a source of error for the ApoGlowTM assay. The surface of the 
skin contains significant levels of ATP, therefore gloves were worn when performing the 
assay, and ATP-free microtitre plates and tubes were also used to minimize errors . 
The N2a cells were cultured in 75cm2 culture flasks until confluent, trypsinised, and 
following a cell count, 2.5 x 104 cells were dispensed into each well of the microtitre 
plates. The Jurkat cell line, being a suspension cell line, did not require trypsinisation. To 
minimize dilution of the mycotoxins by the media in the pure cell suspension, cells were 
concentrated in small volumes of CCM (~ 1 0-15 1-11). 
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4.2.2.2 Preparation of the mycotoxin stock solutions 
Fumonisin BI and FA (lmg) were dissolved in 30~1 DMSO and 970~1 CCM (using the 
defined media required for each cell line), to a stock solution of 1 mg.mr l. The control 
solution for each toxin was made up of30~1 DMSO and 970~1 CCM. A range of dilutions 
of both the mycotoxin stocks and controls were assessed as shown in Figures 4.2- 4.3. In 
addition, the cells were exposed to equal volumes ofa combined solution of FBI and FA at 
each concentration. For example, at 100~g.mrl (FBI+FA), if 1O~1 of cell suspension was 
used to obtain 2.5 x 104 cells per well, this volume was topped up to a total of 100~1 per 
well with 45~1 of FBI and 45~1 of FA using separate stock solutions of 100~g.mrl of each 
mycotoxin. Duplicate testing of each mycotoxin was carried out on both cell lines. The 
final volume of cell suspension and diluted mycotoxins together was 100~1 according to 
the manufacturers' instructions. The culture plates were then incubated at 37°C for 
between 22 .5-24 hours, after which the ApoGlowTM assay was carried out. 
4.2.2.3 Outline of the method 
Before cellular adenylate nucleotides were measured by bioluminescence, they were first 
extracted from the cell. For the N2a adherent cells, 100J .. tl of nucleotide releasing reagent 
(NRR) was added to each well of the microtitre plate using a multi-channel pipette, and 
extraction was allowed to occur for five minutes at R T. The extracts were transferred to an 
opaque white microtitre plate and loaded into the luminometer. Where the cells were 
cultured in white walled clear-bottomed tissue culture plates, extraction and measurement 
of adenylate nucleotides was carried out in the same plate. The assay procedure differed 
slightly between the N2a adherent and the Jurkat non-adherent cells. With the Jurkat 
non-adherent cells, one bottle of nucleotide monitoring reagent (NMR) (20m I) was 
reconstituted in one bottle of NRR (20ml), enabling simultaneous release and 
measurement. 
4.2.2.4 Equipment 
The assay was fully automated usmg the Lucy 1 Anthos Luminoskan Labsystems 
microplate luminometer. The data was expressed as relative light units (RLUs). 
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Dispenser 1 was primed with NMR and set to dispense 20!!1 in the case of the N2a 
adherent cells, and 100!!1 for the Jurkat non-adherent cells. The instrument was 
programmed to dispense into each well and take an immediate one-second integrated 
reading before moving on to the next well. Dispenser 2 was primed with ADP converting 
reagent, and also programmed to dispense 20!!1 into selected wells and take an immediate 
one-second integrated reading before moving on to the next well. At all times the 
luminometer dispensing lines were kept scrupulously clean. Any residual luciferase in the 
dispensing line was removed using a cleaning reagent that neutralised the enzyme. 
The specifically formulated luminescence cocktail (NMR) was automatically added to the 
wells and an ATP reading (A) was taken. After 10 minutes, the second injector added the 
ADP Converting Reagent and a second reading was taken (B; baseline ADP levels). After 
a further 5 minutes, the final converted ADP reading was taken (C). These three values 
were then used to calculate the ADP:ATP ratio . 
4.2.2.5 Interpretation of results 
The ADP:ATP ratio was then calculated from measurements A, Band C as follows:-
(C-B)/A 
Interpretation of different ratios obtained within each experimental situation varied 
according to the cell type and conditions used . However, the following criteria, provided 
by the manufacturers of the assay were used as guidelines: -
1. If a test gives markedly elevated ATP values (compared to seeding cell densities) with 
no significant increase in ADP levels, this indicates proliferation. Stimulation with 
growth/mitogenic factors will induce proliferation, and thus lead to an increase in ATP 
readings. 
2. If a test gives considerably lower ATP levels than control but greatly increased ADP, 
this indicates necrosis . 
3. If a test gives similar or slightly higher levels of ATP, and with little or no change in 
ADP compared to control, this indicates that the treatment arrests proliferation but 
does not kill cells. 
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4. If a test gives lower levels of ATP to control but shows an increase in ADP, this 
indicates apoptosis. These ratios vary according to the degree of apoptosis in the cell 
population. 
According to the manufacturers guidelines and the LumiTech ™ representative 
(Scholfield pers comm., 2002), as a further guide on interpretation of data, ratios greater 
than twice the control values, but less than four times control values, were an indication 
that cells were undergoing apoptosis. Ratios four times greater than the control values were 
an indication of necrotic cell death. Ratios slightly lower than the ADP : ATP ratio of 
control cells were indicative of cells undergoing growth arrest, and those with ratios 
significantly lower, as an indication of cell proliferation. 
The experiments presented were performed in duplicate and the results are presented as 
means ± SD. 
4.3 RESULTS AND DISCUSSION · 
Interpretation of the ApoGlowTM assay results is based on a companson of the ATP 
readings and ADP:ATP ratios with values from treatment-free control wells . The 
ADP :ATP ratios obtained within each experiment vary according to the cell line or cell 
type being assessed, the experimental and exposure conditions, and the equipment used . 
Although an experiment may be repeated according to a defined method, intra- and inter-
laboratory variability in results often occurs. To remove this level of variability, when 
comparisons are made in assays such as this, treated cells are always compared to control 
cells of the same origin, such that each assay has its own internal control. In general, if a 
test gives considerably lower ATP levels than the control, but greatly increased ADP levels 
it would indicate necrosis . Whereas if the test gives slightly lower levels of ATP to control, 
but shows an increase in ADP it would point to apoptosis. These ratios vary according to 
the degree of apoptosis in the cell population. It is the relationship between the treated cells 
ratios and the control cell ratios, that is the key to the indication of the mode of cell death. 
In this study, the control cells, as well as the FBI and FA-treated cells were exposed to a 
maximum concentration of 3% DMSO, with subsequent decreases in the percentage of 
DMSO across the dilution range in CCM. The control cells in the Jurkat assay exhibited a 
small , but gradual increase in viability with a decrease in the DMSO content (Figure 4.2). 
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These results indicate that DMSO may have induced some level of cytotoxicity on the 
lurkat cells. No significant differences however were noted between concentrations in the 
range for the control cells, which implies that exposure to DMSO as the solvent vehicle for 
the mycotoxins, had negligible effects on these cultured cells. 
The volume of media per well (i.e., 100 Ill) was sufficient to sustain the cells for 24 hours 
prior to changes being induced as a result of nutrient deficiency, and therefore both assays 
did not exceed 24 hours. This limitation of a maximum volume of IOOIlI CCM per well in 
the microtitre plate may be considered a drawback of the test, as some compounds require 
longer interaction with cells for biochemical changes to become apparent. However, the 
assay has a sensitive detection limit with as few as 100 cells per well. In cases where 
longer incubation times may be required for a particular compound, the cell count per well 
may be decreased in order to enable a longer incubation time. 
The measurement of ATP alone shows cytotoxic effects, but it is not sufficient for 
determining apoptosis, or for distinguishing primary and secondary necrosis. LumiTech™ 
have tested 15 different cell lines and four primary cell types for the induction of 
apoptosis/secondary necrosis and primary necrosis. In all cell types tested for apoptosis by 
flow cytometry and ADP: ATP ratio, there was a significant correlation (p<O.OOI) between 
the two methods (LumiTech™, 1999). 
The results of the ApoGlowTM assays on the lurkat and N2a neuroblastoma cells are 
shown in Figures 4.2 and 4.3, respectively. The results are presented as ADP:ATP ratios 
obtained against the concentrations of FBI, FA, and (FBI+FA) to which cells were 
exposed. The results of the 22.5 hour exposure of the lurkat cell line to FB I and FA, 
individually as well as in combination (Figure 4.2) were interpreted as suggested in section 
4.2.2.5, and by comparison of the ADP: ATP ratios of treated to untreated control cells. 
Comparative analyses of the effects of FBI, FA and (FBI+FA) exposure on the lurkat and 
N2a cells were carried out against matched controls at each test concentration (Appendices 
3 and 4), since although the effects of DMSO as the diluent were considered negligible, 
these differences needed to be taken into account. In theory, in a population of cells 
exposed to death inducing conditions, the ratio of ADP to ATP increases as cells become 
more compromised. Analyses of the ADP: ATP ratios indicate that FBI induced apoptosis 
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in the lurkat human suspension cell line at concentrations of 1.56, 12.5 and 50 ).lg.mr l , 
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Figure 4.2: Effects of FB), FA and (FB)+FA) on the Jurkat cell line as 
determined by the ApoGlow assay following 22.5 hour exposure period 
Qureshi and Hagler (1 992) reported that in primary cultures of chicken peritoneal 
macrophages following exposure to 2.8).lM FBI, significant cytotoxicity and morphological 
features consistent with apoptosis (nuclear fragmentation and membrane blebbing). 
Similarly, Schmelz et al. (1998) showed that incubation of the HT29 human colonic cell 
line with FBI caused a significant reduction in cell number, reflected by increases in DNA 
fragmentation and percentage of apoptotic cells, and that exposure to 10).lM FB I caused the 
accumulation of Sa. These biochemical disruptions may also have occurred and contributed 
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to apoptosis in the lurkat cells following the 22.5-hour exposure period at the mycotoxin 
concentrations used in this study. Increased apoptosis in turkey lymphocytes following in 
vitro exposure to FBI were also reported by Dombrink-Kurtzman et at. (1994). In those 
studies, induction of apoptosis was considered a consequence of CER synthase inhibition, 
and disruption of sphingolipid metabolism by FBI. In addition, at concentrations similar to 
those assessed in the present study, Tolleson et at. (1996b) found that FBI inhibited 
incorporation of eH]-thymidine by cultured neonatal human keratinocytes and HepG2 
human hepatocarcinoma cells at 0.1 ~ (O . 072~g . mrl) and 100~M (72.18~g . mrl) FBI, 
respectively. The results of the present study support the hypothesis that cells responses to 
a mycotoxin are dose and cell type specific. The three most commonly encountered 
explanations for cell to cell variability in toxin sensitivity are, cell to cell variability in the 
amount of target enzymes or other cellular functions which interacts with the toxin, the 
amount of metabolic enzymes which activate a non-toxic precursor molecule into a 
metabolite with non-specific toxicity, and the efficiency of detoxification mechanisms that 
protects the cells and tissues that are less susceptible to the toxic agent (Shier et at., 1991). 
In the present study, FA also induced apoptosis in the lurkat cells at a concentration of 
3.15~g.mrl, and in combination, (FBI+FA), induced apoptosis at 1.56, 3.15, 12.5 and 
800~g.mrl following the 22 .5 hour exposure period. At 6 . 25~g.mrl FBI and (FBI+FA), 
ADP: ATP ratios of the mycotoxin-treated cells approached apoptotic levels . Fumonisin BI 
induced proliferation in the lurkat cells at 400~g . mrl FBI, but initiated growth arrest at 
concentrations of 100, 200 and 800~g. mrl FBI (Figure 4.2, Appendix 3) . These results are 
in keeping with Tolleson et at. (1996b) who reported that FBI inhibited clonal expansion of 
normal human keratinocytes and HET-IA human oesophageal epithelial cells at lO~M 
(7.2~g.mrl) and inhibited growth in mass culture of normal human fibroblasts at 0.1 ~M. 
Riley et at. (2001) have reported that the balance between the apoptotic and proliferative 
rates are critical determinants in the process of tumour genesis. In cells exposed to 
fumonisins, those cells sensitive to the proliferative effect of decreased CER and increased 
So I-phosphate should survive and proliferate, when the conditions under which the cells 
are exposed to fumonisins are such that increased intracellular free sphingoid base 
concentration is not growth inhibitory. Conversely, when the increase in free sphingoid 
bases exceeds a cell's ability to convert Sa:So to dihydroceramide/CER, or their sphingoid 
base I-phosphate, then the free sphingoid bases will accumulate. In this case, cells that are 
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sensitive to sphingoid base-induced growth arrest will die, and non-sensitive cells will 
survive. If the cells selected to die are of normal phenotypes, and those selected to survive 
are abnormal, the risk of cancer would increase (Riley et aI. , 2001). Another condition that 
would promote apoptosis would be if the inhibition of CER synthase was either 
ameliorated or ifCER synthesis increased while free Sa levels were still high. 
Fusaric acid induced proliferation in the Jurkat cells at 1.56~g.mrl, but induced growth 
arrest at concentrations of 100 and 200~g.mrl following the 22 .5hour exposure period. The 
combination of (FB 1+FA) also induced growth arrest at 200~g.mrl, and FA induced 
necrosis at a concentration of 800~g . mrl in the Jurkat cell line (Appendix 3). A possible 
explanation for the ability of FA to induce proliferation in these cells is provided by 
Johnson and McKnight (1989) and Fernandez-Pol (1991; 1992), who propose that FA may 
act by binding Zn2+, which is a structural component of certain zinc-finger DNA-binding 
proteins. In addition, FA may act on cytosol Cu2+/Zn2+ -containing and/or mitochondrial 
Mn2+-containing SOD; these enzymes may be important for growth and survival of 
cancerous cells (Fernanadez-Pol et aI., 1982). A potential explanation for the growth-arrest 
inducing ability of FA is provided by Fernandez-Pol et al. (1993) who has demonstrated 
that FA was a potent inhibitor of DN A synthesis in the MDA-MB-468 human mammary 
cell line. Thompson and Wannemacher (1984) suggest that the different cytotoxic effects 
of a mycotoxin might be influenced by the ability of the mycotoxin to bind to cellular 
receptors and/or penetrate cell membranes. This is dependent on the size, structural 
conformation of the toxin molecule, and its polarity. Furthermore, the relative significance 
of a molecular receptor of a mycotoxin is determined by its affinity to the active form of 
the toxin, its role in vital biochemical processes, the persistence of the lesion it bears, and 
the severity of the consequence of the lesion. 
There seems to be a dose-dependent response of an increase in the ADP: ATP ratio with an 
increase in concentration for cells treated with FA alone (Figure 4.2, linear F A trend line). 
Fumonisin B 1 seemed to induce apoptosis successfully at the lower doses, and then lost this 
effect at the higher concentrations. Scholfield pers comm. (2002) indicated that 
LumiTech™ noted this previously In some cell models, and when analysed by flow 
cytometry, a resistant population of cells was seen emerging which were actively 
proliferating, and therefore affected the ratios indicative of proliferation. The combination 
of (FB 1+F A) does produce an apoptotic effect, but this could be due primarily to the effects 
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of FBI . At the very high doses, the combination seems to be limited in its effect suggesting 
some antagonistic mycotoxin-mycotoxin interaction. 
The results of the exposure of the N2a neuroblastoma cells to FBI and FA, individually 
and in combination are shown in Figure 4.3. Consistent with the findings in the lurkat cell 
line, a decrease in DMSO induced minor increases in cell viability in the N2a cell line, as 
indicated by the linear control trend line (Figure 4.3). Distinct apoptotic ADP: ATP ratios 
were not reached with the N2a cells when treated with FBI. However, at the higher range 
of concentrations between 512 to 1000~g.mrl FBI, ratios started to approach values 
indicative of apoptosis (Appendix 4). The trend in the ADP: ATP ratios however indicate 
the potential for exposure to higher FB I concentrations than those used in this study to 
induce apoptosis in the N2a cells. These results correlate well with the MTT assay results 
(Chapter 3, Table 3.1) where at 200 and 250~M FBI (i.e., 144.36~g.mrl and 
180.45~g.mrl), 29.8% and 42.1% cell viabilities were observed in the N2a cells 
respectively. Although the MTT assay was carried out over 48 hours and the ApoGlowTM 
assay over 24 hours, both sets of result show similar response patterns for the N2a cell 
line. 
A similar trend to that of the FBI-treated N2a cells response was noted with both 
the FA-treated and (FBI+FA)-treated N2a cells (Figure 4.3). At the higher range of 
concentrations (i.e., between 256 and 1000~g . mrl), the ADP: ATP ratios of the FA-treated 
N2a cells started to approach apoptotic levels. In the (FB 1+ F A) treated N2a cells, this 
effect started at the lower doses of8~g.mrl and 32~g.mrl, going up to 512 ~g.mrl with the 
combination of the mycotoxins (FBI+FA) potentially acting together to induce apoptosis in 
the cells following the 24 hour exposure period (Appendix 4). These results also correlate 
with the MTT assay results where on exposure to 250~M FA, 33.2% cell viability was 
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Effects ofFB" FA, and (FB,+FA) on the N2a mouse 
neuroblastoma cel/line as determined by the ApoGlow assay 
following 24 hour exposure 
Consistent with the interpretation of results for lurkat cells, N2a cells with ADP: ATP 
ratios slightly lower than that control cells were interpreted as being in a state of growth 
arrest induced by exposure to the mycotoxins. Fumonisin BI at 8!lg.mr l, FA at 
128!lg.mrl, and (FB1+FA) in combination at 2 and 4Jlg.mr l induced growth arrest. 
Necrosis was not induced in the N2a cell line at any of the mycotoxins test concentrations 
according to the results reported for the ApoGlow™ assay (Figure 4.3). 
Fernandez-Pol et al. (1993) exposed WI-38 fibroblasts to 500!lM (90!lg.mrl) FA, and 
reported that cell proliferation ceased. Anti-proliferative effects of FBI have also been 
reported in a panel of rat hepatoma cell lines (namely, H4TG, H4-II-E-, H4-IIE-C3, Zfao, 
MHICl, McA-RH777 and McA-RH8994), LLC-PKI cells and MDCK cells, with ICso 
values rangmg from 2.5JlM FBI (-2Jlg.mr l ) and 50!lM FBI (-37Jlg.mr l ) 
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(Shier et aI., 1991; Yoo et aI. , 1992; Abbas et at., 1998). Counts et al. (1996) also reported 
that rabbit renal epithelial cells are also very sensitive to fumonisin-induced inhibition of 
cell growth. 
Further support for the growth arresting effect of FBI are provided by Mobio et al. (2000), 
who reported that after 24 hour incubation of rat C6 glioma cells with 3 to 18~ of FB, 
(- 2-16/lg.mr l ), the number of cells in phase G:JM increased significantly as compared to 
the control (p<O.OS) from 4S.7±0.4% to 54.8±1.1% for 9/lM FB, (- 7/lg.mr l ) , whereas no 
change occurred in the number of cells in the phase Go/G,. This indicates that cytotoxic 
concentrations of FBI induce cellular cycle arrest in phase G2/M in rat C6 glioma cells 
possibly in relation with genotoxic events. 
The cytotoxicity of FA may be attributed to the S-butyl side chain, which because of its 
lipid solubility may allow better cellular penetrability of this agent. 
Telles-Pupulin et al. (1998) using isolated rat mitochondria showed that FA affects 
mitochondrial energy metabolism by inhibition of succinate dehydrogenase 
(in the 10-3 _1O-2M range), inhibition of oxidative phosphorylation (in the 10-5_1 OAM range) 
and inhibition of a-ketoglutarate dehydrogenase (in the 10-5_1 0-4M range) . The inhibition 
of oxidative phosphorylation seems to be the result of a direct action on the ATP 
synthasel ATPase without significant inhibition of the ATPI ADP exchange. In the present 
study, cell viability is partially reflected by the higher ADP: ATP ratios. These high ratios 
may have been a consequence of the inhibition of oxidative phosphorylation, as a result of 
exposure to FA. 
From the analyses of the lurkat and N2a cell lines in this study, the major factors affecting 
modes of cell death are the concentrations of the compounds tested and the cell types being 
tested. A mycotoxin may induce apoptosis at low concentrations, but kills cells by necrosis 
at higher concentrations probably due to the rapid collapse of cellular integrity, including 
plasma membrane disruption, a large calcium influx, as well as intracellular ATP depletion 
(Tsujimoto, 1997). Apoptosis and necrosis were detected in the cell lines assessed in this 
study on exposure to FB, and F A at various concentrations. 
From the analyses, it would appear that FA is more toxic to the lurkat and N2a cells than 
FB, . However, this assay was carried out using mass-based concentrations, and not 
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molarity-based concentrations as in Chapter 3. The molecular weight of FBI is 721.8 and 
that of FA is 179.2. This implies for example that 7 . 218~g FBI in Iml of CCM is 
equivalent to 101lM FBI, whereas 1.792~g FA in Iml is equivalent to 10IlM FA. This 
implies that on a mass-to-mass comparison, all cells were exposed to comparatively higher 
molarities ofF A in these assays. 
Studies have indicated that the effects of FBI on different cell lines vary depending on cell 
type. The effects on FB I and FA on the lurkat and N2a cells differ with more pronounced 
effects being evident in the lurkat suspension cell line. A possible hypothesis for varying 
susceptibility may be due to the greater surface area of exposure to the mycotoxins in the 
CCM that the lurkat suspension cells are bathed in, in comparison to the adherent N2a 
cells, providing an additional explanation for the lower susceptibility of these cells to the 
mycotoxins. 
4.4 CONCLUSION 
The ApoGlowTM assay was used successfully in this study to determine the effects FB I, FA 
and (FBI+FA) on the N2a neuroblastoma cell line and the lurkat leukaemic suspension 
cell line. Interpretation of the data revealed at specific concentrations whether these 
mycotoxins individually, or in combination induced proliferation, apoptosis, necrosis, or 
growth arrest. Apoptosis was induced by FBI in the lurkat cell line at 1.56, 12.5 and 
50~g.mrl, and FBI induced growth arrest at 100, 200 and 800llg.mrl in these cells. Only at 
400llg.mrl did FBI induce proliferation of the lurkat cells. Fusaric acid however induced 
proliferation at the lower end of the concentration range at 1.56 Ilg.mrl and apoptosis at 
3.15 ~g.mrl. At 100 and 200llg.mrl, FA induced growth arrest in the lurkat cells, with 
necrosis at 800llg.mrl . In combination, (FBI+FA) induced apoptosis at 1.56, 3.15, 12.5 
and 800llg.mrl, while at 200llg.mrl, this combination of mycotoxins induced growth 
arrest in the lurkat leukaemic suspension cell line. These results have bearing on the 
potential effects of these mycotoxins on white blood cells in the circulatory system of 
humans and requires further consideration. 
In the N2a cell line, necrosIs and proliferation were not detected at any of the 
concentrations of FBI or FA assessed in this study. Instead, FBI at 8Ilg.mrl , and FA at 
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128Ilg.mrl, induced growth arrest after 24 hour exposure to these mycotoxins. In 
combination (FBI+FA) also induced growth arrest at 2 and 4llg.mr1 Fusaric acid alone 
and in combination with FBI , at 256 and 5121lg.mrl induced apoptosis in the N2a cells. In 
addition, FA at 1000J.lg.mr l also induced apoptosis in the N2a cells. The effects noted on 
the N2a cells are important because it provides some insight as to how neural cells would 
respond in vivo on exposure to these mycotoxins. No distinct trends were noted in the 
responses of the N2a neuroblastoma and the Jurkat suspension cell line on exposure to 
these mycotoxins. However, depending on the cell line analysed and the concentrations of 
exposure, the mycotoxins acted either antagonistically, in synergism, or induced some level 
of cytotoxicity by disrupting normal cellular metabolism. 
Although the ApoGlowTM assay does provide a range of results that are useful, it is not 
widely used as it is expensive and requires specialized equipment such as the luminometer, 
for the analysis of treated cells. The purchase of such specialised equipment and its 
maintenance is not feasible in resource poor settings. Instead, assays that do not require 
such specialised equipment are opted for, and at a lower cost provide similar information. 
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CHAPTERS 
Fluorescent microscopic and cytofluorometric analyses of 
N2u neuroblastoma cells exposed to selected Fusarium 
mycotoxins and sphingoid bases 
5.1 INTRODUCTION 
The ordered sequence of biochemical and cellular events that exemplify apoptosis and 
necrosis are paralleled by specific changes in the morphological and physical properties in 
both the cell nuclei and cytoplasm (Wyllie, 1980; Vaux, 1993; Bradbury et ai., 2000). 
These changes provide features that permit recognition of apoptotic or necrotic cell death 
by various methods, and for apopto~is include the loss of Ll\jJm, loss of plasma membrane 
asymmetry, and the condensing and eventual fragmentation of chromatin into 
internucleosomal fragments. Necrosis, in contrast, is characterised by cell and nuclear 
swelling, patchy chromatin condensation, swelling of mitochondria, vacuolisation of 
cytoplasm, and plasma membrane rupture, leading to the formation of 'ghost-like' cells and 
finally, dissolution of DNA. Apoptotic and necrotic cell death are different from a 
mechanistic point of view, because necrosis is the passive result of cellular injury, and 
apoptosis forms an integral part of normal physiological cell processes (Kerr et at., 1972; 
Vermes et ai., 2000). 
Flow cytometry (FCM) facilitates quantitative analyses of components or structural 
features of cells primarily by optical means, allowing characterisation of several cell 
parameters and functions (Dolbeare et ai., 1983; Shapiro, 1985; Cossarizza et at., 1991; 
Nicoletti et at., 1991; Barbieri et ai., 1992; Darzynkiewicz et aI., 1992). Advantages of 
FCM techniques include the ability to analyse large numbers of living or fixed cells in a 
few minutes, providing a statistically significant picture of the cells physical and 
biochemical make-up. Cells are passed single-file through a laser beam by continuous flow 
of a fine stream of the suspension. When cells pass through the laser beam, they disrupt 
and scatter the laser light, which is then detected as forward scattered (FSC) and side 
scattered (SSC) light, that are related to cell size or diameter, and to the cells internal 
complexity or granularity, respectively. In addition to scatter, a flow cytometer measures 
fluorescence parameters. Cells exhibit a change in light scatter characteristics when they 
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die, or when their membranes become permeabilised. On a flow cytometer, this manifests 
as a reduction in the FSC signal and an initial increase in the SSC signal, partly due to a 
change in the refractive index of the celIs cytoplasm. As the majority of the events that 
characterize apoptotic death, can be revealed by multiparameter FCM, methods have been 
proposed to analyse and quantify the apoptotic process through evaluation of light 
scattering parameters of celIs. Since no single parameter defines programmed celI death, a 
combination of techniques is recommended for reliable detection of apoptosis and/or 
necrosIs. 
In this study, fluorescent probes for studying apoptosis and necrosis were organized into 
categories based on the identification of different aspects of these cellular processes. A 
crucial event in the mitochondrion is the formation of permeability transition pores 
(mitochondrial megachannel) in its outer membrane leaflet allowing flux of mitochondrial 
proteins into cytosol (Marchetti et aI., 1996; Susin et aI., 1998). Opening of megachannels 
results in colIapse of asymmetric distribution of protons on both sides of the inner 
mitochondrial membrane, known as transition of the mitochondrial transmembrane 
potential (TMP) (Martinou, 1999) and will be measured using Rhodamine 123 (Rh 123) 
and the dual emission potential sensitive probe 5,5', 6, 6'-tetrachloro-l, 1',3,3'-
tetraethylbenzimidazol-carbocyanine iodide (JC-l). The transition of the mitochondrial 
transmembrane potential is an early and universal event in apoptosis. These probes 
facilitated analysis of changes in mitochondrial membrane potential and plasma membrane 
integrity, following treatment with the selected mycotoxins and sphingoid bases. The 
cytofluorometric study of mitochondria in their physical environment within intact cells 
presents several advantages in that it is possible to evaluate at a single cell level, potential 
variation in mitochondrial transmembrane potential. This is of fundamental importance 
when coping with heterogeneous cell populations. 
Robb et al. (1990) showed that after incubation with 20 mycotoxin standards and extracts 
of fungi and feedstuffs, fluorescent FCM was successfully used to measure viability of the 
suspension NS-l mouse melanoma cell line, and compared well to microscopic assessment 
of cytotoxicity on Hep-ll monolayers. Both methods gave essentially the same results, but 
the cytometric analysis using Rh 123 offered a more quantitative approach. In the present 
investigation the effects of FBI, MON, FA, ZEA, T2, DON, Sa and So on the N2a cell line 
were assessed following a 48-hour exposure period, qualitatively using fluorescence 
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microscopy (FM) and quantitatively using FCM. The principle of FM is based on the ability 
of a fluorescent compound to absorb ultraviolet (UV) light and re-emit the energy as 
visible light. The advantage of this technique is that by using light of short wavelength as 
the illuminating beam, there is an increase in the detail observed, and the light of long 
wavelength given off, amplifies the label. Rhodamine 123 was used in conjunction with 
PI, to measure cell viability and permeability on unfixed cells. Ethidium bromide (EtBr) 
and AcO were used to indicate the presence of apoptosis and loss of plasma membrane 
integrity. Analyses included fluorescent microscopic detection, cytofluorometric 
identification and quantitation of apoptotic or necrotic cells, based on interaction with these 
fluorochromes. 
5.2 MA TERIALS AND METHODS 
Techniques reported in this chapter were studied under the supervision of Mrs Anne Cox, 
Dr Dawn Bradbury, and Professor Martin Griffin (July-September 1999), NTU, UK, and 
applied in the Departments of Physiology and Haematology, and the Optics and Imaging 
Centre, UKZN (December 2001). 
5.2.1 Materials 
Cell culture materials, media, antibiotics and sterile disposable consumables were 
purchased from Adcock-Ingram, SA, unless otherwise indicated. Pre-sterilised Corning 
plastic tissue culture flasks (2Scm2) were used as culture vessels. Sterile centrifuge tubes 
(ISml) were purchased from Continental Laboratory Suppliers. N, N' -dimethylformamide 
(DMF), D-sphingosine, DL-erythro-dihydrosphingosine, PI, Rh123, AcO, EtBr and 
phosphate buffered saline (PBS) tablets were purchased from Sigma-Aldrich Chemical 
Company, SA. The JC-l probe was purchased from Molecular Probes, UK. All mycotoxins 
were obtained from the Mycotoxin Research Group, UKZN. 
A Nikon E600 fluorescence microscope fitted with a camera was used at the Optics and 
Imaging Centre, UKZN. A Beckman Coulter EPICS XL flow cytometer fitted with a 
488nm argon laser was used in King Edward VIII Hospital, Department of Haematology, 
UKZN. Blue tubes for FCM analysis and Isoflow sheath fluid was purchased from 
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Beckman Coulter, SA. The instruments were set up according to standard operating 
procedures. 
5.2.2 Precautions 
Since ~\lfm is sensitive to both temperature and pH, all reagents were brought to RT prior 
to use, to ensure that pH 7.4 was maintained. As the fluorochromes used were light 
sensitive, all staining procedures and incubation times were carried out in the dark . 
5.2.3 Preparation of the mycotoxin and sphingoid base stock solutions 
The mycotoxins FBI, FA, MON were dissolved directly into CCM (1mg.mr l ) , with CCM 
as the control solution for these mycotoxins. Zearalenone, T2, DON, Sa and So were 
dissolved in ethanol (EtOH) (100111 per mg) and CCM (900111 per mg) to a total stock 
solution of 1 mg. mr I . The control for this set of compounds was made up of EtOH (100111) 
and CCM (900111). All stock solutions were vortexed thoroughly to ensure complete 
resuspension of the compound in the solvent vehicle and CCM, and then used to prepare 
dilutions of 50, 100 and 200llM of each compound in CCM. 
5.2.4 Preparation of N2a cells for fluorescence microscopy 
Flasks of confluent N2a cells were incubated (37DC) in each test or control solution (2m!) 
for 48 hours prior to analysis. As FM involved qualitative analysis of the N2a cells, tests 
for the effects of each compound were carried out in duplicate at the 100/lM concentration 
only. However, as cells were analysed using FM for three separate combinations of 
fluorochromes, namely AcOlEtBr, Rh1231PI, and JC-l, three replicates for each test 
compound at the 100/lM concentration were prepared in duplicate. Following the 48-hour 
incubation period, all flasks were removed from the incubator, and gently rinsed with 
HESS (5m!) to remove the detached dead cells and test solutions. The washes were 
discarded and the cells replenished with either fresh CCM or PBS as detailed below. 
5.2.4.1 Acridine orange and ethidium bromide staining of N2a cells for 
assessment by fluorescence microscopy 
A 2.5ml aliquot of PBS (pH 7.4) was added to the first set of confluent N2a cells 
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in flasks, followed by 100~1 each of a mixture (1: 1) of AcO (1 OO~g . mrl in PBS) and EtBr 
(1 OO~g. mrl in PBS). The flasks were shaken gently to ensure proper mixing of the 
solutions, and incubated at RT for between two to five minutes with checking. The staining 
solution was discarded and the top half of the flask was cut off using a heated wire. The 
cells were immediately bathed in PBS (1 ml) to prevent drying out, prior to analysis on the 
Nikon E600 fluorescence microscope. 
5.2.4.2 Rhodamine 123 and propidium iodide uptake by N2a cells assessed by 
fluorescence microscopy 
To the second set of flasks ofN2a cells, following rinsing with HBSS (Sml), the cells were 
supplemented with CCM (1ml) and Rh123 (20~1 of 10~g. mrl in PBS, pH 7.4) was added 
and gently mixed. Following a five minute incubation at 37°C, PI (20~1 of 10~g.mrl in 
PBS) was added to the flask, gently mixed and incubated at R T for a further five minutes 
prior to analysis. 
5.2.4.3 Measuring the mitochondrial transmembrane potential of N2a cells 
with JC-1 
The JC-1 fluorescent probe was dissolved in DMF (2.Smg.mr\ dispensed into 10-20~1 
aliquots, and stored at -20°C in the dark, until use. The third set of flasks of treated N2a 
cells were rinsed in HBSS (Sml), and replenished with CCM (2ml) . The cells were stained 
with 2.S~g JC-1 per ml CCM (i.e., 2~1 of JC-1 stock to 2ml CCM) and shaken well until 
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the dye was well dissolved giving a uniform red-violet colour. The flasks were incubated 
for 15-20 min. at 37°C in the dark with gentle shaking every five minutes. After 
incubation, cells were rinsed twice with HBSS (Sml) and supplemented with 2ml CCM 
prior to analysis on the FM (with modification from Cossarizza et at., 1993). 
5.2.5 Preparation of N2a cells for cytofluorometric analyses 
Flasks of confluent N2a cells were incubated (37°C) in each test or control solution (2 ml) 
at 50, 100 and 200~M for 48 hours prior to analysis. 
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5.2.5.1 Measuring N2a cell viability and permeability with propidium iodide 
and mitochondrial transmembrane potential with rhodamine 123 
Following the 48-hour incubation period, cells from duplicate flasks of N2a cells were 
trypsinised and pooled into CCM (Sml) in sterile centrifuge tubes (1Sml). The cells were 
pelleted by centrifugation (2S0g, Smin.). The supernatant was discarded and the cell pellet 
resuspended in CCM (SOOIlI) . Cell clumping was avoided with gentle tapping of the 
sample tube every 30 seconds (sec.). A single non-stained N2a cell sample was retained to 
establish where the cells would lie in the quadrants, and determine the light scattering 
properties ofN2a cells. To the rest of the cell suspensions, Rh123 (10111 of IOllg.mr' stock 
solution in PBS, pH 7.4) was added. After a five minute incubation at 37°C, PI 
(10111 of IOllg.mr' stock solution in PBS, pH 7.4) was added, and the N2a cell suspension 
was incubated for a further five minutes at RT, prior to immediate analysis on the FCM, 
where between 1000-2000 events were counted on the EPICS XL (with modification from 
Simmons, 1999). The primary gate was set on cells on the FSC and SCC histogram, and 
this gate was used in all the analyses. 
5.2.5.2 Measuring the mitochondrial transmembrane potential of cells with JC-1 
When staining cells with this dye, speed was critical as IC-l is essentially insoluble in 
aqueous solution, and precipitates out in a matter of minutes. Due to this limitation, it was 
easier when working with the cells in suspension to do the staining using 1 ml volumes, as 
these could be sedimented quickly using a centrifuge. 
Control and treated of N2a cells were trypsinised using 0.1 % EDT A, pooled into sterile 
centrifuge tubes (ISm!), pelleted by centrifugation (2S0g, S min.) and resuspended in CCM 
(1 ml) . The N2a cell suspensions were stained with 2.Sllg.mr' IC-l, and shaken well until 
the dye was well dissolved, giving a uniform red-violet colour. To do this, it is also 
possible to vortex vigorously the suspension immediately after the addition of the probe. 
The cell suspensions were then incubated for IS-20 minutes at 37°C with gentle agitation 
every five minutes. After the incubation period, the cells were washed twice by vortexing, 
then pelleted by centrifugation at 2S0g for S min. with a double volume of PBS (2ml per 
wash) . The cells were then resuspended in O.Sml PBS and analysed immediately on the 
FCM (with modification from Cossarizza et aI. , 1993) . 
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In the flow cytometer, the value of the photomulti plier tube (PMT) detecting the signal in 
fluorescence channel 1 (FL-1) was set at about 390V, and fluorescence channel 2 (FL-2) 
PMT at 320V. With regards to the detector configuration, when excited simultaneously by 
488nm argon-ion laser sources, the IC-l monomer and I-aggregates were detected 
separately in the conventional flow cytometer FL-l (green) and FL-2 (red) channels, 
respectively. The same channels were used for Rh 123 and PI detection as well. 
5.3 RESULTS AND DISCUSSION 
The use of EtBrl AcO, Rh 123IPI and JC-l in the N2a cellular analyses in this study was 
preferred as an alternative over that of the commercially available Annexin V and TUNEL 
assays. Although convenient, the use of commercially available kits is not always feasible . 
The limitation of reagents for a specified number of tests per kit, as well as their high cost, 
coupled with the need to assess the effects of six mycotoxins, two sphingoid bases and 
their matched controls with duplicate testing and multiple test runs on the cells for FM and 
FCM, was not financially feasible in this study. Using the Annexin V and TUNEL assays 
in the assessment of apoptosis in this study would have meant purchase of multiple kits and 
inflated experimental costs. Boehringer Mannheim (1998) also outlined other 
disadvantages associated with the use of the Annexin V and TUNEL kits. Annexin V was 
documented as not being specific for apoptosis since Annexin V can stain the inner 
membrane of ruptured celis, and an additional DNA stain must be used to distinguish 
between necrotic and apoptotic cells. With the TUNEL assay, Boehringer Mannheim 
(1998) outlined that it is labour intensive, time consuming, only a few tests may be 
performed simultaneously, that there was undefined cell loss during fixation, and 
uncertainty with regards to loss of a specific cell population. With all this room for error, 
and the fact that the objectives could also be assessed using the fluorochromes used in this 
study with very similar confounding variables, it was considered unnecessary to purchase 
an expensive kit with the restriction of a limited number of tests when a larger amount of a 
more economical fluorochrome could provide similar findings . Although not an objective, 
this study aimed to establish an alternative cheaper method that could be used in resource 
poor settings. 
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5.3.1 Acridine orange and ethidium bromide staining assessed by fluorescence 
microscopy 
Acridine orange and EtBr were initially used to determine whether apoptosis, and loss of 
plasma membrane integrity occurred in the mycotoxin and sphingoid base-treated N2a 
neuroblastoma cells. In growing cells that are active in protein synthesis, RNA is 
responsible for cytoplasmic basophilia, i.e., the tendency of the cytoplasm to stain with 
basic dyes such as AcO (Vermes et aI., 2000). Acridine orange fluoresces green and EtBr 
fluoresces orange/red when bound to DNA. Acridine orange was permeable to the cell 
membrane, whereas EtBr was excluded from cells with intact plasma membranes 
(Figures 5.1 and 5.2). According to Gorman et al. (1997), AcO is taken up regardless of 
plasma membrane integrity and stains all cells to give green fluorescence, whereas EtBr is 
only taken up by late apoptotic and necrotic cells, i.e., cells that have become permeable, to 
give orange fluorescence . Even though apoptotic cells are beginning to die, their plasma 
membrane continues to exclude special dyes, and their chromosomal DNA fragments 
remain contained within the cell membrane until late in the process (Wyllie et aI., 1980; 
Darzynkiewicz et aI., 1992; Migliorati et aI., 1993). Necrotic cells are metabolically 
compromised, and vital dyes therefore readily penetrate their plasma membranes. 
However, because the plasma membrane of necrotic cells are leaky, the protein content of 
these cells is also reduced, and as a result have very faint staining with dyes such as AcO 
(Figure 5.3). 
Using AcO and EtBr in combination, made it possible to differentiate between viable cells 
(green fluorescence with intact nuclei), early apoptotic (green fluorescence with chromatin 
condensation), late apoptotic (orange fluorescence with chromatin condensation) and 
necrotic cells (orange fluorescence with intact nuclei) following treatment with the 
mycotoxins, Sa and So (Figures 5.1-5.4). Cells at various stages from live (green), dead 
(red/orange) and those that were dying were observed by loss of cell membrane integrity, 
and either dye exclusion or inclusion (Figures 5.1-5.4). The live cells remained green, the 
dead cells red/orange and the transient or dying cells, showed staining with both dyes at 
various levels. Figures 5.1 and 5.2 illustrate the staining typical of control cells, where 
there was a predominance of green staining AcO in healthy cells, and very low levels of 
orange/red staining in apoptotic cells. Apoptosis is characterised by the maintenance of an 
intact plasma membrane during a significant part of its time course (Wyllie et aI., 1980; 
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Vermes et at., 1998) and is a normal physiological process. Low levels of apoptotic cells 
were therefore expected in the control N2a. cells as well. 
Following the 48-hour exposure period, the six mycotoxins, as well as Sa and So induced 
varying levels of apoptosis and necrosis in the cultured N2a celis. As confluent flasks of 
N2a. cells were used at the initiation of the 48-hour exposure period, the large intercellular 
gaps (Figure 5.3 and 5.4) were considered a reflection of the level of cell death induced by 
the treatment regimen. A feature of cells that lose viability in culture is the loss of their 
ability to adhere to the culture substrate. These dead cells consequently float off, and are 
removed in the washes prior to staining cells. 
Significant differences in the staining intensities were apparent by comparison of control 
N2a cells (Figure 5.1) with the FBI-treated (Figure 5.3) and T2-treated N2a. cells 
(Figure 5.4). There was a notable inversion in the ratio of green to red/orange staining, with 
a high proportion of apoptotic and necrotic cells detected following exposure to these 
mycotoxins. In relation to the MTT data generated subsequent to 48-hour exposure to these 
mycotoxins (Chapter 3, Table 3.1 and 3.3), T2 induced ~35% cytotoxicity and FBI ~15% 
cytotoxicity. Comparable patterns of staining were seen following exposure of the NZa. 
cells to the six mycotoxins, as well as Sa and So, although the intensity of staining varied. 
As a result of its basic property, AcO has the ability to accumulate in Iysosomes, which, 
due to an ATP-dependent proton pump have a low pH. Once inside, the dye is protonated 
and becomes entrapped in these organelles. The supravital cell staining with a low 
concentration, which appears as red fluorescence, is the reflection of the activity of the 
proton pumps of Iysosomes (Darzynkiewicz et aI. , 1992). The ability of Iysosomes to 
accumulate AcO remains intact during the initial stages of apoptosis whereas it is 
immediately lost during necrosis . This difference can be exploited for discrimination 
between apoptosis and necrosis. The monomeric binding of AcO to the cellular DNA 
results in green fluorescence, while polymeric binding of AcO to Iysosomes results in red 
fluorescence. During apoptosis, the red fluorescence is not changed because of the intact 
lysosomal membrane, while the green fluorescence may diminish due to DNA breakdown, 
resulting in a net increase of the red signal in apoptotic cells, and a decrease of the red 
signal in necrotic cells, due to ruptured and leaky lysosomes, while the green DNA 
fluorescence remains stable at least during the initial stage of apoptosis. In apoptosis, after 
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loss of the mitochondrial transmembrane potential, the lysosomal pumps lose their function 
(Vermes et aI., 2000). 
Visually, it was difficult to differentiate between the red-staining lysosomes (Figure 5.1) 
and the orange-staining chromatin within cells in this study (Figure 5.3). Quantitative 
assessment of the cells following staining with AcO and EtBr on the FM was omitted, as 
the red and orange staining were difficult to separate due to their closeness in the colour 
spectrum, and hence spectral overlap on the image analysis system. An attempt to quantify 
this type of staining would have led to inaccurate values being obtained if used as a gauge 
of the level of necrosis/apoptosis that occurred. 
5.3.2 Rhodamine 123 and propidium iodide staining assessed by fluorescence 
microscopy 
The ~\jIm results from the asymmetric distribution of protons and other ions on both sides 
of the inner mitochondrial membrane (Chapter 4, Figure 4.1). The matrix side of this is 
negatively charged; consequently cationic lipophilic fluorochromes distribute to the 
mitochondrial matrix (Kroemer et aI., 1997). An early event of apoptosis is TMP, which is 
reflected by a loss of the cells' ability to accumu~ate these fluorochromes. Disruption of 
TMP occurs before cells exhibit nuclear DNA fragmentation or exposure of 
phosphotidylserine on the outer cell membrane leaflet (Marchetti et aI., 1996). Rhodamine 
123 and JC-1 serve as probes for TW. Viable cells incubated in their presence, 
accumulate the probes in their mitochondria, and the efflux of the fluorochrome measured 
by intensity of cellular fluorescence is considered to reflect TMP. 
Rhodamine 123 is a cationic fluorochrome, that fluoresces green when actively taken up 
due to the ~\jIm. When membrane integrity is compromised, cells take up PI that binds to 
DNA or double stranded RNA and fluoresces red . When Rh123 was applied together with 
PI, intact cells stained with Rh 123 (green fluorescence and no PI staining because of intact 
membrane function). Healthy control N2a cells with functioning mitochondria and intact 
cell membranes accumulated the Rh 123 to give fluorescence in the green wavelength, and 
as PI was excluded, no fluorescence in the red wavelength (Figure 5.5). Rhodamine 123 
was taken up by the mitochondria of these cells resulting in cells with brightly staining 
green cytoplasm, while non-viable cells exhibited a diffuse, pale-green fluorescence due to 
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compromised mitochondrial function (Figures 5.6-5 .7). Rhodamine 123 in combination 
with PI, facilitated discrimination between live cells and dying cells (necrotic or late 
apoptotic cells), whose plasma membrane integrity was compromised and consequently 
stained with PI as well. Necrotic and apoptotic cells are shown in Figures 5.6 and 5.7 
where the N2a cells were treated with Sa and So (100IlM), respectively. 
N2a cells with intact membranes (e.g. , viable and early apoptotic cells) excluded PI, 
preventing its intercalation into intracellular nucleic acids. Thus, these cells did not exhibit 
enhanced DNA dependent fluorescence due to the absence of PI-DNA complex formation . 
The early apoptotic cells however, in contrast to viable cells had markedly diminished 
staining capacity for Rh123, and stained with faint green fluorescence, due to fewer viable 
mitochondria than in the viable cells. Apoptotic cells retained their membrane integrity, 
and thus excluded PI. As apoptosis progressed however, the permeability of cell 
membranes gradually increased in discrete stages, resulting in late apoptotic cells staining 
with PI. Furthermore, necrotic N2a cells were intensely labelled with PI, since their 
damaged membranes were incapable of excluding the stain. Overall, cells with 
compromised plasma membranes, namely the necrotic and late apoptotic N2a cells stained 
with PI, showing red fluorescence. 
In this study, optical separation and identification of necrotic and late apoptotic N2a cells 
were complicated to assess using FM, as illustrated in Figures 5.6 and 5.7. Rhodamine 123 
was taken up by the mitochondria of live N2a cells resulting in cells with brightly staining 
cytoplasm, while non-viable N2a cells displayed diffuse fluorescence . The ZEA-treated 
N2a cells shown in Figure 5.8 displayed features of cytoplasmic condensation and cell 
shrinkage that are consistent with the late apoptotic stage. In addition, cells with relatively 
intact cell membranes are noted in comparison to the DON-treated N2a cells shown in 
Figure 5.9. The DON-treated N2a cells were swollen and displayed compromised plasma 
membrane integrity indicative of possible necrosis. The N2a cells treated with DON also 
displayed characteristic features of apoptosis such as membrane blebbing. 
Propidium iodide uptake was a reflection of the extent of membrane damage and 
permeability of these unfixed N2a cells. Propidium iodide was not excluded by necrotic 
cells and after entering the cell, and intercalating with intracellular nucleic acids, induced 
bright red fluorescence of the necrotic DON-treated N2a cells nuclei (Figure 5.9). Cells 
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with their membrane integrity compromised incorporated PI (red fluorescence), with a 
decrease in the green fluorescence reflective of cells whose mitochondria were not 
functioning optimally, or at all (Figure 5.7). Cells with decreased Rh123 fluorescence and 
that were PI positive included necrotic cells (Figure 5.9), indicated by cellular swelling, 
and loss of plasma membrane integrity shown in comparison to control N2a cells that 
stained purely with Rh 123 and excluded PI (Figure 5.5). 
5.3.3 Measuring the mitochondrial transmembrane potential of cells with JC-l 
Variations in mitochondrial membrane potential were detectable at the single cell level by 
staining N2a cells with the lipophilic cation JC-I. This dye fluoresces green in its 
monomeric form. Active mitochondria with high transmembrane potentials, capable of 
accumulating the JC-l at concentrations greater than 100nM, formed J -aggregates that 
fluoresced red. JC-l binding to mitochondria was therefore detected by the shift in 
fluorescence from green to orange/red, which reflected its aggregation in mitochondria 
driven by the L1 \jim. The change in binding of JC-l was reflected by the loss of orange 
fluorescence and a decrease in the green fluorescence, although to a lesser degree than the 
orange. The ratio of green to orange/red fluorescence was dependent only on the membrane 
potential, and not on other factors such as mitochondrial size, shape and density that 
influence single component fluorescence signals. 
As JC-l was light sensitive, speed was critical in capturing the images under the FM once 
exposed to light. During apoptosis there was a marked decrease in orange fluorescence, 
and to a lesser degree, in the green fluorescence of JC-l. The uptake of this cationic probe 
depends not only on the L1\j1m, but also on transport of these molecules through the plasma 
membrane, cytoplasmic loading which is dependent upon plasma membrane potential, and 
mitochondrial loading which is dependent upon ER loading, that theoretically can take 
place after the fall in L1 \jim. In the case of JC-l, aggregates are present no longer when the 
dye is released from mitochondria. Cells with high transmembrane potential were those 
forming J-aggregates, thus showing high red fluorescence and cells with lo~ 
transmembrane potential were those in which JC-l maintained (or reacquired) monomeric 
form, thus showing only green fluorescence. Polarized mitochondria were marked by 
punctate orange-red fluorescent staining in the control N2a cells stained with JC-l 
(Figures 5.10 and 5.11). 
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In the N2a. cells exposed to FA (1 00 ~M) for 48 hours, J -aggregate formation was elevated 
in N2a. cells that were large and apparently unaffected by mycotoxin exposure, in 
comparison to those N2a. cells in the centre of the micrograph, that had decreased staining 
and showed cytoplasmic condensation (Figure 5,12). These were likely apoptotic cells, On 
depolarisation, the orange-red punctate staining was replaced by the diffuse green 
monomer fluorescence. From Figure 5.12, is also evident that large numbers of cells were 
killed as a result of exposure to FA, since large intercellular gaps were evident. All flasks 
of N2a. cells utilized in these experiments were confluent prior to addition of the 
mycotoxins or sphingoid bases, and the duration of exposure to the mycotoxins was 
sufficient to have induced cell death at a detectable level. Dead cells would have been 
rinsed out prior to staining, creating the large intercellular gaps between the cells 
(Figure 5.12), 
In the N2a. cells exposed to MON (100~), a decreased cytotoxicity was apparent in 
comparison to the FA-treated cells by the noticeably higher number of cells with intensely 
coloured J-aggregates (Figure 5,13), These results are supported by findings of the MTT 
assay, (Chapter 3, Table 3.1) where following 48-hour exposure to 100~M MON, 61.4% 
cell viability was noted in comparison to the untreated N2a. controls. In the cells exposed 
to FBI (lOOpM) for 48-hours, fluorescent J-aggregates were visible in the remaining 
adherent cells, but as with FA, large intercellular spaces were noted indicative of the 
proportion of cell death that occurred as a consequence ofFB t exposure (Figure 5.14). 
5.3.4 Flow cytometric analysis of cells stained with rhodamine 123/ 
propidium iodide and JC-l 
Although qualitative analysis of RhI23IPI and JC-l incorporation was done using FM, 
quantitative analyses of apoptotic and necrotic cells was facilitated on the FCM, using 
Rh123IPI uptake as a measure of cell permeability, and determination of ~\lfm using JC-l. 
The results these probes provided were expressed as increases or decreases in fluorescence 
intensity, Consequently, variations of membrane potential were usually expressed as the 
shift of the mean peak channel of a single fluorescence. 
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Flow cytometry was a comparatively more expensive technique In terms of requiring 
higher cell numbers, which involved culturing multiple flasks of N2a cells for treatment 
and analysis, Higher concentrations of mycotoxins and sphingoid bases in larger volumes 
of CCM were also used in comparison to in vitro micro-culture assays to ensure uniform 
exposure of N2a cells to these test compounds during the exposure periods, A further 
requirement was the use of specialized equipment, i.e., the flow cytometer and technical 
expertise to operate the FCM and guide interpretation of data. These drawbacks were 
however considered a trade-off when taking into account the ability to quantitatively 
analyse the effects of a treatment regime on the N2a cultured cells, 
JC-l is a marker of mitochondrial activity, and it changes reversibly its colour from green 
to orange/red as membrane potentials increase (over values of about 80-1 OOm V), This 
property is due to the reversible formation of JC-l aggregates upon membrane polarization 
that causes shifts in emitted light from 530nm (i .e" emission of JC-l monomeric form) to 
590nm (i.e., emission of J-aggregate) when excited at 490nm, the colour of the dye 
changes reversibly from green to greenish orange as the mitochondrial membrane becomes 
more polarized. Normally, green fluorescence of depolarised cells is a little higher than that 
of polarized ones, simply because of the presence of a higher amount of JC-l monomers. 
Consequently, mitochondrial depolarisation is indicated by a decrease in the red/green 
fluorescence intensity ratio, The potential-sensitive colour shift is due to concentration-
dependent formation of red fluorescent J-aggregates, Both colours were detected using the 
filters commonly mounted in all flow cytometers, so that green emission was analysed in 
FL-l and reddish orange emission in FL-2 . 
Use of the fluorescence ratios of cells in each channel allowed comparative measurements 
of membrane potential and determination of the percentage of mitochondria within a 
population that were affected by exposure to the mycotoxins or sphingoid bases 
(Table 5). Subtle heterogeneity in cellular responses was discerned in this way, The 
method using JC-I is both qualitative, as shown by fluorescence microscopic detection, 
considering the shift from green to orange JC-l fluorescence emission, and quantitative, 
considering the pure fluorescence intensity, which was detected in both FL-l and FL-2 
channels. These characteristics were useful in the study of mitochondrial membrane 
potential variation in living N2a cells , For the analysis of cells stained with JC-I, results 
were represented as the proportion of total cells that displayed high red J-aggregate 
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formation, against those that showed a predominance of the monomeric green fluorescence 
(Table 5). Those cells with red J-aggregates were indicative of viable cells and those with 
green monomers only, indicative of apoptotic and necrotic cells with compromised 
mitochondria. 
Rhodamine 123 also served as a marker of decreased mitochondrial transmembrane 
potential, and was used in conjunction with PI to measure cell viability and permeability on 
unfixed cells, for cytometric discrimination of viable versus dying cells. Healthy cells with 
functioning mitochondria and intact cell membranes accumulated the Rh123 to give 
fluorescence in FL-1, the green wavelength fluorescence channel on the FCM, and no 
fluorescence in the red wavelength fluorescence channel, FL-2. Cells with their membrane 
integrity compromised, took up PI to give a population of cells in FL-2, and if their 
mitochondria were not functioning, a decrease in the FL-1 fluorescence was detected . 
Apoptotic cells retained their membrane integrity and thus excluded PI. As apoptosis 
progressed, the permeability of cell membranes increased in discrete stages. Cells with 
compromised plasma membranes (necrotic and late apoptotic cells) stained only with PI, 
showing red fluorescence. Early apoptotic cells, in contrast to viable cells, had markedly 
diminished staining capacity with Rhl23 and less green fluorescence. Cells with intact 
membranes (e.g., viable and early apoptotic cells) excluded PI. Thus, these cells did not 
exhibit enhanced DNA-dependent fluorescence due to PI-DNA complex formation, which 
was detected in the FL2 channel of the FCM. Furthermore, necrotic cells were labelled 
with PI, since damaged membranes were incapable of excluding the stain. Thus, necrotic 
cells exhibited very strong PI fluorescence. 
JC-1 seems to be a more reliable indicator of the true L\\jfm than Rh123 alone as there have 
been a few problems associated with staining with Rh123. Typically, the signal coming 
from cells whose mitochondria had a low potential was much lower than that of control 
samples, and in a classical histogram depolarised populations go to the left. However, after 
the shift to the left the peaks (i.e., that of controls and treated cells) are not always perfectly 
separate, the operator has to decide "by eye" where the population of cells with depolarised 
mitochondria begins. In addition, Rh123 binding to mitochondria is difficult to calculate 
when the cells present certain mitochondrial heterogeneity due, for example, to a high 
number of mature or immature mitochondria, as in a continuously growing cell line 
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(Lopez-Mediavilla et aI. , 1989) as used in this study. Moreover, different mitochondrial 
binding sites for Rh123 exist, i.e., sites which are freely accessible whatever the energy 
status of the mitochondria, and sites which are hidden in the energized state and freely 
accessible in the de-energized form of the organelle. This has been attributed to different 
maturative states of the organelle. Thus, in a single cell the organelles can have different 
Rh 123 mitochondrial binding sites with consequent different binding emissions, and it is 
very difficult to ascertain whether or not mitochondria strongly bind Rh123 in an energy 
dependent or independent manner. However, the probe is considered more reliable when 
used in association with PI, as this combination allows a clear distinction between dead and 
living cells. JC-1 is however considered more specific for mitochondrial versus plasma 
membrane potential, and more consistent in its response to depolarisation, than Rh123. 
The flow cytometric analyses of the staining of the treated N2a cells stained with Rh 123 
and PI are also summarised in Table 5. Cells with green fluorescent Rh123 uptake were 
taken as an indication of the percentage of viable and early apoptotic cells, and those with 
PI uptake as late apoptotic or necrotic cells. As FCM using the specified probes is unable 
to discriminate between necrotic and late apoptotic cells definitively, for this study, cells in 
these two subpopulations were defined as non-viable cells (according to 
Tolleson etal., 1996b). 
Good correlation was found between both methods for the assessment ofN2a control cells. 
JC-1 staining is unaffected by agents that depolarise the plasma membrane, whilst strongly 
affected by drugs/compounds that dissipate .1\jfm (Simmons, 1999). The ratio of red to 
green JC-1 fluorescence is dependent only on the mitochondrial membrane potential and 
not on other factors, such as mitochondrial size, shape, or density that may influence 
















Flow cytometric analyses of the mycotoxin and sphingoid base treated 
N2a cells following staining with JC-l, rhodamine 123 and propidium 
iodide. 
JC-I stained N2a ceUs Rhl23/PI stained N2a cells 
Cone. % Red 0/0 Green %Rh 123 % PI uptake 
(IJ-M) J-aggregates monomers uptake (late apoptotic 
Inecrotic cells) 
94.2±3 .8 (n=4) 5.8±3.8 (n=4) 90.1±3.7(n=2) 9.9±3 .6(n=2) 
50 67.5±3.3(n=3) 32.2±3.7(n=3) 70.2±2.8(n=2) 30.3±2.1(n=2) 
100 64.2±8.9 (n=3) 34 .0+8 .0(n=3) 69 .1 +24.3(n=2) 30.7±24.0 (n=2) 
200 63.4±12.3(n=3) 36.1±12.4(n=3) 73.4±2.4(n=2) 26.55±2.3(n=2) 
50(n=3) 83 .5±5 .8 16.5±5.8 42.7±4.1 57.1±3.9 
100(n=3) 70.8±15.4 29.2±15.5 62.26±1 .6 37.7±1.5 
200(n=3) 75 .2±11.1 24.6±11 .3 41.5±4.0 58.4±3 .8 
50 78.9±16.1(n=3) 20.5±15 .7(n=3) 84.3±6.0(n=2) 14 .8±4.6(n=2) 
100 70.7±1.l(n=2) 26.7±3.7(n=2) 85 .3±2.3(n=2) 14.7±2.3(n=2) 
200 89.5±3 .8(n=2) 1O.1±3.5(n=2) 86.9±1 .8(n=2) 13 .4±2.1(n=2) 
88.5±13 .2(n=2) 11.5±13.2(n=2) 85. 16±2.2(n=3) 14.63±1.9(n=3) 
, 
! 
50 59.4±19.3(n=4) 40.7±19.3(n=4) 16.8±1.3(n=3) 83.2±1 .3(n=3) 
100 53.4±9.7(n=4) 46.0±7.6(n=4) 27.4±9.2(n=3) n .56±9.2(n=3) 
200 53 .1±16.2(n=4) 45.3±15.5(n=4) 23 .5±6.6(n=3) 76.4±6.7(n=3) 
50 5l.1±13 .9(n=3) 48.5± 14.2(n=3) 35±4.5(n=3) 63.8±6.3(n=3) 
100 77.6±4.2 (n=3) 22.4±4.2 (n=3) 4.9±2. l(0=3) 95±2.1(n=3) 
200 75 .7+1.5 (n=3) 24.1 + 1.5 (n=3) 3.0+0.3(n=3) 96 .9±0.3(n=3) 
50 63 .1±2.8 (n=3) 36.9+3 .2 (n=3) 0.3+0.2(n=3) 99.6±0.2(n=3) 
100 55.3±4.4 (n=3) 44 .8±4.4 (n=3) 0.96±0.4(n=3) 99.0±0.4(n=3) 
200 57.8±11 .1(n=3) 41.4±10.6(n=3) 15.6±25.8(n=3) 82.3±25.8(n=3) 
50 51.8±6.1 (n=3) 47.5±7.1 (n=3) 3.5±0.1 (n=2) 96.5±0.2 (n=2) 
100 82.6±4.0 (n=3) 16.7±4.7 (n=3) 1.3±0.3 (n=3) 98.7±0.3 (0=3) 
200 52 .8±22.6(n=3) 47±22.4 (n=3) 1.95±1.2 (n=2) 98.1±1.2 (n=2) 
I, 
50 60.0±4l.4(n=3) 32.9±40.2(n=3) 22.2±0.3 (n=2) 77.8±0.3 (n=2) 
100 68.6±1.4 (n=3) 31.1±1.8 (n=3) 55 .4±1_.8 (n=2) 44 .5±1 .6 in=2) 
200 45.8±9.6 (n=3) 52.3±8.7 (n=3) 7.5±0.4 (n=2) 92.6±0.4 (n=2) 
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Figure 5.15 is a FCM acquisition report showing how the unstained cells were used to set 
the cells into region C3 in Histogram 3 for the analyses. To briefly discuss how the data 
was interpreted, Histogram 1 illustrates how the primary gate A was derived from the cells 
when using FSC against SSC on the X and Y axes respectively. Histogram 2 is the same as 
Histogram 1 except that the FSC and SSC parameters are presented in the log function. The 
gate B was drawn around the events in this Histogram 2. In Histograms 3 and 4, 
Fluorescein isothiocyanate (FITC) (green fluorescence channel 1) and Phycoerythrin (PE) 
(red fluorescence channel 2) were on the X and Y-axes respectively. In Histogram 3, the 
gate A was imposed and region C2 shows the percentage of cells from gate A with red 
I-aggregates that display the double stain, i.e., that fluoresce green and red, and region C4 
shows those cells that fluoresce green only. Green fluorescence was indicative of 
compromised mitochondria with a low transmembrane potential. Histogram 4 has the 
gate B imposed from Histogram 2, and region D2 also shows the percentage of cells from 
gate B with the double stain. In addition, as seen in Histogram 7, all unstained cells 
(illustrated by the peak of cells) were set to lie before the first log position in the PE FL-2. 
Figure 5.16 is an example of a FCM acquisition report showing N2a controls cells stained 
with IC-l. Histogram 7 serves more as an internal reference check, as the approximate 
number of events in linear gate E in the red fluorescence channel of PE should correspond 
with those events in C2 and D2. Note the shi ft in the peak of unstained cells in Figure 5.15 
in Histogram 7 to the position after the first log of the X-axis after staining with IC-l in 
Histogram 7 in Figure 5.16. 
For the N2a control cells stained with IC-l, a mean (n=4) percent viability of 
94.2±3 .7% was established, in comparison to 5.75±3.75% of the cells that showed the 
green monomer fluorescence only. Controls were run on 4 separate occasions with between 
1000-3000 events per FCM analysis. The number of events analysed was considered 
sufficient, as all results presented are a mean of between two to four replicates of the same 
experiments with the N2a cells (Doorasamy pers comm., 2004). In addition, the fact that 
two confluent flasks ofN2a cells were pooled for each analysis at each concentration due 
to the significant levels of cell death and cell losses that occurred as a consequence of 
exposure to these mycotoxins and sphingoid bases, as well as when staining and washing 
the cells prior to analysis, these results were considered valid and representative. 
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In comparison to the JC-l staining, when staining with Rh1231PI, 90.1±3 .67% viable N2a 
cells with intact mitochondrial transmembrane potential (indicated by Rh123 uptake) and 
9.85±3.6% late apoptotic or necrotic cells (indicated by the PI uptake) were analysed. For 
both the JC-l and Rh123IPI analyses, these levels of apoptotic cells were not unexpected, 
as apoptosis is a normal physiological response, and usually occurs in cultured cells where 
the rate of cell turnover is very high. The N2a line is primarily a transformed cell line and 
can therefore be cultured continuously for prolonged periods. This, however, raises concerns 
with respect to normal cell function, for example, with respect to apoptosis. Indeed, 
transformation can be likened to a process of 'dedifferentiation'. Nevertheless, experience 
with a variety of transformed cell lines that retain specialised, differentiated functions has 
indicated that although such cell lines are the exception (most transformed cell lines show 
little functional dedifferentiation), those functions that are expressed are likely to reflect 
accurately the in vivo functions of the parent cell type (Sato et al., 1970; 
Dannies and Tashjian, 1973). It is clear however, that observations made in such systems 
must be confirmed in untransformed cells, in tissues, and ultimately in vivo. 
In the control N2a cells treated with EtOH, in keeping with the results of the MTT assay 
(Chapter 3) where the use of EtOH as a solvent vehicle was shown to induce a 
comparatively minor, but higher proportion of cell death in comparison to EtOH-untreated 
controls; staining with JC-l indicated that 88.5±13.15% of the cells showed J-aggregate 
formation, with 11. 5± 13.15% showing monomeric green fluorescence. In addition, staining 
with Rh123 revealed 85.16±2.18% viable cells with intact mitochondrial transmembrane 
potential, and 14.63±1.92% compromised cells with PI uptake. Figure 5.17 is an FCM 
acquisition report showing higher percentage of green Rh 123 stained cells in region C4 of 
Histogram 3, and a small percentage of cells that have taken up PI in quadrant C2. Once 
these controls were run, the FCM was then set to compensate for this known proportion of 
non-viable cells within each control population when analysing all the treated N2a cells. 
In the N2a cells exposed to FB l , an increase in toxin concentration from 50 to 200~ was 
paralleled by a decrease in red J-aggregate formation from 67.5±3.3% to 63.4±12.3% (n=3) 
(Table 5), suggesting a decrease in the ~\!fm. Similar levels of cell viability were also 
obtained using the MTT assay in Chapter 3, where 72% cell viability was reported for 
those cells exposed to 50IJ.M FB l . With Rh123IPI staining however, although this trend 
was not as evident, approximately the same levels of cell viability were reported 
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(Table 5). Increased apoptosis has been reported following in vitro exposure of turkey 
lymphocytes (Dombrink-Kurtzman et at., 1994), human keratinocytes, fibroblasts, 
oesophageal and hepatoma cells (Tolleson et at., 1996b), as well as CV -I monkey kidney 
cells to FB I (Wang et at., 1996). The FB l-induced inhibition of CER synthase results in an 
increase in the accumulation of Sa within the cell, and may indirectly be responsible for 
increased cell death from exposure to FBI (Merrill et al., 1993a). Inhibition of sphingolipid 
metabolism leads to compromised cell membrane integrity, and may have increased N2a 
cell membrane permeability to PI. The results of this study on the N2a cells are also 
supported by findings of Galvano et al. (2002) who exposed rat astrocytes to FB I, and after 
72 hours treatment found that FBI (50 and I00I-lM) induced DNA damage of apoptotic 
type in the astrocytes. 
JC-l staining revealed that following treatment with FA, at the highest concentration of 
20 0 I-lM, 24. 56±11.31 % of the N2a cells had compromised mitochondria. Staining with 
RhI23/PI indicated that at this concentration, 58.4±3.83% of the N2a cells were either late 
apoptotic or necrotic as indicated by the uptake of PI. Figures 5.18 (a-c) are FCM 
histograms showing the N2a cells treated with 50, 100 and 200l-lM FA for 48 hours, and 
then stained with Rh123/PI. The results summarised in Table 5 indicate that staining the 
cells with Rh 123/PI shows a higher proportion of cells that are compromised at all 
concentrations. In this treatment set, the JC-l and Rh 123/PI staining results did not 
correlate. 
Telles-Pupulin et al. (1998) USIng isolated rat mitochondria reported that FA affects 
mitochondrial energy metabolism by inhibition of succinate dehydrogenase, oxidative 
phosphorylation and a-ketoglutarate dehydrogenase. The inhibition of oxidative 
phosphorylation seems to be the result of a direct action on the ATP synthase/ATPase 
without significant inhibition of the ATP/ADP exchange. In the present study, cell 
viability was partially reflected by the maintenance of the L1\jfm, and the lower cell 
viabilities may have been detected as a result of the FA induced inhibition of these 
enzymes in the N2a cell line, and subsequent loss of TMP. As apoptosis is an active 
process requiring energy, ATP f!1ay be generated by glycolysis in cells where 
mitochondrial membrane potential has been compromised. It has been reported that 
malignant cells are able to change their energy production from oxidative phosphorylation 
to glycolysis (Chen, 1988). This shift to glycolysis may enable the apoptotic process to 
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continue in cells in which oxidative phosphorylation has been impaired by a reduction in 
the number of functioning mitochondria. 
Shimizu et at. (1996a) measured intracellular ATP levels during cell death and showed that 
intracellular ATP levels remain unchanged until the very end of the apoptotic process. As 
disruption of plasma membrane potential that halts mitochondrial energy production is an 
early step in apoptosis (Zamzami et ai., 1995a; Shimizu et at., 1996a), intracellular ATP 
required for the rest of apoptosis must be provided by glycolysis. When glucose is 
provided in culture medium, respiratory chain inhibitors induce apoptosis or necrosis 
(Shimizu et ai., 1996b). According to Tsujimoto (1997), this distinction is due to the cells 
dependence on respiration to maintain intracellular ATP levels . Cells depending more on 
mitochondria for ATP, die by necrosis because of an energy crisis and cells with a larger 
contribution of glycolysis, die by apoptosis because of lowered intracellular ATP levels 
which are still sufficient for apoptosis (Tsujimoto, 1997). 
Results of the treatment of the N2a cells with MON for 48 hours were similar when 
assessed using both JC-1 and Rh 123IPI staining, with viabi I ities not falling below 70% 
across the tests range of concentrations (Table 5). These results are also similar to those of 
the MTT assay where at 50 and 200~M MON, viabilities of -70% were reported (Chapter 
3, Table 3.1). Although decreased protein synthesis and oxidative damage have been 
ascribed to MON (Norred et at., 1990), Thiel (1978) reported that the principal mechanism 
of action of MON is believed to involve selective inhibition of mitochondrial PDH and a-
ketoglutarate dehydrogenase. Moniliformin binds to PDH, preventing entry of pyruvate 
into the TCA cycle, therefore decreasing mitochondrial respiration (Burka et ai., 1982). Rat 
brain transketolase and PDH were inhibited 59% by 1O-4M MON (Burka et ai., 1982). 
Thiel (1978) also reported that a 5~M concentration of MON caused a 50% inhibition of 
oxygen uptake by rat liver mitochondria with pyruvate as the substrate. 
As was previously indicated the N2a cell line also required sodium pyruvate in the CCM 
to ensure cell proliferation. Cells grown in CCM without sodium pyruvate ceased growing 
and died. It is possible that MON and the added pyruvate may have competed for the 
binding site on PDH. By adding MON as a suicide substrate of PDH, it is likely to have 
caused a block on, or decreased mitochondrial respiration causing cell death. This 
hypothesis is supported by Gathercole et at. (1986) who showed that supplementation with 
pyruvate resulted in decreased MON-induced inhibition ofPDH function . However, in the 
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present study, sodium pyruvate was added at a concentration of 2mM. The higher 
concentration of pyruvate than MON in the CCM may explain why cell viability never 
decreased below 70% in these cells. Even at the highest concentration of 200~ MON, 
~90% cell viability was noted with JC-1 staining which indicates that the high 
concentration of sodium pyruvate in the media may have protected cells from the toxic 
effects of MON. These results are in keeping with the results of MaN treatment of N2a 
cell using the MTT assay (Chapter 3). 
The results of the Sa, So, T2, ZEA and DON treatments appear discrepant when comparing 
JC-1 staining to Rh 123IPI results (Table 5). However, apoptosis is a sequential process of 
variable duration, depending on inducer and cell type. As a result, any method has an 
optimal 'time-window' for analysing the apoptotic process, and it is possible that the 
percentage of apoptotic cells in the same population may not be identical when two 
methods are utilized (Cossarizza et aI., 1993). 
Using JC-1 staining, viabilities for the Sa-treated cells were reported to be between 53-60% 
(Table 5). Using Rh 123IPI staining however, necrotic and late apoptotic cells were 
established to comprise between 72 to 83 % of the total cell population. Figure 5.19 show 
the analyses of the cells treated with 50llM Sa and then stained with Rh1231PI, and 
Figure 5.20 shows the FCM analyses of N2a cells treated with 200j..l.M So. The linear 
gate E in Histogram 7 of Figure 5.20 shows the good correlation between the gating 
strategy and the linear gate E indicating the percentage of cells stained with PI. 
Ohta et al. (1994) reported that So induced apoptosis in neutrophils. Jarvis et al. (1996) 
also reported that So induced apoptosis in HL-60 and U937 cultured cells. In this study, So 
induced high levels of apoptosis and/ or necrosis in N2a cells following the 48 hours 
exposure period as indicated by the high proportion of PI uptake reported in 62-97% of the 
N2a cells analysed (Table 5). The accumulation of free Sa has also been shown to be 
growth inhibitory and cytotoxic (Merrill et aI., 1983; Stevens et aI., 1990; Hannun et aI., 
1991; Sweeney et aI., 1996). The Sa results on the N2a cells correlate well with the MTT 
assay data, where viability of Sa-treated cells after 48-hour exposure at 50, 100 and 200j..l.M 
was found to be 29, 46, and 50%, respectively (Chapter 3, Table 3.2). 
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With the N2ex cells exposed to T2 and DON, staining with Rh 123!PI, revealed that the late 
apoptotic and necrotic N2ex cells comprised greater than 80% of the N2ex cell population 
(Table 5). Staining with JC-1 however showed that a potential toxin-dependent decrease in 
viability was evident from 63 to 57% for T2, with larger standard deviations evident at the 
highest concentration of 20011M with many of the compounds tested . The viabilities of the 
N2ex cells exposed to DON also varied considerably when the methods were compared. No 
dose dependent mechanism of cell death was established using either method, with 
fluctuations from 51. 8% at 50 !lM, up to 82% at lOO!lM, and then a decrease back to 53% 
at 200 !lM (Table 5). Using Rh123!PI cell viabilities were consistently below 5% at all 
three levels of exposure. 
Trichothecenes produce toxicity vIa inhibition of protein synthesis (Ueno, 1983; 
Kiessling, 1986), inhibition of DNA synthesis (Thompson and Wannemacher, 1984; 
Kiessling, 1986), impairment of ribosome function (Coulombe, 1993), inhibition of 
mitochondrial protein synthesis (Pace, 1983) and induction of reparable single strand 
breaks in DNA. The variable potency at the cellular level is probably due to the rate of 
transport into the N2ex cells, the metabolism of mycotoxins by cytosolic enzymes, changes 
in affinity for the active binding site or reduced capacity to interfere with protein synthesis. 
Metabolism may be more important in detoxification than in producing toxicity, as the 
trichothecenes are directly toxic without activation. 
T -2 toxin inhibited the mitochondrial electron transport system in yeast by inhibiting 
succinate dehydrogenase (Khachatourians, 1990), and induced cell membrane injury with 
haemolysis, apparently via a free-radical mechanism (Coulombe, 1993). T -2 toxin also 
affected the permeability of cell membranes in vitro at concentrations of O.4pg.mr l 
(Bunner and Morris, 1988). The fact that T2 is able to increase permeability of cell 
membranes may explain why PI was detected in such a high proportion of N2ex cells, and 
its effects on mitochondrial electron transport may be responsible for the disruption of the 
mitochondrial transmembrane potential. 
With the ZEA-treated N2ex cells, the results seemed more reliable as there was a decrease 
in J-aggregate formation from 60 to 46%, with an increase in PI uptake by the N2ex cells 
from 78 to 92%. The Rh 123!PI method of staining gave consistently higher levels of 
compromised cells than the JC-1 staining method. With the ZEA-treated N2 ex cells, the 
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JC-1 staining method gave viability levels similar to those obtained using the MTT assay 
(Chapter 3, Table 3.3). 
There are many criteria that require consideration for the unbiased interpretation of these 
results. Flow cytometric measurement of apoptosis, regardless of the method used, is 
associated with selective loss of apoptotic cells during sample preparation. The inherent 
setback of JC-1 staining is that in the cell preparation procedure, following staining, cells 
have to be pelleted and washed twice prior to analysis on the flow cytometer to remove this 
probe. Its' use nonetheless, was considered more accurate than the staining with Rh 123IPI 
when compared with the MTT assay results in Chapter 3. With Rh 1231PI, there was no 
washing step prior to analysis on FCM. In cases where a course of treatment results in 
induction of a major proportion of cellular damage via apoptosis or necrosis, washing the 
cells is responsible for the loss or removal of these damaged, fragmented populations of 
cells. This is evident from the visible decrease in the cell pellet size between washing 
stages, and the lower number of cells available for analysis on the flow cytometer when 
compared to controls. Intact cells are easily pelleted and retained in a greater proportion 
following centrifugation, and a large proportion of fragmented and damaged cells are 
discarded in the washes. This presents a problem as a major percentage of treated 
compromised cells are removed and not included in the absolute analysis. This problem is 
unavoidable however as JC-1 is insoluble in water and crystallizes out quickly, and needs 
to be removed from the cell suspension prior to FCM analysis. 
The major advantage of FCM is that it offers the possibility of multi-parametric analysis of 
several cell attributes . On the other hand, the major drawback ofFCM methods stems from 
the fact that identification of apoptotic or necrotic cells is not based on morphology and 
cannot be correlated with morphological classification. Rather, it relies on a single 
parameter reflecting the change in biochemical or molecular attributes of the cell, 
presumed to represent either apoptosis or necrosis. In addition, most FCM methods do not 
allow for a clear distinction between late apoptotic and necrotic cells. In cases such as this, 
it becomes clear why more than one method of analysis is required for determination of 
apoptosis, why unbiased interpretation of results is necessary, and why microscopical 
analysis of cells remains the gold standard for apoptotic measurements. Apoptosis in an 
individual cell is a rapid event but the time that the cells take to display the characteristics 
that identify them vary, and it must not be assumed that signs of apoptosis by enabling 
FCM analyses, will be quantifiable at all times. There is no single feature that will 
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discriminate between cells that have died by apoptosis and those that have died by 
necrosis. Therefore, it is still important to use FCM in conjunction with other methods 
especially where cell morphology can be assessed, such as in this study with FM. 
5.4 CONCLUSION 
Using FM in conjunction with FCM facilitated an investigation that enabled quantitative 
correlation between the structural and biochemical changes in the N2a cells . Following the 
48-hour exposure period, the six mycotoxins, as well as Sa and So induced varying levels 
of apoptosis and necrosis in these cells, the features of which were identified by 
microscopic examination. Using AcOlEtBr staining in combination with FM, facilitated 
identification of viable, early apoptotic, late apoptotic, and necrotic cells following 
treatment. Cells at various stages from live (green), deac;l (red/orange) and those that were 
dying were observed by loss of cell membrane integrity, and either dye exclusion or 
inclusion. The live cells remained green, the dead cells red/orange and the transient or 
dying cells, showed staining with both dyes at various levels. Significant differences in the 
staining intensities were evident by comparison of the mycotoxin (e.g., FB I-treated and T2-
treated cells) and sphingoid base-treated cells to N2a control cells. There was an inversion 
in the ratio of green and red/orange staining, w}th a predominance of apoptotic and necrotic 
cells being detected following exposure to these compounds. 
The TMP was measured using Rh123 and the dual emission potential sensitive probe JC-l, 
and facilitated analysis of changes in mitochondrial membrane potential and plasma 
membrane integrity, following treatment with the sphingoid bases and mycotoxins. The 
results were expressed as increases or decreases in fluorescence intensity, and 
consequently, variations of membrane potential were usually expressed as the shift of the 
mean peak channel of a single fluorescence . Rhodamine 123 in combination with PI, 
facilitated discrimination between vital N2a cells and dying cells (necrotic or late 
apoptotic cells), whose plasma membrane integrity was compromised and consequently 
stained with PI as well. N2a cells with intact membranes (e.g. , viable and early apoptotic 
cells) excluded PI, preventing its intercalation into intracellular nucleic acids. The early 
apoptotic N2a cells had markedly diminished staining capacity for Rh123 , and stained with 
faint green fluorescence, due to fewer viable mitochondria than in viable cells. Apoptotic 
cells retained their membrane integrity, and excluded PI. Overall, N2a cells with 
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compromised plasma membranes, namely the necrotic and late apoptotic cells stained with 
PI, showing red fluorescence . Optical separation of necrotic and late apoptotic N2a cells 
was difficult to assess using FM (e.g., in the ZEA and DON-treated N2a cells) . Cells with 
decreased Rh 123 fluorescence and that were PI positive included necrotic cells, indicated 
by cellular swelling and loss of plasma membrane integrity, in comparison to control N2a 
cells that stained with Rh 123 and excluded PI. 
Although qualitative analysis of Rh 123IPI and JC-1 incorporation was done using FM, 
quantitative analyses of apoptotic and necrotic cells was facilitated on the FCM, using 
Rh123IPI uptake as a measure of cell permeability, and determination of ~\jJm using JC-l. 
Variations in mitochondrial membrane potential were detectable at the single N2a cell 
level by staining cells with JC-1 that fluoresced green in its monomeric form. Active 
mitochondria with high transmembrane potentials capable of accumulating the JC-1 
formed J-aggregates that fluoresced red . These were assessed using both FM and FCM. 
In this study, the FCM results of the JC-1 and Rh123IPI staining did not correlate 
consistently. However, both the FM and FCM results showed that the mycotoxins and 
sphingoid bases at the 50, 100 and 200~ test concentrations induced varying levels of 
apoptosis, necrosis, and cytotoxicity on the N2a neuroblastoma cell line. As FCM was 
unable to discriminate between necrotic and late apoptotic cells definitively using 
Rh1231PI, cells in these two subpopulations were defined as non-viable. The FCM results 
indicated that Rh 1 23IPI staining showed a higher proportion of compromised cells at all 
concentrations. Overall the FM and JC-1 FCM results correlated well with the results of 
the MTT assays. The Rh 1 23IPI method of staining gave consistently higher levels of 
compromised cells than the JC-l staining method for FCM analyses. JC-l was considered 
more specific for mitochondrial versus plasma membrane potential, and more consistent in 
its response to depolarisation, than Rh123 . 
This in vitro study also highlights the importance of microscopic assessment of cells in 
combination with quantitative analyses in order to gauge the direct effects of a mycotoxin 
or sphingoid base on cellular organelles, cellular metabolism, and hence on their influence 
on mechanisms of cell death be it via cytotoxic, apoptotic or necrotic pathways. 
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Figure 5.1: Fluorescence micrograph of control N2a neuroblastoma ceils stained with 
AcO and EtBr. Vital ceUs with intact cell membranes are characterised by 
intense green fluorescence (yellow arrows) and red staining Iysosomes 
(white arrows) (Magnification (Magn.) X 100). 
Figure 5.2: Fluorescence micrograph of control N2a neuroblastoma cells stained with 
AcO and EtBr, showing vital cells characterised by the intense green 
fluorescence (white arrow). A potentially apoptotic or necrotic giant cell is 





f luorescence micrograph of IOOJ,lM FBI-treated N2a neuroblastoma cells 
following stainjng with AcO and EtBr. Vital cells are indicated by the intense 
green fluorescence (white arrows). Red stained Iysosomes are shown within 
possibly early apoptotic cells coupled with diminished green fluorescent cytoplasm 
(yellow arrows). Late apoptotic or necrotic cells are characterised by bright orange 
and diffuse green fluorescence (orange arrows) (Magn. X 100). 
Fluorescence micrograph of 100 J,lM T-2 toxin-treated N2a cells stained with AcO 
and EtBr. Vital cells are characterised by intense green fluorescence (white 
arrows), early apoptotic cells by diminished green fluorescence with orange 
staining within cell cytoplasm (yellow arrow), and late apoptotic or necrotic cells 
by orange fluorescence (orange arrows) (Magn. X 400). 
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Figure 5.5: Fluorescence micrograph of control N2a cells stained with Rh123 and PI. 
Intact vital ceUs are characterised by intense green fluorescence and 
absence of PI staining (Magn. X 400). 
Figure 5.6: Fluorescence micrograph ofN2a cel\s exposed to 100~M sphinganine and 
then stained with Rh 123 and PI. Compromised N2a cells are characterised 
by diminished green fluorescence and red PI stained nuclei (late apoptotic 
or necrotic cells) (Magn. X 100). 
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Figure 5.7: Fluorescence micrograph of sphingosine-treated (i OOIlM) N2a. cells 
stained with Rh123 and PI. Compromised N2a. cells are characterised by 
diminished green fluorescence and red PI stained nuclei (late apoptotic or 
necrotic cells) (Magn. X 100). 
Figure 5.8: Fluorescence micrograph of ZEA-treated (lOOIlM) N2a. cells stained 
with Rh 123 and PI. Necrotic cells are characterised by diminished green 
fluorescence with red/orange staining nuclei and cytoplasmic 
condensation (Magn. X 1000). 
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Figure 5.9: Fluorescence micrograph of DON-treated (I OO).LM) N2a cells stained with 
Rh 123 and PI. Cells were characterised by their compromised plasma 
membrane integrity and diminished green fluorescence, with PI staining 
nuclei, cellular swelling and membrane bleb bing (Magn. XI 000). 
Figure 5.10: Fluorescence micrograph ofN2a cells control JC-I stained cells showing 
intracellular distribution of J-aggregates. The stain in its monomeric form 
is shown by green fluorescence and red/orange staining J-aggregates 
(Magn. X 400). 
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Figure 5.11: Fluorescence micrograph of control JC-l stained N2a ceUs showing 
intracellular distribution of red/orange J-aggregates that are indicative of 
functioning mitochondria (Magn. X 1000). 
Figure 5.12: Fluorescence micrograph of FA-treated (lOO).!M) N2a cells stained with 
JC-l showing cellular distribution of high levels of orange/red J-aggregates 
in viable cells (orange arrow), and cells with cytoplasmic condensation 
with very low levels of J-aggregates (yellow arrows) (Magn. X 40). 
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Figure 5.13: Fluorescence micrograph of MON-treated (lOO)lM) N2a cells stained with 
JC-I showing variable levels of intraceUular distribution of orange/red 
J-aggregates (Magn. X 40). 
Figure 5.14: Fluorescence micrograph of FBI -treated (I OO)lM) N2a cells stained with 
JC-I showing intracellular distribution of orange/red J-aggregates and large 
intercellular gaps between remaining adherent cells (Magn. X 400). 
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An Immunochemical study into the effects of fumonisin Bh 
zearalenone and T -2 toxin on the N2a neuroblastoma cell line 
6.1 INTRODUCTION 
Light and EM are complementary techniques used in structural and ultrastructural studies 
of cells. Immunological advancements and improved technology have impacted on 
histological procedures, leading to the incorporation of immunological techniques into 
microscopy, increasing use of antibodies as laboratory reagents and accelerating research 
on cellular components. To confirm presence of known antigens in altered cellular 
organelles, antibodies raised for use in their detection, have expanded knowledge of an 
antigens effects on internal structure and function of cells (Goers, 1993). The availability 
of immunoglobulin fractions, monoclonal and polyclonal antibodies to clinically relevant 
mycotoxins has expanded immunohistology. Mycotoxins within cells may be identified 
and localised by chemical high-affinity interactions. The binding of antibodies to the 
antigens (i.e. , mycotoxins) within cells can be labelled by either insoluble coloured 
compounds observable at the light microscope level, or electron scattering gold particles 
that may be seen with the electron microscope. 
Immunocytochemistry (ICC) facilitates identification and localisation in a biological system 
of any constituent or inclusion to which an antibody may be raised and marked by a 
microscopically visible label. Its potential for localising various types of molecules, provides a 
correlation between structure and function (Snyman, 1993). Immunohistochemistry (!HC) in 
this study was used in the detection of FBI, ZEA and T2 at the light microscope level by 
specific antigen-antibody (Ag-Ab) interactions labelled with the chromogen 3,3-
diaminobenzidine tetrahydrochloride (DAB). The peroxidase-anti -peroxidase (PAP) method 
of immunochemical detection was utilised. 
At the electron microscope level, gold probe labelled monoclonal antibodies was used to 
tag FBI within cellular organelles and components. The indirect method of 
immunochemical analysis was used to identify antigenic sites due to its increased 
sensitivity. The primary antibody was not labelled and was identified by a labelled 
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secondary antibody raised to the immunoglobulin of the species providing the primary 
antibody. 
When USing light and EM in combination with immunochemical techniques, an 
investigation in cell culture allows one to construct a probable sequence of events to 
account for the effects of a mycotoxin in a biological system. This in vitro investigation 
aimed to monitor the effects of FBI, ZEA, and T2 on the structure and ultrastructure of 
cultured N2a cells, and to evaluate the sites of action of these environmental xenobiotics. 
Immunohistochemical techniques were carried out on lEA, FB I and T2-treated N2a 
neuroblastoma cells, as these were the only mycotoxin antibodies available at the time. 
Immunoelectron microscopy analyses were also carried out on FBI-treated N2a celis, as 
this was the mycotoxin of fundamental importance in this study. 
6.2 MATERIALS AND METHODS 
6.2.1 Materials 
Cell culture media and consumables were purchased from Adcock-Ingram, SA All reagents, 
solvents, bovine serum albumin (BSA), normal goat serum (NGS), and chemicals were 
purchased from MERCK, SA All light and EM materials, copper and nickel grids 
(200/lm mesh size), Araldite and Spurr epoxy resin kits, and the DAB Peroxidase Substrate 
Tablet set, and Tris-(hydroxymethyl)-aminomethane (Tris) salt were purchased from Sigma-
Aldrich, SA Antibodies used for IHC and ICC, were purchased from Sigma-Aldrich, SA, 
unless otherwise indicated. Neogen supplied the primary monoclonal mouse anti-FBI 
antibody The secondary antibody was goat anti-mouse IgG. The PAP complex used was 
developed in mouse and purchased in its non-conjugated form . For the detection of ZEA 
and T2, the polyclonal anti-lEA primary antibody developed in rabbit fractionated serum and 
the polyclonal anti-T -2 toxin primary antibody developed in rabbit fractionated serum were 
used respectively. The secondary antibody used for both T2 and lEA, was anti-rabbit IgG 
whole molecule peroxidase conjugate developed in goat. 
A Reichert Ultracut ultramicrotome was used to cut 50nm sections whilst a Nikon Optiphot 
photomicroscope was used to digitise images at the Optics and Imaging Centre, UKZN. The 
JEOL 1010 TEM was used at the Electron Microscope Unit, UKZN for ultrastructural 
examination and electron micrographs. 
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6.2.2 Methods 
Descriptions of all cell culture techniques employed were as previously documented in 
PaJanee (1998). 
6.2.2.1 Growth and preparation of N2a neuroblastoma cells for light microscopy 
Using aseptic techiques, N2a neuroblastoma cells were trypsinised and plated onto 25cm2 
sterile Corning tissue culture flasks as described previously (Palanee, 1998). Cells were 
grown in culture flasks for all analyses, because N2a neuroblastoma cells did not adhere 
successfully to glass coverslips. The N2a cells were cultured at 37°C for 24 to 72 hours, or 
until confluency was reached. 
6.2.2.2 Haematoxylin and eosin staining of control N2a neuroblastoma cells 
An untreated flask of confluent N2a neuroblastoma cells was rinsed in HBSS (2ml), fixed in 
1% glutaraldehyde in HBSS (5ml) (37°C for 30min.), rinsed again in HBSS (2ml) and then 
rinsed thoroughly in distilled water (2x5ml) prior to staining routinely with Mayer's 
haematoxylin and eosin stain (H&E) (5%) (2ml) (Humason, 1972; Drury and Wallington, 
1980). The stained cells were viewed and photographed on a Zeiss photomicroscope using a 
Nikon FX camera. 
6.2.3 Preparation of the mycotoxin stock solutions 
Fumonisin Bl was dissolved directly in CCM (Img.mr l ), with CCM as the control solution 
for this mycotoxin. Zearalenone and T2 were dissolved in EtOH (100/.11 per mg) and CCM 
(900/.11 per mg) to a stock solution of Img.mr 1. The control for this set of compounds was 
made up of a combination of EtOH (100/.11) and CCM (900/.11). All stock solutions were 
vortexed thoroughly to ensure complete resuspension of the mycotoxins in the solvent 
veh icle and CCM, and then used to prepare a dilution series of 50, 1 00 and 200/.1M in CCM. 
165 
6.2.4 Preparation of N2a neuroblastoma cells for microscopy 
Flasks of confluent cells were incubated (37°C) in each mycotoxin or control solution (2 
ml) for 48 hours prior to analysis. As IHC involved qualitative analysis of the cells only, 
testing was carried out for each compound at 50,100 and 200llM in duplicate flasks for 
ZEA and T2. An additional set of flasks of FBJ-treated cells was also prepared for ICC 
analysis . 
Following the 48-hour incubation period, flasks of N2a neuroblastoma cells were removed 
from the incubator, and gently rinsed with HBSS (5ml) to remove detached dead cells and 
all CCM containing mycotoxin. The washes were discarded and the cells fixed as outlined 
below (in section 6.2.6) . 
6.2.5 Preparation and dilution of the fumonisin Bl monoclonal antibody 
The FBJ primary antibody stock solution was prepared by diluting the lyophilised antibody 
(1mg) in O.OIM PBS (pH 7.4) (100111). Aliquots of this stock solution were further diluted 
(1 : 1 00) in PBS containing 1 % BSA (pH 7.4) prior to use. 
6.2.6 Preparation of cells for immunohistochemical staining for light microscopy 
The immunostaining procedures using the PAP technique on the FBI, ZEA and T2-treated 
N2a cells in culture flasks are outlined in Table 6.1. 
Method controls were used in all immunohistochemical analyses to ensure that the staining 
detected was the result of immunological interaction between the primary antibody and the 
ant igen. The primary antiserum was omitted in the method controls and replaced with the 
antibody diluent buffer. Positive staining in method controls was considered caused by 
non-specific binding of the secondary antibody and the chromogen to cellular components. 
The negative controls consisted of the untreated N2a cells, and the positive controls were 
those N2a cells that were exposed either to FBI , ZEA or T -2 toxin . The primary antibodies 
were added to these cells to verify specificity of the methods used . 
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Tallie 6.1: Immunostaining procedures using the PAP technique on treated N2a 
cells in culture flasks. 
PROCEDURE TIME (min.) 
FBI- T2 and 
treated ZEA 
N2a. cells treated 
N2a. cells 
Washed 25cm2 flasks ofN2a. cells thrice in HBSS (2 ml per rinse) 10 
Fixed cells in 1 % glutaraldehyde in HBSS (3 ml) 30 
Wa~ l led N2a. cells in HBSS (3 ml) 3 
Washed flasks ofN2a. cells in distilled water (10 ml) 5 
Incubated N2a. cells in 5% H20 2 in methanol (2 ml) 30 
Poured off methanol 2 
Washed flasks ofN2a cells in PBS (pH 7.4)(10 ml) 20 
Incll lJated in NOS (lml)(l :20 in 1 %BSA in PBS) 20 
Inct l Jated in primary antibody [anti-FBi (1: 100), anti-ZEA (1 :200) or 60 
anti l'2 (1 :500)], diluted in PBS containing 1 % BSA (pH 7.4) (l ml) . The 
prinlry antibody was replaced with PBS (pH 7.4) (lml) on the method 
cont'·ols 
~ led flasks ofN2a cells with PBS (2x5 ml) 5 5 
For FBI-treated cells: Incubated in secondary antibody I.e ., goat 45 Omitted 
anti nouse IgO (1 :200) in 1 % BSA in PBS (pH 7.4) step 
r--
Omitted Rin ·d flasks ofN2a cells with PBS (pH 7.4) (2x5 ml) 5 
step 
Fo r f<'Brtreated cells: Incubated in PAP enzyme developed in mouse 45 Omitted 
(l: . I) in PBS containing 1 % BSA (pH 7.4) step 
~
60 For T2 and ZEA-treated cells: Incubated in secondary antibody i.e., Omitted 
ant :lbbit IgO (whole molecule peroxidase conjugate, antibody developed step 
ill !' It) diluted (1 :400) prior to use in 1 % BSA in PBS (PH 7.4) 
-----'" 
Ri l d flasks ofN2a cells with PBS (pH 7.4) (2 x 5ml) 5 -
USl· - heated wire to remove the top cover offlasks ofN2a cells 
St~l : :d with DAB chromogen (prepared according to manufacturers 3-5 with checking 
insl .ctions) 
!---
W .. cd the adherent N2a. cells with distilled water (2 x 5 ml) 
!---
~3 with checking Stil :d N2a cells with haematoxylin (2 ml) 
~-
W:; ..:d N2a cells in distilled water (2 x 5ml) 1 -
~ , N2a cells in ammonia water (1 % v/v) or hot water (60°C) 5 
Co .sliQped N2a cells using glycerol jelly -
Vie· ~d and photographed immunostained N2a cells on a Zeiss photornicroscope fitted with a Nikon 
FX mera 
"-- . 
6. 7 Preparation of flasks of treated and control N2a neuroblastoma cells for 
transmission electron microscopy and immunocytochemistry 
A :sk of untreated N2a neuroblastoma cells was fixed for transmission electron microscopy 
(1 . VI) Transmission electron microscopy allowed characterization of cellular detail 
L itated by infiltration of the cell s with osmium tetroxide in the processing. Cellular detail is 
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no t as preserved in specimens fi xed for ICC as osmium is omitted since it masks antigenic 
sit , s. The remaining control flask ofN2cx cells and all FBI-treated cells were fixed for ICC as 
Oll " :ned in Table 6.2 (Robinson and Gregory, 1977). 
Processing of N2cx neuroblastoma cells for transmission electron 
microscopy and immunocytochemistry. 
'rocedure Time (minl -
TEM ICC -
r- ixed confluent N2a cells in 1% glutaraldehyde in HBSS (3 mJ) 45 
IZinsed in HBSS (3 ml x 2) 5 
f--
Omitted step ,micated (4°C) (3 ml) 60 
f--, insed in HESS (3 ml) 2x5 Omitted step 
I- . 
20 I lehydrated III 70% EtOH (3 mJ) 
I- 90% EtOH (3 ml) 20 
r 
100% EtOH (3 m!) 20 
~ 
100% EtOH (3 m!) 20 -
, filtrated with EtOH: Araldite resin (1: I) (2 ml) - 30 Omitted step 
I filtrated with Araldite resin (60°C) 2 x 90 Omitted step 
-
- nbedded in Araldite resin (60°C) 24 hours Omitted step 
tiltrated with EtOH Spurr resin (l: 1) (2 ml) Omitted 30 
I-
step 
filtrated with Spurr resin (60°C) Omitted 2 x 90 
f--
step 
11bedded in Spurr resin (60°C) Omitted 24 hours 
'-
step 
TI embedded flasks of N2cx cells were cut into 5-10mm blocks using a heated wire. The 
bJ ( ks, which comprised of cells sandwiched between the resin and the plastic flask, were 
trined and vertically sectioned on a Reichert UItracut ultramicrotome. Sections (50nm) cut 
for rEM were picked up on 200 mesh copper grids, stained with uranyl acetate followed by 
Rc ooIds' lead citrate (1963), then viewed and photographed on the JEOL 1010 TEM 
tr(1 smission electron microscope. Sections (50nm) cut for ICC were picked up on 200~m 
mE il-size nickel grids, stained as outlined in Table 6.3, then viewed and areas of interest 
ph, "ographed on the JEOL-TEM 100S transmission electron microscope. 
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Staining procedure using immuno-gold on resin sections for electron 
microscopy. 
Procedure 
Etched non-osmicated sections on nickel grids by placing in S% H20 2 (20~1) 
PI,)<"cd grids on droplet of distilled water. Jet-washed with distilled water (I Oml) and dried 
on " ore-free filter paper with specimen-side up 
Submerged grids at RT in NGS (20~1) (1 :20 in 50mM Tris buffer) (pH 7.2)(Appendix S)* 
Drained on fibre free paper 
Pla red in monoclonal mouse anti-FB I (lO~I) (l: 100) in 1% BSA in SOmM Tris buffer 
~. )cndix S). Placed method controls in Tris buffer only (pH 7.2)(10~1) 
PI:! ...: d grids in Tris buffer (pH 7.2) (20~1). Jet washed with 20mllgrid Tris buffer (PH 7.2) -
Pb :d grid in droplet Tris containing 0.2% BSA weight per volume (w/v) (pH 7.2) then jet 
wa led with Sml per grid (Appendix S) 
Pb ...:d grid in droplet of SOmM Tris containing 1 % BSA (w/v) (pH 8.2) (Appendix S) 
PJa ...:d in droplet of mouse anti-rabbit IgG conjugated to 10nm gold (1:1S in SOmM Tris 
COl ' l ining 1 %BSA (pH 8.2) centrifuged at 2000g for 20 min.) 
f-=-
PL :d in droplet ofTris containing 0.2% BSA (w/v), pH 7.2. Jet washed using: 
SO \I[ Tris containing 0 .2% BSA (w/v), pH 7.2 (l0 ml per grid), 
SO \I[ Tris, pH 7.2 (S mllgrid) and distilled water (l0 ml per grid) 
'---
Cc Iterstained with 2% uranyl acetate (20~1) , then jet washed with distilled water (lOml) 
(A 'endix 61) . 
-
Co Iltcrstaincd with Reynolds' lead citrate (20!lI) , then jet washed in distilled water (lOml) 
(A , ,endix 6.2) . 
~ 
* i\ thods for preparatIon of buffers and stams used m the ICC run are outlmed ill Appendix S. 
6. : RESULTS AND DISCUSSION 












Th . N2a cell line grew as a monolayer culture with a doubling time of between 48-72 hours. 
COl\ventional light microscopy in combination with H&E staining revealed that N2a cells 
w ·' e epithelioid in morphology, characteristically large with centrally located large nuclei 
an, multiple nucleoli (Figure 6.1) The cellular processes of control N2a cells extended over 
a L rge surface area and were firmly attached to the culture substrate (Figure 6.2). 
TI l : cytoplasm surrounding the nucleus of the majority of control N2a cells were uneventful, 
in l ~rms of the absence of cytoplasmic lyses or vacuolation. 
Ewn in untreated N2a cell populations, a percentage of cells showing features characteristic 
of .lpoptosis were identifiable (Figures 6.1, 6.2 and 6.3). This was not unexpected, as 
apt ptosis is a normal physiological process, and usually occurs in cultured cells where the 
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rate of cell turnover is high. The N2a cell line is primarily a transformed cell line and can 
therefore be cultured continuously for prolonged periods. This, however, raises concerns 
wit il respect to normal cell function, for example, with respect to apoptosis. Indeed, 
transformation can be likened to a process of 'dedifferentiation'. Nevertheless, experience 
wit'h a variety of transformed cell lines that retain specialised, differentiated functions has 
indicated that although such cell lines are the exception (most transformed cell lines show 
litt Ie functional dedifferentiation), those functions that are expressed are likely to reflect 
accurately the in vivo functions of the parent cell type (Sato et at., 1970; 
Dannies and Tashjian, 1973). It is clear however, that observations made in such systems 
mll -t be confirmed in untransformed cells, in tissues, and ultimately in vivo. 
Th~ morphological criterion on which recognition of apoptosis is based still remains the 
go:J standard of analysis of this mode of cell death. Cells showing two characteristic 
mor'phological features of reduced size due to cell shrinkage, and cytoplasmic condensation 
(A ~ ~nds et at., 1990; Arends and Wyllie, 1991) that are typical of the apoptotic process, are 
seen in cells shown in Figures 6.1 and 6.2. Control cells that have completely retracted 
cy1 )plasmic processes, cytoplasmic condensation, and plasma membrane undulations or 
'bLbbing', i.e., features typical ofapoptosis are also indicated (Figure 6.3). In control N2a 
ee l ,>, this apoptotic population constituted a negligible percentage of the entire cultured 
cel l population, whereas in treated cells there was a distinct increase in the proportion of 
eel, s that displayed this mechanism of cell death due to exposure to an exogenous cytotoxic 
cOJ.lpound . 
6.3 2 Immunohistochemical analysis of mycotoxin treated N2a cells 
Til ',' PAP method of immunochemical detection was applied, and is based on the combination 
of lnti-peroxidase with peroxidase before applying it to a specimen of interest. The 
coI~lbination produces a very stable cyclic complex with three peroxidase molecules to two 
anl.body molecules. The complex is separated from non-reacted antibody and peroxidase 
beflre use, 
The criteria for the selection of the mycotoxin concentrations to which the N2a cells were 
eX I~osed in this study, was based on the results of the MTT assay (Chapter 3), Using the 
M1T assay, at concentrations of 50, 100 and 200).lM FBI, approximately 27%, 13%, and 
70' 0 N2a cell mortalities were reported following the 48 hour exposure period. For the 
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ZEA-treated cells, 55%, 19%, and 44%, and for T-2 toxin, 35%, 34% and 20% cell 
mortalities were reported following exposure to 50, 100 and 200~ of these mycotoxins 
respectively. These concentrations were selected and standardised across all mycotoxin 
treatments involving microscopic assessments. It was accepted that a proportion ofN2a cells 
would be damaged and lost at all test concentrations, since dead cells retract processes 
completely, float off the substrate, and are removed in the washes. Using these exposure 
levels, a proportion of N2a cells that were compromised at various stages would still be 
attached to the culture substrate for microscopic assessments. 
6.3.2.1 Immunohistochemical analyses of the fumonisin Bl-treated N2a cells 
Method controls were used in all immunohistochemical analyses to ensure that the staining 
detected was the result primarily of immunological interaction between the primary 
antibody and the antigen. A significant advantage of a monoclonal antiserum is that it 
contains a population of antibodies that recognise only one epitope on the antigen, reducing 
the likelihood of non-specific binding. 
The method specificity for the FBI immunohistochemical staining procedure was verified by 
the absence of DAB chromogen adhesion to cellular components of N2a cells that were 
tre8ted with 50ll-M FBI, but where the primary antibody was omitted and replaced with PBS 
(Fiuure 6.4). A further confirmation of the method specificity was provided by the absence of 
chromogen adhesion to untreated control N2a cells, where all antibodies were applied as for 
the treated N2a cells (Figure 6.5). This provides further support for the specificity of the 
Ag-Ab interaction since potential exists for non-specific immunological complexes to bind to 
cel l'Jlar components, leading to false positive staining of cells with chromogen. 
The steady-state concentration of many biologically active lipid intermediates and 
end products are usually altered by fumonisin-induced disruption of sphingolipid 
me: abolism. As there are many potential molecular sites that may be affected by fumonisin 
exposure, a diversity of cellular and structural alterations were expected in the FBI-treated 
N2a. cells . 
Untreated control N2a cells exhibited a high degree of confluence, with characteristic 
epi .helioid morphology and well-defined cellular processes (Figure 6.5) . The presence of 
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comparatively more cellular processes in FBI-treated N2a cells than in the control cells, 
may indicate the absence of a toxicological stress in their environment. This ensured that 
cell growth was unimpeded and cells consequently adhered tightly to the flask surface. The 
FBI-treated N2a cells however tended to retract from the culture substrate as more 
mycotoxin was incorporated from the surrounding medium, and cells gradually rounded up 
(Figures 6.6-6.10). Some N2a cells had irregular shapes, and the cell mono layers exhibited 
a number of intercellular gaps, as with retraction, more cellular processes became apparent 
as different regions of the cells progressively detached from the culture substrate 
(Figure 6.10). 
Fumonisin BI bears structural similarity to sphingoid bases, and because sphingoid bases 
inhibit cell growth, differentiation, transformation, and apoptosis, FBI can also alter growth 
of certain mammalian cells. Riboni et al. (1995) showed that CER plays a mediator role in 
the regulation of cellular differentiation of the N2a cell line. Fumonisin BI blocked 
So-induced differentiation, which established that conversion of So to CER was required, 
and that de novo CER synthesis was important in the differentiation of the N2a cells. 
The biochemical consequences ofFB\ exposure and subsequent disruption of sphingolipid 
metabolism most likely to have altered cell regulation are, increased intracellular levels of 
free sphingoid bases and their I-phosphates, alterations in complex sphingolipids, and 
decreased CER biosynthesis. Because free sphingoid bases and CER can induce cell death, 
the fumonisin inhibition of CER synthase can inhibit cell death induced by CER, but 
promote free sphingoid base induced cell death. Exposure to FBI potentially blocks 
sphingol acylation, and should therefore result in the loss of CER, and may also stimulate 
growth and prevent apoptosis. However, studies of this inhibitor have shown that Sa and 
So accumulate. Sphinganine and So compounds are active as growth inhibitors and growth 
stimuiJtors, and may possibly undergoing rapid phosphorylation to form sphingol 
phosphates. Unfortunately, most studies have made the simplistic assumption that the 
observed changes were due to slowing the cerami de synthase enzymatic step. Little 
though t· has been given to the concept that depleting an enzyme leads to depletion of it's 
products due to the normal catabolism of those products. In addition, there can be 
accumu lation of the enzymes substrates and diversion of these precursors to other bioactive 
product s. 
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Continuous signalling by cell-cell contacts and cell-matrix interactions are necessary for 
cells to refrain from undergoing apoptosis. Aberrations in cell death signalling In 
membranes or cytoplasmic receptors, or alterations in genes that govern apoptosis are 
involved in the pathogenesis of congenital malformation and many acquired diseases 
(Vermes et at., 2000). In this study, it is likely that these interactions were affected in the 
N2a cells on exposure to, and incorporation of FBI (Figure 6.6), as FBI is known to affect 
membrane integrity. Sphingolipids serve as important structural molecules in membranes 
(Hannu n and Bell, 1989; Hakomori, 1990; Merrill, 1991) and related intracellular 
membranes, such as Golgi and lysosomal membranes (Merrill et al., 1997). Complex 
sphingulipids are required for cell survival and growth, and the loss of complex 
sphingolipid biosynthesis and membrane biogenesis would be expected to alter cell 
behaviuur, and lead to cell death. Therefore, those N2a cells that were most sensitive for 
surviVe] I signals would stay alive, and cells that could not compete with their more avid 
sister cells would have apoptosed due to relative shortness of survival factors. 
Yin ef (/1. (1998) studied the effects of FBI on lipid peroxidation in membranes and showed 
that flf lTIonisins disturb the ordering of membranes, enhances oxygen transport in 
membr:lnes, and also increases membrane permeability. The study provided evidence that 
incorp( (ation of FB I in test samples made the membranes highly susceptible to oxidation, 
and t11 .1 t fumonisin appears to increase the rate of oxidation, promote free radical 
interm l d iate production, and accelerate the chain reactions associated with lipid 
peroxil: ation. The disruption of membrane structure, the enlargement of the relative oxygen 
diffusi( d-concentration products, as well as the enhancement effects on membrane 
perme~ , h i1ity, provide additional insights into potential mechanisms by which fumonisins 
could ( lhance oxidative stress and cell damage. 
In add ion, Beier el al. (1995) reported that the amine and carboxylic acid groups of FBI 
were ~ .ltially related, suggesting that they have chelating properties, and hence, could 
cause I IlC mbrane ion leakage. These characteristics may have also contributed to membrane 
damag. in the N2cx. cells treated with FBI. Fumonisin BI was immunolocalised within 
cytopl. ') Illic organelles, the cytoplasm (Figure 6.6) and in cell nuclei and provides data that 
higlJ!i~ . ts the ability ofFB t to traverse N2a neuroblastoma cell membranes. 
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IncorpCl '- ::J tion of FBI into N2cx cells was visualized by the binding of the brown DAB 
chrom 'en with the peroxidase-labelled mycotoxin within the cells exposed to 501JM FBI 
(Figure 6_6). This low power light micrograph illustrates cells that have incorporated FBI are 
distinct I y larger than the blue haematoxylin stained N2cx cells, and hence that toxin 
incorpor:ltion may be associated with their formation (Figure 6.7). The primary site of action 
of FBI is distinctly cytoplasmic as indicated by the absence of DAB staining within the 
nuclei cf the majority ofN2cx cells exposed to 1001JM FBI (Figures 6.8 and 6.9). Extensive 
areas 0 1' cytoplasmic lyses or swelling of the ER were also characteristic of the DAB stained 
N2cx giant cells, and were visualised as white clearings (indicated by the arrows) within the 
cells (I - .' Llfe 6.7). 
Fowler t.!I al. (1989) have indicated that the effects of toxicants on cells are mediated via 
damag,: to one or more of the specialised subcellular compartments, and that formation of 
giant . lis may be a consequence of organelle damage as a consequence of toxicant 
expOSLI . Specific organelle systems become damaged if the organelle plays a primary role in 
the me' .bolism of the toxicant, when a toxicant is stored intracellularly, or as a result of an 
inhere] sensitivity of some essential biochemical pathway In the organelle 
(Fowle .' tal., 1989). 
Fumon In BI disrupts sphingolipid metabolism by inhibition of CER synthase that is 
localiz . in the ER. This inhibition results in an accumulation of intracellular cytotoxic 
sphing- . .:1 bases and a decrease in the production of complex sphingolipids. In cultured 
hippor . 1pal neurons, FB I inhibited sphingolipid synthesis and axonal growth, and also 
decre8 j cellular sphingolipids (Hare I and Futerman, 1993). Schwarz et al. (1995) further 
showe( . hat FB I a flected the formation of axonal branches in these cells, and that this 
inhibit ' 11 could be reversed by addition ofCER with FBI. In this study on the N2cx cells, 
FBJ-il !(:ed inhibition of CER synthase may have lead to the formation of the giant cells. 
As the it plays a crucia l role in facilitating metabolic processes, its alteration due to the 
effects ' FBI may have hindered cell growth and decreased cellular viability. As the areas of 
cytopl: .ll ic clearing in these FBI-treated N2cx cells are not clearly distinguishable, they may 
potent: ' y be either swollen ER or swollen Golgi complexes (Figure 6.7). These cellular 
abnon : lies may have arisen as a consequence of the combined exposure to FBI and 
Increa~ sphingoid bases, as well as the compromised membrane integrity of these cells. 
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Free s· : Ilgoid bases are growth inhibiting and cytotoxic at micromo[ar concentrations 
(Stevel L' t aI. , 1990; Merrill 1991; Hanada et aI., 1992) and reduced complex sphingolipid 
biosyn ' 'S IS reduces cel[ proliferation (Hanada et aI., 1992; Yoo et aI., 1992; 
Radin , 01. , 1993). Altering levels of sphingo[ipids may affect the physical properties of 
the p[" :la membrane and may also affect cytoske[eta[ structures disrupting cell growth 
(Spieg\ _'{ aI. , 1986; Fentie and Roisen, 1993). The cellular uptake of certain compounds 
such a' itamins is enabled by the action of membrane-anchored receptors . If however, the 
build t · of the membrane is impaired by the action of fumonisins , the vitamin uptake will 
























'd, this may lead to, or contribute to cell death (Wang et aI., 1996). These effects 
:y have compromised the integrity of the cell membranes facilitating entry ofFB, 
Jls . 
' t-eated N 2a cells di splayed features of progressive damage leading from gradual 
of processes, to loss of cytoplasmic volume and complete rounding. All these are 
with progression to cell death (Figure 6 .8). Cell rounding could be attributed to a 
rgidity and subsequent perturbation of the cytoplasm. The attachment of cells to 
,He and to each other is also mediated by cell surface glycoproteins, as well as 
tel mag lles ium ions. The loss of cell viability would imply a loss of production of 
and the g lycoproteins that facilitate cell adhesion (Freshney, 1983). 
'. (1992) reported similar findings in the LLC-PK 1 renal epithelial cell line, and 
.I t that there was a concentration-dependent association between the inhibition of 
,:d biosy nthesi s by FBI , and growth inhibition and cell death. After 24hour 
FB I , many cell s developed fibroblast-like appearance, with loss of cell-cell 
lei an e lo ngated, spindle shape. In this present study, a proportion of FBI-treated 
; were reduced in size due to cell shrinkage and displayed cytoplasmic 
. l l1 , whi ch are features consistent with the apoptotic mechanism of cell death. 
.). Cell s at different stages of the cell cycle with varying maturative states of 
rganelles metabo[ise, incorporate, and respond differently to an exogenous 
~ such (IS FB I By visual comparison, a positive correlation seemed to exist 
':::a ce ll s t llat displayed high intensity of chromogen adhesion or incorporation, 
that Clppea red more compromised by FBI exposure, indicating higher 
,.j ns of tox in incorporation. 
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As these in vitro experiments were initiated with confluent flasks of N2a cells, at the 
exposure level of 200IJ.M FBI a significant proportion of cell death was indicated by the 
gaps between remaining adherent cells (Figure 6.10). These results are supported by the 
data of the MTT assay (Chapter 3, Table 3.1) where only 29.8% cell viability was noted 
after exposure to FBI. Cell detachment suggests a loss of viability, as anchorage 
dependency is a characteristic feature of cultured cells (Freshney, 1983). Cell division 
reqUires an appropriate substrate, and partial or complete cell detachment from the 
substrate would suggest an inhibition of mitosis and cell growth. 
Hidari et a!. (1996) reported that FBI-induced inhibition of biosynthesis of GSLs disrupted 
cell substratum adhesion in mouse melanoma cells, and concur with the findings on the 
N2a cells. Other studies have also shown that FBI altered the manner in which glycosyl-
phosphatidylinositol-anchored proteins, such as the folate receptor, are organized and 
function in membranes (Hanada et a!., 1993; Stevens and Tang, 1997). Fumonisin B 1 
inhibition of galactosylceramide biosynthesis has also been documented to disrupt 
assembly and disassembly of cytoskeletal proteins responsible for lipid transport and 
maintenance of the subcellular architecture in the human adrenal carcinoma SW13 cell line 
(Gillard et a!., 1996). The findings on the N2a cells also support earlier findings by 
Merrill et al. (1993b) who showed that in cultured neuronal cells de novo, SM biosynthesis 
appeared to be more sensitive to fumonisin inhibition than biosynthesis of GSLs. The loss 
of complex sphingolipids would also have contributed to the abnormal behaviour and 
altered morphology of the FBI-treated N2a cells. Taken altogether, these documented 
findings (Gillard et a!. , 1996; Merrill et aI., 1993b) may have similarly influenced the level 
of cytotoxicity noted in the N2a cell line. 
6.3.2.2 Immunohistochemical analyses of the zearalenone-treated N2a cells 
A polyc1onal antibody was used for the immunolocalisation of ZEA within the N2a cells. The 
method specificity for the IHC staining procedure for this mycotoxin was established by the 
absence of chromogen adhesion to cellular components in the N2a cells treated with 50IJ.M 
ZEA, but where the ZEA primary antibody was omitted and replaced with PBS. 
Exposure of the N2a cells to ZEA (50IJ.M) seemed to have accelerated cell growth at the 
foci indicated by the multi-layering of the cells in combination with concentrated DAB 
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staining demonstrating lEA incorporation (Figures 6.11 a and 6.11 b). Exposure to lEA 
(100/lM) also induced giant cell formation (Figures 6.11 and 6.12), nuclear condensation 
(Figure 6.12), peripheral location of nuclei and intense nuclear and cytoplasmic staining 
Additional effects of lEA exposure in the N2a cells included loss of cell membrane 
integrity and membrane blebbing (Figure 6.13). The MTT assay results on the N2a cell 
line indicate that 50/lM lEA induced cytotoxicity in 55% of the cell population following 
a 48-hour exposure period (Chapter 3). 
Based on the staining pattern of lEA-treated N2a cells, it appears that the primary cellular 
target of lEA was cytoplasmic (Figure 6.13), although nuclear staining was also evident 
(Figure 6.12). learalenone mimics oestrogenic compounds and seemed to promote 
mitogenesis when compared to untreated N2a controls (Figures 6.11a and 6.11 b). Natural 
oestrogens at a physiological level promote cellular proliferation. Oestrogens diffuse in and 
out of cells, but are retained with high affinity and specificity in target cells by an 
intranuclear receptor. learalenone has shown a DNA damaging effect in recombination 
tests with Bacillus cereus and DNA adduct formation in mice. learalenone also induced 
pituitary adenomas In mice following consumption of a lEA-spiked diet 
(United States National Toxicology Program. 1982), indicating that the CNS may be a 
target for the effects of this mycotoxin in vivo. Other in vitro studies have shown that lEA 
induced sister chromatid exchange, chromosomal aberrations and polyploidy in CHO cells 
in the absence of exogenous metabolic activation 
6.3.2.3 Immunohistochemical analyses of the T -2 toxin-treated N2a cells 
A polyclonal antibody was used for the immunolocalisation ofT2 within the N2a cells. As 
with both FBI and lEA, the specificity of the mc staining procedure for this mycotoxin 
was demonstrated in the method control by the absence of chromogen adhesion to cellular 
components in N2a cells treated with 50/lM T2, but where the T2 primary antibody was 
omitted and substituted with PBS. As with the previous two mycotoxins (i.e., FBI and 
lEA) exposure, induction of giant cell formation was a feature of T2 exposed N2a 
neuroblastoma cells (Figure 6.14). 
The susceptibility of a cell to the adverse effects of a mycotoxin may be a reflection of its 
ability to incorporate the toxicant (Holt and Deloach, 1988). T-2 toxin inhibits the 
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mitochondrial electron transport system, with succinic dehydrogenase as one site of action 
(Khachatourians, 1990). The most prominent effects of T2 at the biochemical and cellular 
level are the strong inhibitory effect on protein synthesis by binding to ribosomes, the 
inhibitory effect on RNA and DNA synthesis, and the toxic effects on cell membranes 
(Eriksen and Alexander, 1998). 
To gain access to the cytoplasm and cellular organelles, trichothecenes must pass through 
the plasma membrane. T -2 toxin is an amphipathic molecule that diffuses into the 
membranes and disrupts their function. Susceptibility to lysis is species dependent and 
correlates with the presence of phosphatidylcholine. Owing to their amphipathic nature T2 
and other trichothecenes could exert their cytotoxicity by acting on cell membranes 
(Khachatourians, 1990). T -2 toxin is known to increase lipid peroxidation and membrane 
damage (Rizzo et aI., 1994). Visual comparison of the immunostaining intensity among the 
three mycotoxin treatments assessed in this study, indicate that T-2 toxin appeared to traverse 
the cell membranes more easily than either FBI or ZEA, by the comparatively higher intensity 
of DAB staining in these cells . This may be attributed to its high lipophilicity. In this study, 
the N2a. neuroblastoma cells grew as a monolayer with no barrier interface, and this may 
have rendered the cells more susceptible to the cytotoxic effects of this mycotoxin. 
T-2 toxin induced extensive cytoplasmic lyses and membrane damage in the N2a. cells, 
evident by the high level of DAB-stained cellular debris, which increased progressively with 
exposure to higher concentrations of this mycotoxin (Figures 6.14-6.19). Full receptor 
occupancy is a good candidate as the first step towards the expression of T -2 toxin toxicity, 
and this idea is consistent with the suggestion that the cell membrane is involved in and 
may modulate T2 cytotoxicity (Gyongyossy-Issa and Khachatourians, 1984). As T2 is an 
amphipathic molecule, it tends to partition into cell membranes. This differential 
permeability would be subject to constraints of parameters influencing the partition 
coefficient, as well as factors influencing the state of the cells membrane 
(Gyongyossy-Issa and Khachatourians, 1984). In Figure 6 .16, disintegration of the N2a. 
cell membrane is indicated, and this would have led to impairment of the cell's ability to 
maintain homeostasis, causing swelling and rupture of the cell membrane, and subsequent 
cytoplasmic leakage into the surrounding media. These results concur with studies by 
Bunner and Morris (1988) who reported that T2 affected multiple cell membrane functions. 
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Blebbing of the cell membrane and condensation of the nucleus are markers of apoptosis, 
and result in the fragmentation of the cell into apoptotic bodies, which swell and finally 
lyse (Figures 6 ,19 and 6,20), Support for the apoptotic effects of T2 are provided by 
studies of Deno et a!. (1995) where 40nM T2 induced apoptosis in HL-60 human 
promyelotic leukaemic cells within two to six hours without significant cytotoxicity, 
Shifrin and Anderson (1999) reported that lO~M T2 caused apoptosis in Jurkat cells, and 
Yang eta!. (2000) also reported that 40nM T2 caused apoptosis in Raw 264,7 cells, In this 
study, >50% cell death was reported between 5 and 1 O~M T2 after the 48hour exposure 
period in the N2a cells using the MTT assay (Chapter 3), In the flow cytometric analyses, 
T2 treated N2a cells that were stained with Rh 1231PI, showed ~ 15% viability, with ~82% 
of the cells taking up PI, indicating compromised membrane structure (Chapter 5), 
In vivo, T2 caused dilation and swelling of microvessels, damage to the plasma membrane 
and tearing of the blood vessel wall, compromised endothelial cells in the capillaries of the 
BBB, and altered amino acid transport into the brain (Yarom and Yagen, 1986), In this in 
vitro cell study, intracytoplasmic swelling (Figure 6,18), as well as damage to the cell 
membranes were evident in the N2a cells following exposure to T2, Although T2 was 
concentrated in the CCM bathing the cells membranes for a limited period, this time was 
sufficient to provide T2 ample opportunity to exert its noxious effects, Pace and 
Watts (1989) examined subcellular distribution of eH] T2 in perfused rat liver, noting that 
after five minutes the plasma membrane fraction contained 38% of the labelled T2 ; a 
concentration greater than that observed from the smooth ER (27%), mitochondria (10%) 
and nuclear fractions (7%), The data in this present study concurs with these earlier 
findings where high levels of T2 were incorporated into the cells, T -2 toxin also induces 
cell membrane injury with haemolysis, apparently via a free-radical mechanism 
(Coulombe, 1993), As the mc staining for T2 seemed predominantly cytoplasmic, it may 
have altered mitochondrial function in the N2a cells, as in the study by Pace and Watts 
(1989), Khachatourians (1990) have indicated that T2 inhibited the mitochondrial electron 
transport system by inhibiting succinate dehydrogenase, and Jone et al. (1987) reported 
that T2 inhibited gap-junctional intercellular communication in Chinese Hamster V79 
cells, 
A notable feature in the T2-treated N2a cells was the intensity of the immunoreactivity of 
T2 around the nuclear membrane of multiple nuclei in cells exposed to 50~M T2 
179 
(Figure 6.16). At this concentration, it was unclear whether T2 traversed the nuclear 
membrane. The nuclei in these N2cx. cells appeared intact apart from the peripheral 
condensation of the chromatin. However the N2cx. cells treated with the higher 
concentrations of T2 (i.e., 100 and 200~M) showed incorporation of this mycotoxin into 
nuclei (Figures 6.17-6 .20). 
Inhibition of DN A synthesis by T2 has been demonstrated in vitro 
(Thompson and Wannemacher, 1984), but evidence exists that this response is probably 
secondary to protein synthesis (Cundliffe et aI., 1974; Munsch and Muller, 1980). Studies 
by Oldham et al. (1980) have indicated that T2 (0.005-0 . 5~g . mrl) induced unscheduled 
DNA synthesis in cultured human fibroblasts, and at the highest doses, protein and DNA 
synthesis were strongly inhibited. Trusal and O 'Brien (1986) also reported that T2 could 
inhibit nucleic acid and protein synthesis and disrupt cytoplasmic membrane function. 
Yike et at. (1999) demonstrated 50% cell death in porcine kidney cells following treatment 
with 0 . 0091~M T2. However in the N2cx. cells, much higher concentrations of T2 were 
used, but based on the MTT assay data (Chapter 3), cell viability was reported to be - 65% 
at the 50~lM exposure level. This reinforces that different cell types have varying cytotoxic 
responses to mycotoxins due to the differing metabolic activity of the target cells. The most 
commonly encountered explanations for cell to cell variability in toxin sensitivity are cell 
to cell variability in the amount of target enzymes, other cellular constituents or functions 
that can interact with the toxin, and the efficiency of detoxification mechanisms that 
protect the cells and tissues (Reubel et aI., 1987; 1989; Holt et aI. , 1989; 
Palanee et al. , 2000; ). 
Biochemically, the trichothecene compounds cytotoxicity IS predominantly due to the 
potent inhibitory effect on protein synthesis (Ueno, 1983). Cundliffe et al. (1974) have 
documented that T2 inhibits protein synthesis by suppressing peptidyltransferase activity, 
and Rosenstein and Lafarge-Frayssinet (1983) subsequently showed that T2 inhibited 
synthesis of DNA and RNA in vitro (>0.1-1 ng.mr l in suspensions of rat hepatocytes 
caused 75% inhibition). T -2 toxin also inhibits protein synthesis in the initiation phase. It 
has been suggested that trichothecenes trigger a ribotoxic stress response causing the 
activation ofMAPK. Such activation may signal either cell survival or induce cell death in 
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various cell types depending on the conditions such as the length of signal, and concurrent 
protein inhibition; the latter appears to favour cell death (Shifrin and Anderson, 1999). 
6.3.3 Transmission electron microscopy and immunocytochemistry of FBrtreated 
N2a cells 
At the EM level, gold probe labelled monoclonal antibodies tagged FBI within cellular 
organelles The indirect method of immunochemical analysis was used to identify antigenic 
sites due to its higher sensitivity. The primary antibody was unlabelled and was identified 
by a labelled secondary antibody raised to the immunoglobulin of the species providing the 
primary antibody. Because at least two secondary antibody molecules can bind to each 
primary antibody molecule, this method is considered more sensitive than the direct 
method, i.e., smaller amounts of antigen were detected, or a stronger signal was given for 
the same number of bound primary antibody molecules (Polak and van Noorden, 1986). 
Transmission electron microscopy revealed that control cells were characterised by an 
elongated (since transverse sectioned) nucleus of medium density (Figure 6.21) The 
perinuclear space was narrow and many nuclear pores were observed. Regular distribution 
of heterochromatin aggregates appearing adjacent to the nuclear envelope between the 
nuclear pores was typical. The presence oflarge centrally located nucleoli in nuclei of control 
N2a cells was consistent with the findings oflight microscopy (LM) (Figure. 6.5). 
Microsegregation and peripheral condensation of the nucleoli were typical features of the 
FBI-treated N2a cells (Figures 6.22, 6.23a-6.25). Gold-labelled FBI was immunolocalised 
within the nucleoli, nucleoplasm and in swollen cellular processes of the N2a cells 
(Figures 6.23b-6.25). These findings support the ruc analyses that indicated the ability of 
FBI to traverse the nuclear membrane. The exposure to FBI may have compromised the 
integrity of the nuclear membranes of N2a cells thus facilitating its passage into nuclei 
(Figures 6.24 and 6.25). 
Ramasamy et al. (1995) have shown that FBI increases the rate of albumin transfer across 
endothelial cell monolayers in addition to elevation of Sa levels, the latter possibly 
explaining the loss of endothelial barrier function. Changes in the N2a cell membranes 
were characterised by focal disappearance of membrane structure and partial loss of 
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continuity These findings support the results on the N2a neuroblastoma cells since there 
were disruptions and clear discontinuity of the cell and nuclear membranes in these 
cultured cells (Figures 6.24 and 6.25). 
Further immunocytochemical analysis of FBI-treated N2a cells revealed gold-labelled FBI 
in association with discontinuous nuclear membranes, as well as within the nucleoplasm 
(Figure 6.26). The N2a cells exposed to FBI also displayed nucleoli with single or double 
distinctive fibrous centres which are features associated with inhibition of protein synthesis 
(Ghadially, 1982) The presence of nucleoli with an enlarged fibrillar component is reported 
to be characteristic of an inhibition of nucleolar RNA synthesis. These results are supported 
by studies of Norred et al. (1990) where FBI was shown to inhibit protein synthesis and the 
secretion of CER into very low-density lipoprotein. Monnet-Tschudi et al. (1999) also 
showed that FBI selectively affected glial cells by decreasing the total content of MBP in 
cell cultures of foetal rat telencephalon. From the ultrastructural differences between the 
nuclei of control and FBI-treated cells, along with the immunolocalisation of toxin within 
FBI-treated cells, nuclear function appears to be affected by FBI exposure. The filamentous 
component of the nucleolus is the site of precursor ribosomal RNA synthesis, while the 
granular component of the nucleolus represents a pool of accumulating partially completed 
ribosomal precursor particles (Daskal et aI., 1974). An enlarged nucleolus is indicative of an 
active process of synthesis of ribosomal RNA and hence, ribosomes and proteins 
(Ghadially, 1985). The feature of microsegregation was accompanied by that of peripheral 
clumping of chromatin (Figure 6.23b) at the nuclear membrane, a feature indicative of an 
inhibition of protein synthesis. Margination of the chromatin appears to be an early event that 
occurs in the nucleus after irreversible injury leading to death (Ghadially, 1982). 
Mobio et al. (2000) showed that nine to18!lM FBI induced significant hypermethylation in 
the DNA in C6 glioma cells. Hypermethylation is involved in regulation of DNA 
replication and gene expression, in cell division and differentiation processes. In addition, 
methylated CpG sites can bind specific nuclear proteins (Nan et al., 1993), which could 
conceivably block or modify the DNA repair process (Tornaletti and Pfeifer, 1995). 
Hypermethylation of CpG islands in the region of genes like those involved in tumour 
suppression have been associated with decreased gene expression (Rouleau et aI., 1995). 
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Sahu et al. (1998) reported that at concentrations ranging from 40 to 300iJ,M, FB I induced 
lipid peroxidation concurrently with DNA strand breaks in isolated rat liver nuclei . 
Although FB I is considered a non-genotoxic carcinogen, Sun and Stahr (1993) using a 
bioluminescent bacterial (Vibrio jischeri) genotoxicity test, further claimed that FB I 
showed genotoxic activity without the metabolic activation of S9 fraction at the 
concentration range of 5-20iJ,g.mr I The results of these studies concur with findings in the 
present study where FBI was directly immunolocalised within nuclei of N2a 
neuroblastoma cells, indicating interaction with nuclear DNA 
Transmission electron microscopy revealed that the cytoplasm of control N2a cells 
contained moderately large Golgi apparatus, several ovoid mitochondria and long profiles 
of rough ER (rER). Innumerable polyribosomes were also seen in the cytoplasm. The 
cytoplasm was of medium density, and the cellular margin was regular with some 
cytoplasmic projections/cellular processes. The mitochondria of control N2a cells showed 
well developed and ordered cristae, whereas mitochondrial distortion was a common feature 
ofFBdreated N2a cells (Figure 6.28-6.31). 
Fumonisin B I was immunolocalised within myelin figures, which are considered an 
indication of degenerating mitochondria, and of an increase in mitochondrial turnover 
(Figure 6.28) . In addition, the internal architecture of the mitochondria was highly 
disintegrated (Figures 6.29-6.31), with the cristae being distorted, dilated and decreased in 
number. Mitochondria of the FBI-treated N2a cells showed irregular multiple masses of 
electron dense material (Figures 6.29 and 6.30), as well as mitochondria that were distorted 
(Figure 6.31), swollen, elongated, dough-nut or C-shaped. Other mitochondrial abnormalities 
included clearing of the mitochondrial matrix (Figure 6.30), as well as distortion or disruption 
of the outer mitochondrial membrane The disorientation of the cristae from the usual 
transverse to longitudinal arrangement was an additional alteration occasionally observed in 
N2a cells exposed to FBI. The distortion of mitochondria in FBI-treated N2a cells with 
abnormalities such as mitochondrial matrix condensation (Figure 6.27), disorientation of the 
cristae and occasional swelling due to a flooding of the matrix chamber with water were also 
evident (Figure 6.28). Gold-labelled FBI immunolocalisation within elongated and distorted 
mitochondria, as well as on the cristae of mitochondria (Figures 6.27 and 6.31) of the 
treated N2a cells, indicate direct association of this mycotoxin with the organelle where 
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these ultrastructural changes were observed. Structural irregularities observed In the 
mitochondria of FBI-treated N2a cells were therefore attributed to FBI exposure. 
Mitochondrial protein synthesis, independent of nuclear control, is almost exclusively directed 
to production of the cristae and the inner membrane of the mitochondrial envelope. The 
synthesis of the outer membrane of the mitochondrial envelope is controlled by nuclear 
DNA-dependent RNA synthesis (Nass et aI., 1965; Leduc et aI., 1966; Anderson, 1969; 
Bergeron and Droz, 1969). If the outer mitochondrial membrane that is involved in 
phospholipid biosynthesis is dependent on the complex sphingolipids produced via 
sphingolipid metabolism, the altered sphingolipid metabolism may have been a factor in the 
disruption of normal mitochondrial structure. Coupled with these structural changes would 
have been the functional disruption, which then could be considered a consequence of 
FBI-induced inhibition of sphingolipid biosynthesis. 
It is widely accepted that there is a positive correlation between the metabolic activity of cells, 
the number and size of the mitochondria and the concentration of the cristae 
(GhadiaUy, 1982). The disorientation of cristae from the usual transverse to a longitudinal 
arrangement in the FBI-t~eated N2a cells indicates a deficiency of cytochrome oxidase 
activity (Figure 6.30). Cytochrome oxidase is the terminal component of the chain of 
respiratory carriers (electron transport chain) found in mitochondria, and is therefore 
responsible for the reaction where electrons coming from the oxidation ofNADH and F ADH2 
by dehydrogenases, are transferred to their final acceptor, oxygen. A disruption in the electron 
transport chain, leads to a decrease in ATP production and ultimately leads to a decline in the 
functional activity of cells. 
Condensation of the mitochondrial matrix is another feature associated with the loss of 
respiratory control, and at least partial uncoupling (Trump et aI., 1978). The swelling of 
mitochondria and the clearing the mitochondrial matrix in this investigation may be associated 
with both uncoupling and an inhibition of oxidative phosphorylation in FBI-treated cells. 
Mitochondrial damage suppresses ATP production, which in turn leads to a failure of the 
ATP-dependent sodium/potassium pump at the cell membrane resulting in cellular 
compartments flooding with water (Ghadially, 1982). Meldolesi et al. (1967) reported a 
positive correlation between swollen mitochondria and low levels of ATP. 
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Oxidative phosphorylation occurs across the inner mitochondrial membrane and results in 
the synthesis of ATP. As discussed in Chapters 4 and 5, the transient opening of the PT 
pores, which span the inner to the outer mitochondrial membrane, are necessary for the 
equilibration of essential ions between the cytosol and mitochondrial matrix. These PT 
pores open irreversibly during apoptosis (Simmons, 1999; Bradbury et at., 2000). 
Fumonisin BI has been shown in earlier chapters to have the ability to induce apoptosis at 
various concentrations in the N2a cells. This disruption in PT is believed to be the cause of 
the collapse in the ~\vm, and brings about the release of cytochrome c from the mner 
mitochondrial membrane to the cytosol (Simmons, 1999; Bradbury et at., 2000). 
Mitochondrial damage suppresses ATP production, which in turn leads to a failure of the 
ATP-dependent sodium/potassium pump at the cell membrane resulting in cellular 
compartments flooding with water (Ghadially, 1982). Zamzami et al (1995b) also suggest 
that swelling of mitochondria may be attributed to the production of reactive oxygen species 
(ROS). Reduction in the transmembrane potential as reportedly induced by FBI in the N2a 
cell line (Chapter 4 and Chapter 5), concomitant with uncoupling of oxidative 
phosphorylation caused by FBI exposure, may have caused increased generation of ROS, 
which in turn are important mediators of apoptosis. With an inhibition of mitochondrial DNA 
replication and inhibition of the respiratory chain, there could be an induction of 
mitochondrial ROS generation that may induce apoptosis in cells. 
In this study, control N2a neuroblastoma cells contained an extensive system of rER with 
long profiles often seen in association with mitochondria. The ER profiles of the FBI-treated 
N2a cells however were shorter and discontinuous (Figure 6.32) in comparison to control 
cells, showing features of dilation with occasional vesiculation of the cisternae of the ER seen 
in association with immunolabelled FBI (Figures 6.33 and 6.34). Swelling of the ER was also 
associated with a loss of ribosomes and accompanied by dissolution of the cisternae. The 
results of the present study concur with that of Cawood et al. (1994), where cytotoxicity 
and binding studies using subcellular fractions revealed that 14C-labelled FBI bound tightly 
to microsomal and plasma membrane fractions of hepatocytes. 
In several models of cell injury, changes in the ER have been considered one of the earliest 
cytological changes (Trump et al., 1978). Dilatation of ER is also a feature of apoptosis 
(Arends et at., 1990; Arends and Wyllie, 1991). The swollen, shorter strands ofER reported 
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for FBI-treated N2a cells were an indication of a disruption or inhibition of protein synthesis, 
whereas in control N2a cells, the well-developed ER indicates increased functional activity 
and the potential for cell differentiation. The swelling of the ER may be linked to the storage 
of secretory products and/or the influx of water due to defects in the enzymatic or mechanical 
defects in the rER (Ghadially, 1982). 
Numerous mitochondria in association with an extensive network of ER are an indication of 
increased protein synthesis. Biochemical alterations induced by FBI may have affected the 
integrity of the membrane leading to an influx of fluid, and retardation of protein synthesis. 
The initial steps from the condensation of serine and palmitoyl-CoA, through to the 
formation of CER in sphingolipid metabolism, takes place in the ER. The ultrastructural 
observations of the N2a cells treated with FBI , together with direct immunolocalisation of 
FBl in association with the ER, provide further support for the mechanism of action of FB I 
to be via inhibition of sphingolipid metabolism. 
Phospholipids are synthesised in the smooth ER (sER). Transport vesicles pinch off from the 
smooth ER and become absorbed into the Golgi complex, carrying the phospholipids with 
them. Phospholipid synthesis is completed on the cytosolic side of the membrane lipid 
bilayer. This bilayer fuses with cisternae of the Golgi complex, which buds off to yield 
vesicles that fuse with the plasma membrane and with membranes of other organelles. It 
seems likely that this is a route not only for extracellular secretion, but also for transport of 
membrane lipids to the plasma membrane (Mathews and van Holde, 1990). As CER 
synthase is localised in the ER, it is likely that this cycle was inhibited by FBI and 
accompanied by the swelling of the ER, may have lead to altered sphingolipid biosynthesis. 
De novo biosynthesis of GSLs is coupled to intracellular vesicular transport of the growing 
molecules through the cisternae of the Golgi apparatus and to the plasma membrane. 
Biosynthesis of SM also takes place in the Golgi apparatus. Ceramide is processed in the 
Golgi apparatus, and complex sphingolipids are packaged, sorted and transported to all cell 
membranes (Simons and van Meer, 1988; Schwarzmann and Sand hoff, 1990). Golgi 
complexes were not clearly apparent in both the untreated and FBI-treated N2a celis, as 
they seemed morphologically indistinguishable with areas of cytoplasmic lysis. In the 
untreated cells, the mimi mal Golgi bodies seen may be due to the fact that confluent 
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culures were used and de novo biosynthesis of GSLs was minimal at that stage of cell 
growth . 
In the FBI-treated N2a cells the sparseness of the Golgi complexes may further be 
attributed to the inhibition of sphingolipid metabolism, since the presence of a 
well-developed Golgi complex is indicative of the active process of packaging of secretory 
materiaL The reduced number of Golgi in the FBI-treated N2a treated cells may indicate an 
inhibition of the modification, condensing and packaging of secretory material, as well as a 
decrease in the turnover of glycosaminoglycans and/or sphingolipids. Figure 6.22 illustrates 
the difficulty in distinguishing between areas of cytoplasmic swelling and that which appears 
to be swollen Golgi complexes. A disruption induced by FBI on the normal functioning of 
Golgi complexes would lead to degradation of the cell membrane as well, since complex 
sphingolipids would no longer be directed to the cell membranes. 
Areas of cytoplasmic lysis were also noted in the FB I-treated N2a cells and may be 
considered a consequence of the disintegration of swollen ER (Figure 6.29). Gold-labelled 
FBI was localised within areas of cytoplasmic lysis and in the surrounding cytoplasm 
(Figure 6.34). The cellular processes of FBI-treated N2a cells were numerous and swollen 
(Figures 6.28 and 6.29) with FBI immunolocalised within, providing good correlation with 
the results ofLM. 
6.4 CONCLUSION 
These immunohistochemical and immunocytochemical microscopic analyses highlight 
variability that exists with regards to the cellular sensitivity, and consequences of exposure 
to a specific mycotoxin The immunolocalisation of T2, ZEA and FBI within N2a cellular 
organelles that exhibit structural and ultrastructural pathology provided good correlation 
between potential cause and effects of exposure to these mycotoxins. 
At the LM level, FBI-treated cells displayed features of progressive damage leading from 
gradual retraction of processes, to loss of cytoplasmic volume and complete cell rounding. 
Some N2a neuroblastoma cells were reduced in size due to cell shrinkage and displayed 
cytoplasmic condensation; features consistent with the apoptotic mechanism of cell death. 
A positive correlation existed between cells that displayed increased intensity of 
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chromogen adhesion, and cells that appeared more compromised by toxin exposure. Prior 
to cell death however, cells that incorporated FBI were larger. The primary site of action of 
FBI was distinctly cytoplasmic, and extensive areas of cytoplasmic lysis or swelling of the 
ER were characteristic of FBI-treated N2a giant cells. 
At the EM level, microsegregation and peripheral condensation of the nucleoli were typical 
features of the FBI-treated N2a cells. Gold-labelled FBI was immunolocalised within the 
nucleoli, nucleoplasm and in swollen cellular processes of the N2a cells. These findings 
support the IHe analyses that indicate that FBI is able to traverse the nuclear membrane. 
Further immunocytochemical analysis of FBI-treated cells revealed the presence of 
gold-labelled FBI in association with the discontinuous nuclear membrane, as well as 
within the nucleoplasm. Alterations of mitochondrial morphology included markedly 
swollen mitochondria with circular arrangement of the cristae, disintegration of the internal 
architecture of mitochondria, and distorted cristae, clearing of the mitochondrial matrix, as 
well as distortion or disruption of the outer mitochondrial membrane. The distortion of 
mitochondria in FBI-treated N2a cells with mitochondrial matrix condensation, disorientation 
of the cristae from the usual transverse to longitudinal arrangement and occasional swelling, 
due to a flooding of the matrix chamber with water, were also observed. Gold-labelled FBI 
immunolocalisation within elongated and distorted mitochondria, as well as on the cristae 
of mitochondria of the treated cells, indicate direct association of FBI with this organelle 
where these ultrastmctural changes were observed. Structural irregularities observed in the 
mitochondria of FB I-treated cells were therefore attributed to FBI exposure. 
The ER profiles of FBI-treated N2a cells were short and discontinuous, dilatated or swollen 
with occasional vesiculation of cisternae of the ER, in association with immunolabelled FBI. 
Swelling of the ER was associated with a loss of ribosomes and accompanied by dissolution 
of the cisternae. Sparseness of the Golgi complexes in FBI-treated cells may be attributed to 
the inhibition of sphingolipid metabolism, and may indicate an inhibition of the 
modification, condensing and packaging of secretory material. Dismption induced by FBI on 
functioning of Golgi apparatus would lead to degradation of the cell membrane, since 
complex sphingolipids would no longer be directed to the cell membranes. Areas of 
cytoplasmic lysis were also seen in the FBI-treated N2a cells, and were considered a 
consequence of the disintegration of swollen ER. Gold-labelled FBI was localised within 
areas of cytoplasmic lysis, as well as in the surrounding cytoplasm. 
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Treatment of the N2a cells with ZEA accelerated cell growth at foci indicated by the 
multi-layering of the cells. Exposure to ZEA (1 OO~M) induced giant cell formation , 
nuclear condensation, peripheral location of nuclei, membrane blebbing and intense 
nuclear and cytoplasmic staining, and loss of cell membrane integrity. Based on the 
staining pattern of ZEA-treated cells, it appears that the primary cellular target of ZEA was 
cytoplasmic, although nuclear staining was also evident. 
Induction of giant cell formation was also a feature of T2-treated N2a cells. T -2 toxin 
induced extensive cytoplasmic lysis and membrane damage in N2a cells. Disintegration of 
N2a cell membranes caused swelling, cell membrane rupture, and subsequent cytoplasmic 
leakage of contents into the surrounding media. As the IHe staining for T2 seemed 
predominantly cytoplasmic, it may have altered mitochondrial function in the N2a cells. 
The N2a cells treated with the higher concentrations of T2 (i.e., 100 and 200~M) however 
showed incorporation of toxin into the nuclei. 
The capacity of the N2a cells to incorporate these mycotoxins and effect cytological changes 
as a result of this exposure represents a major factor in the initiation of malignant 
transformation. The immunolocalisation of FBI, ZEA and T2 in association with cellular 
degeneration highlights the potential toxic effects of these mycotoxins on cells in the nervous 
system, and draws attention to the cytotoxic effects that may be induced in vivo and lead to, or 
exacerbate malignant transformation . 
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Figure 6.1: Light micrograph of untreated N2a. cells displaying epithelioid morphology. 
Potentially apoptotic (A) cells are indicated with the arrows with reduced cell 
size due to ceH shrinkage and cytoplasmic condensation (H&E, Magn. X 100). 
Figure 6.2: Light micrograph of untreated N2a. cells with large, centrally located nuclei (N) 
with mUltiple nucleoli (Nu), cellular processes extending over a large area (black 
arrows). Cells in the initial stages of apoptosis (A) are characterised by reduced 
cell size, cell shrinkage and cytoplasmic condensation (H&E, Magn. X 1000). 
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Figure 6.3: Light micrograph of control N2a cells with cells in the final stages of apoptosis 
(A) characterised by reduced cell' size, cell shrinkage, cytoplasmic 
condensation, as well as membrane blebbing (MB) (H&E, Magn. X 1000). 
Figure 6.4: Light micrograph of 50f.!M FBI-treated N2a cells used as the method control 
in an me run. The absence of DAB chromogen adhesion is an indicator of 
the method and antibody specificity (Haematoxylin, Magn. X 400). 
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Figure 6.5 : Light micrograph ofN2a. control cells stained in an IHe run. Absence of the 
DAB staining highlights the immunospecificity of the antibodies used 
(Haematoxylin, Magn. X 100). 
Figure 6.6: Light micrograph of 50/-!M FBI-treated N2a. cells with DAB-labelled FBI 
immunolocalised within cells indicating mycotoxin incorporation. Giant cell 
(G) formation is a consequence of FBI incorporation as indicated by the 
selective staining of these cells (Haematoxylin, Magn. X 100). 
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Figure 6.7: Light micrograph of 50llM FBI-treated N2a cells with DAB-labelled FBI 
immunolocalised within giant ceIJs (0) with extensive areas of cytoplasmic 
swelling, lysis or vacuolation (black arrows) (Haematoxylin, Magn. X 400). 
Figure 6.8: Light micrograph of 100llM FBI-treated N2a cells with DAB-labelled FBI 
immunolocalised in cells showing reduced cell size due to cell shrinkage and 
cytoplasmic condensation (C) (Haematoxylin, Magn. X 400). 
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Figure 6.9: Light micrograph of IOOIlM FBI-treated N2a. cells with DAB-labelled FBI 
immunolocalised in rounded-up dead cells (arrows) and in the cytoplasm (C) 
of cells that appear less compromised, but with some cellular swelling (S) 
(Haematoxylin, Magn. X 400). 
Figure 6.10: Light micrograph of 200llM FBI-treated N2a. cells with DAB-labelled FBI 
immunolocalised in the cytoplasm of cells. The large gaps between adherent 
cells are indicative of the proportion of cell death induced leading to cells 
detaching from the culture substrate (Haematoxylin, Magn. X 400). 
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Figures 6.1 1 a and b: Light micrographs of 50)lM ZEA-treated N2a cells with 
DAB-labelled ZEA immunolocalised within multinucleate giant cells 
(G), the cell cytoplasm, condensed cells (arrows), and foci of multi-
layered cells (M). (Haematoxylin, Magn. X 400 [a], X 100 [b]). 
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Figure 6.12: Light micrograph of IOOIlM ZEA-treated N2a cells with DAB-labelled ZEA 
immunolocalised in multinucleate giant cells (G), the cell cytoplasm, and in 
condensed cells (arrows) (Haematoxylin, Magn. X 400). 
Figure 6.13: Light micrograph of200llM ZEA-treated N2a cells with DAB-labelled ZEA 
inununolocalised in cell cytoplasm and rounded-up dead cells (arrows) and in 
cells with membrane blebbing (B) (Haematoxylin, Magn. X 1000). 
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Figure 6.l4: Light micrograph of 50jlM T-2 toxin treated N2a cells with DAB chromogen 
within giant cells (G) and in the cell cytoplasm. Cellular debris (D) and 
remnants of dead cells are a'Iso shown (Haematoxylin, Magn. X 400). 
Figure 6.15: Light micrograph ofN2a cells treated with 50jlM T-2 toxin, immunolabelled 
with DAB within the focus (F) of cells. There is a predominance of 
cytoplasmic staining, and absence of toxin incorporation within the nuclei 
(Haematoxylin, Magn. X 400). 
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Figure 6. 16: Light micrograph of 50~ T-2 toxin treated N2a. cell with DAB-labelled 
T-2 toxin immunolocalised within the cytoplasm of a cell showing loss of cell 
membrane integrity, and a concentration of T2 around the nuclear membrane. 
Multiple nuclei and peripheral condensation of chromatin (arrows) were also 
features ofT2-treated cells (Haematoxylin, Magn. X 1000). 
Figure 6.17: Light micrograph of 100j.lM T -2 toxin treated N2a. cells with DAB-labelled 
T2 localised within giant cells (G), in the cytoplasm, as well as in 
rounded-up dead cells. Fragmented DAB stained cellular debris was also 
evident (Haematoxylin, Magn. X 400). 
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Figure 6.18: Light micrograph of 100).tM T -2 toxin treated N2a ceIJs with DAB-labelled 
T2 immunolocalised in the cytoplasm of a ceIJ showing cytoplasmic swelling 
or lysis (arrows), and within the nucleus in association with features of 
peripheral condensation of chromatin. (Haematoxylin, Magn. X 1000) . 
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Figure 6.19: Light micrograph of 200llM T -2 toxin treated N2a cells with 
DAB - labelled T2 immunolocalised in the cytoplasm of giant cells and the 




Figure 6.20: Light micrograph of 200).!M T-2 toxin treated N2a cells with DAB labelled 
T2 localised within cells with lysed membranes and cellular debris. Large 
intercellular spaces between cells are indicative of the level of cell death 
induced (Haematoxylin, Magn. X 400). 
Figure 6.21: Transmission electron micrograph of a control N2a cell contammg a 
prominent single centralised nucleolus. The area above the cell is the flask to 
which the cell was attached, and the area below, is the araldite resin in which 
the cell was impregnated and embedded (Magn. X 4000). 
200 
Figure 6.22: Transmission electron micrograph of a 50llM FBI-treated N2a cell with 
peripheral condensation of nuclear chromatin, and areas of swelling within 
the cytoplasm of what appears to be the Golgi complexes (?G)(Magn. 





Figures 6.23a and b: Transmission electron micrographs of a 50JlM FBI-treated N2a cell with 
peripheral condensation of nuclear chromatin (NC) [a] (Magn. X 6 000) 
with FBI immunolocalised within the same nucleolus (Nu) and cellular 




Figure 6. 24: Transmission electron micrograph of 50/-lM FBI-treated N2a. cell with 
peripheral condensation of nuclear chromatin and distinct nuclear pores 
(arrows) in association with immunolabelled FBI (gold probes circled) 
(Magn. X 25 000). 
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Figure 6. 25: Transmission electron micrograph of 100/-lM FBI-treated N2a. cell with 
gold-labelled FBI (gold probes circled) localised within the nucleoplasm and 
cytoplasm (Magn. X 30 000). 
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Figure 6.26: Transmission electron micrograph of 100J,!M FBI-treated N2a cell with gold-
labelled FBI (gold probes circled) localised in association with the 
discontinuous nuclear membrane (arrow) and the nucleoplasm of the N2a 
cells (Magn. X 60 000). 
Figure 6.27: Transmission electron micrograph of 100)lM FBI-treated N2a cell with 
gold-labelled FBI (gold probes circled) localised in association with a 
mitochondrion (M) (Magn. X 60 000). 
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Figure 6.28:Transmission electron micrograph of 100J.LM FBI-treated N2a cell within a 
myelin figure (arrow) in association with immunolocalised FBI (gold probes 
circled). Also note the swollen cellular processes (P) (Magn. X 25 000). 
Figure 6.29: Transmission electron micrograph of 100JlM FBI-treated N2a cell with swollen 
mitochondria with mitochondrial matrix (M) clearing (arrow), disruption of the 
outer mitochondrial membrane, and swollen cellular processes (P) 
(Magn. X 30 000). 
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Figure 6.30: Transmission electron micrograph of 100l-lM FBI-treated N2a. cell with 
swollen mitochondria showing clearing of the mitochondrial matrix and 
rearrangement of the cristae (arrows)(Magn. X 35 000). 
Figure 6.3 I: Transmission electron micrograph of 100l-lM FBI-treated N2a. cell with 
swollen mitochondria showing clearing of the mitochondrial matrix (M) and 
areas of cytoplasmic lysis (Magn. X 25 000). 
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Figure 6.32: Transmission electron micrograph of 50)lM FBI-treated N2a cell with short 
profiles of ER (arrows) seen in association with swollen mitochondria (M) 
where the cristae are not clearly visible (Magn. X 30 000). 
Figure 6.33: Transmission electron micrograph of 100)lM FBI-treated N2a cells with 
profiles of swollen ER seen in association with areas of cytoplasmic matrix 
clearing (arrows) and immunolocalised FBI (gold probes are circled) 
(Magn. X 30 000). 
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Figure 6.34: Transmission electron micrograph of 100llM FBI-treated N2a cells with profiles 
of swollen ER seen in association with areas of cytoplasmic matrix clearing and 
immunolocalised FBI (Magn. X 40 000). 
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CHAPTER 7 
Development and optimisation of methodology for isolation and 
quantitation of fumonisin BI , sphinganine and sphingosine from 
hunlan serum samples using high performance liquid 
chromatography 
7.1 INTRODUCTION 
The ubiquitous occurrence of FB I in maize and maize products presents a potential threat 
to human and animal health, highlighting the need for development of effective methods or 
biomarkers to quantitatively monitor exposure to fumonisins. Toxicokinetic experiments 
using oral dosing of radiolabelled FBI in vervet monkeys have shown that FBI is 
eliminated rapidly from serum (Shephard et a/. , 1994a). Even though fumonisin is rapidly 
excreted, only 76% of the total radioactivity could be accounted for (Shephard et a/., 
1994a), highlighting the possibility of fumonisin being sequestered into tissues or possibly 
into blood (Shephard et a/., 1994b). The estimation of free FB I in blood however has been 
considered impractical due to its poor absorption and rapid excretion from the gut leading 
to low serum levels (Prelusky et a/., 1994). This rapid elimination, low bio-availability and 
lack of a major metabolite, impy that direct measurement of fumonisin may not be ideal as 
a quantitative biomarker for exposure, but may be feasible as a qualitative biomarker. 
Fumonisin induced inhibition of CER synthase leads to an elevation in the Sa: So ratio in 
cells. As the changes in free sphingoid bases occur before other biochemical markers of 
fumonisin induced cellular injury, the Sa: So ratio has been proposed as a biomarker for 
consumption of fumonisin contaminated feed (Riley et a/., 1994b). Methods based on 
measurement of Sa and So that accumulate due to the action of FB 1 have been developed 
(Riley et a/., 1994c). Riley et al. (1996) have recommended that detection of high 
concentrations of free Sa in serum or tissues be viewed as a clinical tool to be developed 
and used in conjunction with other clinical tools, in situations where animal or human 
toxicity resulting from exposure to fumonisin is suspected . This approach appears to give 
some hope to appraising human exposure to FBI, but a disadvantage is the erratic 
recoveries of the sphingoid bases from physiological fluids. 
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The development of reproducible methods for the determination of the ratio of Sa and So 
in serum will enable investigations to be conducted into the suitability of this ratio as a 
biomarker for fumonisin exposure. Its applicability in animal studies where animals are 
exposed to heavily contaminated feed has already been demonstrated. Studies however are 
required to address its applicability in human populations that are chronically exposed to 
fumonisin contaminated staple food supplies (Shephard and van der Westhuizen, 1998). 
High performance liquid chromatography is used for both the quantitative and qualitative 
analysis of compounds. Depending on the polarity of the stationary phase (polar, silica or 
non-polar, C18 modified silica), HPLC can be differentiated into normal and reverse phase, 
respectively. The polar fumonisin molecule is soluble in water and polar solvents, and 
suited for determination by reverse phase HPLC. Fumonisin B], as well as Sa and So lack 
ultraviolet chromophores, and are inherently non-fluorescent. As a result, sensitive 
detection of low levels of FBI, Sa and So present in physiological samples, require 
derivatisation and concentration of sample extracts (Shephard, 1998). O-phthaldialdehyde 
(OPA) has proved to be a sensitive derivatisation reagent for compounds possessing a 
primary amine group (NH2) and suitable for determination of FB] (Shephard et aI., 1990), 
Sa and So (Yoo et a/., 1996). 
The objectives of this study were to assess established methods for FBI, Sa and So 
isolation (Shephard et aI., 1992; Kwon et aI., 1998; Shephard et aI. , 1998; Shephard and 
van der Westhuizen, 1998; Shephard, 1998; van der Westhuizen et a/., 2001), and develop 
optimised methods sufficiently sensitive and suitable for the quantitative detection of low 
levels ofFB I, as well as free Sa and So in human sera. 
7.2 MATERIALS AND METHODS 
7.2.1 Materials 
All materials and sterile disposable consumables were purchased from Adcock Ingram, 
SA Sterile polypropylene 15ml centrifuge tubes were purchased from Continental 
Laboratory Suppliers. Fumonisin B] was purchased from the Programme on Mycotoxins 
and Experimental Carcinogenesis (PROMEC), Medical Research Council (MRC), 
Tygerberg, SA DL-erythro-dihydrosphingosine (sphinganine) and D-sphingosine 
(sphingosine), 2-mercaptoethanol, PBS tablets, OPA and orthophosphoric acid were 
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purchased from Sigma-Aldrich, SA All analytical grade and HPLC grade reagents 
(acetonitrile, methanol (MeOH)), solvents, chemicals, silica 60 (40-63!J,m particle size), 
granular and powdered anhydrous sodium sulphate, sodium dihydrogen orthophosphate, 
potassium chloride (KCI) were purchased from MERCK, SA unless otherwise indicated . A 
Bond Elut vacuum system, Bond Elut strong anion exchange (SAX) solid phase extraction 
cartridges (1 Oml capacity SAX cartridges containing SOO mg sorbent) and sample 
microfilters, 200~tl glass inserts and sample vials were purchased from Varian (Set Point 
Instruments, SA) 
The HPLC system consisted of a Spectra Physics P200 binary pump, an AS3000 
Autosampler and a FL2000 fluorescence detector (Thermo Separation Products, Set Point 
Instruments, SA). The analytical column was a Waters NovaPak C I8 cartridge (4!J,m, ISO x 
3.9mm) (Waters, Microsep, SA) preceded by a HIRPB-I0C guard column (Hichrom Ltd. , 
Set Point Instruments, SA). 
Human serum was obtained from a healthy non-cancer female volunteer. All the 
optimisation steps outlined involved spiking the sera with known levels of Sa, So or FBI, 
and establishing recoveries following application of the published methods mentioned 
above. 
7.2.2 Methods 
This chapter outlines the method development and optimisation procedures followed for 
FBI , Sa and So extraction from human sera. This chapter therefore deviates from the 
conventional format of presentation in order to present a logical explanation of the chain of 
events contributing to the methodology changes. 
7.2.2.1 Collection and handling of specimens 
Following informed consent, blood (Sml) was collected as required from a healthy urban 
dwelling female volunteer into yellow-capped serum separation blood tubes . The blood 
samples were centrifuged at 1200g x 10 min at RT within IS minutes of collection . Serum 
obtained was stored in 1 ml aliquots in 1. S ml eppendorf tubes at -70°C until processing for 
HPLC analyses. 
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7.2.2.2 The optimised method of fumonisin BJ extraction from human serum 
Prior to HPLC analyses, the serum from the subject was purified of matrix impurities (such 
as serum proteins) and concentrated as outlined below. The methods of Shephard et at. 
(1992), Shephard (1998) and Coumi (2000) were used after modification and optimisation. 
Serum (SOO!..d) (Figure 7.1, Step 1) was combined with 2ml PBS (pH 7.2-7.4) in a 
ISml polypropylene centrifuge tube (Figure 7.1, Step 2), vortexed for 30 sec., and boiled in 
a water bath (100°C for 15 min .) (Figure 7.1, Step 3). The suspension was cooled to RT 
and ice cold MeOH (Sml) was added to precipitate the proteins (Figure 7.1, Step 4). The 
suspension was vortexed thoroughly and then centrifuged for 10 min. to pellet the protein 
precipitate (1200g, lOOC) (Figure 7.1, Step 5). The mixture of PBS and MeOH was 
transferred to a new ISml centrifuge tube, and the pellet was resuspended in Sml ice-cold 
MeOH The supernatant was vortexed again to ensure extraction of any remaining FBI 
within the protein pellet, and re-centrifuged (1200g, 10°C, 10 min .) (with repetition of 
Steps 4 and 5 shown in Figure 7.1).The supernatant was combined with the previously 
retained supernatant (Figure 7.1, Step 6), and the total supernatant was then applied to a 
pre-conditioned SAX cartridge (Figure 7.1, Step 7) . 
The SAX cartridge was pre-conditioned with Sml MeOH: water (3:1 ,v/v) followed by Sml 
MeOH using vacuum suction. The flow rate was regulated at 1 ml. min-I through the SAX 
cartridge for both the application and the elution. At no stage was the cartridge allowed to 
run dry. Immediately after the entire sample supernatant was applied and passed through 
the column, the sorbent was successively washed with Sml MeOa water (H20) (3: 1, v/v) 
and Sml MeOH. The toxin was then eluted from the sorbent with ISml freshly prepared 
5% (v/v) acetic acid in MeOH The eluate was evaporated to dryness at 60°C under a 
gentle stream of N2 gas in a fume cupboard (Figure 7.1, Step 8) and the samples were 
stored at 4°C until analysis . The residue was redissolved in 100~1 acetonitrile: H20 (1: 1, 
v/v) and incubated at RT for Smin. prior to derivatisation and HPLC analyses. 
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Figure 7.1: Optimised method for Fumonisin B\ extraction from the serum 
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Cooled to RT 
~ 
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7.2.2.3 Chromatographic analysis conditions 
Reverse phase HPLC analyses of the serum samples were carried out under isocratic 
conditions using phosphate buffer: MeOH (29:71; v/v) as the mobile phase. The buffer was 
O.IM Na2HP04, adjusted to pH 3.3 with orthophosphoric acid. The buffer was filtered 
prior to use through a O.4S/J.m nylon filter. The mobile phase was degassed and pumped at 
a flow rate of 1 mimin- I at ambient temperature. 
For fluorometric detection, the excitation wavelength was set at 230nm and emission at 
440nm. To avoid interference from impurities eluting at the beginning of the 
chromatographic run, the emission wavelength was set at 660nm for the first 4.S min. and 
switched automatically to 440nm from 4.S to 8 min. Calculations of peak area and all data 
collected were processed using PC1 000 software (Thermo Separations Products, Set Point 
Instruments, SA). 
The OPA reagent was prepared by dissolving 12mg of OPA in 600/J.l of MeOH, followed 
by the addition of Sml ofO.lM disodium tetraborate (adjusted to pH 10.S with 1M sodium 
hydroxide (NaOH)) and 20/J.1 2-mercaptoethanol. This reagent was stored in the dark at RT 
and prepared on the day of analysis. Derivatisation of the purified sample was achieved by 
addition of 40/J.l of the sample extract to 80/J.1 of the OPA reagent, followed by vortexing 
for IS sec. The time from derivatisation to injection did not exceed 1.S min . Injection of 
SO/J.l of derivatised sample was performed in duplicate. 
7.3 RESULTS AND DISCUSSION OF METHOD DEVELOPMENT OF 
FUMONISIN Bl EXTRACTION AND ANALYSIS FROM SERUM 
Numerous analytical methodologies for the determination of FBI in physiological fluids 
exist. In this study, the methods of extraction and analysis of the serum samples were based 
on methods of Shephard et al. (1992), Shephard (1998) and Coumi (2000). 
The original method of Shephard et al. (1992) involved deproteinization of a SOO/J.I aliquot 
of serum by the addition of 2.Sml methanol. The protein precipitate was centrifuged down 
and a 2ml aliquot of the supernatant was applied to a pre-conditioned SAX cartridge. The 
cartridge was then washed with Sml ofMeOH: H20 (3:1, v/v) and Sml methanol , and FBI 
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was eluted with 5% acetic acid in methanol. Overall , the method involved solid phase 
anion exchange clean-up, pre-column derivatisation with OPA and reversed phase HPLC 
with fluorescence detection. Shephard et al. (1992) showed this method to be sensitive 
(detection limits around 50ng.mr\ reproducible (relative SD on six replicates less than 
5%) and accurate (recoveries on spiked blank samples above 85%)(Shephard et aI., 1992) 
As in all quantitative analytical work however, it was important to validate this method in 
our laboratory with respect to reproducibility and analytical recovery of the relevant 
analytes from the matrix of interest. Modifications were then required and applied to the 
sample preparation procedure in this study to optimise the recoveries of low levels of FB I 
from serum. 
The chemical nature of fumonisins makes them amenable to extraction USIng polar 
solvents. They are generally extracted using methanol/water (Sydenham et aI. , 1996) or 
acetonitrile/water mixtures (Bennett and Richard , 1994). 
Because fumonisins do not absorb UV and are not fluorescent, their sensitive detection 
required derivatisation of extracts (Pohland, 1994) to form fluorescent derivatives. The 
OPA method is widely used for derivatisation of primary amines, and methodology using 
this derivative for fumonisins has been the subject of international collaborative trials 
(Thiel et at. , 1993; Visconti et aI., 1993; Sydenham et at., 1996). 
Derivatisation of FB I with OPA and 2-mercaptoethanol in borate buffer is considered rapid 
and reproducible at RT. The method however suffers from the disadvantage of the limited 
stability of the fluorescent reaction products. Shephard (1998) found that these products 
were stable for four minutes after preparation then a decrease (5%) in fluorescence 
response of the FB I derivative was noted after eight minutes, with further decreases as time 
progressed . To minimise the decrease in fluorescence response, Shephard (1998) suggested 
standardizing the time between reagent addition and HPLC injection to approximately two 
minutes. In this study, significant decrease in fluorescence response of OPA derivatives of 
FBI was noted after ten minutes, and thus the time between derivatisation, and injection 
was not allowed to exceed 1.5 minutes. 
The chromatographic method of analysis did not differ significantly from Coumi (2000) . In 
short, isocratic elution with phosphate buffer: methanol eluant on a C I8 column was applied 
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to the OPA derivatised samples. Fluorescence detection of the derivatives was achieved by 
setting excitation wavelength at 230nm and emission at 440nm, and significantly improved 
detection limits. The detection settings used by Shephard et al. (1992) (with excitation and 
emission wavelengths being 335nm and 440nm, respectively) did not allow for the 
detection of the toxin when present in amounts less than 0 1/lg, while application of the 
lower excitation wavelength brought the detection limit down to 5ngmr l with a signal to 
noise ratio of 5: 1. However, changing the excitation wavelength reduced the specificity of 
the detection. 
There was a marked increase in intensity of the peaks due to the polar constituents of 
serum samples that eluted before FBI leading to detector overload . In order to reduce this 
interference without compromising sensitivity for the FB] , the detection parameters were 
modified. For the first 4.5 minutes, the emission wavelength was changed to 600nm and 
then returned to 440nm for the remainder of the run. The excitation wavelength remained 
at 230nm. 
Once the method for HPLC analysis was optimised, the reproducibility of the method was 
tested by injection of the 200ng.mr l FBI standard over several days . The results of this 
study concur with those obtained by Coumi (2000) . Reproducibility between injections of 
the same sample was found to be excellent as indicated with the three chromatograms of 
70ngmr] FBI shown in Figure 7.2. 
An extensive optimisation procedure for the extraction of FBI from human serum samples 
was followed . As the matrix of human serum differs from that of rat serum, it was 
necessary to use a method that provided efficient clean up of the serum to reduce the 
amount of polar compounds that eluted. Reddy (1999) applied a method adapted from 
Shephard et al. (1992), which involved solid phase extraction (SPE) of deproteinised 
human sera using SAX columns, with satisfactory results . The SAX cartridges achieve 
superior purification over reversed phase cartridges (Bennet and Richard, 1994; 
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Figure 7 .2: High perfonnance liquid chromatograms of three injections ofFB, (70 ng .ml"') showing 
reproducibility of the retention times . 
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Stockenstrbm et ai, 1994), but require monitoring of the pH of the sample extract (above 
pH 5.8 for adequate retention on the SAX cartridge), and careful control of elution flow 
rates at less than 1 mLmin-1 for reproducible recoveries (Sydenham et ai, 1992). 
To optimise the method of extraction of FB I from human sera, the procedure outlined 
below was followed . Serum from a healthy female volunteer was used for determination of 
recoveries of FBI from spiked serum. Serum (500ill) was spiked with 200ng of FBI in 
acetonitrile : water (1: 1, v/v) and processed according to the method of Shephard et al. 
(1992) analysed by HPLC for FBI and the result was used for calculation of the percent 
recovery. 
Briefly, spiked serum samples were vortexed and incubated at RT for fi ve minutes to 
ensure complete mixing of FBI into the sample. To the remaining 500ili aliquot of each 
sample, lOOill of acetonitrile: water (1: 1; v/v) was added and these samples served as 
controls and were used to monitor baseline levels of FBI Both non-spiked and spiked 
samples were extracted and derivatised using the method described in section 7.2.2.3. 
In order to determine whether the toxin was being lost or poorly retrieved, the original 
multi-step extraction procedure was applied with spiking of serum samples with 200ng FBI 
at various points along the isolation procedure (Figure 7 .3a). All tests were done in 
duplicate and run parallel to non-spiked controls . 
• Serum samples (Figure 7.3a, NA1 and NA2) were spiked prior to the addition of 
MeOH to the serum, and vortexed vigorously . This was to establish whether FBI was 
completely extracted with methanol, and whether any toxin was trapped in the protein 
precipitate. 
• The supernatants from the serum samples were spiked following centrifugation, 
pelleting, and removal of the protein precipitate (Figure 7.3a, NB 1 and NB2) . This was 
to determine whether the column was efficient in binding all the FBI applied, and 
whether the elution mixture was strong enough and sufficient in volume to elute the 
total FBI Fumonisin BI was added directly to the supernatant and then applied to the 
prepared column. 
• The elution reagent (i.e., 5% acetic acid in MeOH) used for serum samples 
(Figure 7.3a, NCI and NC2) was spiked prior to the drying step. This was to determine 
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whether toxin was being degraded during heating and drying of the sample. The results 
of these analyses are shown in Table 7.1. 
The HPLC chromatograms obtained from each of the duplicate samples (i.e., NA1, NB 1, 
NCl and NDl) are shown in Figure 7.3b. 
Table 7.1: Quantitative determination of recoveries of fumonisin Bl from serum 
samples spiked as indicated in Figure 7.3a and shown in Figure 7.3~. 
Method 0/0 FBI recovered 
(Mean ± SDl 
Samples were spiked with FBI prior to addition of MeOH to the 33.3±4.8 
serum (Figure 7. 3a, NA 1 +NA2) 
The MeOH supernatants from the serum samples were spiked with 94.4 ± 2.3 
FBI prior to application to SAX column (Figure 7.3a, NB1+NB2) 
Sample supernatants were spiked with FBI after elution from the SAX 98.1±2.3 
column, directly into elution solvent and prior to drying on the heating 
block (Figure 7.3a, NCl+NC2) 
These results indicate that major losses (- 70%) in recovery of FBI from samples occurred 
at the first step of the multi-stepped isolation procedure (Table 7 .1). This implies that the 
protein pellet may have retained a major proportion of FBI that the samples were spiked 
with. Although there were losses in the subsequent steps of the procedure, they were 
minimal in comparison to the initial step. These results also indicate that the SAX cartridge 
was not overloaded with sample, since high recoveries were obtained in subsequent steps 
(Table 7.1). The next step in the optimisation procedure was therefore to increase the 
volume ofMeOH used to extract the serum from 5ml tol0ml, in an attempt to increase the 
recoveries of FBI from the sample. 
In the subsequent set of analyses, duplicate serum samples (500111) were spiked with 200ng 
FB I and a double extraction of the protein pellet was carried out. The effect of diluting the 
serum with an equal volume of water was also assessed as indicated in Table 7.2 . The 
supernatant was removed after the initial pelleting stage; the pellet was re-extracted with 
Sml MeOH, vortexed thoroughly and re-centrifuged. The pooled supernatant was then 
carried through steps 6 to 8 in the remaining unmodified method outlined in Figure 7.1 . 
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Figure 7.3b: High perfonnance liquid chromatograms of serum samples spiked with Fumonisin BI shown 
with retention times of ~3 . 8-3 . 9 minutes . 
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The results in Table 7.2 and Figure 7.4 indicate that the highest recoveries of 40.2±0.1 % 
FB I were obtained by dilution of the serum with 500111 deionised water, followed by 
extraction with two 5ml volumes of methanol. However, recoveries were only marginally 
above the previous recoveries of 33% (Table 7.1) and still below 50%. An additional 
problem with the chromatographic method was that elution of another compound close to 
the retention time (RTi) of FBI made graphical integration, and interpretation of data 
difficult This is shown in Figure 7.4 by the pink trace (Sample NFl) where a compound 
with a RTi of3.2 min . eluted very close to FBI (green trace, RTi of3.3 min.). 
Table 7.2: Quantitative determination of recoveries of fumonisin Bl from spiked 
serum samples that were diluted with water. 
Method 0/0 FBI recovered 
(Mean ± SD) 
SOOIlI spiked serum samples were diluted with SOOIlI deionised water 40.2±0.1 
and extracted twice with Sml MeOH per e:-..1:raction 
Undiluted spiked SOOIlI serum samples were e:-..1:racted twice with Sml 28.8 ± 3.2 
MeOH per extraction 
2S01l1 semm samples were spiked with 1 OOng FBI and diluted with 27.7 ± S.3 
2S01l1 deionised water. The samples ,,,,ere extracted twice with Sml 
MeOH per extraction 
Having established that dilution of the serum improved recovenes, further optimisation 
involved increasing the volume of water used in dilution of the serum (Table 7.3), and 
boiling the serum sample prior to extraction. As the use of two 5 ml volumes ofMeOH for 
the extraction of FBI improved the recoveries from 33.3±4.8% (Table 7.1) to 40.2±0.1% 
(Table 7.2), this modification to the method was retained. Since decreasing the volume of 
serum from 500lli to 250IlI, and diluting with 250lll water did not improve recoveries, the 
use of 500lli serum for all further analyses was kept constant 
With the next set of samples, the supernatant was removed after the initial pelleting stage, 
and the pellet was re-extracted with 5ml MeOH, vortexed thoroughly and re-centrifuged 
(Table 7.3). The supernatants were pooled and then taken through steps 6 to 8 as in the 
method description. The results of these modifications are shown in Table 7.3. These 
samples were spiked with 200ng FBI and vortexed thoroughly to ensure proper mixing 
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Figure 7.4: High perfonnance liquid chromatograms of spiked serum samples showing a compound with a 
retention time of 3.2 min. eluting very close to Fumonisin BI 
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The results in Table 7.3 and Figure 7.5 indicate that dilution of the serum sample with 2ml 
of water improved (shown by the green trace, sample NLl) recoveries of FBI to 
48 .8±7.4%, with further improvement to 52 .0±3.0% by boiling of the sample prior to 
extraction (as indicated by the purple trace, sample NQl in Figure 7.5) . Increasing the 
volume of water to 4ml in the dilution, prevented passage of the sample through the SAX 
column due to blockage of the column packing. This was possibly due to saturation of the 
column packing with the matrix impurities. 
Table 7.3: Quantitation of recoveries of fumonisin Bl obtained from spiked serum 
samples diluted with increasing volumes of water. 
Volume of diluent 0/0 FBI recovered 
(Mean ± SD) 
50011-1 deionised water (blue trace NJ in Figure 7.5) 38.3 ± 0.02 
Iml deionised water (red trace NK in Figure 7.5) 25.7 ± 10.8 
Dilution of 2ml deionised water (green trace NL Figure 7.5) 48.8 ± 7.4 
500f.!1 spiked 4ml deionised water Not completed I 
serum samples 2ml de ionised water, and boiling in water bath 100°C 52 .0 ± 3.0 
(n=2) with: for 15 minutes . Samples were cooled to RT and MeOH 
was added to precipitate proteins and extract FBI 
(purple trace NQ in Figure 7.5) 
I Samples were not completely analysed SInce samples blocked the SAX column. The samples were thus 
discarded. 
In addition, it was found that the protein precipitate did not pellet well. As a result, all 
centrifugation stages were carried out in the refrigerated ultracentrifuge. These 
chromatograms also indicate the increasing difficulty experienced with graphical 
integration and analyses, as co-eluting compounds were evident (Figure 7 .5). Fumonisin Bl 
has an approximate RTi of - 3.4 min. (Figure 7.5) 
To improve the precipitation of proteins out of the serum samples, ice cold MeOH was 
used. Following addition of MeOH, samples were refrigerated for 15 min. to maximize 
precipitation of serum proteins . Samples were also vortexed at five-minute intervals during 
the 15 minutes, to ensure more thorough extraction of FBI from the sample. 
Biden pers comm. (2001) found that for antibody work, extraction of serum with PBS 
(pH 7.2-7.4) gave good recoveries when the serum sample was diluted with an equal 
volume of PBS, and then boiled for 15 minutes. The use of PBS was modified in this study 
by combining water and PBS in different ratios and using it in dilution of the serum 
samples prior to extraction (Table 7.4) . In these modifications, serum (500~1) was spiked 
with 200ng FB 1 and then boiled in a water bath for 15 minutes in sealed polypropylene 
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Figure 705: High perfonnance liquid chromatograms of spiked serum samples indicating improved 
recoveries of Fumonisin BI following dilution and boiling of the serum samples 
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cooled to RT and 5ml ice-cold methanol was added to precipitate the proteins. The 
suspensions were vortexed thoroughly and then centrifuged to pellet the protein precipitate 
(1200g, lOoC, 10 min .). The PBS MeOH supernatants were transferred to new centrifuge 
tubes (I5ml) , and the pellets were resuspended in another 5ml ice cold methanol, vortexed 
once more to ensure extraction of any residual FBI within the protein pellets and 
re-centrifuged (1200g, lOoC, 10min.).The supernatant was pooled with the previously 
retained supernatant, and this total supernatant was then applied to a pre-conditioned SAX 
cartridge. 
Table 7.4: Recovery of fumonisin Bl from diluted and boiled spiked serum 
samples. 
Volumes of diluent 0/0 FBI Recovered 
(Mean ± SD) 
1 ml deionised water 58.9 ± 3.4 
1 .5ml deionised water 55.9 ±10.1 
Dilution of 5001-1-1 spiked 2ml deionised water 64.7 ± 6.3 
serum samples (n=2) with ImlPBS 55.3 ± 14.8 
1.5ml PBS 69 .5 ± 9.8 
2ml PBS 89.4 ± 0.4 
The results in Table 7.4 indicate that maximum recoveries of 89.4±0.4% were obtained by 
boiling the serum samples in PBS . Although the recoveries were greatly improved, 
modification and improvement on the retrieval of FBI brought with it the problem of 
compounds eluting very close to FBI. Samples processed according to the modified 
method showed additional chromatographic peaks interfering with quantitation of FBI 
making graphical integration, and guantitation more difficult. 
Boiling of spiked serum samples with 2ml PBS improved recovenes substantially 
(Table 7.4) therefore further optimisation of the extraction was not pursued. The 
reproducibility of the modified method was determined on replicate serum samples 
following spiking with 200ng, 300ng and 400ng FBI dissolved in MeOH. These results are 
summarized in Table 7.5 (Appendix 7.1). The mean recovery from the 15 serum samples 
spiked with FBI was 95.8% (Table 7.5). 
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Table 7.5: Recoveries of different concentrations of fumonisin BJ used to spike 
500).11 serum samples. 
Amount of FBI used Recovery of FBI (ng.mr l ) % FBI Recovery (Mean ± SD) 
200ng (n=4) 413.5 ± 41.1 103.4 ± 10.3 
300ng (n=5) 552.1 ± 57.3 92.0 ± 9.6 
400ng (n=6) 735.5 + 52.5 91.9 ± 6.5 
Mean (n=15)_ 95.8% 
This method was considered suitably optimised for application to the serum of brain cancer 
patients and the non-cancer human subjects (data in Chapter 9). Shephard et at. (1992) 
reported recoveries of 86% for FBI in serum. However, the samples in that study contained 
much higher concentrations of fumonisins, namely lA).1g.mr l and 6.2).1g.mr l in spiked 
serum samples. In this study, samples were spiked with 200, 300 and 400ng FBI per 500~1 
of serum indicating improved sensitivity of this extraction method with recoveries of 
between 85-105% (Table 7.5) The excess 5% could be attributed to analytical error or the 
presence of FB I in the serum prior to spiking. Shephards' et al. (1992) method gave 
detection limits of about 50ng.mr' with a signal to noise ratio of 4: 1. This study improved 
on detection limits to approximately 5ng.mr l at a signal to noise ratio of 5: 1. 
It is possible that boiling of the serum samples with PBS pnor to deproteinization, 
facilitated unravelling of the coiled protein structure exposing the side groups and allowing 
release and hence retrieval of higher amounts of FB I. The large amount of polar impurities 
detected indicated that the clean-up procedure for the serum samples was not optimally 
efficient. In the present study, the method of Coumi (2000) was further optimised for 
recoveries and purity of the samples analysed. The boiling of the serum sample with PBS, 
and the double extraction of the protein pellet with MeOH did improve the efficiency of 
recoveries of FB I, but as with Coumi (2000) problems where still experienced with the 
large amount of impurities in the column. These impurities affected the analytical HPLC 
column by excessive absorption onto the stationary phase. It was therefore necessary to use 
a guard column to prevent system blockage and reduction of column efficiency. 
Reproducibility of RTi was dramatically affected by integrity of the guard column. Thus, 
the guard column had to be changed and cleaned regularly which slowed down the 
analytical procedure. 
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The identity of the FBI peak from serum samples was confirmed by comparison with a 
chromatogram of the FBI standard, and every three sample runs were normally bracketed 
by running a FBI standard with comparison of the RTi (±3.4 min.) . Figure 7.6 shows 
chromatograms of serum samples from three non-cancer volunteers, as well as that of a 
FBI standard . As can be seen varying levels of FBI were detected in non-cancer controls. 
The complete quantitati ve data set of the analyses of sera from brain-cancer and 
non-cancer participants in this study are presented and discussed in Chapter 9. 
7.4 METHOD DEVELOPMENT FOR DETERMINATION OF SPHINGANINE 
AND SPHINGOSINE LEVELS IN HUMAN SERA 
The second part of this study focussed on the optimisation of methods for Sa and So 
isolation and analysis from sera of non-cancer and brain cancer subjects, as the Sa:So ratio 
has been proposed to be suitable as a biomarker for FBI exposure. 
7.4.1 Modification and application of the method of Kwon et al. (1998) for 
extraction of free Sa and So from human sera 
Firstly, the method of Kwon et at. (1998) originally used on brain and spinal cord tissue, 
was assessed for applicability to determination of Sa and So in sera. Briefly, the method 
involved ultrasonication of 500111 spiked serum (Table 7.6) with 2ml 50mM potassium 
phosphate buffer (pH 7.0; for 10 sec.) in a 15ml polypropylene screw capped vial. The 
samples were vortexed thoroughly and 0.5ml O.IM borate buffer (pH 13 .1) and 
4ml CHCb: MeOH (9 : 1, v/v) were added. The solutions were vortexed and then 
centrifuged for 8 min. at 600g at 4°C. The CHCb layer was transferred into a glass 
scintillation vial and evaporated to dryness under nitrogen gas at 37°C. The vials were 
shaken for five minutes, then centrifuged following addition of 0.4 M borate buffer 
(pH 4.4) (500111) and 3ml n-hexane to the residue . The hexane layer was removed and 
discarded by suction. Potassium hydroxide (lOM) (40111), followed by 4ml CHCb : MeOH 
(2 : 1, v/v) was added to the aqueous layer, and the mixture was shaken. The organic layer 
was rinsed with O.IM borate buffer (pH 10.5) and evaporated . All samples prepared 
according to this method and subsequent methods were derivatised prior to HPLC analysis, 
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Figure 7.6: High perfonnance liquid chromatograms of varying levels of Fum on is in BJ isolated from the 
sera of non-cancer subjects (N6, N20 and N14; blue, red and green traces respectively). Also 
shown by the uppennost blue trace blue is the FBJ standard at a concentration of SOOng. 
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7.4.2 Derivatisation of sphingoid bases for high performance liquid 
chromatographic analysis 
The OPA reagent was prepared by dissolving 15mg of OPA in 600!J.,1 of MeOH, followed 
by the addition of7 .5ml ofO.1M disodium tetraborate (adjusted to pH 10.5) and 20!J.,1 of 
2-mercaptoethanol. This reagent was stored in the dark at RT during use and prepared fresh 
daily. The sample extract was suspended in 250!J.,1 MeOH by ultrasonication for one minute 
and incubated for 15 min. at RT. The solution was derivatised by addition of 50!J.,1 OPA 
reagent, ultrasonicated for one minute, and then incubated at R T for a further 15 min. The 
samples were then filtered through a nylon microfilter (0.22!J.,m pore size) into 200!J.,1 
inserts placed in 2ml autosampler vials. Refrigerated samples were stable for at least 24 
hours when stored in the dark. 
7.4.3 High performance liquid chromatographic analysis of the sphingolipid 
derivatives 
A Waters NovaPak C I8 cartridge (4!J.,m, 150 x 3.9mm) (Waters, Microsep, SA) preceded 
by a HIRPB-10C guard column (Hichrom Ltd., Set Point Instruments, SA), was used for 
separation of sphingolipids. The temperature of the column was maintained at 35°C. 
Fluorescence detection was employed for the analysis of the OP A derivatives, with 
excitation wavelength 230 nm and emission wavelength of 440nm. 
Reverse phase HPLC analysis of the samples were carried out under gradient elution 
conditions (flow rate 1 ml.min-I) using 0.07M K2HP04 buffer: MeOH (19) as Solvent A 
and MeOH as Solvent B. The HPLC method was based on that ofCastegnaro et al. (1998). 
The gradient elution profile was modified to reduce the total run time from 1 hour to 22 







Programme of gradient elution for high performance liquid 
chromatographic analysis of sphinganine and sphingosine. 
Solvent A Solvent B 






All solvents were degassed in the ultrasonic bath prior to use. All samples were injected in 
duplicate (injection volume 50~1) . Standard solutions of Sa and So were run daily to verify 
column performance, stability of the OP A reagent, as well as the RTi and response factors 
for both Sa and So. 
7.4.3.1 Preparation of calibration curves for both sphinganine and sphingosine 
A concentration range between 75 and 1 OOO~g. mr! gave linear area/amount responses for 
both Sa and So. Injections of 50~1 derivatised sample standards were performed in 
duplicate to confirm reproducibility. Data collected was processed using PC 1 000 software 
(Thermo Separation Products, Set Point Instruments, SA). Peak area was used to quantify 
the concentration of Sa and So present by taking the relevant dilution factor into account. 
7.4.4 Results of the extraction method of Kwon et al. (1998) for sphinganine and 
sphingosine from sera 
For these analyses, two 500~1 serum samples were spiked at three concentrations of Sa and 
So as outlined in Table 7.7. In all the analyses the Sa and So were resuspended in 
methanol. The samples were vortexed vigorously to ensure proper mixing and then the 
method outlined in 7.4.1 was followed. In the chromatographic analyses of these samples, 
each derivatised sample was injected in duplicate. Hence for each concentration of spiking 
evaluated, a mean of the 2 injections of duplicate samples was taken and these results 
summarized (Table 7.7) . This method of evaluation was applied to all the results shown in 
Table 7.7 onwards unless otherwise indicated. 
Table 7.7: Results of the application of the method of Kwon et al. (1998) for 
extraction of free Sa and So from spiked serum samples. 
Spiking levels of the 500!l1 serum samples (ng) % Recovery (Mean ± SD) 
So Sa So Sa 
100 100 10.4 ± 0.5 4.9 ±0.5 
200 200 6.7 ± 0.98 3.3 ±0.2 
300 300 6.0 ± 2.0 3.7 ± 1.6 
Using this method, So recoveries of between 6 and 11%, and Sa recoveries of between 
3 and 6% were obtained. The method did not provide reproducible results. It is possible 
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that this method modified the exogenous Sa and So making retrieval difficult. For these 
reasons, the method of K won et af. (1998) was not pursued any further. 
7.S APPLICATION OF THE METHOD OF VAN DER WESTHUIZEN et al. 
(2001) ON SERUM SAMPLES 
van der Westhuizen et al. (2001) reported a method for the determination of Sa and So in 
serum and urine. Since very low recoveries were obtained with previously published 
methods, this method was applied to determine its suitability for adequate retrieval of Sa 
and So from spiked serum samples. Briefly the method described was documented as that 
of Riley et af. (1994c) with minor modifications. Lipids were extracted from the serum 
(SOOr-tI) by incubation with 4ml MeOH: CHCb (2 :1) (containing 0.01% butylated 
hydroxytoluene as an antioxidant) under nitrogen at 37°C for one hour. Thereafter, the 
mixture was washed twice with alkaline water (Appendix 7.2) (~pH 8.6), the phases 
separated by centrifugation and the CHCb fraction dried under nitrogen gas below 40°C. 
The residue was hydrolysed to release the free bases by redissolving it in 0 1M methanolic 
potassium hydroxide (KOH) : chloroform (CHCb) (4: 1, v/v) and incubation at 37°C for one 
hour. After washing with alkaline water, the CHCh phase was dried under nitrogen at a 
temperature below 40°C. The dried residues were stored at -20°C overnight. Prior to 
analysis, residues were redissolved in 2S0r-t1 MeOH, sonicated and derivatised with SOr-t1 
OPA reagent prepared as described previously. 
For these analyses, duplicate SOOr-t1 serum samples were spiked with Sa and So as outlined 
in Table 7.8 . The samples were vortexed vigorously to ensure proper mixing, and then the 
method outlined above was applied. In the chromatographic analyses of these samples, 
each derivatised sample was injected in duplicate. The recoveries of Sa and So from these 
samples are shown in Table 7.8 . 
Table 7.8: Recoveries of sphinganine and sphingosine from spiked serum samples 
processed according to van der Westhuizen et al. (2001). 
Spiking levels of the 500!J.l serum samples (n~d % Recovery (Mean ± SD) 
So Sa So Sa 
100 100 lS.3±0.3 S.3±0.1 
200 200 17.7±0.1 7.1±0.2 
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These results indicate that using the method of van der Westhuizen et al. (2001) although it 
was an improvement from retrievals based on the method of K won et al. (1998) 
(Table 7.7), was not efficient based on the low recoveries of Sa and So (Table 7.8). In 
addition, the levels of Sa retrieved were at least three times lower than the levels of So. 
This indicated that separate optimisation would first be required for increasing retrieval of 
Sa, before the overall method could be optimised. This method was not pursued any 
further, and instead the method of Shephard and van der Westhuizen (1998) was applied to 
the next set of serum samples. 
7.6 APPLICATION OF THE METHOD OF SHEPHARD AND VAN DER 
WESTHUIZEN (1998) FOR RETRIEVAL OF SPHINGANINE AND 
SPHINGOSINE FROM HUMAN SERUM SAMPLES 
The method of Shephard and van der Westhuizen (1998) was investigated for the 
efficiency of recovery of So and Sa. Briefly, duplicate serum samples (SOO~I) were spiked 
with 100, 200 and 300ng each of Sa and So dissolved in MeOH (Table 7.9). Serum was 
deproteinised with 2ml MeOH in ISml polypropylene tubes, and the protein precipitate 
was pelleted after vortexing in a refrigerated centrifuge (1200g, 10 min. at lOOC). An 
aliquot of the supernatant (2 ml) was mixed with distilled water (H20) (1.9 ml) and 0.3SM 
ammonium hydroxide ~OH) (1.2ml) and extracted with 4ml CHCb. After vigorous 
vortexing, the layers were separated by centrifugation (1200g, 10 min., lOOC) and a portion 
of the lower CHCb layer (3ml) was transferred to a silica minicolumn prepared in a 6ml 
polypropylene cartridge with a lower layer ofO .Sg of silica 60 (40-63flm particle size) and 
an upper layer of powdered anhydrous sodium sulphate (Sg). The minicolumn was 
pre-conditioned with 4ml CHCh. After loading the sample, the minicolumn was washed 
with CHCb (lml), and Sa and So were eluted with CHCb: MeOH: concentrated NH40H 
(20:20:0.8, v/v), Sm\. The eluate was dried under N2 gas at 38°C. 
The dried residue was resuspended by ultrasonication in 0.12SM KOH (1 ml) in 
MeOH: CHCb (4:1, v/v) and incubated at 37°C for 1.S hours. After cooling on ice, CHCh 
(1ml) was added and the solution was washed with alkaline water (dilute NH40H; ~pH 8; 
S ml). The phases were separated by centrifugation (1200g, 10 min at lOOC), and the lower 
CHCI3 layer was dried under nitrogen gas at approximately 38°C. 
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The sample extract was redissolved in 250~1 MeOH by ultrasonication for one minute and 
incubated at RT for 15 minutes. The solution was derivatised by addition of 50~1 OPA 
reagent, ultrasonicated for one minute, and incubated at RT for a further 15 minutes . As in 
all previous analyses, the samples at each concentration of spiking evaluated were injected 
in duplicate and a mean of four injections of duplicate samples were taken. These results 
are summarized in Table 7.9. 
Table 7.9: Recoveries of sphinganine and sphingosine from spiked serum samples 
prepared according to Shephard and van der Westhuizen (1998). 
Spiking levels of the SOO!!I serum samples (ng) % Recovery (Mean ± SO) 
So Sa So Sa 
100 100 10.0±0.1 12.5 ± 3.1 
200 200 8.9 ± 3.4 7.5 ± 1.6 
300 300 13 .3±3.1 15 .0 ± 1.9 
The results in Table 7 .9 show that average recoveries of between 7% and 16% for So and 
Sa were obtained respectively (Table 7.9). This indicates an improvement on recoveries 
obtained using other methods applied in this study. As relatively equal amounts of Sa and 
So were retrieved at this stage, separate optimisation steps for retrieval of either Sa or So 
individually were not required . Shephard and van der Westhuizen (1998) reported 53% and 
55% recoveries of the sphingoid bases, however recoveries obtained in this study were 
considerably lower (Table 7.9). This was initially considered to be potentially due to use of 
a powdered instead of granular anhydrous sodium sulphate bed as recommended by 
Shephard and van der Westhuizen (1998), since this was the only variable that was 
inconsistent with the published method. The experiment was therefore repeated with the 
granular sodium sulphate bed suggested in the original method . These results were 
summarized in Table 7.10 . 
Table 7.10: Recoveries of sphinganine and sphingosine from spiked serum samples 
carried out according to the method of Shephard and van der 
Westhuizen (1998) using a granular sodium sulphate bed. 
Spiking levels of the SOO!!1 serum samples (ng) % Recovery (Mean ± SO) 
So Sa So Sa 
100 100 18 .6 ±4 .3 14 .7 ± 2.5 
200 200 23.4 ± 3.3 10.1±0.8 
300 300 13 .7 ± 0.6 6.9 ± 1.8 
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The use of the granular sodium sulphate bed slightly improved recovery of So to between 
13-26%, but did not significantly improve on Sa recoveries (5-17%). These recoveries 
however, still did not approach the 50-55% recoveries documented by Shephard and van 
der Westhuizen (1998). As the sodium sulphate bed improved recoveries initially, alternate 
beds with similar chemical properties were substituted (Table 7.11), and the remaining 
steps of the method were unmodified. In the first instance, a magnesium sui phate bed was 
substituted for the anhydrous sodium sulphate bed. These results are presented in 
Table 7.11. 
Table 7.11: Recoveries of sphinganine and sphingosine from spiked serum samples 
carried out according to the method of Shephard and van der 
Westhuizen (1998), but using a magnesium sulphate bed. 
Spiking levels of the 500!!1 serum samples (ne) % Recovery (Mean ± SD) 
So Sa So Sa 
100 100 38.7 ± 13 .8 17.6±0.3 
200 200 10.6 ± 4.5 4.5 ± 0.1 
300 300 15.5 ± 3.5 9.9 ± 2.5 
There was a negligible increase in recoveries to between 10-40% for So, and between 
4-18% for Sa by substituting a magnesium sulphate bed (5 grams) for a sodium sulphate 
bed. However, taking the poor reproducibility between duplicate samples into 
consideration as indicated by the large SD, the use of this magnesium sulphate bed was not 
pursued further . 
Subsequently, a calcium chloride (CaCh) bed was substituted for the anhydrous sodium 
sulphate and the method repeated . In this instance, the sample preparation was made 
difficult by the CaCh bed becoming soggy, the sample clogging the bed and not passing 
through the column easily. Only two (of 10) samples passed through the column and were 
run on HPLC, clogged the guard column and prevented further running of the samples 
(data not shown) . The use of the CaCh bed was therefore not pursued further. 
As this stage a different approach was introduced to achieve the optimal recoveries of Sa 
and So from serum. Taking into account the nature of the sample preparation procedure, a 
protocol similar to that applied for the optimisation of the FB 1 isolation was followed, and 
the samples were spiked at each step of the isolation procedure to establish at exactly 
which stage the major losses occurred (Figure 7.7, A-F; Table 7.12). 
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All 500~1 serum samples were spiked with 200ng Sa and 200ng So at the specific stages of 
the isolation procedure outlined in Table 7.12 and Figure 7.7, and then processed through 
the rest of the isolation procedure. Duplicate samples were run for each stage of spiking, 
and these samples were injected in duplicate into the HPLC for analyses. The results are 
summarized in Table 7.12 . 
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Addition of 2m I MeOH to 500)l1 serum ( ) with vortexing for 30 sec. 
Centrifugation at 1200g for 10 min at 10°C 
(B) 
p' , '. 
Vortexing of 2m I aliquot of total supernatant + H20 (1.9ml)+ 0.35M N~OH (1.2 ml) 
+ 
Extraction of total supernatant with 4 ml CHCI3 
ee) 
Mixinglvortexing thoroughly (30 sec.) 
+ 
Separation by centrifugation at 1200g for 10 min at lOoC 
+ 
Retention of lower CHCb layer for application to minicolumn 
*** 
LOADING OF SAMPLE ONTO PREPARED MINICOLUMN 
Loading and passing 3ml of retained CHC b extract through column 
+ (D) 
Washing column with 1 ml CHCb 
+ 
Elution with 5 ml CHCI3: Me~H: concentrated N~OH (20:20:0.8, v/v) 
Drying of eluate under N 2 gas (-38°C). 
+ 
Ultrasonication of residue in 0.125 M K~H (lml) in MeOH: CHCb (4:1, v/v) 
Incubation at 37°C for 1.5 hours (F) 
+ 
Cooling on ice, CHCh (1 ml) was added 
+ 
Washing of solution with alkaline wa~er (Dilute N~OH, -pH 8 (5ml» 
Separation of phases by centrifugation at 1200g, 10 min at 10°C 
• Drying of lower CHCI3 layer under N2 gas at 38°C in glass vial 
(E) 
Figure 7.7: Isolation of sphinganine and sphingosine from serum according to Shephard 
and van der Westhuizen (1998). 
237 
Table 7.12: Quantitative analyses of serum samples spiked with sphinganine and 
sphingosine at different stages of the isolation procedure to determine 
where losses occurred. 
Methodology % Recovery ± SD 
So Sa 
Serum samples were spiked prior to deproteinization at Step 1, 22 .9 ± 1.9 16 .8 ± 1.2 
Figure 7.7 (A)l 
The supernatant was spiked after deproteinization at step (B) 33.9 ± 6.9 20.5 ± 8.3 
The supernatant was spiked after passed directly through the 29.3 ± 0.7 17.3±0.1 
extraction with CHCb at step Iprepared 0.5g silica bed 
(C). This supernatant was not passed through the prepared 1 g 21.4±3 .6 11.9±3 .0 
vortexed with the sodium silica bed 
sulphate bed but : 
The supernatant was spiked after through the prepared 0.5g silica 25.2 ± 1.1 14.4 ± 1.0 
extraction with CHCb at step bed 
(C). The supernatant was prepared Ig silica bed 14.8 ± 6.2 11.3±5.3 
vortexed with the 0.5g sodium 
sulphate bed, prior to passing the 
CHCh layer: 
The supernatant was spiked after was not washed with CHCh The 12.4±1.5 17.0±3.1 
extraction with CHCh and sample was then eluted from 
passing through column at step column 
(D). The sodium sulphate bed was washed with 1 ml CHCh The 14.9±3.1 14.1 ± 1.9 
was removed completely and the sample was then eluted from 
column: column. 
The elution agent "vas spiked at step (E) after passing through the 18.5±1.7 18.9 ± 0.5 
column . 
The resuspended ultrasonicated residue was spiked after the 1.5 hour 10.7 ± 7.2 14.3 ± 8.4 
incubation at 37°C stage at step (F) 
Spiking at each step of the isolation procedure revealed that significant losses occurred 
throughout the method (Table 7.12). Modification of the method involved vortexing the 
sample in the recommended weight of sodium sulphate directly, and following 
centrifugation to separate the bed and sample, the resultant supernatant was passed through 
the prepared silica column. 
The initial steps of the procedure were targeted for optimisation . The volume of MeOH 
used in deproteinization and extraction of the initial serum sample was doubled from two 
to four miJlilitres in the first step. The supernatant was diluted with 1 %KCI in 1.9ml water 
and 1.2ml 0.35M NfLtOH, or 1.9ml water and 1.2ml 0.35M NH40H. Following elution 
with 5ml CHCb: MeOH: concentrated NILOH solution (20 :20:0.8, v/v), a further 2.5ml 
I A-F are graphically illustrated in Figure 7.7 where the samples were spiked at a specific stages in the isolation 
procedure to detennine where losses of Sa and So occurred. 
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MeOH or 2.5ml CHCb was passed through the minicolumn (Table 713) to improve 
elution. In addition, the sodium sulphate bed was removed completely since recoveries 
improved in its absence. Reference has been made to steps in Figure 7.7 in Table 7 .13 to 
aid description of the methodology. 
Duplicate samples were run for each highlighted stage where the methodology was 
changed, and each sample was injected in duplicate into the HPLC for analyses. These 
results are summarized in Table 7.13. 
Table 7.13: Optimisation of steps in the method of Shephard and van der 
Westhuizen (1998) for retrieval of sphinganine and sphingosine from 
spiked serum samples. 
Methodology Solvent X % Recovery (Mean ± SD) 
So Sa 
The supernatant was 1.2 ml 0.35M N~OH at step 2.5 ml MeOH. 18A ± 1.0 15.5 ± OA 
diluted in 1 %KCI in (B). Following elution with 2.5 ml CHCI3 30.3 ±0.1 27 .00 ± 0.1 
1.9ml water and: 5ml CHCh: MeOH: 7ml ethyl acetate 15 .8 ± 1.6 5.4 ± 0.1 
concentrated N~OH 
The supernatant was (20:200.8, v/v) at step (E) 2.5 ml MeOH 6.0 ± 0.001 4.3±0.1 
diluted in 1. 9ml (Figure 7.7), Solvent X was 2.5 ml CHCl3 4.4 ± 0.2 3.1 ± 0.02 
water and: passed through the column 7ml ethyl acetate 16.1±3.2 5.1±0.3 
These analyses (Table 7.13) indicate that: 
• increasing the volume of methanol for deproteinization of the serum from 2 to 4ml, 
• dilution of the entire volume of supernatant in a solution of 1 %KCI in 1.9ml water and 
1.2ml NH40H at step (B) (Figure 7 .7) ; 
• and eluting Sa and So from the column with 5ml CHCb: MeOH: concentrated NH40H 
(20:20:0.8, v/v), followed by 2.5ml CHCh improved recoveries to 30% for So, and 
27% for Sa. The use of ethyl acetate as the elution reagent was not pursued further as it 
resulted in significantly lower levels of recoveries of So and Sa .. 
Because boiling the serum in PBS improved recoveries of FBI, the effects of boiling the 
samples at step (A) (Figure 7.7) prior to the addition of MeOH to the serum sample was 
also investigated on Sa and So recoveries. All samples in Table 7.14 were boiled for 15 
minutes prior to extraction . The 500~1 serum samples used in these analyses were spiked 
only with So at three concentrations (Table 7.14), the reason being that as relati vel y equal 
amounts of Sa and So were retrieved using the method optimised to this stage, in order to 
minimise costs, only So was used in the spiking. References were made to steps in Figure 
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7.7 to aid description of the methodology. The quantitative results of the duplicate samples 
analysed for each highlighted stage where the methodology was changed are summarized 
in Table 7.14. 
Table 7.14: Effects of boiling serum samples on the recovery of sphingosine. 
Spiking level of the 500/11 Methodology Solvent X 0/0 So recovery 
serum samples with So (Mean ± SD) 
(ng) 
100 The spiked serum sample was boiled at 2.5 ml MeOH 10.6 ± 0.9 
step (A) for 15 minutes prior to 2.5 ml CHCh 18.4±0.1 
200 extraction. In addition, following 2.5 ml MeOH 27.0 ± 1.5 
elution with 5ml CHCh: MeOH: 2.5 ml CHCh 6.1 ± 0.5 
300 
concentrated NfLOH (20:20:0.8, v/v) 
2.5 ml MeOH 15.3 ± 0.3 at step (E), (Figure 7.7), Solvent X was 
2.5 ml CHCh 11.3 ± 0.2 passed through the column 
No significant improvements on recoveries were noted. A maximum of27% of the So was 
retrieved following boiling of the spiked sera. Elution with an additional volume of MeOH 
improved retrieval of So from samples spiked with 200 and 300ng So (Table 7.14). As 
boiling of sera was not pursued further in the optimised method however, this step was not 
included in the optimisation procedure to retrieve Sa and So. 
To determine whether smaller volumes of serum could be used in these analyses, 300~ .. tl of 
serum was diluted with 200/..tl 1 %KCl in distilled water, to establish whether dilution of the 
serum would be appropriate in the optimisation and application of this method 
(Table 7.15). All samples in Table 7.15 were spiked with 200ng Sa and 200ng So. To 
further determine whether increasing the concentration of KCl would improve recoveries, 
samples were incubated with 1%, 3% or 5% KCl in the required 1.9 ml distilled water and 
1.2ml 0.35M NH40H at step (B) in Figure 7.7 for 5 minutes prior to extraction. The use of 
the crystalline anhydrous sodium sulphate bed was also reassessed. 
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Table 7.15: Effects of increasing concentrations of KCI in the sample diluent and 
the use of the sodium sulphate bed on retrieval of sphinganine and 
sphingosine from 300~1 spiked serum samples. 
Methodology x 0/0 % Recovery (Mean ± SD) 
KCI So Sa 
The supernatant was diluted in 1 The sample was passed 19.1 ± 0.4 16.6±0.1 
x % KCI in 1.9ml water and 3 through the minicolumn 32 .3 ± 0.2 33.4 ± 0.2 
1.2 ml 0.35M NH40H at step 5 containing the crystalline 18.3 ±0.2 17.9±0.1 
(B). anhydrous sodium sulphate 
bed 
1 The sample was passed 14.5±0.1 16.0 ± 0.4 
3 through the pre-conditioned 65.6±8.0 36.9 ± 4.9 
5 minicolumn where the 29 .6 ± 0.7 30.4 ± 0.6 
crystalline anhydrous 
sodium sulphate bed was 
omitted 
These analyses indicate that removal of the crystalline anhydrous sodium sulphate bed, 
dilution of 300~1 serum with 200~1 1 %KCI in water up to 500~1, and use of 3%KCI in the 
1.9ml of water improved recoveries of So and Sa to 65.6% and 36.9%, respectively 
although high SDs were evident (Table 7.15). Figure 7.8 shows the chromatograms of Sa 
and So retrieved from a non-spiked sample (NSa 79 shown by the dark blue 
chromatographic trace) in contrast to the spiked sample that showed 65.6% and 36.9% 
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Figure 7.8: lligh performance liquid chromatograms of sphinganine and sphingosine isolated from the 
spiked sera of a non-cancer subjects (NSa 79 and 84, blue and red traces respectively) seen in 
association with the Sa and So standards (green trace). 
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For the next set of analyses, the volume of serum used reverted to 500~d (Table 7.16). All 
samples shown in the next table were spiked with 200ng Sa and 200ng So. 
Table 7.16: Effects of 1 % and 3%KCI in the sample diluent and the use or 
omission of the sodium sulphate bed on retrieval of sphinganine and 
sphingosine from spiked 5001J,1 serum samples. 
Methodology % Recovery Mean ± SD) 
So Sa 
The supernatant was diluted in containing the crystalline 7.7 ± 0.3 6.4 ± OJ 
I%KCI in 1.9ml water and 1.2 anhydrous sodium sulphate bed 
ml 0.35M N~OH at step (B). where the crystalline anhydrous 23.5±3.3 22.7 ± 1.7 
The sample was passed through sodium sulphate bed was omitted 
the pre-conditioned minicolumn : 
The supernatant was diluted in containing the crystalline 23.6±0.1 21.7±1.0 
3%KCI in 1.9ml water and 1.2 anhydrous sodium sulphate bed. 
ml 0.35M ~OH at step (B). where the crystalline anhydrous 29.5 ± 1.1 29.4 ± 0.4 
The sample was passed through sodium sulphate bed was omitted 
the pre-conditioned minicolumn : 
The samples that were passed through the minicolumn where the anhydrous sodium 
sulphate bed was omitted, and 1.9ml 3% aqueous KCI was used, were found to give better 
recoveries of29.5% and 29.4% of So and Sa respectively (Table 7.16). 
It is likely that some level of absorption of Sa and So to the sodium sulphate bed occurred, 
resulting in losses of the sphingoid bases at this stage of the isolation procedure. This set of 
analyses led to the removal of the anhydrous sodium sulphate bed in all subsequent 
optimisation procedures In the next set of samples, spiking with 200ng So only 
(Table 7.17) was carried out, for the same reason as given earlier in the discussion of 
Table 7.14 . In the next set of analyses different solvent combinations were tested to 
determine when the maximum levels of retrieval would be achieved. Reference has been 
made to steps in Figure 7.7 in Table 7.17 to aid in description of methodology. 
The results in Table 7.17 indicate that extraction of the sera spiked with 200ng So, with 
, 
2ml methanol and 2ml acetonitrile by successive resuspension and extraction of the pellet 
improved the recoveries of So to 51.2%. Large standard deviations between duplicate 
samples were noted however (Table 7.17). Although using 2ml acetonitrile to extract the 
spiked Sa and So from the serum samples did improve recoveries, it was not reproducible. 
For this reason, the use of 4ml methanol as an alternative step to improve recoveries was 
pursued, but by double extraction with 2 x 2ml portions of this solvent. 
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Table 7.17: Determination of the effects of different solvents extraction efficiency 
for sphingosine from spiked serum samples. 
Methodology Solvent X 0/0 So recovered 
(Mean ± SD) 
Protein was 2ml MeOH. The sample was 51.2±7 .2 
precipitated The supematant was removed recentrifuged as in 
from spiked and the pellet was re-extracted step (B), the 
500111 serum with 2ml acetonitrile to extract su pematants were 
samples with the So from the pellet. pooled and taken 
Solvent X at 4 ml acetonitrile through the rest of 28.3 ± 0.7 
step (A). 4 ml MeOH the optimised 39.7 ± 13 .7 
4 ml isopropanol method. 22.6 ± 5.8 
In the next set of analyses, 500!l1 serum samples were spiked with both 200ng So and 
200ng Sa. The sample supernatants were diluted in 3.8ml 3% aqueous KCl and 2Aml 
0.35M ~OH at step (B) in Figure 7.7. The volumes of the KCl diluent and ~OH were 
increased to compensate for dilution effects as the volumes of the solvents used in the 
extraction were increased . Samples were extracted by vortexing for longer periods 
(- 2 minutes per sample) in the methanol and acetonitrile extraction reagents being 
assessed. Duplicate samples were run for each highlighted stage where the methodology 
was changed (Table 7.18), and each sample was injected in duplicate into the HPLC for 
analyses. The quantitative analyses are summarized in Table 7.18. 
The results presented in Table 7.18 indicate that that double extractions of the spiked 
serum samples with methanol increased recoveries to 67% and 34.2%, for So and Sa 
respectively. The inclusion of acetonitrile in the extraction procedure did not improve the 
extraction to any significant degree. However a concern was that the recoveries of Sa were 
not as consistently high as those of So indicating different affinities of the two sphingoid 
bases to the solvents (Table 7.18). All subsequent samples were therefore spiked with both 
Sa and So to monitor the recoveries of sphingoid bases. 
Since the double extraction with MeOH improved recoveries, the MeOH extraction was 
repeated with an increased volume ofMeOH to 3ml per extraction with resuspension of the 
pellets twice. The 500111 serum samples were spiked with 200ng So and 200ng Sa and the 
supernatant was diluted in 3%KCI in 3.8ml deionised water and 2A ml 0.35M NH40H, and 
taken through the rest of the optimised method. After elution at step (E) (Figure 7.7) 2ml 
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chloroform was also passed through the column. Recoveries noted were 62.6±7.8% for So 
and 38.1±1.6% for Sa respectively, indicating minimal improvement in recoveries. 
Table 7.18: Assessment of methanol and acetonitrile as extraction reagents for 
sphinganine and sphingosine recoveries from spiked serum samples. 
Methodology Solvents used 0/0 Recovery 
(Mean ± SD) 
Solvent X Solvent Y Solvent Z So Sa 
The SOO/-ll spiked serum samples were 2ml - - 67.0±0.S 34.2± 0.02 
extracted with 2ml MeOH at step (A) MeOH 
(Figure 7.7). The sample was re- 2ml 2ml MeOH - 24.1±0A ISA±0.2 
centrifuged as in step (B), the supernatant acetonitrile 
was retained and the pellet was re-extracted 2ml 2ml MeOH 2ml lS.6±0.3 7.8±0.2 
with Solvent X. The sample was re- acetonitrile acetonitrile 
centrifuged, the pellet re-extracted with 
Solvent Y and the supernatants pooled. 
The sample was re-centrifuged once more, 
and after a fmal extraction of the pellet 
with an additional Solvent Z, the 
supernatant was pooled. The total 
supernatant was diluted in 3%KCl in 3.8ml 
water and 2Aml 0.3SM N~OH at step (B) , 
and taken through the rest of the optimised 
method. 
In the next set of analyses, duplicate 500/-LI serum samples were spiked with Sa and So, and 
extracted twice with either 3ml or 4ml volumes of methanol (Table 7.19). The total volume 
of supernatant was used in the extraction procedure, and mixed with distilled H 20 
containing 3.8ml potassium chloride and 3.6ml O.3SM ammonium hydroxide. These results 
are summarized in Table 7.19. 
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Table 7.19: Efficiency of the double extraction of sphinganine and sphingosine from 
spiked serum samples with increasing volumes of methanol. 
Methodology Sa and So Solvent 0/0 Recovery 
(ng) (mt) (Mean ± SD) 
X Y So Sa 
The 500I-Ll semm samples spiked with Xng So and 200 3ml 50.0 ± 1.6 31.3 ± 0.4 
Xng Sa were extracted with Yml MeOH at step 4ml 16.8 ± 1.9 11.4 ±0.5 
(A) in Figure 7.7. The supernatant was removed 100 3rnl 55.3 ± 3.7 31.5 ± 1 
and the pellet was re-extracted with Y ml MeOH to 4rnl 23.4±1.1 13.0 ± 0.4 
extract the Sa and So from the protein pellet. The 
150 3ml 31.2 ±4.6 17.9±1.7 
sample was re-centrifuged as in step (B) and the 
4ml 25.5 ± 0.8 12.2 ± 10.2 supernatants pooled The total supernatant was 
diluted in 3%KCl in 3.8ml water and 3.6ml 0.35M 50 3ml 70.6 ± 15.4 40.7 ± 4.8 
NH40H at step (B), and taken through the rest of 
the optimised method . After elution at step (E), 
2ml chloroform was passed through the column. 
These results indicate that better recoverIes were consistently obtained USIng two 3ml 
volumes of MeOH at all concentrations of spiking (Table 7.19) . To optimise this method 
further still, extraction of the serum samples with the same total volume of methanol, but 
decreased volumes of the solvents per extraction repeated to increase retrieval and 
extraction of Sa and So were used (Table 7.20). Duplicate 5001-11 serum samples were used, 
and the methanol supernatant (6ml) was mixed with distilled H20 containing 3.8ml 3%KCI 
and 3.6ml 0.35M NH40H. The difference from the results in Table 7.19 was that instead of 
using two 3ml volumes of methanol in the extraction, three 2ml volumes of methanol were 
used. These results are summarized in Table 7.20. 
These results indicate that that the triple extraction of the spiked serum samples with 
methanol improved retrieval of Sa and So significantly (Table 7.20). When carrying out 
these extractions, the time that the samples were vortexed with methanol was increased to 
about two minutes per sample to ensure maximal extraction . These results are an 
improvement on the results presented in Table 7.19 where double methanol extractions 
with larger volumes of methanol were used. This shows that significant losses of sphingoid 
bases occur during the protein extraction step. 
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Table 7.20: Effects of triple methanol extraction on the retrieval of sphinganine and 
sphingosine from spiked serum samples. 
Methodology Spiking with 0/0 Recovery 
Sa and So (ng) (Mean ± SD) 
X So Sa 
500fll serum samples spiked with both Xng So and 200 50.!±2. ! 33.5±10 
Xng Sa were extracted with 2ml MeOH at step 150 47.4±0.8 30.3±0.1 
(A)(Figure 7.7). 100 41.7±7 .0 25.6±1.1 
The supernatant was removed and the pellet was re- 50 72.6±12.6 41.04±3.3 
extracted with 2m! MeOH to extract the Sa and So 
30 67.9±5.51 54.20±2.3 from the protein pellet. The sample was re-
centrifuged as in step (B) (Figure 7.7), the pellet was 20 52.5±6.7 53.2±2.2 
re-extracted with 2 ml MeOH and the supernatants 10 
pooled. 
77.9±1.3 85.0±1.5 
After a final e>..'traction of the pellet with an additional 
2ml acetonitrile the pooled supernatant was diluted in 
3%KCl in 3.8ml water and 3.6ml 0.35M NlLOH at 
step (B), and taken through the rest of the optimised 
method. 
After elution at step (E) (Figure 7.7), 2ml chloroform 
was passed through the column 
These results also indicate that with a decrease in the level of spiking of the samples to 
lOng, there was an increase in recovery of sphingoid bases to 78% for So and 85% for Sa, 
indicating that the lower the concentration of spiking in the sample, the better the recovery 
(Table 7.20). This possibly indicates that the solvent volumes used during the sample 
isolation were insufficient at the higher concentrations of spiking with Sa and So. The 
chromatograms in Figure 7.9 shows the recoveries of selected samples from Table 7.20. 
In Figure 7.9, the non-spiked sample is shown in comparison to spiked serum samples 
(i.e., trace NSa 192). Also shown are samples that were spiked with 50ng Sa and 50ng So, 
and then extracted with three 2ml volumes of methanol (i.e., traces NSa 189 and 190). In 
addition, serum that was spiked with 150ng Sa and 150ng So (i.e, trace NSa 195), and 
serum that was spiked with 200ng Sa and 200ng So (i.e., trace NSa 194), were extracted 
with two 3ml volumes of methanol is shown. Clearly, by visual comparison of the area 
under the peaks, there is an increase in the amount of Sa and So recovered with higher 
levels of spiking. 
Further optimisation of this method was not pursued due to time constraints, and to the 























THP 19JulyNSa 192, Inj 1, FL2000/FL3000 
THP19JulyNSa194,lnj1, FL2000/FL3000 
THP19JulyNSa 195,lnj 1, FL2000/FL3000 








j, ~ /\ \ ~ " p. __ -------:L '-~--=--
T 
.,----
2.0 3.0 4.0 
Minutes 
5.0 6.0 7.0 
High perfonnance liquid chromatograms of sera of a non-cancer subject spiked with 
increasing concentrations of recovered Sa and So standards. The traces shown are NSa 189 
(blue), NSa 190 (red); Nsa 195(green), Nsa 194 (blue) and NSa 192(pink) from the bottom 
up. 
248 
spiking with the sphingoid bases. It was evident that there was significant improvement on 
the recoveries obtained at the initiation of the study (Table 7.9), where the method of 
Shephard and van der Westhuizen (1998) was used prior to optimisation. With the 
optimised method used in this study, recoveries of 72 .6% and 41.0% for So and Sa 
respectively were obtained at a level of spiking with SOng per SOO~1 of serum, and 77.9 
and 8S.0% at a level of spiking at lOng per 500~1 of serum. 
The final optimised method applied in the isolation of Sa and So from the human serum 
samples is summarized below. 
7.7 FINAL OPTIMISED METHOD OF RETRIEVAL OF SPHINGANINE AND 
SPHINGOSINE FROM HUMAN SERA 
The SOO~1 serum sample was deproteinised with 2ml ice-cold MeOH in a ISml 
polypropylene tube. The protein precipitate was pelleted by centrifugation (l200g for 
10min. at lOOC) after vortexing for 2 minutes . The resultant pellet was resuspended in ice-
cold 2ml methanol and re-extracted by vigorous vortexing for 2 minutes. The protein 
suspension was pelleted by centrifugation (1200g for 10min at lOOC), and the supernatant 
pooled with the retained 2ml methanol. The protein pellet was resuspended once again in 
2ml ice-cold methanol and re-extracted by vortexing for 2 minutes . The centrifugation step 
was repeated (1200g for 10min. at lOOC) to obtain the methanol supernatant, which was 
then pooled with the previously retained 4ml methanol. 
The 6ml methanol supernatant was combined with 3.8ml 3%KCl in distilled H20 and 
3.6ml 0.3SM NH40H, and vortexed vigorously. This suspension was then extracted twice 
with CHCb (2.Sml per extraction). Following vortexing, the layers were separated by 
centrifugation (1200g, 10min., lOOC) The CHCb layers were pooled and retained for 
application to a minicolumn . The CHCh layer (Sml) was transferred to a silica minicolumn 
prepared in a polypropylene cartridge with a layer of O.Sg of silica 60 (40-63~m particle 
size) that was placed on a bed of inert glass wool. 
The minicolumn was pre-conditioned with 4ml CHCI3 . After loading the CHCh extract, 
the minicolumn was washed with 1ml CHCb, and the Sa and So were eluted with Sml 
CHCh: MeOH: concentrated NH40H (20:20:0.8,v/v). An additional 2ml CHCb was 
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passed through the column into the 25ml scintillation vial. The eluate was dried in a fume 
cupboard under nitrogen gas at 38°C. The dried residue was redissolved by ultrasonication 
in I ml 0.125M KOH in MeOH: CHCI J (4:1, v/v) and incubated at 37°C for 1.5 hours in a 
shaking water bath. After incubation, the samples were allowed to cool for 10min. on ice 
and 2.5ml CHCb was added and vortexed thoroughly . An additional 1 ml CHCh was added 
and the mixture was vortexed thoroughly with 5ml alkaline water (dilute NH40H; - pH 8) . 
The phases were separated by centrifugation at 1200g for 10 min . at 10°C, and the lower 
CHCb layer was removed and dried under a stream of nitrogen gas on a heating mantle 
(38°C). The dried residue was then ready for chromatographic analyses . 
7.8 RESULTS AND DISCUSSION ON THE DEVELOPMENT OF THE 
METHODOLOGY FOR SPHINGANINE AND SPHINGOSINE 
RETRIEVAL FROM SPIKED SERUM 
The applicability of published methods for the retrieval of exogenous and endogenous 
compounds, and hence their recoveries from physiological fluids between laboratories and 
within laboratories, is subjective. Under ideal conditions, one would be able to replicate an 
experiment under the exact conditions recommended in publications, but this is not always 
possible due to variability in research equipment and facilities . Often substitutions are 
made to create as closely as possible those ideal conditions suggested, but the 
standardization and calibration of machinery and purity and age of compounds used , 
differences in glassware and general hardware all add variability . All these factors require 
consideration when attempting to replicate experiments. Under ideal conditions, variation 
in results would be negligible and statistical differences would be minor. However, in the 
cases where percentage recoveries of the compounds of interest are not clearly indicated, 
this places a question on whether they were investigated, and on the reproducibility of 
methods. It was difficult to repeat published studies to an acceptable level, although as far 
as possible the experimental conditions were recreated and adhered to, and the routes of 
possible variation minimised . This part of the study dealt with the application of a few 
published methods to recover and quantify Sa and So from spiked sera. 
As detailed in the optimisation procedures for retrieval of Sa and So above, samples were 
prepared using various published methods (Kwon et aI , 1998 ; van der Westhuizen et ai , 
2001) but optimisation was primarily pursued on the method of Shephard and van der 
Westhuizen (1998) that was reported to yield 53-55% recoveries. The methods of 
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van der Westhuizen et af (2001) and Kwon et af (1998) on serum samples, although 
attempted, were not pursued due to the low recoveries obtained when applied in our labs 
(Tables 7.7 and 7.8). 
Application of the method of Shephard and van der Westhuizen (1998) led to extensive 
optimisation to improve retrieval of So and Sa to an acceptable level. Unlike the published 
study, where an internal standard was used as a means to quantify recoveries of Sa and So, 
in the present investigation, quantitation was done based on external standards and by 
means of spiking with known quantities of Sa and So. It was believed that the use of C20 
Sa internal standard could not serve as an adequate measure of recovery of So and Sa in the 
complex extraction procedure due to differences in solubility, and solvent affinity of all 
compounds. It was shown during this optimisation study that the recoveries achieved for Sa 
and So were often unequal depending on the extraction procedure being followed. 
The optimisation procedures carried out in this present study increased the volumes of 
solvents, whilst omitting certain steps in the procedure. For example, the step involving 
passing the sample through the sodium sulphate bed was removed, as it was shown to 
reduce efficiency of retrieval of the sphingoid bases. 
Attempts were made to reduce the suggested volume of serum used by dilution of 300!J,1 
serum with 1 %KCI, since the subsequent step involved the use of potassium chloride 
diluted in deionised water. In many studies, obtaining adequate volumes of serum from 
patients for laboratory analyses usually is a problem In this study, the attempt to minimise 
the volume of serum required led to large analytical errors. Dilution of samples was found 
to be inappropriate since although higher recoveries were initiall y obtained, the method 
was not reproducible between replicate samples. This led to subsequent standardization of 
the use of 500!J,1 serum in the isolation procedure. 
Optimisation of the method with extraction of the serum using smaller volumes of MeOH 
with repeated multiple extractions improved recoveries of Sa and So (Table 7.20) In the 
original method, serum samples were deproteinised with MeOH and after centrifugation, 
only a 2ml portion of the methanolic supernatant was used for the lipid extraction step with 
chloroform under alkaline conditions. Initial efforts by Shephard and van der Westhuizen 
(1998) to determine the ratio of the Sa and So in serum by direct application of the serum 
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to the silica mini column was unsuccessful, as the use of serum without pnor 
deproteinization gave large chromatographic interferences. Therefore samples were 
deproteinised . The method in the present study differed from the method of Shephard and 
van der Westhuizen (1998) in that the entire volume of the methanolic supernatant was 
used in the subsequent steps. Although the use of the supernatant was considered to 
eliminate major interferences (Shephard and van der Westhuizen, 1998), these still 
remained. 
A second step in the procedure that attempted to clean up the sample extract was the 
alkaline hydrolysis step of Shephard and van der Westhuizen (1998). This was placed after 
clean-up on the silica minicolumn, and cleaved acylglycerolipids and hydrolysed 
Iysosphingolipids (free sphingoid bases modified at the hydroxyl group on carbon 1 of So 
or Sa) to release free So and Sa. The procedure yielded an extract suitable for 
chromatographic determinations of the ratio of the sphingoid bases. 
Gaver and Sweeley (196S) documented that sphingolipid bases are extracted from 
hydrolysates with solvents such as diethyl ether, chloroform, ethyl acetate, or mixed 
solvents such as isoamyl alcohol in heptane. When a further 2.Sml CHCb was passed 
through the column after the final elution stage (Tables 7.13 and 7.14); the Sa and So 
recoveries were improved by -10%, in comparison to the addition of MeOH These 
solvents were selected based on the fact that they were components of the elution reagent, 
and that Sa and So are soluble in these solvents. The use of ethyl acetate although 
attempted, was found to be inefficient in retrieval of Sa and So (Table 7.13) . 
The method was considered sufficiently optimised once recoveries of72.6% and 41.0% for 
So and Sa respectively were obtained at a level of spiking with SOng per SOOI-.d of serum 
and 77.9% and 8S.0% at a level of spiking at lOng per SOOIl-I of serum (Table 7.20). The 
reason that optimisation was not pursued any further was due to time constraints, and the 
fact that many months of work and high costs had already been invested to reach this level 
of recovery. 
7.9 CONCLUSION 
Several extraction methods for determination of FB 1, Sa and So from serum were assessed 
in this study. These published methods were not found to be as efficient as required in 
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retrieval of these compounds from spiked samples, and thus extensive optimisation 
procedures were pursued in order to obtain reproducible results with sufficiently high 
analyte recoveries . The HPLC analyses of sera described facilitated both qualitative and 
quantitative assessment of FBI, Sa and So from the spiked samples. Major losses in 
recovery of FBI, Sa and So occurred in the first protein extraction step and it have found 
that optimal retrieval was achieved with the use of smaller volumes of solvents, increased 
vortexing times, and triple extraction of the protein pellet with methanol for Sa and So. The 
recoveries observed in the individual sphingoid bases could be considered a function of the 
affinities for the solvents used. 
With recovery of FBI from spiked sera, boiling of the sera followed by extraction with 
methanol enhanced retrieval of higher concentrations of this mycotoxin. The boiling of 
sera with PBS, and the double extraction of the protein pellet with MeOH improved the 
efficiency of recoveries of FBI, but large amounts of impurities in the column affected the 
analytical HPLC column by excessive absorption onto the stationary phase. The mean 
recovery of FB I from human serum samples that was obtained in this study following 
optimisation was 9S.8% (n=lS). This study also improved on the detection limits of FBI to 
approximately Sng.mr l at a signal to noise ratio of S: 1 by modifying the HPLC detection 
settings. 
With regards to the recovery of Sa and So from spiked sera, optimisation involved 
increasing the volumes of solvents, whilst removing the sodium sulphate bed as this 
affected the efficiency of retrieval of the sphingoid bases. The method was considered 
sufficiently optimised once recoveries of72.6% and 4l.0% for So and Sa respectively were 
obtained at a level of spiking with SOng per SOO/ll of serum, and recoveries of 77.9% and 
8S.0% at a level of spiking at lOng per SOO!.!1 of serum. 
Overall, the methods were considered adequately optimised for use in the analyses of sera 
obtained from non-cancer and cancer patients, to determine whether a correlation exists 
between FB I exposure, serum Sa: So ratios and brain cancer. 
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CHAPTER 8 
Effects of fumonisin Bl on sphingolipid metabolism in the 
N2a neuroblastonla cell line 
8.1 INTRODUCTION 
The disruption of sphingolipid metabolism has been proposed to be the initial step of the 
toxicity and carcinogenicity of FB I (Merrill et aI., 1996b). Ceramide synthase is 
responsible for acylation of Sa in the de novo synthesis of sphingolipids, and reacylation of 
So in sphingolipid turnover. Its inhibition in cells in vitro results in inhibition of de novo 
sphingolipid biosynthesis, an increased intracellular concentration of free Sa, and 
sometimes free So, depletion of complex sphingolipids, an increase in So and Sa 
degradation products, and an increase in lipid products derived from the increase in 
sphingoid base degradation products (Merrill et aI., 1993b; Riley et aI. , 1994a; 
Yoo et aI. , 1996) . 
Free sphingoid bases are growth inhibiting and cytotoxic at micro molar concentrations 
(Stevens et aI. , 1990; Merrill, 1991; Hanada et aI. , 1992), and reduced complex 
sphingolipid biosynthesis reduces cell proliferation (Hanada et aI. , 1992; Yoo et aI., ] 992; 
Radin et aI. , 1993), and causes cell death (Yoo et aI., 1992). The two most likely 
explanations for the increased cell death after inhibition of sphingolipid biosynthesis by 
fumonisins are that the accumulation of free Sa or a Sa degradation product, such as the 
I-phosphate, are growth inhibitory and cytotoxic for the cells (Stevens et aI., 1990; Hannun 
et af. , 1991; Sweeney et aI., 1996). Secondly, more complex sphingolipids are required for 
cell survival and growth, and the loss of complex sphingolipid biosynthesis would be 
expected to alter cell behaviour and also lead to cell death . 
The sensitivity of cultured cells to fumonisin exposure varies . Fumonisins inhibit overall 
sphingolipid biosynthesis in cultured hepatocytes (Wang et aI., 1991) and in a renal cell 
line (Yoo et aI., 1992), but no investigations of the effects of this mycotoxin on 
sphingolipid metabolism on the N2a mouse neuroblastoma cell line have been pursued. 
The objective of this study therefore was to investigate whether the sensitivity of cultured 
N2a neuroblastoma cells to fumonisin exposure in vitro is related to the mechanistic 
relationship between the FBI-induced inhibition sphingolipid metabolism, and elevated 
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free Sa levels. The methods of extraction and analyses of FBI from CCM in which these 
cells were cultured, was based on the optimised method detailed in Chapter 7, section 
7.2 .2.2. Sphingolipid extraction methods for the free sphingoid bases and total 
sphingolipids from the N2a. neuroblastoma cells were as described in detail in 
Yoo et at. (1996) and Chapter 7, section 7.7, and were applied in this study. An additional 
objective was to assess this method for detennination of free sphingoid bases, total 
sphingoid bases, and total sphingolipids in these cultured cells. 
8.2 MA TERIALS AND METHODS 
8.2.1 Materials 
Cell culture materials, media, antibiotics, and sterile disposable consumables were as 
described in Chapter 3, section 3.2.1. Pre-sterilised Corning plastic tissue culture flasks 
(25cm2) were used as culture vessels. Reagents, chemicals, solvents, the HPLC system and 
conditions used for the analyses described in this chapter were as described in 
Chapter 7, section 7.2.1, unless otherwise indicated. 
8.2.2 Methods to assess effects of fumonisin BI on the N2a. neuroblastoma cells 
The sensitivity of sphingolipid metabolism in cultured N2a. neuroblastoma cells exposed to 
50llM and lOOIlM FBI for 72hours was assessed using HPLC. A FBI stock solution 
(lmgmr l or 1.39mM in CCM) was used to prepare dilutions of 50llM and 1 00 11M FBI in 
CCM. Complete culture media was used as the control solution. 
Both extracellular and intracellular Sa and So were measured by HPLC. The original 
method for the determination of free sphingoid bases (base hydrolysis) was described by 
Merrill et al. (1988) and modified by Riley et al. (1994a), while the original method for the 
determination of total sphingoJipids used the method of acid hydrolysis of 
Gaver and Sweeley (1965). 
The quantitative analyses of the Sa and So levels in the CCM that the cells were cultured in 
were as described for serum samples in Chapter 7, section 7.7. 
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8.2.3 Extraction of free sphingoid bases and total sphingolipids from the N2a 
neuroblastoma cells 
Reagents for analysis of total sphingolipids were prepared as described by 
Gaver and Sweeley (196S) and Yoo et at. (1996). 
Three sets of six 2Scm2 confluent flasks of N2a neuroblastoma cells were incubated for 
72 hours at 37°C in 1 ml each of SO~ FBI in CCM, 100llM FBI in CCM, or CCM only, 
prior to analysis. The controls comprised of those flasks where the N2a cells were treated 
with 1ml CCM only. 
All flasks ofN2a cells were removed from the incubator following the 72hour incubation 
period. The CCM (lml) containing cellular debris was transferred into l.Sml 
polypropylene tubes and centrifuged at 4000g for 10 minutes. The cell-free media was 
transferred to 1. Sml polypropylene tubes, and retained for quantitative HPLC analysis of 
non-incorporated FBI, and determination of Sa and So levels in the CCM. The cell pellets 
were retained in the l.Sml polypropylene tubes (pellet 1). 
The remaining adherent cells in the flasks were trypsinised and pelleted at 4000g for 
10 minutes (Pellet 2). The supernatant was discarded and the pellets (Pellet 1 +Pellet 2) 
were combined and stored in l.Sml polypropylene tubes for base hydrolysis, or 10ml glass 
tubes for acid hydrolysis until further processing. 
8.2.3.1 Base hydrolysis and extraction of free sphingoid bases from N2a cells 
The cell pellets in polypropylene tubes were base-hydrolysed with O.12SM methanolic 
KOH in CHCb (4:1)(2ml) for 2 hours at 37°C in a shaking water bath to ensure complete 
base hydrolysis, since incomplete base hydrolysis was found to result in chromatograms 
with numerous peaks interfering with quantification of Sa and So. Following base 
hydrolysis, 2ml CHCb, 2ml alkaline water, (Appendix 7.2) and 4ml of 2M ~OH were 
added. The mixture was vortexed, centrifuged (4000g, 10 min, lOOC) and the aqueous 
layer then aspirated. The CHCb phase was rinsed with 0.9ml alkaline water three times, 
transferred to a glass scintillation vial, and dried under a stream of nitrogen gas. 
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8.2.3.2 Acid hydrolysis and extraction of total sphingolipids from N2a cells 
The cell pellets in screw-capped glass tubes were hydrolysed with a modified aqueous 
methanolic HCl solution (2ml) (Appendix 8.1) overnight (~15hr) at 65-70°C 
(Gaver and Sweeley, 1965). After acid hydrolysis, saturated methanolic KOH (2ml), 
alkaline water (2m I), 2M ~OH (400 Ill) solution and CHCh (2.4 ml) were added and 
mixed. The mixture was centrifuged (700g, 10 min.) and the aqueous layer aspirated. The 
chloroform layer was washed thrice with 0.9ml alkaline water. The chloroform layer was 
transferred to a 25ml glass scintillation vial and dried under a stream of nitrogen gas in a 
fume cupboard. 
8.2.3.3 Determination of free sphinganine and sphingosine levels in cell culture 
media 
The optimised method of extraction of Sa and So described in Chapter 7, section 7.7 was 
applied, except that instead of serum, the CeM in which the N2a cells were cultured was 
analysed for levels of free Sa and So. 
8.2.3.4 Derivatisation of the sphingoid bases for high performance liquid 
chromatographic analyses 
The OPA reagent was prepared and used in the derivatisation of samples for quantitative 
HPLC analysis of Sa and So as described in Chapter 7, section 7.4.2. The filtered samples 
in glass inserts were placed in the autosampler and injected in duplicate using an injection 
volume of SOil!. 
8.2.3.5 Analysis of the sphingolipid derivatives using high performance liquid 
chromatography 
Chromatographic analysis of the sphingolipid derivatives were carried out under the 
conditions as described in Chapter 7, section 7.4.3 . Standard solutions of Sa and So were 
run daily to verify column performance, stability of the OPA reagent, as well as the RTi 
and response factor for both Sa and So. Derivatised samples were stable for at least 
24 hours when refrigerated in darkness. The successful use of refrigerated samples for this 
length of time was previously documented in studies by Y 00 et af. (1996) and was verified 
in this study. 
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8.2.4 Fumonisin Bl extraction from the N2a cells complete culture media 
The CCM containing FB I in which the N2a cells were cultured, was extracted, and purified 
for removal of matrix impurities and concentration of FBI prior to HPLC analysis, The 
method used was a modification of the method of Shephard et at. (1992) used for human 
serum samples, The method optimised in this study is outlined in detail in 
Chapter 7, section 7,2,2,2 as applied to human serum, but was also applied here on the 
CCM that the N2a cells were treated with , In this part of the study, instead of using 500~1 
serum, 500~1 CCM was used, and FBI was successfully extracted , The final residue was 
redissolved in 100~1 of acetonitrile water (1:1 , v/v) and incubated at RT for 5 minutes prior 
to derivatisation and HPLC analysis, 
8.2.4.1 Derivatisation and high performance liquid chromatographic analyses 
of fumonisin Bl from culture media 
The chromatographic analysis conditions used in the quantitative analysis of FBI from the 
CCM was as described in Chapter 7, section 7,2,2,3, The OPA reagent for FBI 
derivatisation was prepared as described in Chapter 7, section 7,2 ,2,3, The derivatised 
samples were injected in duplicate (50~1 per injection) for determination of reproducibility 
and statistical viability, 
8.2.5 Statistical analyses 
All data were presented as means±SD, Comparative assessments were carried out using the 
paired 2-tailed Student's t test. A p value <0,05 was considered statistically significant. 
Correlation analyses were determined using Microsoft Excel. 
8. 3 RESULTS AND DISCUSSION 
The sensitivity of N2a mouse neuroblastoma cells to FB I exposure was investigated to 
determine whether inhibition of overall sphingolipid biosynthesis, and elevation of free Sa 
and So levels would occur as a result of exposure to this mycotoxin , In an earlier study 
Riboni et al. (1995) indicated that FBI-treatment completely inhibited So-induced 
differentiation of the N2a cells, and also established that conversion of So to CER was 
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required , as CER plays a mediator role in the regulation of differentiation in these cells. 
This data suggests a specific bioregulatory function of CER in the control of N2a cell 
growth and differentiation, and poses the general hypothesis of a mediator role of CER in 
the differentiation of cells of neural origin. 
Sphinganine is known to be a highly bioactive molecule capable of inhibiting cellular 
protein kinases, enzymes, and ion-transporters (Merrill et at , 1993a) . Sphingosine is also 
of interest because it influences the synthesis of DNA and interacts with DNA in 
competition for the binding sites with histones, some enzymes, and transcription factors 
(Riley et aI. , 1994a). For these reasons, both intracellular and extracellular levels of Sa and 
So were also assessed quantitatively. 
8.3.1 Analyses of the intracellular and extracellular levels of sphinganine and 
sphingosine following exposure of cultured N2a cells to fumonisin Bl 
The results of the analyses of the intracellular (whole cell analyses) and extracellular levels 
(cell culture media analyses) of Sa and So, as well as the proportion of FBI remaining in 
the CCM are summarized in Tables 8.1 to 8.4. This is the first study where quantitative 
analyses ofFB( , Sa and So were concurrently carried out on N2a cultured cells. 
Cell counts at the initiation of the experiments prior to addition of FB I indicated that there 
were approximately 2 .Sxl0s N2a cells per flask. With this approximate cell number in 
mind, quantitative analysis of FBI remaining in the CCM following the 72hour exposure 
period enabled an estimation of the levels of FBI incorporated by the N2a cells per culture 
flask. These results are summarized in Table 8.1 (and Appendix 8.2) and indicate the 
potential for either binding (absorption) or entry of FB 1 into the N2a cells in vitro. 
Table 8.1: Recoveries of Fumonisin Bl from the N2a cell culture media following 
the 72 hours exposure period. 
Treatment with FBI (f..lM) FBI recovered (f..lM) % FBI taken up by N2a. cells 
(Mean ± SD) 
50f..lM (0=5) 16 .3 ± 4.2 67.4 ± 8.3 
100yM FBI (11=6) 23 .8 + 1.6 76.2 + 1.6 
259 
The limitation of the number of replicate samples throughout this in vitro investigation 
were due to the high cost of pure FBI . A total of20mg of FB I was purchased and budgeted 
for use in the cell culture work (presented in Chapters 3, 4, Sand 6), optimisation of the 
extraction of FB I from serum samples for HPLC analysis (presented in Chapter 7), as well 
as for this in vitro investigation 
Figures 8.1 and 8.2 present chromatograms showing FBI recovered from the CCM after the 
2Scm2 flasks of confluent N2a cells (i.e., ~2Sxl05 cells) were treated with SOIJ,M and 
100lJ,M FBI for 72 hours. The FBI content of the CCM that the N2a cells were cultured in 
was significantly decreased from the original concentrations that these cells were exposed 
to, and the proportion that was unaccounted for in the CCM was considered indicative of 
the level of cellular uptake of FBI by the N2a cells (Table 8.1). This indicates that the FBI 
that traversed the cell membranes occupied all the molecular binding sites within the cells 
and that at these levels of uptake, saturation was potentially reached between the 
intracellular levels and extracellular levels of this mycotoxin. 
In the N2a cells treated with SOIJ,M FBJ (n=5) (Appendix 8.2), a mean of 16.3±4.2IJ,M FBI 
was recovered from the CCM, indicating that 67.4 ± 8.3% of the FBI was potentially taken 
up by these cells. In the N2a cells treated with 100lJ,M FBI , a mean of 23 .8±1.6IJ,M FBI 
was recovered from the CCM, indicating that 76.2 ± l.6% FBI was taken up over the 
72hour incubation period. The recoveries of FBI from the flasks of N2a cells treated with 
50lJ,M and the 100lJ,M FBI (Appendix 8.2) were significantly different (p=O .OlS) indicating 
that cellular uptake of FBI by the same number of cells per flask (i .e. , ~2.Sx 105 cells) N2a 
cells at these two concentrations differed significantly. Although the cells treated with 
100lJ,M FBI took up a higher percentage of FBI (Table 8.2), a higher SD between replicate 
flasks of cells exposed to 50lJ,M FBI was evident. Taking the large SD into consideration, it 
is likely that equimolar amounts of FBI were metabolised at both concentrations, lending 
further support to the hypothesis that a saturation point was reached within the cells 
preventing further entry of the mycotoxins. 
The results of the quantitative analyses of FBI in the CCM (Table 8.1) are supported by the 
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High performance liquid chromatograms showing FBI retrieved from the culture media after 
N2a. cells were exposed to 50flM FBI for 72 hours. The traces shown are AH4, AH5 and AH6 
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Figure 8.2 : High performance liquid chromatograms showing FBI retrieved from the culture media after N2cx. 
cells were exposed to lOOIJ.M FBI for 72 hours. The traces shown are AHIO, AH12 and ABll 
and are illustrated in blue, green and pink respectively. 
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(Chapter 6) following the 48-hour exposure period, and provides further support to 
substantiate that FBI traverses the cell membranes and enters cells. The results of the MTT 
assay (Chapter 3) in combination with the light microscopic observation of the N2a cells 
treated with SO~M FBI and 100~M FBl for 72 hours prior to trypsinisation, confirmed the 
decrease in cell viability characterized by the high number of cells floating in the CCM. 
The remaining adherent cells appeared fibroblastic in morphology in comparison to 
untreated confluent control N2a cells. In concurrence with the findings documented 10 
Chapter 6, the FB l-treated cells displayed features of progressive damage leading from 
gradual retraction of processes to cells exhibiting loss of cytoplasmic volume and complete 
cell rounding; all features associated with cell death. Cell rounding could be attributed to a 
loss of turgidity and subsequent disruption of the cytoplasm. The attachment of cells to the 
substrate and to each other is also mediated by cell surface glycoproteins, as well as 
calcium and magnesium ions (Freshney, 1983). The loss of cell viability noted in the cells 
would imply a loss of production of these ions and the glycoproteins that facilitate cell 
adhesion. 
Yu et at. (2001) made similar observations with the LLC-PK1 cells, with cells displaying 
fibroblastic morphology, as well as the presence of many floating cells following exposure 
to FB 1 for at least 72 hours. Taken together, these results indicate that FB 1 has the potential 
to affect the structure and morphology as well as adhesion capability of the N2a 
neuroblastoma cells following exposure and entry. 
Having established the levels of FBl potentially taken up by these N2a cells, intracellular 
and extracellular levels of Sa and So levels also were assessed. The purpose of acid 
hydrolysis was to liberate free Sa and So from complex sphingolipids, resulting in 
hydrolysis of both the amide linked fatty acids and any group esterified on carbon 1 of the 
sphingoid base. Studies by Wang et at. (1992) revealed that inhibition of CER synthase in 
cultured cells reduced cellular levels of complex sphingolipids and increased the amounts 
of free Sa and So . Similar findings were noted in this study on the N2a neuroblastoma 
cells . 
Chromatograms obtained following acid hydrolysis of the isolated control (blue trace) and 
FBI-treated (pink and light blue trace) N2a cells are shown in Figure 8.3 relative to a 
SOOng Sa and So standard (green trace) . The cellular levels of total Sa and So freed after 
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acid hydrolysis are summarized in Table 8.2 (Appendix 8.3) It is evident by visual 
comparison that the So and Sa area under the peaks are much larger in controls cells than 
in the FBI-treated cells indicating decreased levels of complex sphingolipids in these cells 
following exposure to FB I. 
Table 8.2: Total sphingosine and sphinganine levels in N2a cells following 
Fumonisin Bl treatment for 72 hours: acid hydrolysis of N2a cells. 
Treatment Mean ± SD 
So ()lM) Sa ()lM) Sa:So ratio 
Untreated controls (n=3) 4.9 ± 1.03 0.6±0.12 0.13 ± 0.05 
50~M FBI (n=3) 1.0±1.4 0.2 ± 0.09 0.16 ± 0.25 
100flM FBI (n=3) 1.8 ± 0.5 0.2±0.1 0.14±001 
From Table 8.3 , there was a five-fold decrease in So levels to 0.15 ± 0.091lM, and a four-
fold decrease in Sa levels to 0.2 ± 0.1 11M in the 501lM FBI-treated N2a cells in comparison 
to untreated controls. Furthermore, a three fold decrease in both the mean Sa and mean So 
concentrations to 0.2 ± O.IIlM and 1.8 ± O.SIlM respectively was noted in cells exposed to 
IOOIlM FB I for the same length of time when compared to controls . The lowered amounts 
of Sa and So released from the complex sphingolipids in both sets of FBI-treated N2a 
cells, indicates that FBI exposure decreased complex sphingolipid formation in the N2a 
cells. Although the Sa:So ratio in the untreated cells was the same as the 100llM FB I-
treated cells, the absolute values of the Sa and So were significantly different. These results 
indicate that sphingolipid biosynthesis in the N2a cells are susceptible to the inhibitory 
effects of FBI on CER synthase, and the subsequent depletion of complex sphingolipids. 
Merrill et al. (1993a) reported similar findings with rat primary hepatocytes where as a 
consequence of in vitro inhibition ofCER synthase by FBI, there was depletion of complex 
sphingolipids. Complex sphingolipids have numerous functions in cell membranes, 
including stabilization of the membrane, sorting of lipids and proteins, binding to 
cytoskeletal elements and cell-cell recognition (Riley et aI., 1993). Depletion of complex 
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High perfonnance liquid chromatograms of Sa and So obtained following acid 
hydrolysis of the isolated control (blue AHC6 trace) and FBl-treated (pink AHl2 






membrane leading to cellular damage as indicated by the IHC and ICC results (Chapter 6), 
levels of cytotoxicity indicated by the MTT assay (Chapter 3), necrosis and apoptosis 
indicated by the Apoglow assay (Chapter 4) as well as the flow cytometric analyses 
(Chapter 5) in this study. 
The findings of Riboni et al. (1995) may be used to explain why higher concentrations of 
Sa and So were hydrolysed from complex sphingolipids in the untreated N2a cells in 
comparison to the FBI-treated cells. Riboni et al. (1995) found that complex sphingolipid 
concentrations changed markedly with the degree of confluency and age of the N2a cells 
in culture. In this study, all culture flasks were confluent prior to exposure to FBI for the 
72-hour period. However, due to the level of cytotoxicity induced by FBI, extensive loss of 
cells occurred as cells lost their ability to adhere to the culture substrate, and floated into 
the CCM. Although these fragmented cells were pelleted by centrifugation, retained and 
pooled for extraction, some cells may have disintegrated due to extensive damage as a 
result of the cytotoxic, growth-arrest, necrotic or apoptotic effects of FB I in the CCM, and 
would have been discarded in the washes. These effects of FBI on N2a cells may be 
attributed to the depletion of complex sphingolipids, and the subsequent alterations in 
cell-cell and cell-matrix interactions which are known to induce apoptosis in cells 
(Frisch and Francis, 1994). 
The purpose of base hydrolysis was to cleave acylglycerolipids and hydrolyse 
lysosphingolipids (free sphingoid bases modified at the hydroxyl group on carbon 1 of So 
or Sa) to release free So and Sa. Base treatment does not liberate sphingoid bases from 
complex sphingolipids (Merrill et aI., 1988; Yoo et aI., 1996). Mild base treatment 
followed by chloroform/methanol extraction effectively removes phospholipids 
(phosphotidylethanolamine and phosphotidylserine) that can react with the OPA reagent 
(Merrill et aI., 1988). 
Chromatograms obtained following analysis of the base hydrolysed extracts of the isolated 
control and treated N2a cells are presented in Figure 8A along with the Sa and So 
standards. The quantitative results of the analysis of the base hydrolysed cells for 
determination of the concentration of free sphingoid bases are summarised in Table 8A and 
Appendix 8A . In Figure 8A the Sa and So standard is shown by the green trace, and 
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control cells by the light blue trace. The cells treated with 50~M and 100~M FB I are 




Free sphingosine and sphinganine levels in N2a cells after treatment 
with fumooisin Bl for 72 hours: base hydrolysed extracts of the N2a 
cell line. 
Mean ±SD 
So (nM) Sa (nM) Sa:So ratio 
36.4 ± 6.0 19.2±9.1 0.52 ± 0.2 
FBI at 50~M (11=3) 53.6 ± 6.6 60.6 ± 5.7 1.14±0.2 
FBI at 100flM (11=3) 46.9 ± 2.9 65.1 ± 12.4 1.4±0.3 
In the control N2a cells where FBI was omitted, after the 72-hour incubation period the 
mean free Sa concentration of replicate flasks (n=3) was 19.17±9.14nM and the mean free 
So was 36.39±5.96nM (per ~2.5x10s cells per confluent 25cm2 flask) (Table 8.3). The 
mean free Sa: So ratio in the control cells was 0.52±0.19. The maintenance of a low 
concentration of free So and free Sa is important because these compounds have intrinsic 
biological activity (Merrill and Stevens, 1989; Hannun and Bell, 1989; Merrill , 1991). 
As would be predicted for an inhibitor of CER synthase, FBI caused accumulation of free 
Sa in the treated N2a neuroblastoma cells, while the levels of So were not significantly 
affected. The amount of free Sa that accumulated in cells was considered a function of the 
extent of inhibition of CER synthase, the concentration of essential precursors (serine, 
palmitoyl-CoA), the growth rate of the cells, the rate of Sa degradation and elimination 
from the cells. 
In N2a cells treated with 50~M FBI, there was a 3.2 fold increase in the free Sa 
concentration to a mean of 60.59±5.68nM, and in those cells exposed to 100~M FBI over 
72 hours, a 3.4 fold increase in the mean free Sa concentration to 65.10±12.43nM. Using 
Student's t-test and comparing the levels of free Sa in the untreated N2a control cells and 
the 50~M FB ,-treated N2a celis, the levels were significantly different (p=0.003). There 
was also a significant difference between control Sa levels and the Sa levels in the 1 OO~M 
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High perfonnance liquid chromatograms of Sa and So obtained following base hydrolysis 
of the isolated control (light blue BHCl trace) and FBI-treated (pink BHl and dark blue 
BH7 trace) N2a cells relative to a 125ng Sa and So standard (green 125 SaSo trace) 
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The free So concentration in the controls differed significantly from the 50!lM (p=0.03) 
and 100!lM FBI-treated N2a cells (p=0.05) (Table 8.3). The occurrence of free So in 
mammalian cells is always as a product of catabolism of complex sphingolipids. In cell 
culture, there is initially little change or decrease in free So concentrations, consistent with 
it arising from turnover rather than de novo biosynthesis, and this is apparently less rapid 
than Sa biosynthesis However, when cells begin to die, So would be expected to increase 
due to the breakdown of membrane lipids (Merrill el aI., 1996b). Yoo el at. (1992) reported 
that with renal epithelial LLC-PKI cells treated with FBI, the increase in free So occurred 
before any evidence of increased cell death or inhibition of cell proliferation, and although 
free So levels became significantly elevated, this occurred to a much lesser extent than free 
Sa. Studies by Zhang et at. (1990) and Jacobs and Kester (1993) have shown that low 
concentrations (below lO!lM) of So stimulated the synthesis of DNA in Swiss and A 7r5 
cells, but a higher content of So caused cell death. In contrast, Wang et at. (1991) and 
Gelderblom et at. (1995b) reported that the basal levels of free So did not change 
significantly in primary rat hepatocytes when FBI-induced inhibition of sphingolipid 
metabolism occurred. These comparative studies highlight that the response of cultured 
cells to FB I exposure are cell type specific. 
The accumulation of free So is an indication that either reacylation of So derived from 
sphingolipid turnover, or acylation of So derived from the serum component of the culture 
media was also inhibited. The fact that the Sa accumulated to a much greater extent than 
So in the N2a cells suggests that the de novo pathway was the primary target for 
FBI-induced inhibition. 
This differential inhibition led to increased Sa:So ratios of 1.14±0.2 in the 50!lM 
FBI-treated N2a cells, and a further increase to 1.4±O.3 in the lOO!lM FBI-treated celis, 
from a ratio of O.52±O.2 in the N2a control cells. Significantly different Sa:So ratios to 
controls were noted with both the 50!lM FBI-treated N2a cells (p=O.016) and the lOO!lM 
FBI-treated cells (p=O.017) in comparison to the untreated N2a cells. The intracellular 
elevation of free sphingoid bases is only one aspect offumonisin disruption of sphingolipid 
metabolism that may cause cellular deregulation. 
Merrill et at. (1993b) reported similar findings to that of the N2a neuroblastoma cell line 
when using cultured mouse cerebellar neurons. These authors reported that free Sa 
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increased significantly when the cells were treated with FBI Within 24 hours, Sa increased 
20 fold , and this elevation was maintained over 168 hours of incubation with 251-1M FB I 
Free So initially increased about 2 fold over the controls, however it was the same as for 
the controls at 96 and 168 hours (Merrill et al., 1993b). In the present study on N2a. 
neuroblastoma cells, although analyses were carried out after only 72 hours and the 
concentrations of FBI to which the cultured cells were exposed were higher, a similar trend 
in the response was noted . Distinct increases in Sa concentrations from 19.2±9.1 nM in 
controls up to 60.6±5.7nM in the 50l-1M FBI-treated cells, then further to 65.1±12.4nM for 
those cells exposed to lOOI-1M FBI after 72 hours were noted (Table 8.3). 
Collectively, the results of Merrill et af. (1993b); Riley et af. (1994a) and Yoo et al. (1996) 
support the findings of the acid and base hydrolyses of the FB I-treated N2a. neuroblastoma 
cells in this study, where FBI was shown to inhibit sphingolipid metabolism. 
Merrill et af. (1993 b) found that FBI inhibited sphingolipid biosynthesis in cultured 
cerebellar neurons as reflected by accumulation of free Sa and a reduction in the mass of 
total sphingolipids. The regulated maintenance of low levels of free sphingoid bases in 
cells is important because these compounds have considerable intrinsic biological activity 
and can be cytotoxic at elevated concentrations. The results in this study are in keeping 
with other published studies, since the response of the N2a. neuroblastoma cell line also 
indicates an accumulation of free Sa (Table 8.3) and a reduction in the mass of complex 
sphingolipids (Table 8.2) . 
The depletion of complex sphingolipids following exposure of the N2a. neuroblastoma cell 
line to FBI (Table 8.2) concurs with findings reported for cultured CHO cells by 
Stevens et af. (1990). Complex sphingolipids have numerous important functions in cell 
membranes, including stabilisation of the membrane, sorting of lipids and proteins, binding 
to cytoskeletal elements, and cell-cell recognition. Depletion of complex sphingolipids in 
membranes disrupts the normal function of membranes (Riley et af., 1994a). Complex 
sphingolipids were required for cell survival of this N2a. neuroblastoma cell line, and it is 
likely that as with other cell lines (Hanada et af., 1990; Hanada et af., 1992; Radin, 1994), 
depletion of complex sphingolipids led to increased N2a. cell death as indicated by the high 
number of cells floating in the CCM. These findings are supported by the results of the 
MTT assay (Chapter 3, Table 3.1) where -30% cell death was observed in those N2a. cells 
exposed to 50 and 1 OOI-1M FB I. 
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A further finding of this study during the base hydrolytic treatment of the N2a cells was 
that exposure to FB I caused formation of two compounds other than Sa and So that were 
absent in both the N2a control cells (light blue trace), and the standards solution of Sa and 
So (green trace) (Figure 8.4) . This was taken to be an indication that these compounds that 
eluted were not degradation products of the Sa and So sphingoid bases, nor products of 
sphingolipid metabolism in the N2a cells. Figure 8.4 shows chromatograms containing two 
unknown compounds at approximate RTi of 8.08 and 11.35 minutes, respectively that are 
possibly unnatural sphingoid bases with modified backbones. 
Merrill et al. (1993 b) also reported a similar finding in the study with cultured neurons. It 
was reported that FBI caused the accumulation of a long sphingoid base that eluted after Sa 
on C I8 column, but before the [C20] Sa internal standard . The nature of the compound was 
not known, but Merrill et al. (1993b) noted that they had begun to observe it in other cell 
lines treated with FBI as well. It did not appear to be one of the well known long chain 
bases, such as phytosphingosine (which elutes before So) nor 3-keto Sa (which was ruled 
out by comparison with a synthetic standard (Merrill et aI., 1993b). The identification of 
these compounds in the present study however was beyond the scope of the investigation 
on the N2a cell line. 
8.3.2 Analysis of the culture media for free sphinganine and sphingosine 
When CER synthase is inhibited by fumonisins, large quantities of Sa and So, which are 
lipophilic and normally occur at very low concentrations in cells accumulate, cross 
membranes and enter the circulatory system in vivo. As time progresses and as a 
consequence of this inhibition, Sa and So spill over and increase in the serum of affected 
animals and exert their biological activity. As this inhibition persists, the Sa is released 
from the cell and in animals, the serum may be analysed to detect any increase from 
baseline levels of free Sa. In in vitro systems, the free Sa and So are released into the 
extracellular fluid that in vitro, is equivalent to the CCM. The results of the Sa and So 
analyses of the culture media for the N2a cells are summarized in Table 8,4 and 
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High performance liquid chromatograms of Sa and So obtained following analyses of 
the culture media of the control (green MEDAHC6 trace) and FB I-treated (MED 
BH3, BHIO and AHIO traces) N2cx cells in relation to the SaSo standard (SaSo 125 
dark blue trace) . 
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Hannun et al. (1991) reported that in LLC PK 1 cells, So had little difficulty in crossing cell 
membranes, and Riley et al. (1998) subsequently reported that the half-life of Sa inside 
LLC-PK1 cells was much longer than the half-life of FBI in LLC-PK1 cells. This suggests 
that inhibition of CER synthase is persistent, that Sa does not easily diffuse out of cells, or 
that Sa degradation is slow relative to its biosynthesis. The saturating effects of FB I on the 
Sa levels may be due to either the inhibitory action ofFB I on target enzymes, or saturating 
ofFB, transport across cell membranes because FB, is an inhibitor ofCER synthase, and is 
a hydrophilic compound with a large molecular weight. In this study on the N2a cells, the 
extent of the diffusion was considered a function of the concentration gradient outside and 
inside the cells. The results indicate that in comparison to the untreated controls that Sa 
seemed to diffuse out more from the FB,-treated cells as indicated by the levels of Sa 
released into the culture media in comparison to So levels in all three groups (Table 8.4, 
Appendix 8.5). 
Table 8.4: Total free sphinganine and sphingosine in CCM following N2a cell 
treatment with 50 and 100J.lM FB. over 72 hours. 
Treatment (replicates) Mean +SD 
So (nM) Sa (nM) Sa:So ratio 
Control (n=5) 27.7±11.7 45 .5±10.7 1.7±O.3 
50llM FBI (n=5) 26.4±5.6 51.7±9.9 2.0±O.2 
1 OOIlM FBI (n=5) 26.6±2.5 66 .5±13.4 2.5±O.4 
In the control cells, the mean free Sa concentration in the CCM was 4S.S4±10.67nM, and 
this increased to a mean Sa concentration 51. 72±9. 87nM in cells treated with SOIlM FB ,. 
Using Student's t-test however, these values were not significantly different to each other 
(p=O.18). A further increase to 66.5±13.43nM Sa was noted for those N2a cells treated 
with 100llM FB lover the 72-hour incubation period, and this increase in Sa was 
significantly different to that of control N2a cell levels (p=O.012). 
The So levels in the CCM did not increase to any significant degree, and were very close to 
control levels (Table 8.4, Appendix 8.S). Furthermore, the Sa:So ratio in CCM increased 
from 1. 73±O.3 for the control cells to 2.0±O.2 (1.16 fold increase) in the N2a cells exposed 
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to SO/l-M FB j . A further increase to a Sa:So ratio of 2.S0 ± 040 (143 fold increase) was 
noted for the 1 OO/l-M FB I-treated N2a cells . 
The Sa:So ratios of the CCM of the SOI-lM FB]-treated N2a cells did not differ 
significantly from controls (p=0.07), while those for the N2a cells exposed to 100l-lM FBJ 
did (p=0.004) . There was clearly a FBJ-concentration-dependent increase in free Sa in 
those cells treated with SO and 100l-lM FB 1, with no significant change in the So 
concentration across all three test groups (i.e., in controls and FB I-treated cells). 
In order to determine if a concentration gradient for So and/or Sa exists across the cells 
membranes (i.e. , between intra and extracellular levels of Sa and So in these cells), the 
mean ratios of Sa and So from the base hydrolyses and CCM analyses from Tables 8.3 and 
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This data indicates that there appears to be an elevation in the ratio between intracellular 
and extracellular levels of So from control levels in cells exposed to FB 1 (Table 8 S), but 
not to as distinct levels as with Sa. Sphingosine is usually elevated if there is cell death and 
membrane lipids are being turned over more rapidly. For Sa, the intracellular:extracellular 
Sa ratios increased with higher concentrations of FBI exposure, indicating build up of 
intracellular Sa as a result of inhibition of CER synthase, and its passage or diffusion out of 
the cells into the CCM. 
Clearly, FBI inhibited sphingolipid biosynthesis in the cultured N2a. cell line in vitro as 
reflected by the accumulation of free Sa and a reduction in the mass of total sphingolipids. 
These results suggest that both the elevation of free sphingoid bases and the decrease in 
complex sphingolipids contribute to the cytolethality of FB I in these cells . The fact that Sa 
274 
accumulated to a much greater extent than So suggests that the de novo pathway was the 
primary target for inhibition. As a result of this differential inhibition, the Sa:So ratio 
increased after exposure to FBI. 
Figure 8.6 is a correlation graph that illustrates the relationship between FBI exposure and 
Sa: So ratios in the cells and in the CCM. 
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Figure 8.6: Correlation between concentrations of FBI exposure and intra and 
extracellular Sa:So ratios in the N2a cells and the CCM 
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From Figure 8.6, the R2 values on the trend lines are 0.73 and 0.56 for the cells and CCM 
respectively. This implies that the correlation coefficients ( R ), for the Sa:So ratios to FBI 
in the CCM is 0.75, and that of the free Sa:So in cells is 0.85. Although both these 
measures provide valuable information, in this study the results indicate that the use of the 
free Sa:So ratio in cells appears to be a better biomarker than the Sa:So in the CCM (taking 
into account the large standard deviations), and may be used as a more reliable measure of 
exposure to fumonisins in vitro. These findings are supported by the hypothesis of 
Wang et ai. (1992) that an elevated Sa:So ratio in serum is due to the movement of free Sa 
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from tissues into the blood. In this in vitro model, the cells are equivalent to the tissue and 
the CCM equivalent to the blood in vivo. As all cells types differ in the levels of enzyme 
systems and xenobiotic metabolising systems they possess, it is essential to assess each 
system individually Some cells may react differently from others in vitro and in vivo, 
nullifying the overall effects noted here, and may not result in the expected increase in 
Sa: So ratios . 
As in the analyses of the base hydrolysed N2a cells, analyses of the CCM revealed the 
presence of another compound that seemed to accumulate with the increase in 
concentration of FBI that the cells were exposed to. The compound eluted at times 
different from the peaks observed in the chromatograms of FB I-treated cells after base 
hydrolysis (Figure 8A). This compound eluted at ~ 9.8-10 minutes and was not present in 
the standards run, and to a much lower extent in the control cell extracts (Figure 8.5). The 
identification of this compound however, was beyond the scope of the present 
investigation. 
8.4 CONCLUSION 
It is documented that when fumonisins are added to cells, inhibition of de novo CER 
generation occurs, and there is the potential for accumulation of free sphingoid bases and 
their downstream sphingoid base I-phosphates. Exposure of the N2a neuroblastoma cell 
line to FBI caused an increase in intracellular free Sa and depletion of complex 
sphingolipids. These results indicate that altered sphingolipid metabolism is closely 
associated with the effects of FBI on cell death. A portion of the adverse effects may be 
attributed to the build up Sa, which in itself is toxic. Another part of the adverse effect of 
FBI on cells may be attributed to a decrease in more complex sphingolipids that are 
essential for normal cell behaviour. 
Chromatographic analysis of the CCM that the N2a cells were cultured in for 72hours with 
50llM FB I and IOOIlM FB I indicate that the N2a cells took up approximately 67% and 
76% of the mycotoxin, respectively. Determination of levels of total Sa and So from 
complex sphingolipids in the N2a cells, were facilitated by acid hydrolysis of the cultured 
cells . The hydrolysis procedure liberated free Sa and So from complex sphingolipids, and 
resulted in hydrolysis of both the amide linked fatty acids and any group esterified on 
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carbon 1 of the sphingoid base . The quantitative results revealed that there was a reduction 
in the concentrations of Sa from a level of 0.6 ± 0.12 ~M in control cells, to 0.2 ± 0.09~M 
in those cells exposed to 50~M FB I and to 0.2 ± 0.1 ~M in those cells exposed to 100~M 
FBI over the 72 hours incubation period . In terms of So, there was a reduction from 4.9 ± 
10~ in control cells to 1.0 ± 1.4~M and 18 ± 0.5ilM in those cells exposed to 50~M 
FB I and 100~M FB 1 for the 72hours incubation period, respectively . These results indicate 
that there was as reduction in the cellular levels of complex sphingolipids 
Determination of the levels of free Sa and So in the N2a cells were facilitated by base 
hydrolyses that cleaved acylglycerolipids and hydrolysed Iysosphingolipids, and released 
free So and Sa. The results of the base hydrolyses of the N2a cells indicated that there was 
an increase in the free Sa from 19.2 ± 9.1nM in controls to 60.6 ± 5.7nM and 
65 .1 ± 12AnM in those cells exposed to 50~M FBI and 100~M FBI for the 72 hours 
incubation period. There was an increase in the free So levels from 36A ± 6.0nM to 53.6 ± 
6.6nm and 46 .9 ± 2.9nM in the 50~M FBI and lOOilM FBI-treated N2a cells respectively. 
There was a distinct increase in the free Sa:So ratio from 0.52 ± 0.2 in control cells, to 
114 ± 0.2 in those cells exposed to 50~M FBI. There was also a further increase in the 
SaSo ratio to 1A ± 0.3 in those cells exposed to 100~M FBI for the 72 hours incubation 
period. 
Finally, analysis of the CCM in which the cells were cultured over the 72hour incubation 
period revealed that the free Sa increased from a level of45.5 ± 10.7nM in control cells to 
517 ± 9.9nM and further to 66.5 ± 13AnM in those cells exposed to 50~M FBI and 
100ilM FBI, respectively. The So levels however remained close to control levels. The 
Sa:So ratio in the CCM also increased from 1.7 ± 0.3 for controls cells to 2.0 ± 0.2 and 
2.50 ± OA for cells exposed to 50~M FBI and 100~M FBI respectively. 
The data presented supports the use of the Sa:So ratio as a biomarker for a dose response of 
FBI on sphingolipid metabolism in the N2a neuroblastoma cell line. The use of the 
intracellular free Sa: So ratio however, appears to be more reliable biomarker than the 
Sa:So in the CCM. This framework is reasonably consistent with observed Sa:So ratios 
and FBI concentrations in the examined cells and culture media, as well as the current 
literature of FB I effects on sphingolipid biosynthesis in cultured cells. 
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CHAPTER 9 
Quantitative high performance liquid chromatographic analysis 
of sphinganine, sphingosine and fumonisin Bl from the serum of 
human brain cancer and non-cancer subjects 
9.1 INTRODUCTION 
On the basis of toxicological evidence, rARC has declared that Fusarium moniliforme 
toxins are possibly carcinogenic to humans (Class 2 B carcinogens) (IARC, 1993b). High 
levels of fumonisin contamination in homegrown maize (Rheeder et at., 1992) have been 
correlated with the high incidence of OC among the maize consuming population in 
Transkei in SA (Jaskiewicz et at., 1987; Makaula et at., 1996), in Linxian County, China, 
and in KZN in SA (van Rensburg et at., 1985). The ubiquitous occurrence of FBI in maize 
and its products presents a threat to human and animal health, highlighting the need for the 
development of effective methods and suitable biomarkers to quantitatively monitor human 
exposure to fumonisins. 
Fumonisins exert their toxicological and carcinogenic effects via inhibition of CER 
synthase and the disruption of sphingolipid metabolism (Riley et al., 1994c). Inhibition of 
CER synthase by FB I causes accumulation of Sa and So, which normally occur at very low 
concentrations in cells. As time progresses and as a consequence of this inhibition, Sa and 
So spill over from inside the cells and enter the circulatory system in vivo, increasing in the 
serum of affected animals (Merrill et at., 2001). The Sa: So ratio appears to be a better 
biomarker for the consumption of fumonisin-contaminated feed than absolute levels of the 
individual sphingoid bases (Riley et al., 1994b), and may be used to detect dietary 
exposure to fumonisin. If detected early enough, this Sa: So ratio may allow a response 
such as removal of the contaminated food before the mycotoxin causes irreversible injury. 
Sustained regional and global analyses of human physiological fluids for determination of 
levels of exposure to this mycotoxin is therefore required. 
Published methods for analysis of Sa, So and FBI from serum samples were assessed 
(Shephard et at., 1992; Kwon et at., 1998; Shephard and van der Westhuizen, 1998; 
Shephard et at., 1998; Shephard, 1998; van der Westhuizen et at., 2001), of which some 
were optimised and presented in Chapter 7. These optimised methods were considered 
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sufficiently sensitive and suitable for the quantitative detection of FBI, Sa and So in human 
sera and were applied in this study. The aim of this study was to quantitatively analyse 
serum samples obtained from patients presenting at Wentworth Hospital (WWH) for 
removal of brain tumours, as well as sera from non-cancer volunteers from KZN, Durban, 
SA to determine the levels of FBI , Sa and So. 
9.2 MATERIALS AND METHODS 
9.2.1 Materials 
Reagents, chemicals, solvents, the HPLC system and conditions used for the work 
described in this chapter were as described in Chapter 7, section 7.2.1, unless otherwise 
indicated. The specimens analysed were serum samples obtained from brain cancer patients 
presenting at WWH and non-cancer volunteers from KZN. 
9.2.2 Methodology of sample collection 
Following informed consent, blood (5ml) was collected from 50 brain cancer patients from 
whom brain tumour tissue was removed, and from 21 non-cancer volunteers, into yellow 
capped serum separation blood tubes between February 1999 to November 2001. The blood 
samples were transferred immediately to the laboratory and centrifuged at 1200g x 10min. at 
RT. The serum was stored in 1 ml aliquots in 1.5 ml eppendorftubes at -70°C until processing 
for HPLC analyses. 
9.2.3 Fumonisin BI extraction and quantitation from the serum 
Prior to HPLC analysis to determine the amount of FBI present in the sera of the human 
subjects, samples were purified of matrix impurities and concentrated using the optimised 
method outlined in detail in Chapter 7, section 7.2 .2.2. 
9.2.4 Derivatisation and High performance liquid chromatographic 
analyses of Fumonisin BI from human serum 
The chromatographic analysis conditions used in the quantitative analysis of FBI from the 
human serum were as described in Chapter 7, section 7.2.2.3. The OPA reagent for FBI 
derivatisation was prepared as described in Chapter 7, section 7.2.2.3 . The derivatised 
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samples were injected in duplicate (SO/ll per injection) for determination of reproducibility 
and statistical validity. The time between the injection of sample and the derivatisation was 
not allowed to exceed 1. S min. 
9.2.5 Determination of sphinganine and sphingosine levels in human serum 
The optimised method of extraction of Sa and So from human serum described In 
Chapter 7, section 7.7 was applied on the cancer and non-cancer serum samples. 
9.2.6 Derivatisation of sphingoid bases for high performance liquid 
chromatographic analyses 
The OP A reagent was prepared and used in the derivatisation of samples for quantitative 
HPLC analysis of Sa and So as described in Chapter 7, section 7.4.2. The filtered samples 
in 200/ll inserts were placed in the autosampler, and injected in duplicate using an 
injection volume of SO~1. 
9.2.7 Analysis of the sphingolipid derivatives using high performance liquid 
chromatography 
Chromatographic analyses of the sphingolipid derivatives were carried out as described in 
Chapter 7, section 7.4.3. Standard solutions of Sa and So were run daily to verify column 
performance, stability of the OPA reagent, as well as the RTi and response factor for both 
Sa and So. Derivatised samples were stable for at least 24-hours when refrigerated and 
stored in darkness. The successful use of refrigerated samples for this length of time was 
previously documented in studies by Yoo et al. (1996) and was confirmed in this study. 
9.2.8 Statistical analyses 
All data were presented as means±SD. Comparative assessments were carried out using the 
paired 2-tailed Student's t test. A p value <0.05 was considered statistically significant. 
Correlation analyses were determined using Microsoft Excel. 
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9.3 RESULTS AND DISCUSSION 
Sample collection commenced in February 1999 and proceeded until November 2001. The 
number of cancer subjects recruited in this study was dependent upon the number of 
patients that presented at WWH with operable brain tumours, and on their willingness to 
participate in this study. Even if a patient was willing to participate, on occasion the 
anaesthetist decided against blood sampling. The safety of the patient was always the first 
priority and at times when the patient was hypotensive, blood sampling was not 
permissible. Due to these constraints, and although brain tumour tissue (data presented in 
Chapter 10) was collected from the patient at scheduled operations at WWH, matched 
bloods were not always obtained, or too small a volume of blood insufficient for matched 
FBI, Sa and So analyses were given. Although these factors substantially decreased the 
number of samples in the study, a total of 50 blood samples from brain cancer patients 
were analysed. 
The results of the extraction and HPLC analyses of serum from the non-cancer and cancer 
samples for Sa, So and FBI are summarised in Tables 9.1 and 9.2. 
The wide range of the ages of the cancer patients (15 months to 67 years) posed a problem 
in terms of matching samples with non-cancer controls either by age or race. Due to ethical 
considerations and logistics, it was not possible to recruit non-cancer participants as young 
as those in the cancer group to obtain blood for analysis. However, 21 students at the 
Nelson R. Mandela School of Medicine in KZN willingly donated their blood for analysis 
for FBI, Sa and So levels (Table 9.1 a). These samples were used in the determination of 
baseline levels of FBI, Sa and So levels in non-cancer subjects 
The presence of the FB I in the serum samples was confirmed chromatographically by 
comparison of a sample chromatogram with that of a FBI standard . Every three runs were 
normally bracketed by pure FBI standards, allowing accurate comparison ofRTi. 
The serum of 21 urban dwelling non-cancer volunteers (nine males and 12 females) were 
analysed for the presence of FBI (Table 9.1 a) . The mean serum concentration of FBI 
recovered was 76.7 ± 62 .2nM (n=21) and the mean age of these subjects was 18.8 ± 0.6 
years (Appendix 9.1). Figure 9.1 presents chromatograms of FBI isolated from the sera of 
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three non-cancer volunteers, as well as an FB I standard. These samples showed the 
presence of FBI at various levels, and this variation is illustrated by comparison of the 
areas under the FBI peaks in the chromatograms of the non-cancer serum samples (blue, 
green and pink traces) at RTi of ~3.4 minutes in Figure 9.1. The red trace is the 
chromatogram of the FBI standard at a concentration of500ng.mr l 
The mean Sa:So ratio within these non-cancer serum samples was 1.7±O.7. Figure 9.2 
presents the chromatograms obtained from serum analyses of three non-cancer volunteers 
(purple, blue and red traces), as well as Sa and So standards for comparison (green trace). 
The RTi for Sa is ~6 minutes and that for So is ~4.6 minutes (Figure 9.2, green trace) 



























Determination of the serum concentrations of sphinganine, 
sphingosine, and fumonisin Bl in 21 non-cancer subjects 
Race Sex FBI (nM) So (nM) Sa (nM) Sa:So ratio 
A F 20.1 18 ND ND 
I F 22. 3 - - -
I M 22.5 129 91 0.71 
I F 24.1 57.7 80 1.39 
W F 24.4 - - -
A M 26 119 102 0.86 
I M 41.2 47.9 84 1.75 
I F 46.3 35.2 79 2.24 
A M 50.3 88 .2 99 1.12 
I F 60.7 29.9 81 2.71 
A F 66 50.9 88 1.73 
W F 69 .8 83.9 92 1.10 
I F 74 .2 22.8 76 3.33 
I M 91.6 47 .2 79 1.67 
I M 95 .2 343 801 2.34 
I F 106 26 .1 40 1.53 
I M 106 - - -
A F 118 73. 2 88 1.20 
I M 122 - - -
I M 127 - - -
I F 296 86.8 95 1.1 
Mean + SD 
76.7+62.1 78.7+78 131.7±185.7 1.7±O.7 
W M F - ND 
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Figure 9.1: High performance liquid chromatograms showing the variable levels of FBI retrieved 
from the sera of three non-cancer volunteers (N6, N 14 and N20 which are the pink, 
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Figure 9.2: High performance liquid chromatograms showing the Sa and So bases retrieved from 
the serum analyses of three non-cancer volunteers (norm S 10, S 1 and S5, red, blue 
and purple traces) , as well as a 150 ng.mr! Sa and So standard (green trace). 
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These serum Sa:So ratios of urban volunteers from KZN differed markedly to those 
presented by van der Westhuizen et af. (1999) (Table 9.1b), where serum Sa:So ratios in 
rural male and female volunteers consuming a staple diet of homegrown maize in Transkei 
was 0.34±0.36 (n=154) In Kenyan volunteers, the serum Sa:So ratios were 0.28±0.07 
(n=27), and in KZN, the mean serum Sa:So ratio was 0.44±0.26 (n=26) 
(van der Westhuizen et af. , 1999). The respective Sa and So levels are summarized in 
Table 9.1b. 
Table 9.1b: Comparison of Sa: So ratios reported by van der Westhuizen et al. 
(1999) and the current study. 
Mean ±SD 
So (nM) Sa (nM) Sa:So ratio (range) 
This study : Urban volunteers from KZN 78 .7±78 131.7±185.7 1.7±O.7 (0.7-3 .3) 
(n=21) 
van der Westhuizen et af. (I 999) 
Transkei (n=154) 74.7±83.0 19.7±27.8 0.34±0.36 (0.01-2.97) 
Kenya (n=27) 215±105 58.6±31.0 0.28±0.07 (0 .17-0.50) 
KZN (11=26) 128±115 66.8±88 .2 0.43±0.23 (0.12-0.88) 
The values reported in this study from urban non-cancer volunteers from KZN (Table 9.1b) 
indicate that higher levels of Sa were retrieved compared to the data reported by van der 
Westhuizen et af. (1999). This led to higher Sa:So ratios in the serum samples analysed in 
the present study in comparison to the Sa:So ratios obtained from serum samples of van der 
Westhuizen et al.(1999) from Kenya, KZN and Transkei. 
Only 16 of the 21 serum samples were analysed for FBI , as well as matched Sa and So 
levels due to the limited volume of serum obtained from the rest of the non-cancer 
volunteers (Table 9.1a). This group comprised White (n=l), African (n=5) and Indian 
(n=10) subjects (Appendix 9.2) . The mean age in this group was 18.9±0.6 years, and the 
mean serum FBI was 75.5±66.3nM. The mean Sa:So ratio in these subjects was 1.65±0.7. 
Analysis of the data from non-cancer volunteers according to race showed that the mean 
age of the Indian subjects was 18.7±0.5 years (n=14) and the mean serum FBI 
concentration was 88 .2±70.3nM. The mean age of the African subjects was 19±1years 
(n=5) and the mean serum FB I concentration was 56.1±39.3nM. Comparative assessment 
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ofthe FBI levels detected in the Indian and African subjects using Student's t test indicated 
that these levels were not significantly different from each other (p=0.23). The mean age of 
the White subjects was 19 years (n=2) and the mean serum FBI concentration was 
47.1 ± 32.2nM (Table 9.3). Due to the small sample size of white subjects, it was not 
feasible to compare or statistically analyse the data with the other race groups. The mean 
serum Sa: So ratios of the non-cancer volunteers was 1.0 ± 0.6 for African subjects, 1.9 ± 
0.8 for Indian subjects, and 1.1 for white subjects. 
The lowest level of FB I detected in the sera of the 21 non-cancer serum samples was 
20.1nM, and in this subject the Sa level was undetectable, making it impossible to establish 
a serum Sa:So ratio (Table 9.1a). Cases such as this were expected since normally free So 
and Sa are present in tissues and cells in trace amounts (Merrill et ai., 1988; 
Riley et ai., 1994c). Free Sa is a metabolic intermediate in the sphingolipid biosynthetic 
pathway, and free So is generated primarily as a consequence of sphingolipid turnover or 
degradation; therefore neither should accwnulate under normal conditions (Merrill, 1991; 
Rother et ai., 1992; Michel et ai., 1997). 
Figure 9.3 correlates the serum FBI levels and the corresponding Sa:So ratios reported for 
the non-cancer volunteers. The R2 value on the trend line is 0.0681, and the correlation 
coefficient (R) is 0.261 (even after removal of the outlier with a FB I concentration of 
296nM). This indicates that there is no distinct correlation between these variables in the 
non-cancer volunteers recruited in this study. 
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Figure 9.3: Correlation between Fumonisin B) concentration and the Sa:So 
ratio in non-cancer subjects 
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For example, the highest concentration of FB I detected in this group of urban non-cancer 
volunteers (n=21) was 296nM and the matched Sa So ratio was only 1.10 (Table 9.1 a) . At 
the same time, the range of Sa: So ratios in this group varied from 0.71 to 3.3 (Table 9.1b) 
It is likely that the poor correlation between serum FBI levels and the serum Sa:So ratio is 
the consequence of the rapid excretion/metabolism of FBI from the body into faeces and 
urine. Unlike cell culture models where the CCM can be retained and analysed (as in 
Chapter 8), drawing a defined correlation between Sa:So ratios and FBI levels in vivo are 
difficult. However these however indicate that the general public are exposed to varying 
levels of FBI, and variation in the Sa:So ratios are evident although no correlation exists 
between these two variables. Clearly, there are factors, both environmental and genetic that 
could influence this ratio in an individual. 
What then would be potential routes of exposure to FBI in the urban volunteers in this 
study? It is normal for urbanized people to eat maize products (e.g., corn flakes, pop com 
uphuthu or pap), rye, beans and other products that are infected with fumonisins 
presumably from urban stores, and therefore, may be unaware of its quality. Exposure to 
this mycotoxin was likely through the route of ingestion of commercially available food 
products . As documented in Chapter 2, Table 2.4 (Marasas, 1997), studies have indicated 
that the PDI of FBI from commercial maize in SA in an urban population was 1.6~g.kg-1 
body weight per day, and this increased to 2.6~g.kg-1 body weight per day for rural 
populations. Maize examined by Dutton et al. (1993) showed 50% incidence of FBI 
contamination. Dutton and Kinsey (1995) analysed 417 agricultural commodities in KZN 
for fungi and mycotoxins. The majority of samples handled were maize (198; or 479%) 
Selected samples (73) were analysed for FBI and of these 69 (94%) were found to be 
positive. As a consequence of these results and the high incidence of Fusarium species 
(over 70% in maize and maize containing feeds), attention was drawn to the actual and 
potential presence of fumonisin in the SA food chain (Dutton and Kinsey, 1995). 
Subsequently, Dutton and Kinsey (1996) analysed over 1600 samples of agricultural 
commodities in KZN for fungi and mycotoxins between 1984-1993. Since 1989, selected 
maize samples with high levels of Fusarium species were examined for FBI and of these 
(n=20) in 1993 , 90% were positive. These studies indicate that the general population in 
KZN would be exposed to varying levels of Fusarium mycotoxins as a result of ingesting 
contaminated food products. 
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The results of the analyses of the 50 brain cancer serum samples analysed for FBI, Sa and 
So levels are shown in Table 9.2. Typical chromatograms obtained following isolation of 
FBI from sera of two cancer volunteers (green and pink traces) are presented In 
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Sphinganine, sphingosine and fumonisin Bl levels in the sera of 50 
brain cancer subjects. 
Sa:So 
Race Tumour FBI (nM) So (nM) Sa (nM) ratio 
A Adenoma 52.8 24.0 194 8.08 
A Cerebellar hemangioblastoma 167 83 .9 116 1.38 
A Choroid plexus tumour 84.7 148 115 0.78 
I Cranial pharyngioma 24.2 380 1210 3.18 
A Tumour -subtype not specified 75.7 66.3 118 1.78 
A Tumour -subtype not specified 60.0 192 147 0.77 
A Tumour -subtype not specified 66.6 74.9 117 1.56 
W Tumour -subtype not specified 105 166 665 4.01 
A Glioblastoma multiforme 34.7 185 521 2.82 
A Haemorrhagic lateral ventricle 
tumour 33.4 74.4 607 8.16 
I Left CPA tumour 39.8 194 III 0.57 
A Medu llob lastoma 298 92.3 105 1.14 
A Medulloblastoma 56.4 56.4 ND ND 
A Meningioma 65.8 58.0 83.8 1.44 
A Meningioma 283 58.1 148 2.55 
A Meningioma 25.7 229 949 4.14 
A Meningioma 312 91.6 105 1.15 
A Meningioma 49.6 422 565 1.34 
A Meningioma 101 78.9 93.6 1.l9 
A Meningioma 88.8 378 205 0 .54 
A Meningioma 104 124 145 1.17 
I Meningioma 23.7 29.5 ND ND 
I Meningioma 59.7 240 456 1.9 
I Meningioma 99.6 208 182 0.88 
I Meningioma 64 .2 74.4 148 1.99 
W Meningioma 329 102 96.6 0.95 
W Meningioma 58.8 203 765 3.77 
W Meningioma 23.2 207 357 1.72 
W Meningioma 32.0 389 420 1.08 
W Meningioma 52.3 214 448 2.09 
W Meningioma 83 .0 87.9 103 1.17 
W Metastatic Carcinoma 140 248 325 1.31 
A Metastatic cancer- Left frontal 213 98 .9 95 .2 0.96 
cystic tumour 
I Neurilememmoma (schwannoma) 39.8 47 .9 82.1 1.71 
A Occipital encephalocoele 72 .5 362 391 1.08 
A Occipital tumour 31.8 162 689 4.25 
A Pilocytic astrocytomas 30.4 345 305 0.88 
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M 10 A Pilocytic astrocytomas 90.3 183 251 1.37 
F 5 A Pilocytic astrocytomas 73.4 517 387 0.75 
F 6 A Pineob lastoma 24.2 297 1290 4.34 
M 35 A Pituitary adenoma 226 185 359 1.94 
M 21 A Pituitary Adenoma NA 50.2 88.4 1.76 
M 67 A Pituitary Thoracoadenoma 420 299 120 0.40 
F 34 A Posterior fossa tumour 68.1 174 103 0.59 
M 46 W Posterior fossa tumour 602 46.8 76.0 1.62 
M 4 A Posterior fossa tumour 40.7 198 202 1.02 
M 20 A Posterior fossa tumour 79.7 271 204 0.75 
M 10 I Posterior fossa tumour 61.2 393 417 1.06 
M 4 A Posterior fossa tumour with 
presence of medulloblastoma 38.4 60.2 84.5 1.40 
F 49 A Transphenoidal excision of tumour 
56.3 160 418 2.6 1 
Mean +SD 
32.0±19 107±116.2 181±121 ~16±288.~ 1.9±1. 7 
Key: 
A I W M F ND 
Mrican Indian White Male Female Not Detectable 
The 50 serum samples from brain cancer patients analysed included African 
(n=33; 28.9 ± 19.7 years), Indian (n=8; 33.5 ± 17.5 years), and White subjects (n=9; 42 ± 
14.8 years) . Their mean age was 32±19 years (Table 9.2). The absence of coloured patients 
in this study is supported by trends shown in Table 1 (Chapter 1). In comparison to other 
race groups, there are also a relatively low percentage of coloured people living in KZN. In 
addition , Sitas et at. (1998) reported that in coloured males, the lifetime risk of developing 
brain or CNS tumours was 1 in 1429, and in coloured females the lifetime risk was 1 in 
2500. This potentially low incidence of CNS tumours in this population group may have 
contributed to the absence of coloured subjects in this study cohort . 
The mean serum level of FBI in the cancer cohort was 107.4 ± 116nM (range 105-298nM) 
(Table 9.3). When analysed according to race, the mean FBI concentration in serum of 
African brain cancer subjects was 107 ± 99.2nM, 51 .5 ± 25 .2nM for Indian subjects, and 
158.4 ± 190.5nM for White subjects (Table 9.3) . Although these analyses indicate that 
mean serum FB I levels appear higher in the African and White brain cancer subjects, than 
in the African (561 ± 39.3nM FBI) and White non-cancer subjects (47.1 ± 32.2nM FBI), 




































Figure 9.4 : High perfomlance liquid chromatograms showing the levels FBI retrieved from the sera 
of two cancer volunteers (green B82 and pink B88 traces), as well as a 200ng.mr l 
FBI standard (dark blue trace). 
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cancer versus non-cancer p=0.44). Similar results were found in the Indian sub-group, in 
that although higher serum levels of FBI were detected in the non-cancer subjects 
(88.2±70.3nM FBI) than cancer subjects (Sl.S±2S.2nM FBI), when analysed statistically, 
they did not differ significantly (Indians, cancer versus non-cancer, p=0.17). This indicates 
that there was no predominance of exposure to FB I in the cancer group over the non-cancer 
group when analysed in terms of racial classification. 
To determine whether any correlation exists between FBI serum levels and the serum 
Sa:So ratios (Table 9.2) in the cancer subjects, a correlation analyses was carried out 
(Figure 9.S). The correlation coefficient between these variables was -0.23 (R2=0.OS3), 
indicating absence of a correlation between Sa:So ratios and the serum levels of FB I in the 
cancer patients in this study cohort. 
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Figure 9.5: Correlation between FBI levels and Sa :So ratios in sera of brain cancer 
subjects 
The poor correlation between FBI serum levels and the Sa:So ratio is largely due to the fact 
that FBI is poorly absorbed from the GIT, cleared rapidly from circulation in the serum, 
and excreted primarily III the faeces even after intravenous administration 
(Bucci et ai., 1998). Therefore even though quantitative analyses were done in this study, 
the results provide more of a qualitative indication of exposure to FB I. Although an 
optimised isolation method for FBI was applied in this study, direct quantitative correlation 
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with Sa and So levels would be more applicable to controlled studies where the amount of 
FBI ingested was known or regulated. In humans however, this is not possible, and studies 
such as this one serve the purpose of elucidating the potential use of Sa: So ratios as a 
biomarker under real in vivo conditions versus in vitro laboratory studies. 
The serum Sa and So levels, and Sa: So ratios in the Indian, White and African brain cancer 
and non-cancer subjects are summarized in Table 9.3. The mean serum Sa: So ratio in the 
brain cancer subjects (n=50) was 1.9±1.7 (range 0.40-8.16), and in the non-cancer subjects 
(n=21) was 1. 7±O. 7(range 0 .7-3 .3). There appeared to be no significant difference between 
the groups. The Sa:So ratios for the cancer subjects were 1.61±O.9 for the Indians, 1.97±1.1 
for the Whites and 2.0±1.9 for the African subjects, which again are not different from data 
for the respective non-cancer subjects. These analyses indicate that race is not a factor in 
the variation or determination of the serum SaSo ratios. 
Table 9.3: Summary of serum levels of fumonisin Bb sphinganine and sphingosine 
retrieved from non-cancer and brain cancer su bjects. 
Mean± SD 
Healthy volunteers Age (years) FBI (nM) So (oM) Sa (oM) Sa:So ratio 
Males (n=9) 18.67 ± 0.71 75.56 ± 41.02 129.05 ± 110.30 209.33 ± 289.99 1.41 ± 0.62 
Females (n=12) 18.92 ± 0.51 77.33 ± 76.08 48.45 ± 25.90 71.9 ± 29 .55 1.63 ± 0.94 
All subjects n=(21) 18.81 ± 0.60 76.65 ± 62.10 78.7 ±78 131.7 ± 185.7 1.7±0.7 
African (n=5) 19 ± 1 56.1 ± 39.3 69.9±38.1 75.4 ± 42.6 0.98±0.6 
Indian (n= 14) 18.7 ± 0.5 88.2 ± 70.3 82.6 ± 97.1 150.6 ± 229 1.87 ± 0.78 
White (n=2) 19 47.1±32.2 83.9 92 1.09 
Cancer volunteers 
Males (n=27) 29.46 ± 19.74 125.83 ± 143.24 153.17±97.15 259.504 ± 208.22 1.81 ± 1.60 
Females (n=23) 35 ± 17.82 86 .51± 72.60 212.79 ± 139.44 378.07 ± 350.35 2.09 ± 1.74 
All subjects (n=50) 32.006 ± 18.9 107.38 ± 116 180.59 ± 121 316.32 ± 288 1.86 ± 1.67 
African (0=33) 28.9±19.7 107 ± 99.16 175.7 ± 124.0 291.3 ± 279 2 ± 1.94 
Indian (n=8) 33 .5 ± 17.5 51.5 ± 25.2 195.9 ± 141.0 372.3 ± 397.9 1.61 ±0.88 
White (n=9) 42 ± 14.8 158.4 ± 190.5 184.9 ± 101.9 316.32 ± 288 1.97 ± 1.14 
Adults (n=35) 41.7±13.6. 123 ± 130 157 ± 107 251 ± 216 1.91 ± 1.78 
Children (n=15) 9.5 ± 5.2 7l.1±67.84 236 ± 137.48 474 ± 380.20 201 ± 1.39 
Meningiomas 41.44 ± 12.24 103.08 ± 98.10 177.47 ± 121.22 310±258.67 1.71 ± 0.99 
(n= 18) 
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Large standard deviations indicate large inter-patient variability in the absolute serum 
levels of Sa and So . Figures 9.2 and 9.6 present chromatograms of Sa and So retrieved 
from the sera of three non-cancer volunteers and four brain cancer subjects respectively . 
The identification of serum Sa and So were confirmed by comparison with the Sa and So 
standards. 
Comparative analyses were also carried out between serum concentrations of Sa, So, 
Sa: So ratios and FBI in adults and children (birth to 18 years) from the cancer group to 
determine whether age plays a role in these variables. The mean age of the children was 
9.5±5.2years, the mean FBI sera concentration was 71.1±67.8nM, and the mean sera Sa:So 
ratio was 2.0±1A. In the adults (> 18 years), the mean age of the subjects was 41.7±13.6 
years (Table 9.3). The mean serum FBI concentration and Sa:So ratio was 123±130nM, 
and 1.9±1.8 respectively. Although these results indicate that the adults were exposed to 
slightly higher levels of FBI, they were not significantly different (p=O.15), and there was 
no correlation between serum levels of FB I and age of the patients (Figure 9.7; R=O.32). 
The Sa:So ratios between the adults (l.91±1.78) and children (2 .01±1.39) were also not 
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Figure 9.6: High performance liquid chromatograms showing the Sa and So bases retrieved by 
serum analyses of four brain cancer subjects, as well as a chromatogram of the 
250ng.mr l Sa and So standard (purple trace) . 
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Figure 9.7 : Correlation between age of cancer subjects and serum FBI levels 
The most prevalent tumour subtype diagnosed in cancer subjects enrolled in this study was 
the meningioma. Eighteen of the 50 cancer patients (36%) were admitted for removal of 
meningiomas and their mean age was 41.4 ± 12.2 years (Table 9.3). The mean serum FBI 
concentration in these patients was 103.1 ± 98.1 nM FB I and the mean serum Sa:So ratio 
was 1.7 ± 1.0. In comparison to the healthy volunteers, although their mean Sa:So ratio 
was 1.7 ± 0.7; the serum levels of Sa and So, as well as the serum levels of FBI (76.7 ± 
62.1) were much higher in the meningioma patients (Table 9.3). However there was no 
correlation (R = - 0.23) between the serum FBI and Sa:So levels in the patients with this 
tumour sUbtype (Figure 9.8). 
Ramasamy et al. (1995) established that FBI alters sphingolipid metabolism in endothelial 
cells from pulmonary arteries, and that FB I and D-erythro Sa interferes with the 
permeability barrier function of these cells. This increase in Sa was attributed to inhibition 
of CER synthase by fumonisins, and accumulation of this intermediate of de novo 
sphingolipid biosynthesis. Complex sphingolipids have been implicated in cell-cell 
interaction, as well as cell-extracellular matrix interactions. The blockage of de novo 
sphingolipid synthesis may have weakened intercellular interactions, and affected the 
barrier function of endothelial cells making the barrier "leaky" (Ramasamy et al., 1995). In 
addition, complex sphingolipids, as well as So and Sa, affect numerous signal transduction 
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pathways, some of which have been implicated in the control of endothelial cell 
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As sphingoid bases have intrinsic biological activity, and their elevation may have been 
related to, or contributed to exacerbation of the cancer condition, the serum levels of Sa 
and So were assessed in relation to the serum levels of FBI in the meningioma patients 
(Figures 9.9 and 9.10). 
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Figure 9.10: Correlation between serum FBI and So levels in meningioma 
patients 
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No positive correlations however, were noted between serum levels of Sa and FB! 
(R= -0.505; Figure 9.9), nor So and FB! (R= -0.48; Figure 9.10) in the meningioma 
patients. Furthermore, there was no correlation between the serum FB! and Sa levels of the 
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Figure 9.11: Correlation between serum FBI and Sa levels in the 
50 brain cancer patients 
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Sphingolipids are integral components of membranes. It would therefore be tempting to 
speculate that as FBI is an inhibitor of sphingolipid metabolism, and that the meninges are 
membranes that surround the brain; the presence of FBI in these patients serum may have 
disrupted sphingolipid metabolism and endothelial barrier function in the meninges . 
However, the analytical results of the sera in this study do not provide statistically 
significant evidence to support this hypothesis. 
The serum Sa and So levels, as well as Sa:So ratios for male and female non-cancer 
subjects are summarized in Table 9.3. The mean serum Sa:So ratio in the healthy male 
subjects (n=9) was 1.41 ± 0.6 and the serum FBI concentration was 75.6 ± 41.0nM 
(Table 9.3). For the serum samples analysed from non-cancer female subjects (n=12), the 
Sa:So ratio was 1.6 ± 0.9 and the FBI mean concentration was 77.3 ± 76.1nM (n=12). 
These results indicate that although the absolute amounts of Sa and So were higher in the 
male non-cancer volunteers, the Sa:So ratios were somewhat higher in female subjects 
(Table 9.3). As the mean concentrations of FBI retrieved from male and female subjects 
were not significantly different (p = 0.95), there was no potential for a correlation of FBI 
levels and So:So ratios, but possibly for gender differences in Sa and So levels alone. 
Statistical analyses of the healthy male and female Sa: So ratios however indicate no 
significant differences in this study cohort (p = 0.63). The ratios determined overlapped 
between the sexes as indicated by the large standard deviations calculated, indicating large 
inter-individual variation (Table 9.3). When the serum samples of the cancer subjects were 
analysed according to gender, the serum FBI levels determined for the females subjects 
was 86 .51 ± 72.60nM FBI (Table 9.3). These levels were not significantly different to the 
serum levels in the healthy females (p = 0.73). The mean Sa:So ratio in the female cancer 
patients (n = 23) was 2.09 ± 1.74, and although higher than the serum Sa:So ratio 
established for female subjects in the healthy group (1.63 ± 0.94) (Table 9.3), this ratio was 
not significantly different either (p = 0.43). The mean serum FBI levels in male cancer 
subjects was 125.83 ± 143.24nM FBI, and was not significantly different to the serum 
levels of the healthy male subjects (p = 0.31). Comparative analysis of the Sa:So ratios of 
the cancer and healthy males revealed that these levels did not differ significantly either 
(p = 0.56). 
The results of this study are in coherence with Abnet et at. (2001 a) where no differences 
between male and female serum sphingolipid concentrations were found. 
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Castegnaro et a!. (1998) also reported values for Sa: So ratios in sera from healthy human 
volunteers from France (eight males and 10 females) and SA (13 females of Asian origin), 
in which the values ranged from 0.09 to 0 .78 and overlapped between the sexes. 
van der Westhuizen et a!. (1999) also did not find any significant differences in the Sa:So 
ratios between males and females within the Transkei region of the Eastern Cape, KZN in 
SA, the Bomet District in western Kenya, nor between the different regions (p>0.05). It 
was considered possible that the ratio was not sensitive enough to act as a biomarker for 
fumonisin exposure in humans at the levels of contamination in maize of 580ng.g- 1 in 
Transkei, < lOngg-1 in KZN and 60ng.g-1 in Kenya (van der Westhuizen et a!. , 1999). In 
urban areas and in developed countries where maize is not the staple diet but merely one 
item in a mixed diet, intake offumonisin will be correspondingly reduced depending on the 
individual consumption patterns. At this level, any increase in the ratio may be masked by 
the natural variation between and within individuals. 
This study assessed the relationship between sphingoid base levels as biomarkers of 
fumonisin exposure and cancer incidence. No significant association between sphingolipid 
levels and risk of brain cancer were found from sera analyses for FBI , Sa and So, nor the 
Sa So ratio. In the present study, the serum Sa: So ratio did not prove a potential biomarker 
to distinguish between brain cancer and non-cancer subjects exposed to FBI, nor was there 
sufficient evidence for the use of the Sa:So ratio as a suitable biomarker for susceptibility 
to brain cancer. Large inter-individual variations in the serum Sa: So ratios made 
interpretation difficult, and was not considered sensitive enough to act as a biomarker for 
fumonisin exposure in humans at the levels of exposure through commercially available 
food products. 
These results are supported by findings by Abnet et al. (2001 b) in a study to determine 
whether sphingolipids could be used as a biomarker for fumonisin exposure and risk of 
oesophageal cancer squamous cell carcinoma (OSCC), that although approximately one 
third of the subjects in that study went on to develop oesophageal cancer between one to 
six years after the serum was collected, serum sphingolipids did not differ between controls 
and eventual cases. Collection of serum before diagnosis, as well as the lack of an 
association between sphingolipid levels and oesophageal cancer incidence allowed the 
authors to combine the groups for the purposes of another study. Median serum 
concentrations for the entire study population were 47 .3nM (unadjusted) and 52.2nM 
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(lowess adjusted) for So . No significant associations were found between serum Sa, So or 
the SaSo ratio and osee incidence in conditional and unconditional logistic regression 
models with adjustment for age, sex, tobacco use, and alcohol use. This study assessed the 
relationship between sphingolipid levels, as biomarkers of fumonisin exposure and cancer 
incidence. No significant association between sphingolipid levels and risk of osee were 
found (Abnet et aI. , 2001b). 
The presence of varying levels of FBI in the serum of brain cancer and non-cancer 
volunteers suggests that it is present in the circulatory system of the general population, 
and these levels are probably dependent on the level of exposure (Table 9.3). The varying 
Sa and So levels also indicate great variation between individuals, as most, if not all , 
tissues have the capacity to synthesize long chain bases de novo (Merrill et al. , 1985). 
Although in past studies attention has been given to the possibility of the formation of 
fumonisin degradation products, which is likely due to the acidic nature of the stomach and 
the microbial activity of the GIT, little is known about the GIT absorption of FBI . A 
limited amount of FBI is absorbed into the bloodstream in its intact form. However, when it 
loses the tricarballylic side chains by hydrolysis, absorption IS enhanced 
(Hopmans et aI., 1997). This may explain the greater toxicity of hydrolysed FBI in 
comparison to FBI . One school of thought that FBI is polyanionic and may decrease its 
own absorption by binding cations such as sodium, potassium and other large molecules . 
Polycations have been known to inhibit active transport of sugars and amino acids across 
the intestinal membrane in rats (Elsenhans et aI., 1983). The serum samples in this study 
were not analysed for the presence of hydrolysed FB I products due to the limited volume of 
blood obtained. It would be interesting in future studies to correlate the percentage of 
hydrolysed and non-hydrolysed FBI in the serum of human subjects. 
In this study, due to theatre times and hospitalisation of patients it was not possible to 
standardise times of blood draw, nor recruit large numbers of brain cancer subjects, both 
factors that were confounding variables in this study. Fears of Human Immunodeficiency 
Virus (HIV) testing in clinical settings also prevent the general public from volunteering 
their blood research for studies such as this. Should future studies be pursued to revisit the 
use of FBI levels and corresponding Sa:So ratios as a biomarker, it would be advisable to 
recruit larger numbers (n>200) of healthy volunteers whose diets could be monitored 
strictly, where blood draw time would be standardized to specific times of the day so as to 
300 
monitor any subtle changes that occur prior to pursuing the link to the aetiology of cancer. 
Access to larger sample sizes would enable the establishment of credible correlations, 
9.4 CONCLUSION 
This study reports for the first time matched measurements of Sa:So ratios and FBI levels 
in human serum samples obtained from brain cancer patients and non-cancer volunteers 
from KZN, Using HPLC, an analytical approach was adopted to isolate and quantify serum 
levels of FBI, Sa and So from non-cancer (n=21) and brain cancer (n=50) subjects, 
Fumonisin BI was detected in the serum of both non-cancer (76 ,7 ± 62,2nM) and brain 
cancer subjects (107.38 ± 116nM), Considerable overlap in the serum Sa:So ratios also 
occurred between non-cancer subjects (range 0.7-3 ,3) and brain cancer subjects (range 
0.40-8 ,16). 
The mean serum Sa: So ratio of 21 non-cancer volunteers was 1. 7 ± 0 .7 , Correlation graphs 
indicated that there was no correlation (R = 0,26) between serum FBI levels and Sa:So 
ratios in the non-cancer subjects, This implies that there is no causal relationship between 
serum levels of this exogenous sphingolipid inhibitor and inhibition of sphingolipid 
metabolism in this study popUlation , However non-cancer subjects are equally at risk to the 
biochemical effects of exposure to this mycotoxin, and this is of growing concern due to 
the possible side effects of cumulative, and long-term exposure to FBI , 
The mean sera FBI level in the brain cancer subjects were 107.4±116nM (range 10,5-
298nM) (n=50) and the mean Sa:So ratio (n=50) was 1.9±1.7 (range 0.40-8 .16) 
Correlation analysis of these variables indicated absence of a correlation between serum 
FBI levels and Sa:So ratios (R = -0,23), There was also no correlation between serum 
levels of FBI and age of the patients (R=O ,32) , Race was not a factor in the variation of 
sera Sa: So ratios , 
Gender-based statistical analyses indicated no significant differences in the non-cancer 
subjects serum Sa: So ratios in this study cohort either (p = 0,63). In the female brain 
cancer subjects, the serum FBI levels were 86.5 ± 72 ,6nM FB j , These levels were not 
significantly different to the levels in the non-cancer females (p = 0.73), The mean Sa: So 
ratio in the female cancer patients (n = 23) was 2,1 ± 1.7, and although higher than the 
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serum Sa: So ratio established for female subjects in the non-cancer group (16 ± 0.9), were 
not significantly different (p = 04) . Comparative analysis of the Sa:So ratios of the male 
cancer and non-cancer subjects also revealed that these levels were not significantly 
different (p = 0.6) . 
Analyses of the sera of meningioma patients (as this tumour subtype was the most 
frequently seen in this study) , revealed no positive correlations between serum levels of Sa 
and FBI (R = - 0 .505), nor So and FBI (R= - 048). Furthermore, there was no correlation 
between the serum FBI and Sa levels of the 50 brain cancer subjects (R= - 0.38) . 
A further complication in the potential use of the Sa:So ratio lies in determining the 
' normal' levels of Sa and So, since this and previous studies in human and animals have 
demonstrated considerable inter and intra-individual variation in the Sa: So ratio over time. 
As individual levels vary widely, repeated serum analyses on an individual may be 
necessary and this would detract from its usefulness as a biomarker. The sexual differences 
in the Sa: So ratios, as well as the diet and foods consumed by the su bj ects prior to testing 
would also need consideration. 
Limiting variables in the study included the sample size; limited volumes of blood and the 
inability to match all subjects for age and gender. The serum analyses reported in this study 
reveal that the general public are exposed to FBI at varying levels, probably via the 
ingestion of commercially available foods (although this route could not be verified in this 
study). A conceptual framework and data are presented that possibly contests the primary 
use of the Sa:So ratio as a biomarker for a dose response of FBI-induced inhibition on 
sphingolipid metabolism, or as a biomarker for brain cancer in human subjects. The 
potential exists that FBI may be a contributing factor by its mere presence in sera, but not a 
primary cause in the aetiology of brain cancer in the participants in this study, unless it can 
be located directly within the brain tumour tissue. The analysis of the data from these 
volunteers from KZN suggests that the serum Sa:So ratio may not be useful as an indicator 
or biomarker of fumonisin exposure in human subjects. 
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CHAPTER 10 
Ultrastructural and immunochemical analyses of brain 
carcinomas for fumonisin Bl 
10. 1 INTRODUCTION 
One of the challenges in environmental health is to attribute a certain health effect to a 
specific environmental exposure, and to establish a cause-effect relationship. The supposed 
limited susceptibility of the brain to environmental diseases including cancers, due to the 
presence of the BBB, increases interest in neurotoxicological studies. This interest stems 
from the prevalence of these diseases such as cancer regardless of the level of protection of 
the brain. Diagnoses of neurological disease caused by fungi can be difficult as clinical 
signs are often ambiguous or similar to those found in other diseases, and histological 
lesions may be non-specific or absent (plumlee and Galey, 1994). Therefore, the diagnosis 
of diseases caused by neurotoxic mycotoxins depends not only on clinical history and 
lesions, but also on finding the specific mycotoxin in the tissue concerned in association 
with histopathological changes. 
Animal studies have shown that ELEM is characterised by severe oedema and multi-focal 
liquefactive necrosis predominantly in the white matter of the brain, although the grey 
matter may also be involved (Maras as et ai., 1988a). The causes ofELEM after FBI dose 
may be direct, via the mediated presence of Sa in brain (i.e., by direct inhibition of CER 
synthase in brain cells), or indirect, via FBI-induced hepatotoxicity and nephrotoxicity, 
disruption of barrier function of cultured endothelial cells, and damage to the cerebral 
blood vessels. Kwon et al. (1997a) have shown that small amounts of FBI entered brain 
tissue in developing rats and increased Sa levels, and that plasma Sa elevation due to FBI 
exposure probably did not contribute to the elevation of brain Sa levels. Altered brain Sa 
levels and Sa: So ratios indicate that sphingolipid metabolism in the CNS of developing 
rats was vulnerable to FBI exposure (Kwon et al., 1997a). Alteration of blood vessels in the 
CNS and/or disruption of the BBB may have had effects on the transfer of FBI or Sa into 
brain tissue (K won et aI., 1997b). 
Although F. moniliforme and fumonisins occur worldwide on maize products, this study 
was relevant in the South African context since population groups make preferential use of 
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visibly mouldy maize as an ingredient in the making of traditional home-brewed beers . In 
addition, studies by Dutton and Kinsey (1995) revealed high incidence of Fusarium species 
of fungi in over 70% in maize and maize containing feeds, drawing attention to the actual 
and potential presence of fumonisin in the food chain in SA 
In Chapter 9, the analyses of sera from both brain cancer and non-cancer volunteers from 
KZN suggests that the serum Sa:So ratio may not be ideal as an indicator or biomarker of 
fumonisin exposure in human subjects. However, it was established that FBJ was detected 
in the serum of both non-cancer (76.7±62.2nM) and brain cancer subjects 
(107.38±116nM). The potential exists that FBI may be implicated in the aetiology of brain 
cancer by its mere presence in sera of brain cancer subjects . In order to test this hypothesis, 
human brain tumour tissues from the majority of subjects who provided sera for analysis in 
Chapter 9, and non-tumour tissue specimens were examined to determine whether any 
association exists between FBI presence and human brain cancer. This study was 
conducted in collaboration with WWH, and the Departments of Neurosurgery and 
Physiology, UKZN. 
Brain tissue specimens were screened for the presence of FBI using IHC, employing LM in 
conjunction with EM, and immuno-electron microscopy. When FBI was immunolocalised 
within necrotic tissue, the histopathology of the tissue was analysed in relation to the 
localised mycotoxin. Image analysis was also applied for quantitation of FBI within brain 
tissue. 
10.2 MATERIALS 
Materials used in this chapter were as described in Chapter 6, Section 6.2.1, unless otherwise 
indicated . In addition, LM materials (e.g., paraffin wax and specimen holders), 
Poly-L-Lysine, a Pap delimiting pen, aminoethyl carbozole (AEC) chromogen and beem 
capsules were purchased from Capital Enterprises, SA All organic solvents were purchased 
from MERCK. An automatic tissue processor (Shandon) was used to process the tissues 
for LM at the Department of Anatomical Pathology. A Leica Jung RM2035 rotary 
microtome was used to section wax-embedded tissue specimens, and a Reichert Ultracut 
ultramicrotome was used to section resin-embedded sections at the Optics and Imaging 
Centre, UKZN. The H&E stained sections of the normal and brain tumour tissues were 
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viewed and photographed on a Zeiss photomicroscope using a Nikon FX camera. A Nikon 
Optiphot photo microscope, a Sony 3 charged couple device (CCD) colour video camera 
and the Kontron Elektronik Imaging System 300 software programme (KS 300) were used 
for image analysis at the Optics and Imaging Centre, UKZN. The JEOL 1010 TEM was 
used at the Electron Microscope Unit, lJKZN for all electron microscopic analyses. 
10.3 MEmODS 
10.3.1 Collection of specimens 
Sixty-three brain tumour tissue biopsies were obtained on surgical removal of the tumours 
from brain cancer patients examined at WWH, KZN. In addition, 16 non-cancer brain 
tissue specimens were obtained at autopsies at King Edward Vln Hospital mortuary 
(Appendix 10.1). Twelve wax-embedded brain tumour specimens were also obtained from 
the Department of Anatomical Pathology, lJKZN. Due to ethical considerations, it was not 
possible to age or sex match the brain tumour tissue samples analysed with appropriate 
non-tumour controls. 
Specimens were placed into appropriate fixatives to avoid autolysis and bacterial 
degradation . Fresh specimens were cut into small pieces and immersed In 
Karnovsky's (1965) fixative (pH 7.2) (Appendix 10.2) in O.2M sodium cacodylate buffer 
for TEM. Specimens for ICC were immersed in glutaraldehyde (1 %) in phosphate buffer 
(pH 7.4), and those for LM in 5% formal saline (41% formaldehyde/0 .9% sodium chloride 
(NaCl), 1:8 v/v) dilute formaldehyde (35%) 1:7 in 0.9% NaCI. Specimens were transported 
to the laboratory in sealed vials in this manner. 
Twelve wax-embedded kidney tissue specimens of male Fischer 344 rats fed dietary FBI at 
concentrations ranging from 750 to 25mg.kg- 1 diets for a period of 21 days were obtained 
from the MRC, Tygerberg, SA, courtesy of Dr WCA Gelderblom and Prof WFO Marasas. 
The animal care and use protocol was approved by the Ethics Committee affiliated to the 
.MRC for research undertaken by PR011EC. The selection of rat kidney tissue as a method 
control was based on the fact that cancer induction by FB I was previously investigated by 
studying the mechanisms involved during cancer initiation and promotion in rat kidney in 
this species of rat (Gelderblom et ai, 1993; 1994). In addition, N2a. neuroblastoma cells 
were grown and treated with FBI as described in Chapter 6, Section 6.2.2.1,6.2.4, and 
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6.2.6. These cultured cells were also used as method controls In the IHC technique 
applications. 
Both formalin fixed paraffin embedded (FFPE) kidney tissue sections and non-FFPE 
specimens in the form of the cultured N2a cells, were used as parallel controls in all IHC 
work to verify specificity and sensitivity of the immunological interactions of the 
antibodies for FBI. Since masking of antigenic sites occur with formalin fixation, the 
positive labell i ng of the FB I-treated rat kidney sections verified sensitivity of the method, 





Brain tissue specimens were processed for LM using conventional techniques. Specimens 
immersed in 5% "formal saline" (41% formaldehyde/0.9%NaCI, 1:8 v/v = dilute 
formaldehyde (35%); 1:7 in 0.9% NaCI) were fixed at RT for 12 hours. Samples were 
orientated and placed in tissue cassettes, dehydrated through a series of ethanol (ethanol 
99%), cleared with xylene, and infiltrated with paraffin wax in an automatic tissue 
processor (Shandon). Specimens were then embedded in cassettes and polymerised at 
60°e. 
Tissue sections were cut at 2iJ.m thickness using sterile disposable blades on a rotary 
microtome (Leica lung, RM2035), and heat fixed onto poly-L-Iysine coated glass slides for 
THe. These sections were baked on a hot plate at 60°C for 10 min. prior to cooling then 
dewaxing. Slides for histology were stained routinely with haematoxylin and eosin (H&E) 
(Humason, 1972). 
The procedure employed for mc is outlined in Table 10.1. All antibodies were diluted to a 
pre-determined appropriate dilution factor, using a 1 % BSA (w/v) in PBS (pH 7.4) solution 
as the diluent. The use of method controls involved the omission of the primary antibody 
and its replacement with PBS or with a non-immune serum of the same IgG class. The 
FBI-treated and untreated N2a cells (described in Chapter 6) were used as positive and 
negative controls respectively in conjunction with the FFPE rat kidney tissue specimens 
obtained from untreated control and FBI-treated Fischer 344 rats. 
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The H & E sections of the normal and brain tumour tissues were viewed and photographed 
on a Zeiss photomicroscope using a Nikon FX camera. The tissue sections used for IHC 
were viewed on a Nikon Optiphot photomicroscope and the images were captured on a 
Sony 3CCD colour video camera. Image analysis of the captured images was performed 
using the KS 300 image analysis system 
Table 10.1: Specimen processing schedule for immunohistochemistry using the 
peroxidase anti-peroxidase method. 
Procedure Time (min.) 
Heat fixed specimens on to slides on a heating tray 10 (at 60°C) 
Cooled slides to RT 5 
Dewaxed in 100% xylene 2 
Dewaxed in 100% xylene 2 
Dehydrated in 70% EtOH 2 
Dehydrated in 90% EtOH 2 
Dehydrated in 100% EtOH 2 
Dehydrated in 100% EtOH 2 
Drop washed in distilled water (20 ml) 2 
Delimited specimen with Pap pen 
Placed in a dro~let of distilled water (200 Ill) 1 
Incubated in 0.5% hydrogen Qeroxide (H20 2) in MeOH (200~l 30 
Poured off MeOH 
Drop-washed in PBS (pH 7.4)(20ml) 
Immersed specimens in 10mM sodium citrate buffer (PH 6) 20-30 (at 95°C) 
Cooled slides to RT in the 10mM sodium citrate buffer (pH 6) 20-30 
Drop-washed in PBS (pH 7.4)(20ml) 10 
Incubated in 1 % BSA in PBS (pH 7.2) (blocking agent) (50f,Ll)# 20 
Blotted off excess blocking agent with fibre-free paper 
Placed specimen in primary antibody (mouse anti-FB I) (l: 100) Overnight incubation, 4°C, 
(1 00~1)# 15-16 hours in moist chamber 
Drop-washed in PBS (pH 7.4) (20ml) 
Placed in secondary antibody (Goat anti-mouse IgG) (l :200) 120 
(100~1)# 
Drop-washed in PBS (pH 7.4) (lOml) 
Placed in PAP raised in mouse (PAP soluble complex antibody 120 
developed in mouse) 0:400) (lOO/lll 
Drop-washed in PBS (pH 7.4)(10ml) 
Stained with DAB (0.5% DAB in 0.01 % H20 2) or AEC 3-5min. with checking 
Drop-washed with distilled water (20ml) 3 
Stained with haematoxylin 3min. with checking 
Blued in ammoniated water (1% v/v) or hot water (60°C) 5 
Cover-slipjled specimens using glycerol jelly 
#During all incubation periods, slides were placed in a humidity chamber to prevent drying of 
specimens. 
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10.3.2.2 Evaluation of immunohistochemical staining using image analysis 
Using image analysis, quantitative data were generated on the presence of FBi from the 
immuno-stained brain tissue specimens. Initially, tissue sections were examined, and areas 
of interest were photographed with a Nikon binocular Optiphot photomicroscope using 160 
ASA colour film (Eastman-Kodak, USA). Subsequently, all fields of interest were digitised 
with a 3CCD Sony colour video camera interfaced with the Nikon Optiphot microscope 
that was linked to the KS300 image analysis system. 
Areas of interest were viewed at an initial magnification of 40 times, prior to storage as a 
digital image (Figure I 0.1 a). A scale bar was then inserted on a graphics overlay and 
merged onto the image plane prior to storage as a 24 bit tagged image format. Due to the 
unavailability of a true colour densitometric setting on the KS300 system used, all images 
were converted into grey images (Figure 1O.lb). A true colour densitometric system would 
enable one to read the intensity of the DAB or AEC reaction as a range on a colour scale. 
However, in this system, the intensity of the grey image was represented as numbers 
ranging from black (0) to white (255). Automatic contrast adjustment of the grey image 
was performed on all digitised images (Figure 10.lc). All results reflect this uniform 
contrast enhancement. 
The immunoreactive areas were easily detected, appearing dark grey to black on the image. 
These regions were segmented from the image on the basis of their grey scale. This process 
created a binary image containing only 2 grey values, 0 and 255, (Figure 10.lc) which 
defined the immunoreactive area (white) to be analysed. A grey scale value of zero was 
black and a grey scale value of 255 was white. The grey values in between were displayed 
in grey increments. Binary images were a necessary transition step from original to the 
quantitative data, and defined the areas that were to be analysed. Sometimes, filling holes 
in certain selected regions or deletion of regions in a specified size range was necessary 
(Figure 10.1 d). 
The frame area was defined according to the shape and sIze of the area of interest. 
Immunoreactive regions were expressed as a percentage of the frame area. For quantitative 
purposes, the image was geometrically calibrated according to the initial magnification. 
The immunoreactive regions were expressed as a percentage of the frame area. A record of 
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measurements was extracted from the binary Image according to pre-defined specific 
features . 
To validate the regions measured, a draw mask (segmented areas) of the binary image was 
superimposed onto the original image plane (Figure 10.1 e). Measurement values consisted 
of the defined measurement parameters as a data-list and were stored in a data base file 
The pre-defined measurement parameters and their definitions are listed in Appendix 10.3 
(Tables AI0 .2 and A10.3). The results of image analysis are tabulated in Appendix lOA 
(Table A10A). 
10.3.2.3 Transmission electron microscopy and immuno-electron microscopy 
Specimens collected for TEM and ICC were diced into ~ 1 mm3 pieces using sterile blades. 
Tables 10.2 and 10.3 outline the specimen processing schedules for TEM and ICC, and 
differ from the schedules used for the cultured cells in Ch 6. All incubation steps were 
carried out at RT, unless otherwise indicated. Araldite and Spurr epoxy resins were the 
embedding media used for TEM and ICC, respectively . During all stages of processing, 
specimens were kept immersed to ensure complete and effective specimen processing. 
Table 10.2: Processing schedule for tissue specimens for transmission electron 
microscopy. 
Procedure Time (min.) 
Fixation in Kamovsky ' s fixative in 0.2 M sodium cacodylate (5ml) 60 
Rinsed in 0.2 M sodium cacodylate buffer (2ml) 10 
Rinsed in 0.2 M sodium cacodylate buffer (2m!) 10 
Post fixed in 1 % osmium tetroxide in 0.2 M sodium cacodylate (4°C) 60 
Rinsed in 0.2 M sodium cacodylate buffer (2m!) 10 
Rinsed in 0.2 M sodium cacodylate buffer (2m! 10 
Dehydrated in 70% EtOH (lOrn!) 30 
Deh}'drated in 90% EtOH (1 Om I) 30 
De~~drated in 100% EtOH (1 Oml) 30 
Dehydrated in 100% EtOH (1 Oml) 30 
Infiltrated with propylene oxide 30 
Infiltration with propylene oxide: Araldite resin (l : 1) (5ml) 30 
Infiltrated specimen with Araldite resin (5 ml) 60 (at 60°C) 
Discarded old resin, infiltrated specimen with fresh Araldite resin (5 ml) 60 (at 60°C) 
Discarded old resin, infiltrated specimen with fresh Araldite resin (5 ml) 60 (at 60°C) 
Embedded specimen in beem capsules with Araldite resin 24-48 hours (at 60°C) 
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Ultramicrotomy was performed on the specimens fixed for TEM. To ensure that the resin 
embedded specimens analysed were in the tumour region, semi-thin (1 ~m) sections were 
cut with a Reichert Ultracut ultramicrotome using glass knives. Sections were collected 
onto glass slides, heat-fixed, then stained with 1% Toluidine blue (1%) in a distilled 
water:acetone (1: 1, v/v) solution containing borax (10%, w/v) (Humason, 1972). 
Specimens were examined on a Nikon Optiphot microscope and areas of interest were 
selected, trimmed, and sectioned. Sections (50nm) were picked up on copper grids 
(200 mesh) and stained with uranyl acetate (1%) followed by lead citrate (Reynolds, 1963) 
(Appendix 6.2) prior to viewing on the JEOL-TEM. 
Table 10.3: Processing schedule for tissue specimens for immunocytochemistry. 
Procedure Time (min.) 
Fixation of tissue in 1 % glutaraldehyde in PBS (pH 7.4) (Sml) 30 
Washed specimens in PBS (2 ml) S 
Washed specimens in PBS (2 ml) 5 
Dehydrated in SO% EtOH (lOml) 20 
Dehydrated in 70% EtOH (I Oml) 20 
Dehydrated in 90% EtOH (10ml) 20 
Dehydrated in 100% EtOH (lOml) 60 
Dehydrated in 100% EtOH (1 Om I) 60 
Infiltrated specimen with Spurr epoxy resin: absolute alcohol (1: 1) (S ml) 30 
Infiltration of specimen with absolute epoxy Spurr resin 90 (at 60° C) 
Infiltration of specimen with absolute Spurr epoxy resin 90 (at 60°C) 
Embedded specimen in Spurr epoxy resin 24-48 hours (60°C) 
Ultramicrotomy was also performed on the specImens fixed for immuno-electron 
mIcroscopy, as for the specimens fixed for TEM. For ICC however, following 
identification of the areas of interest, the fields of interest were located on the block face, 
and the block trimmed to produce a "mesa" with a trapezoidal shape. Ultra-thin pale-gold 
sections (50-60 nm) were cut and collected onto uncoated 200 mesh nickel grids prior to 
immuno-electron labelling. The post-embedding labelling schedule utilised for the 
immuno-electron localisation of anti-FBI antibody was as outlined in Chapter 6, Table 6 .3. 
The use of method controls involved omission of the primary antibody and its replacement 
with PBS . The resin embedded FBI-treated and control N2a cells were used as the positive 
and negative controls respectively. Specimens were processed for ICC according to the 
outlined method (Chapter 6, Table 6.3). The primary antibody used was monoclonal mouse 
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anti-FB I and the secondary antibody was goat anti-mouse IgG, conjugated to 10nm gold 
probes. Following labelling, the specimens were double stained with uranyl acetate and 
Reynolds' lead citrate for 2-3 minutes respectively (Reynolds, 1963). All specimens were 
viewed and photographed on the lEOL 1010 TEM. Images were photographed using 
Kodak fine grain electron sensitive plate film or digitised. 
10.4 RESULTS AND DISCUSSION 
10.4.1 Light microscopy 
Criteria used to classify the neoplasms are based on cytoplasmic features, recognised by LM 
examination, either with routine stains or by immunological or histochemical techniques 
separately, or in combination with EM. Histological analyses of H & E stained tissue from 
normal and the most prevalent brain tumour subtypes analysed in this study are discussed 
briefly. 
10.4.1.1 The blood brain barrier 
The CNS differs from other tissues with regard to neoplasia, in that from its well-protected 
position, it is not easily exposed to the various exogenous physical and chemical agents, 
which may constitute determining factors in many cancers of epithelia of the body. Tissues of 
the brain and spinal cord may only be affected by such agents by way of circulating blood . 
The capillaries of the CNS had flattened endothelial cells resting on a basement membrane. 
The endothelial cells were not fenestrated, and were bound together by continuous tight 
intercellular junctions except in the choroid plexus where this was discontinuous 
(Figure 10.2) The choroid plexus arises from the walls of the ventricles of the brain, and 
produces CSF. Each choroid plexus consisted of a mass of capillaries projecting into the 
ventricle, and by modified ependymal cells that were separated from the delicate underlying 
capillaries and supporting tissue by a basement membrane. Long bulbous microvilli projected 
from luminal surfaces of the choroid epithelial cells. The capillaries of the choroid plexus 
were large, thin-walled and occasionally fenestrated . Continuous tight junctions formed a 
blood-CSF barrier preventing ingress of almost all other molecules . Glucose (at about 70% 
plasma concentration) and small amounts of protein are normal constituents of CSF 
(Burkitt et al., 1993). 
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Externally, the basement membranes were completely covered by perivascular foot processes 
of astrocytes. Maintenance of barrier type endothelium appeared to be under the control of 
astrocyte foot processes. A thin layer of the pia mater extended down into the CNS around 
small arteries, veins, arterioles and venules, but were absent around capillaries of the CNS. 
This could potentially be an entry point for xenobiotics to the brain. 
The cerebellar cortex formed a senes of deeply convoluted folds or folia supported by a 
branching central medulla of white matter. The cortex consisted of three layers (Figure 10.3a). 
The outer molecular layer contained relatively few neurons and large numbers of unmyelinated 
fibres. The inner granular cell layer was extremely cellular, and between the two was a single 
layer of huge neurons called Purkinje cells (Figure 10.3b). Purkinje cells had large cell bodies, 
a relatively fine axon extending down through the granular cell layer, and an extensively 
branching dendritic system that arborised into the outer molecular layer (Figure 1O.3b). 
10.4.2 Histological analysis of the brain tumour tissues 
Starting in the meninges, meningiomas are usually solid masses, and their cells tend not to 
infiltrate adjacent normal tissue. Histologically, meningothelial meningioma were often 
characterised by tumour cells that were oval with indistinct borders, often with vacuolated 
nuclei (Figure 10.13). The specimen shown in Figure lOA illustrates the structural pattern 
of a transitional meningioma and consists of diffuse sheets of spindle-shaped cells. The 
nuclei of tumour cells were ovoid and uniform, with only an occasional pyknotic form 
present and their cytoplasm was abundant and eosinophilic. Two rudimentary whorls are 
visible with the cells arranged circumferentially around a central vascular space 
(Figure lOA). 
Glioblastoma multi forme is a highly malignant astrocytoma (grade IV). The majority are of 
astrocytic origin, although some undifferentiated ependymomas and oligodendrocytomas 
may have a similar histological appearance. These tumours grow rapidly and invade nearby 
tissue, and contain cells that are very malignant. Glioblastoma multiforme is usually 
located in the cerebral white matter, but is often deeply seated in the basal ganglia and 
thalamus (Curan and Jones, 1991). The anaplastic astrocytoma illustrated in Figure 10.5 
displayed glioblastomatous transformation. One part of the tumour was a poorly 
differentiated fibrillary astrocytoma cellular tumour composed of elongated cells. There 
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were several blood vessels, and the one in the centre shows endothelial cell proliferation. 
On the right, there is a band of necrosis with palisading of the tumour cells along the 
margins of necrotic tissue. 
The three most common types of pineal region tumours are gliomas, germ cell tumours, 
and pineal cell tumours. The PNETs usually affect children and young adults, and are 
usually very malignant. Other PNETs include neuroblastomas, pineoblastomas, 
medulloepitheliomas, polar spongioblastomas, and ependymoblastomas. Medulloblastomas 
are the most common PNET. Figure 10.6 illustrates a highly malignant undifferentiated 
medulloblastoma from the posterior fossa that consists of sheets of elongated cells, with 
ovoid or round nuclei in which there are very prominent nucleoli. Numerous mitotic 
figures were visible and many nuclei were pyknotic. No definite rosettes were observed. 
The stroma was sparse and consisted largely of small blood vessels. The tumour cells had 
scanty cytoplasm and poorly defined cell boundaries. Some nuclei displayed prominent 
nucleoli and mitotic activity was high. 
Tumours of the choroid plexus are usually located in the fourth ventricle, and less so in the 
lateral and third ventricles . The specimen in Figure 10.7 is an adenoma of the choroid 
plexus. This tumour consisted of many papillae, the surface of which was covered with a 
single layer of columnar epithelial cells. The epithelial cells had strongly eosinophilic 
cytoplasm and small round nuclei. The smaller papillae had a core consisting of a thin 
strand of vascular connective tissue. The cores of the larger papillary processes were more 
fibrous. The structure of the papilloma reflected that of the normal choroid plexus 
(Figure 10.2). 
10.4.2.1 Immunohistochemical analyses of brain tissue specimens 
Formalin fixed tissue required an antigen retrieval step before mc staining could be done 
due to the formation of methylene bridges during fixation. These bridges that cross-link 
proteins mask the antigenic sites. In this study, a heat-mediated antigen retrieval method 
was employed that served to break the methylene bridges, and so expose the antigenic sites 
in order to allow the antibodies to bind. The concept of recovering lost immuno-reactivity 
through exposure to heat near the boiling point of water was first met with scepticism as it 
went against the tenet of protecting proteins from the denaturing effect of heat (Key, 2001) . 
However, Cattoretti and Suurmeijer (1994) were successful when employing a citrate 
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buffer of pH 6. In this study, sodium citrate buffer (pH 6, Table 10 1) was the antigen 
retrieval agent of choice, and improved the IHC detection ofFB\ in the FFPE brain tumour 
tissue sections. 
With peroxidase-labelled antibody techniques, the presence of enzymatically active 
peroxidase, catalase, and haemoprotein in the tissue, that are all capable of reacting with 
H20 2 and reducing DAB, has the ability to confuse the final location of the antigen. This 
was a problem in the FFPE sections, although much of the native enzyme activity was 
destroyed during the processing. Blocking the endogenous "peroxidase" with H20 2 at the 
start of the procedure was suggested (Heyderman, 1979), and was found to be effective. 
This ensured that non-specific binding of the DAB or ABC chromogen to tissue 
constituents did not produce a false-positive result. 
Reagent and tissue controls were necessary for the validation of mc staining results in the 
FFPE tissue specimens. The antibody specificity was verified using the FBI-treated and 
untreated N2a cells that were not FFPE (Chapter 6; Figures 6.4-6.10). The mc method 
specificity was verified with the kidney tissue from FBI-treated and untreated male Fischer 
344 rats. The primary objective of using the rat tissue was to ascertain whether the primary 
and secondary antibodies were specific for their target antigens within the FFPE tissues 
following the antigen retrieval step. For this reason the cultured cells could not be used as 
method controls alone, as they were processed in a dissimilar way, and were neither 
exposed to formalin fixation nor antigen retrieval. The rat kidney tissues used as method 
controls where the primary and secondary antibodies were omitted respectively, lacked 
non-specific binding of the antibodies or the DAB chromogen to tissue constituents 
(Figures 10.8 and 10.9). The absence of non-immunological FBI staining in the untreated 
control rat kidney tissue therefore further confirmed the specificity of the mc method 
applied. 
Cancer induction by FBI exposure was previously investigated by studying the 
mechanisms involved during cancer initiation and promotion in rat kidney in the 
Fischer-344 rats (Gelderblom et aI., 1993; 1994). With this in mind, these kidney tissues 
were obtained from these authors and used as method controls for the mc method 
specificity for FBI. It was understood that with this kidney tissue method control, parallels 
could not be drawn with regards to the mechanism of cancer induction by FBI in these 
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tissues, as brain and kidney tissues differ significantly in structure and function and their 
biochemical profiles. 
Figure 10.10 illustrates the immunochemical-staining pattern of FBI within the kidney of a 
FBdreated Fischer-344 rat, and reveals the localisation of FBI in the distal convoluted 
tubules, and within the lumen and cells of the proximal convoluted tubules (peT). The 
results of the present study concur with earlier findings of Gelderblom et at. (1993; 1994), 
who reported that the most prominent toxic lesions by FBI in the kidneys were restricted to 
the tubular epithelium manifesting as necrosis, apoptosis, calcification and the presence of 
regenerative foci , and scant necrosis in the peT. Although not an objective, unique to this 
present study was the direct immunolocalisation of FBI in the Fischer 344 rat kidney 
tissue, unlike in previous studies where the potential presence of FBI in the tissue was 
based on histopathological changes in the tissue following a known exposure to this 
mycotoxin. The polarity of the FBI molecule would enable rapid excretion and therefore it 
was expected that the kidneys would be at risk. These results support the hypothesis that 
one of the primary target organs of FBI in the rat is the kidney. More importantly for this 
study is that these results illustrate the immunospecificity of the IHe method. 
Human populations differ in their responses to environmental contaminants, and FBI 
exposure in humans is probably exclusively dietary. The severity of health effects depends 
largely on the magnitude of exposure, and exposed individuals would be expected to vary 
both on specific health effects, and the degree to which they are affected. The results of the 
individual me analyses of the brain tumour specimens for FBI are summarized in 
Table lOA. Figures 10.11 and 10.12 are light micrographs ofa non-cancer brain specimen 
that was non-immunoreactive for FBI, and the method control where the primary antibody 
was omitted on a brain tumour specimen respectively . 
Immunohistochemical analyses of the 76 wax embedded brain tumour specimens revealed 
FBI presence at varying levels in 49 of these specimens (64.47%) . Fumonisin BI was also 
minimally detectable in two of the 16 FFPE non-cancer brain specimens. 
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Table 10.4: Immunohistochemical detection of fumonisin Bl in brain tumour tissues. 
Tumour subtypes/subgroups No. of Mean Male Female 
and IHC positive samples specimens Age 
Al W C A W C 
Meningiomas 23 40.91 6 3 1 1 5 2 2 3 
IHC POSITIVE 18 6 2 0 0 4 2 2 2 
Glioblastoma multifonne and 10 14.73 3 2 0 1 1 2 0 I 
gliomas 
IHC POSITIVE 6 2 1 0 0 1 1 0 1 
Medulloblastoma 9 9.22 8 1 0 0 0 0 0 0 
IHC POSITIVE 7 7 0 0 0 0 0 0 0 
Astrocytoma 7 16.57 4 0 0 0 I 1 0 1 
IHC POSITIVE 4 1 0 0 0 1 1 0 1 
Pituitary Adenoma 6 52 .6 4 0 0 1 0 0 0 1 
IH C POSITIVE 4 3 0 0 1 0 0 0 0 
Metastatic adenocarcinoma 4 52.75 1 0 1 1 0 1 0 0 
IH C POSITIVE 3 1 0 0 1 0 1 0 0 
Craniopharyngioma 2 9.5 1 0 0 0 0 1 0 0 
IH C POSITIVE 2 1 0 0 0 0 1 0 0 
Posterior fossa tumour 3 12.5 2 1 0 0 0 0 0 0 
IHC POSITIVE 0 0 0 0 0 0 0 0 0 0 
Transphenoidal excision of 2 34.5 0 0 0 0 2 0 0 0 
tumour 
IH C POSITIVE 0 0 0 0 0 0 0 0 0 
Cerebellar hemangioblastoma 1 57 1 0 0 0 0 0 0 0 
IH C POSITIVE 1 1 0 0 0 0 0 0 0 
Choroid plexus papilloma 1 14 1 0 0 0 0 0 0 0 
IHC POSITIVE 1 1 0 0 0 0 0 0 0 
Pineo blastoma 1 11 0 0 0 0 1 0 0 0 
IHC POSITIVE 1 0 0 0 0 1 0 0 0 
Neurofibroma 1 30 0 0 0 0 1 0 0 0 
IH C POSITIVE 1 0 0 0 0 1 0 0 0 
Plasma cell neoplasm 1 54 0 0 0 0 0 0 I 0 
IH C POSITIVE 1 0 0 0 0 0 0 1 0 
Acoustic schwannoma 1 51 0 0 0 0 1 0 0 0 
IHC POSITIVE 0 0 0 0 0 0 0 0 0 
Occipital craniotomy 1 6 0 0 0 0 1 0 0 0 
IHC POSITIVE 0 0 0 0 0 0 0 0 0 
Left frontal cystic tumour 1 59 1 0 0 0 0 0 0 0 
IH C POSITIVE 0 0 0 0 0 0 0 0 0 
Suprasellar tumour 1 5 0 0 0 0 1 0 0 0 
IHC POSITIVE 0 0 0 0 0 0 0 0 0 
Orbital tumour 1 34 0 1 0 0 0 0 0 0 
IHC POSITIVE 0 0 0 0 0 0 0 0 0 
Total specimens analysed 76 
Total positive specimens 49= 64.5% 
1 A=African, I=indian, W= white, C= coloured 
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Of the 76 brain tumour specimens analysed for presence of FBI using IHC, only 38 were 
matched with serum analyses for FBI , Sa, So and the Sa So ratios (Table 10.5). Of the 38 
samples, 23 showed presence of FBI while 15 did not. The matched mean serum FBI 
concentration in the 23 FBI positive tissue specimens was 118.33 ±114.03nM, and for the 
15 brain tissue specimens where FBI was undetectable, the mean serum FBI concentration 
was 67.46±51.20nM. These values indicate that, although not significantly different 
(p=O .11), the cancer group showing FB I presence within the tu mour tissue had a higher 
level of FBI in the circulation than the cancer group without FBI immunolocalised within 
tissue. Matched serum samples were not obtained from non-cancer patients from whom 
brain tissue was obtained, as these were removed at autopsies at King Edward VIII 
Hospital mortuary. However, the results from Chapter 9 indicate FB I was detected in the 
serum of the non-cancer serum volunteers at a level of 76.7±62.2nM. 
The possibility that FB I may have been stored in the tissues when ingested via the diet over 
time in these cancer patients was a factor considered in the present study. A hypothesis 
exists that on consumption of foods contaminated with Fusarium fungi, compounds present 
in the fungi might alkylate DNA and participate in the induction of tumours 
(Howard et ai, 2001). Support for this hypothesis comes from Bever et ai (2000) who 
reported that the incubation of methanolic extracts of Fusarium cultures with DNA in the 
presence of rat liver S9 proteins resulted in the formation of DNA adducts. The 
chromatographic characteristics of these unidentified DNA adducts suggest they were 
hydrophobic (Bever et ai, 2000). 
In addition, interference with sphingolipid metabolism in response to sustained FB I 
exposure may represent a plausible mechanism by which this mycotoxin may have induced 
mitogenesis (Yoo et ai, 1992; Merrill et ai, 1993a; 1993b; Schroeder et ai, 1994). 
Chronic fumonisin induced disruption of sphingolipid metabolism has also been 
hypothesized to be a contributing factor leading to cellular deregulation and organ toxicity 
(Merrill et al., 1993c; Riley et ai, 1994b; Schroeder et ai, 1994; Tolleson et at., 1996a; 
1996b; 1999). 
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Table 10.5: Immunohistochemical detection of FBI in human brain tumour tissue specimens 
with matched serum sphinganine, sphingosine and FBI levels. 
Sex Age Race Tumour Subtype Tissue Serum Serum Serum 
me FBI So Sa Serum 
(oM) (uM) (oM) Sa:So ratio 
M 57 A Cerebellar hemangioblastoma + 167 83.9 116 1.38 
M 14 A Choroid plexus twnour + 84.7 148 115 0.78 
M 56 A Excision of tumour + 60 192 147 0.77 
M 1.3 A Glioblastoma multiforme + 34.7 185 521 2.82 
M 10 A Medulloblastoma + 298 92.3 105 1.14 
M 40 A Meningioma + 65.8 58 83.8 1.44 
F 25 A Meningioma + 283 58.1 148 2.55 
F 42 A Meningioma + 25.7 229 949 4.14 
F 44 A Meningioma + 312 91.6 105 1.15 
F 32 A Meningioma + 49 .6 422 565 1.34 
F 47 A Meningioma + 101 78 .9 93.6 1.19 
M 11 A Occipital tumour + 31.8 162 689 4.25 
F 5 A Pilocytic astrocytoma + 73.4 517 387 0.75 
M 35 A Pituitary adenoma + 226 185 359 1.94 
M 21 A Pituitary Adenoma + ND 50.2 88.4 1.76 
M 67 A Pituitary Thoraco adenoma + 420 299 120 0.4 
M 4 A jPosterior fossa tumour with presence + 
of medulloblastoma 38.4 60.2 84.5 1.4 
F 17 I CICmial pha1}lngioma + 24.2 380 1210 3.18 
M 25 I Meningioma + 59.7 240 456 1.9 
F 64 I Meningioma + 99.6 208 182 0.88 
F 51 I Meningioma + 64.2 74.4 148 1.99 
F 42 W Meningioma + 32 389 420 1.08 
F 61 W Meningioma + 52.3 214 448 2.09 
33.5± 118.3± 192.1±13 327.8± 1.8±1.0 
20.7 114.0 1.98 302.6 
M 14 A Medulloblastoma - 56.4 56.4 ND ND 
M 23 A Haemorrhagic lateral ventricle -
tumour 33.4 74.4 60.7 8.16 
F 29 A Meningioma - 88.8 378 205 0.54 
M 59 A Metastatic cancer. Left frontal cystic -
tumour 213 98.9 95.2 0.96 
M 15 A Pilocytic astrocytoma - 30.4 345 305 0.88 
M 35 I Meningioma - 23.7 29.5 ND ND 
F 6 A Pineoblastoma - 24.2 297 1290 4.34 
F 49 A Transphenoidal excision of tumour - 56.3 160 418 2.61 
M 34 I Neurilememmoma - 39.8 47.9 82.1 1.71 
M 10 I Posterior fossa tumour - 61.2 393 417 1.06 
M 30 W Meningioma - 58.8 203 765 3.77 
M 51 W Meningioma - 23.2 207 357 1.72 
M 20 A Posterior fossa tumour - 79.7 271 204 0.75 
F 25 W Meningioma - 83 87.9 103 1.17 
F 53 W Metastatic Carcinoma - 140 248 325 1.31 
30.2± 67.5± 193.1± 355.9± 
16.6 51.2 125.1 340.5 2.2±2.1 
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Key: 
A I W M F + - ND 
African Indian White Male Female FBI FB I not Not Detectable 
detected detected 
In this study however, analyses of the matched absolute Sa and So serum levels, do not 
indicate any major differences between the IHC positive and negative groups . In the FBI 
ruC-positive cancer groups the Sa level was 327.84 ± 302.58nM, and the So levels were 
192.1±132nM, and in the FBI ruC-negative cancer group, the Sa levels were 
355 .9±340.5nM and the So levels were 193 .1±125.1nM respectively. The mean serum 
Sa:So ratio in the FBI ruC-positive samples was 1.76±1.03, and in the FBI IHC-negative 
group was 2.23±2.13. Tissue Sa and So levels were not assessed in this study. 
Since there are intra- and inter-individual differences in levels of exposure to FBI , as well 
as in the bioactivity of brain cell types, there was an expected gradient in the intensity of 
staining for the levels of FBI distribution in brain tumour tissue and cells (Figures 10.13 a-
c, 10.14). The intensity of FBI immunostaining in the brain tissue was considered 
proportional to the amount of toxin metabolised, ingested, and/or retained by the individual 
on intermittent dietary exposure. These variations were accompanied by varying serum 
levels of FBI , Sa and So in these patients (Table 10.5). 
Riley et al. (2001) proposed that differences in cell and tissue responsiveness to sphingoid 
bases, sphingoid base-I-phosphates, and/or CER-mediated effects on proliferation or 
apoptosis, are likely critical In FB I carcinogenicity and tumour promotion. 
These workers hypothesized that FBI-induced alterations in sphingolipid signalling 
pathways lead to altered rates of cell death and regeneration. In certain situations, CER 
synthase inhibited cells whose DNA is damaged may survive under conditions that would 
normally lead to their death from CER generated de novo. Conversely, inhibition of CER 
synthase can lead to the accumulation of sphingoid bases and their metabolites, which 
would also alter rates of cell death and proliferation. Given the minimal evidence for DNA 
reactivity of fumonisins, the carcinogenic risk from fumonisin may be related to its ability 
to increase the chance of survival of cells that have been DNA damaged by other means, or 
related to its ability to stimulate cell division directly . Other possible reasons include its 
ability to increase regeneration in response to increased cell death, or its potential to 
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increase the chances of survival of cells whose DNA is damaged through insensitivity to 
apoptotic effects of disrupted sphingolipid metabolism. 
Gelderblom et al. (1992; 1994) have indicated that fumonisins appear to be slow cancer 
initiators, because prolonged exposure of up to 14 days at a relatively high dosage was 
required to effect cancer initiation . Elsenhans et al.(1983) postulated that FBI is 
polyanionic, and may interfere with its own absorption by binding cations such as sodium, 
potassium and other large molecules. The presence of this mycotoxin in brain tissue in 
areas where there were no major lesions, as in the two non-cancer brain specimens where 
FB I was detected at very low levels, does not preclude the potential for persistent 
biochemical dysfunction in the tissue from contributing to brain lesions later on. 
The results of the present study concur with the findings of earlier studies by 
Prelusky et al. (1994), who indicate that following ingestion a fraction of FB I is absorbed, 
distributed and remains in tissues for an extended period of time. Ross et al. (1993) 
highlighted that length of exposure to a mycotoxin, level of contamination, individual 
differences, previous exposure or pre-existing organ impairment may all contribute to the 
appearance of clinical disease. 
The meningiomas were the most common tumour subtype analysed within this study with 
36.73% (18 of 49) of all the FBI mC-positive specimens histologically classified as 
meningiomas (Table 10.4) . This tumour subtype was common to subjects in all races and 
both sexes. These IHC findings are supported by the elevated Sa:So ratios and FBI 
concentrations found in the serum samples from these patients as discussed in Chapter 9. It 
is documented that FBI is a complete carcinogen in that it effects cancer initiation, 
promotion, and progression (Gelderblom et aI., 1991). Although no correlation (R =-0.23) 
was found to exist between the serum FBI and Sa: So serum levels in the patients with this 
tumour subtype (Chapter 9, Figure 9.8), it is possible that that the presence of this 
mycotoxin and the serum levels of FBI and the sphingoid bases may have contributed to 
disruption of sphingolipid metabolism in these patients potentially exacerbating, initiating 
or promoting brain carcinoma formation. 
The present study is the first to directly immunolocalise FB I in human brain tumour tissue, 
providing direct evidence that FBI crosses the BBB and interacts with the underlying 
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tissue. The immunolabelled specimens shown in Figures 10. I3a-c and 10.14 are 
meningiomas. With reference to the results of Chapter 9, the level of mean serum level of 
FBI in the patients with meningiomas was 10307 ± 98.09nM FBI and the mean serum 
Sa So ratio was 1.71 ± 0.98 (Chapter 9, Table 9.3). Meningiomas arise from the 
membranes that surround and protect the brain. Brain tissue is rich in complex 
sphingolipids that serve as important structural components of membranes . The loss of 
complex sphingolipid biosynthesis induced by FBI exposure alters cell behaviour, initiates 
cellular deregulation, and eventually leads to cell death. The fumonisin-induced increase in 
free Sa and depletion of complex sphingolipids contribute to inhibition of cell proliferation 
and increased cell death in some cell types. The consequences of disrupted sphingolipid 
metabolism are therefore cell type specific. It is possible that inhibition of brain CER 
synthase by fumonisins and the resultant depletion of sphingolipids may have led to 
disruption of sphingolipid metabolism, mitogenesis, and subsequent necrosis or malignant 
transformation. 
Cancer promotion by FBI may proceed via the induction of a growth differential because 
this mycotoxin has the potential to both increase the growth rate of pre-cancerous cells and 
arrest the growth of normal cells (Riley et at. , 1994b). The inhibitory effect of FBI on cell 
proliferation appears to be the reason why the fumonisins are slow cancer initiators . A 
threshold level for cancer initiation exists which, as a function of time, will be determined 
by the dosage used and the subsequent inhibitory effect on cell proliferation 
(Gelderblom et al., 1994). Microscopic and other findings suggest that an imbalance 
between cell loss and replacement develops a condition favourable for carcinogenesis. 
Gelderblom et al. (1988a; 1988b; 1992) reported both tumour promoting and initiating 
activity of FBI. These effects can be explained on the basis of sphingolipid metabolism 
disruption since DNA synthesis in cells is stimulated by the addition of sphingoid bases 
(Zhang et at. , 1990) and by exposure of FBI at doses that elevate sphingoid bases 
(Schroeder et ai , 1994) . 
Defects in cell cycle control have been shown to promote genomic instability and 
progression to malignancy (Hartwell and Kastan, 1994). The rates of cell proliferation and 
cell Joss, in conjunction with the differentiation status of a tissue, are among the many 
factors contributing to carcinogenesis Non-genotoxic chemicals such as FBI may affect 
this balance by increasing proliferation through direct mitogenesis, or through a 
321 
regenerative response following loss of cells through cytotoxic (oncotic) or apoptotic 
necrosis. For a given tissue, disruption of sphingolipid metabolism may cause some cells to 
die, some cells to cease growing and some to grow faster. If growth arrested cells are 
selected to enter the cell cycle inappropriately (by passing a cell-cycle checkpoint), 
increased genomic instability could result and consequently increased cancer risk . 
Mitogenic stimulation, which could be supported by food-borne factors, may provide more 
cells at risk in an enlarged target organ, and also increase cell replication rate. The latter 
would decrease the time for error-free DNA repair between replication, and increase the 
potential for any spontaneous chromosome breakage events (and repressor-gene deletion) 
that may be associated with the replication process (Institute of Food Technologists, 1993). 
Fumonisins acting as mitogens, could increase the probability or irreversibly lock in a 
spontaneous genomic error in vivo in the brain tissue. It has been proposed that mitogenesis 
increases cancer risk by increasing the probability of DNA damage being converted to 
mutations, making DNA more sensitive to being damaged, increasing gross chromosomal 
alterations, and increasing the expression of oncogenes (Ames and Gold, 1990; 
Riley et aI., 1994b). Fumonisin BI may be the first example of an apparently 
non-genotoxic agent producing tumours through a mode of action involving apoptotic 
necrosis, atrophy, and consequent regeneration (Dragan et aI., 2001). 
An indirect effect of FBI could be due to disruption of the ' barrier function of endothelial 
cells, hence damage to the cerebral blood vessels. Ramasamy et al. (1995) demonstrated 
that an elevation of Sa due to FBI presence altered sphingolipid biosynthesis and caused 
disruption of the endothelial barrier function. A disrupted or damaged endothelium 
increases leakage of plasma components into underlying tissues. Ramasamy et al. (1995) 
further stated that depletion of complex sphingolipids was important in the maintenance of 
cell communication, and loss of cell-to-cell contact could result. The end result of impaired 
sphingolipid metabolism and subsequent accumulation of sphingoid bases could be a 
' leaky' membrane leading to spilling of vascular fluid into brain and regional tissue 
damage. The relevance of these fmdings is important in the current study as FBI was 
localized within brain tumour tissue . In addition, as FBI was found in the serum of these 
patients (Chapter 9), the damaged endothelium may have been a potential route of entry of 
FB I into the brain tissue. 
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An additional route of FB, entry into the brain may be via cerebral vascular endothelial 
cells that possess a transcellular lipophilic pathway, allowing diffusion of small lipophilic 
compounds. In addition to this route, specific receptor-mediated transport systems are 
present for given molecules, like insulin , transferrin, glucose, purines, and amino acids . 
These transport systems are highly selective and asymmetric. Glucose (at about 70% 
plasma concentration) and small amounts of protein are normal constituents of CSF, and 
this could potentially be a vehicle for entry xenobiotics to the brain. Because hydrolysed 
FBI and FBI-fructose adducts are formed during food processing, Hopmans et al. (1997) 
evaluated the excretion of these products and FB, in Fischer-344 rats. Based on the amount 
of each FB ,-related compound recovered In unne and faeces, it was concluded that 
hydrolysed FBI and the FBI-fructose adducts were better absorbed than FBI 
(Hopmans et aI. , 1997). This pathway may also have potentially facilitated entry of FBI 
into the human brain tissue . 
With further consideration of the secondary effects of FBI exposure of inhibition of 
sphingolipid metabolism and the consequent increase in the free Sa and So, it must be 
noted that endothelial cells also have a high affinity receptor, i.e. , EDG-1 for So-l-
phosphate (Van Brocklyn et al. , 1998; Vesper et al., 1999). As So and So-I-phosphate 
have been shown to stimulate DNA synthesis (Zhang et aI., 1990; Zhang et aI., 1991), 
disruption of sphingolipid metabolism by FB, in the brain tissues would potentially lead to 
an increase in free So-I-phosphate. Therefore, there would be further potential for 
malignant transformation via stimulation of DNA synthesis by its binding to the EDG- l 
receptor on the endothelial cells. 
Glioblastoma multiforme was the second most common brain tumour SUbtype analysed 
using IHC in this study, and 60% (6 of 10) of the specimens analysed in this subgroup 
showed FBI presence (Table 10.5). Kwon et al. (2000) assessed the consequences of FBI 
exposure (0.5-75f..LM) on astrocytes and oligodendrocytes in primary cultures of rat 
cerebrum, and found that exposure to FBI diminished the levels of So at 15 DIV, whereas 
FBI exposed cultures showed significantly increased Sa levels and Sa:So ratios. AJso the 
activity of CNP, an enzyme associated with myelin and oligodendrocytes, was increased in 
FBI-treated cultures, suggesting that short-term exposure to FBI modified the proliferation 
of glial cells (K won et al. , 2000). Glial cells are the cells from which glioblastomas arise, 
and Kwon et al. (2000) have shown direct susceptibility of these cells to FBI in vitro. 
323 
Fumonisin BI also displayed epigenetic properties via induction of hypermethylation of 
DNA, inhibition of protein synthesis and cytotoxic concentrations of FBI-induced cell cycle 
arrest in rat C6 glioma cells. This possibly occurred in relation with genotoxic events in the 
C6 glioma cells (Mobio et ai., 2000). 
Harel and Futerman (1993) showed that FBI (10/lM) inhibited axonal growth from 
hippocampal neurons and decreased cellular sphingolipids. As sphingolipids are structural 
components of membranes, it may be possible that as FBI was directly immunolocalised 
within these brain tumour specimens, that the increased Sa and So in these regions may 
have initiated mitogenesis vIa disruption of sphingolipid metabolism. 
Schroeder et al. (1994) established that FBI is mitogenic via accumulation of sphingoid 
bases, rather than inhibition of complex sphingolipid biosynthesis. Because mitogens can 
often affect cell transformation, this provides a plausible molecular mechanism to explain 
the cancer promoting and initiating activity of FBI, whereby mitogenesis is dependent 
upon disruption of sphingolipid metabolism and accumulation of sphingoid bases 
(Schroeder et aI., 1994). The observation of mitotic figures in the brain tumour specimens 
indicate that the presence of high concentrations of free sphingoid bases in these tissues 
does not preclude cell division, and thus tissue repair processes may have been suppressed. 
Alternatively, clonal selection may have selected for cells sensitive to the mitogenic effects 
of elevated free sphingoid bases. Changes in pool size of specific sphingolipids (e.g., SM 
and CER) which are associated with cellular signalling systems, alter the way extracellular 
messages are transduced. Systems which are important control points for cellular growth 
and differentiation may have been disrupted during the interval when repair processes 
occur, and thus mitogenesis would proceed rapidly (Riley et ai., 1994b). The presence of 
FBI in human brain tumour subtypes that arise from cell types used in in vitro studies bears 
further testament to the cancer initiating potential of this mycotoxin in vivo and provides a 
potential mechanism of initiation of the brain tumours. 
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10.4.3 Image analysis of immunolabelled brain tumour specimens 
Although there are three different areas of image analysis, they are not mutually exclusive. 
These include measuring morphological characteristics of tissues, cells, nuclei or even 
nucleoli ; counting of cell or tissue components; and cytometry and pattern recognition, 
which measures cytochemical, histochemical and molecular cell or tissue features, such as 
the DNA content of nuclei, and to classify cells according to the distribution pattern of 
these features in cells or nuclei (Meijer et ai, 1997). In this study, image analysis 
facilitated the quantitative assessment of the proportion of cells that were positive for FBI 
based on the immunohistochemical staining, as well as the distribution of staining 
intensities over the tumour tissues . Image analysis was applied in this study to obtain 
statistically useful information. 
Definition of terminology used in image analysis, the steps formulated in the macro drawn 
up for image analysis of the brain tumour tissue sections, as well as an example of macro 
utilised for image analysis are outlined in Appendix 10.3. The quantitative results from 
image analyses of these brain tumour specimens are presented in Appendix 104. 
In the two non-cancer brain specimens that showed FBI presence, the intensity and area of 
staining was minimal , being limited to five to ten cells in the entire specimen, and 
consequently these specimens were not statistically analysed . Twenty-two of the specimens 
that were positively labelled for FBI, were analysed using image analysis (Appendix 104). 
The remaining positive specimens could not be adequately analysed due to the intensity 
and area of staining being minimal in a few scattered tumour cells. The selection of the 
frame measurements was dependent on the size of the specimen, and the areas of interest in 
the specimen where the stain was localized in the tumour tissue. The area of the frame 
measurements, which IS the area of the specimens analysed , ranged from 
21210.17 ± 99550.15~m2 (mean 844475.16 ± 20479.62 ~m2). 
The range of the field area that represents the area of the specimens that contained FBI 
staining and were analysed statistically, was 819.59 to 10 42629~m2 (mean: 
4475.79 ± 2383.03 ~m2). Translated to a percentage of the sample with positive staining, a 
mean percentage area of all regions in measurement frames was 5.23 ± 2.25%. 
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In the tumour specimens, the mean grey values, representing the staining intensity of FBJ 
immunolocalised in the tissue, varied across all tumours from 96.8 to 211.5 density units 
(mean 138.5 ± 29.3) . The mean minimum grey value in all regions 27.8 ± 32 .7 and the 
mean maxImum grey value in all regions was 236.5 ± 26.5 density units. This was an 
indication of the upper and lower limits of the staining intensity detected in these tumour 
specimens. The grey value standard deviation in all regions (mean of 22 samples) was 
35.6 ±10.5 density units. 
The low transfer of FBI to the brain, as indicated by the mean percentage area of FBJ 
staining of 5.2 ± 2.3% was probably due to the low lipid solubility of FBI. Although the 
quantity of FBI localised in the tissue was low, it is an environmental xenobiotic and was 
not expected to be found in high concentrations, as would be expected for an endogenous 
compound In addition, the saturation point of FBI on CER synthase may have been 
reached, inhibiting further FBI transport across cell membranes . Of importance however 
the fact that this compound had the ability to traverse the BBB and enter brain cells, 
potentially altering normal biochemical and physiological functioning. Not only is FBI 
directly cytotoxic, but also via its inhibition of sphingolipid metabolism may have 
generated an increase in the tissue levels of cytotoxic sphingoid bases that would have 
further exacerbated both the direct and indirect toxic effects of FB I in vivo. 
Intra- and inter-individual exposure to FBI varies, and this is a likely explanation for its' 
varying distribution in different areas of tissue. It is possible that the patient who showed 
FB I-presence in apparently "normal" tissue was exposed to a higher level of the xenobiotic 
over an extended period of time, facilitating accumulation of the xenobiotic within the 
tissues . In addition, the fact that a greater concentration of toxin was localised in the 
tumour tissues than in normal tissues of two patients, lends support to the hypothesis that 
FBI may playa role in triggering neoplastic transformation in the brain. 
10.4.4 Transmission electron microscopy and immunocytochemistry 
Transmission electron microscopy of the brain tumour tissue facilitated ultrastructural 
exploration of these tissues. 
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10.4.4.1 Transmission electron microscopy of meningiomas 
The ultrastructure of the meningiomas reflected the architecture of the cells forming the pia 
and dura mater. The majority displayed a meningotheliomatous appearance while a few 
had distinct fibroblastoid characteristics. In meningotheliomatous meningiomas, many cells 
were large and rounded and contained spherical nuclei with much euchromatin 
(Figure 10.15). Most of the cytoplasmic organelles were concentrated in the paranuclear 
region, and many flOe filaments occupied most of the cytoplasmic mass. They also 
consisted of cells with elaborate cytoplasmic extensions. The length, complexity and 
degree of inter-digitation of these varied, but distinct desmosomes were frequently found 
between closely apposed cell processes. The densities of cytoplasmic fdaments were also 
variable, and were less prominent in transitional meningiomas that also had relatively short 
blunt processes, with less inter-digitation than the meningotheliomatous variety. 
10.4.4.2 Immunocytochemistry of tumour specimens 
Immunoelectron microscopy enabled localisation of the FBI antigen with high resolution 
and specificity at an ultrastructural level. Of the 49 specimens that were positive for FBI 
presence using IRC analyses at the LM level, ten (of the 49) specimens were randomly 
selected and analysed using immunoelectron microscopy. In these analyses, distinctions 
were not made between tumour subtypes, age, race or sex of the patients, since this part of 
the study aimed to determine any possible association with selected organelles in the 
tumours with FBI exposure and subsequent effects. Specificity of the ICC method at the 
EM level was verified by use of method controls, where absence of immunogold particles 
binding was observed with omission of the primary antibody. 
Considerable data supports the hypothesis that fumonisin-induced disruption of 
sphingolipid metabolism is imp011ant in the cascade of events leading to cellular 
deregulation (Chapter 2, Table 2. I). Based on the immunochemical localisation of FBI in 
brain tumour specimens at the LM level, a diversity of alterations in cellular regulation was 
expected due to fumonisin-induced disruption of sphingolipid biosynthesis because these 
compounds play important roles in cellular structure and function . This was expected due 
to the potential alteration of the steady-state concentration of many biologically active lipid 
intermediates and end products, as well as to the direct presence of FB I. In addition, there 
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are also several studies that hypothesize fumonisin-induced changes in key enzymes 
involved in cell cycle regulation, differentiation and/or apoptosis as initial or secondary 
sites of action (Merrill et ai., 1995; 1996a; 1996b; 1997; Riley et ai., 1996; 
Norred et al., 1996; 1998; Wang et ai. , 1999). 
Electron microscopy of the tumour specImens revealed that the neoplastic cells were 
tightly packed and attached by scattered desmosomes (Figure 10.16). The cytoplasm was 
abundant and evidence of keratinisation in the cytoplasm was seen, preferentially deposited 
on the tonofilament bundles. The size of the tumour cells varied considerably, with a large 
centrally located nucleus in most cells. The nuclei were pleomorphic (Figure 10.15), as in 
all tumours, and were occasionally hyperchromatic with crenated borders (Figure 10.16). 
The nuclei of tumour cells contained moderate quantities of heterochromatin, and 
occasional nucleoli . Nuclear projections and nuclear inclusion bodies were also apparent 
(Figure 10 19). Some cells were seen in mitosis, with scattered separate chromatin 
collections. 
Irregularity in nuclear form provides an increased area of contact between the nucleus and 
the cytoplasm, and is considered to denote increased nucleo-cytoplasmic exchanges and 
heightened metabolic activity (Ghadially, 1982). An inversion in the nucleus to cytoplasm 
ratio was also evident (Figures 10.15 and 10.16). One or several prominent nuclei were seen 
in many tumour cells. The nucleoli were variable in size and were often located at the 
nuclear periphery. Peripheral location of nucleoli was also a feature of FBI-treated N2a 
cells (Chapter 6). Enlargement of nucleoli is a characteristic feature of tumour cells . Their 
large size, indicating rapid RNA turnover, reflects heightened cell replication. In addition, 
nucleolar margination is considered a sign of increased protein synthesis (Ghadially, 1975). 
Gold-labelled FBI was present in convoluted, indented and irregular profiles of nuclei 
(Figure 10.17), in areas of nucleoplasmic clearing, in the nucleoplasm (Figure 10.18), as 
well as in microsegregated nucleoli. The micrograph shown in Figure 10.19 is of a 
medulloblastoma, and shows a pyknotic nucleus and lysing nucleoplasm with gold-labelled 
FBI immunolocalised in association with heterochromatin condensation along the 
periphery of the nucleus . Granules were interspersed with the euchromatin and labelled 
FBI was also found in the nucleoplasm. Sahu et al. (1998) have shown that FBI induced 
DNA strand breaks in isolated rat liver nuclei and the potential for having had the same 
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effect on these cells in vivo exists. Similar ultrastructural alterations were observed in the 
N2cx cell line following in vitro exposure to FBI (Chapter 6). Immunolocalisation of FBI in 
the nuclei of the brain tumour specimens suggests that FB I may potentially be both 
genotoxic and cytotoxic to human brain cells in vivo. 
Due to the potential for FBI by its inhibition ofCER synthase to induce accumulation of Sa 
and So in vivo, the effects of these compounds were also considered in terms of their 
potential role in malignant transformation. Sphingoid bases are found in plasma 
membranes where they are generated from endogenous CER by ceramidase 
(Slife et aI., 1989). Similar to polyamines, the So molecule has a primary amino group 
which forms an ionic bond with the oxygen atom of the phosphate group of DNA 
molecules. This change in the structure of DNA via its interaction with So may have led to 
alteration of the DNA substrate specificity. Koiv et al. (1995) reported that So interacts 
with DNA in competition for the binding sites with histones, some enzymes, and 
transcriptional factors and was found to compete with HI histone for the binding to DNA 
The interaction of DNA with So also hinders the ability of DNA to be methylated 
(Romanenko et aI. , 1995) 
Sphingosine is involved in the control of replication and transcription of DNA through 
regulation of PKC activity . The reason is that RNA-polymerases and topoisomerase II, 
which are key enzymes in the activation of the genetic machinery of the cell and histones 
and proteins of the nuclear matrix, are also substrates of PKC. In addition to PKC, So is 
known to activate a number of other protein kinases (Pushkareva et aI. , 1992), such as 
casein kinase II (McDonald et aI. , 1991), which is involved in the regulation of DNA 
synthesis and translocates into the nucleus during replication. Sphingosine located in the 
nucleus is likely to control the activity of this enzyme. In some cases, So is involved in the 
regulation of activity of MAP kinases (Coroneos et al., 1996) which transmit signals from 
receptors of the plasma membrane to transcriptional factors located in the nucleus. The 
presence of FB J in the nuclei of brain tumour cells in this study may have led to disruption 
of these enzyme functions . 
There were moderate numbers of mitochondria present in the cytoplasm of the tumour 
specimens analysed. The mitochondria varied in size and were pleomorphic (Figures 10.20 
and 10.21) Mitochondria with varying numbers of cristae were swollen, and at times 
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disrupted owing to a flooding of the matrix chamber, as well as the intra-cristal spaces with 
water. The presence of enlarged mitochondria that had a dense matrix and few, if any, 
cristae were also seen (Figure 10.21). The paradox of a fast growing tissue with a paucity 
of mitochondria and/or defective mitochondria may be explained by recalling the historic 
work of War burg (1956), which showed the predominance of glycolysis over respiration in 
the energy metabolism of tumours. Since the enzymes of anaerobic glycolysis occur in the 
cytoplasmic matrix, and not in the mitochondria, one may argue that a paucity of 
functioning mitochondrial mass would affect the metabolic activity of a malignant tumour. 
Thus, there seems a good correlation between what is seen with the EM and the respiratory 
biochemistry of neoplastic tissues (Ghadially, 1982). However, the immunolocalisation of 
immunogold-labelled FBI in areas of cytoplasmic matrix clearing (Figure 10.21) may also 
indicate that FBI also affects anaerobic glycolysis. 
Gold-labelled FBI was also localised in elongated (Figure 10.22) and swollen mitochondria 
(Figure 10.21). Fumonisin BI was also immunolocalised within myelin figures that are 
considered an indication of degenerating mitochondria and of an increase in mitochondrial 
turnover. The mitochondria of N2a cells exposed to FBI showed similar ultrastructural 
pathology in association with the immunolocalised mycotoxin (Chapter 6) . Studies by 
Rumora et al. (2002) showed that on exposure of the RK13 cell line to FBI, impairment of 
cell and mitochondrial membrane integrity at nanomolar concentrations occurred . The 
observations made in the brain tumour tissues concur with the findings of these earlier 
in vitro studies. 
The mitochondrial inner membrane consists of about 70% protein and 30% lipid 
(Mathews and van Holde, 1990). Enzymes of the respiratory chain are firmly embedded in 
the inner membrane of the mitochondria. The outer membrane contains an attached set of 
proteins that include enzymes that are involved in amino acid oxidation, fatty acid 
elongation, membrane phospholipid biosynthesis and enzymatic hydroxylations. The 
soluble enzymes of the ~-oxidation of fatty acids are found in the matrix . This necessitates 
mechanisms for transporting ions, fatty acids and other organic acids, as well as nucleotides 
across the inner membrane. Maintenance of respiratory control depends on the structural 
integrity of mitochondria. Disruption of these organelles causes electron transport to 
become uncoupled from ATP synthesis . Under these conditions, oxygen uptake proceeds at 
high rates even in the absence of added ATP. However, synthesis of ATP does not occur 
330 
even though electrons are being passed down along the respiratory chain and used to 
reduce oxygen to water (Mathews and van Holde, 1990). In the present study on brain 
tumour tissues, disruption of normal mitochondrial structure in association with localised FBI 
may indicate an association with disruption of function. An inadequate supply of ATP reduces 
cellular functions and biosynthesis, and may eventually cause cell death. 
Gold-labelled FBI was also immunolocalised within swollen ER in the brain tumour cells, 
and this may be attributed to the fact that the enzyme CER synthase is located in this 
cellular organelle. The condensation of serine and palmitoyl-CoA through to the formation 
of CER takes place in the ER The binding of FBI to CER synthase is the first event in the 
process of disruption of sphingolipid metabolism. This disruption encompasses all the 
changes that can occur in the biosynthetic rates and intracellular concentrations of 
intermediates and end products within both the de novo sphingolipid pathway and branch 
pathways. These include those leading to changes in biosynthesis of glycerolipids and 
neutral lipids (Riley et aI., 2001). 
Gold-labelled FBI was immunolocalised within the cisternae of the ER (Figure 10.23), in 
grossly swollen cisternae of the ER (Figure 10.24), and in areas of cytoplasmic lysis 
(Figure 10.25). These findings are in keeping with studies by Cawood et al. (1994) where 
binding studies in subcellular fractions from rat hepatocytes revealed that 14C-Iabelled FBI 
bound tightly to microsomal and plasma membrane fractions. Subsequently, 
Merrill et al.(1997) have indicated that FBI-induced alterations in sphingolipid and 
glycerophospholipid metabolism result in alterations in phosphorylation status and cell 
signalling pathways that could contribute to tumour promotion. 
A further explanation for finding FBI in the ER may be taken from observations of 
Merrill et at. (1993a) who showed that FBI might have two modes of interaction with CER 
synthase. In neuronal cells FBI was competitive with both sphingoid base and fatty acyl 
CoA. The 'Sa-like' domain may interact with the Sa binding-site, and the negatively 
charged tricarballylic acid groups may interact with the fatty acyl-CoA binding site, by 
mimicking the polyanionic phosphate groups of the CoA The ability of FBI to interact 
with both the binding sites might account for its potency. EI Bawab et al. (2001) have 
further shown that FBI inhibited the CoA-dependent CER synthase activity in rat brain 
microsomes, and did not inhibit the reverse ceramidase activity purified from rat brain 
clearly indicating that the two activities represent different enzymes and further attest to 
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the specificity of FB). This provides another potential mode of action of FB I in the human 
brain tissue analysed in this study. 
In this study, it was difficult to distinguish between areas of cytoplasmic lysis, or clearing 
of the matrix and grossly swollen ER (Figures 10.24-10.25). Such cellular abnormalities 
were also seen in the FBI-treated N2a cells (Chapter 6). A possible explanation for areas 
of cytoplasmic lysis in association with immunolocalised FB I in many tumour cells is that 
FB I disturbs the integrity of cellular membranes, disrupting the structural integrity of 
mitochondria and the ER, leading to a subsequent release of enzymes into the cell matrix . 
Beier et al. (1995) found that the amine and carboxylic acid groups in FBI are spatially 
related, suggesting that they have chelating properties, and hence, could cause membrane 
ion leakage. Yin et a!. (1998) showed that fumonisins disturb the ordering of membranes, 
enhance oxygen transport in membranes, increases membrane permeability, promotes free 
radical intermediate production and accelerates the chain reactions associated with lipid 
peroxidation. The disruption of membrane structure, the enlargement of the relative oxygen 
diffusion-concentration products, as well as the enhancement effects on membrane 
permeability, provide additional insights into potential mechanisms by which fumonisins 
may have enhanced oxidative stress and cell damage in the brain tumour tissues analysed . 
This may be the mechanism of action that facilitated entry and action of FBI on the brain 
tissue. 
Data exists suggesting that fumonisins cause compositional or oxidative damage to cellular 
lipids, which in turn causes molecular events culminating in oxidative damage to DNA and 
other critical macromolecules (Gelderblom et a!., 1996a; 1997; Abado-Becognee et ai. , 
1998; Abel and Gelderblom, 1998; Yin et a!., 1998; Sahu et aI., 1998). In the present 
study, FBI was immunolocalised within cytoplasmic organelles, the cytoplasm and nuclei 
in tumour tissues and illustrates the ability of FB I to traverse cellular membranes, further 
highlighting potential mechanisms of entry and action of FB I in the brain . It is conceivable 
that the mitogenic, cytostatic, and cytotoxic potential of fumonisin-induced disruption of 
sphingolipid metabolism may all play some role in the increased cancer risk. 
The general expectation for tumours involving multiple events over the lifetime of an 
individual is that it may be possible only rarely to identify single dietary carcinogenic 
agents through population studies. Although the exact mechanism of action of FB 1 in the 
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brain cannot be determined from this study, the immunolocalisation of this mycotoxin in 
the tumour tissue indicates that the factors listed above may have contributed individually, 
or in combination to initiate or promote tumour formation and/or progression in the human 
brain. Although these results reflect carcinogen exposure at the individual level, the 
impact and actual risk of such an exposure is not yet known, as exposure to carcinogens at 
a specific time point does not reflect the outcome of cancer in a specific population and 
vice versa. This data however can be used as part of the exposure assessment in 
establishing risk assessment models, although the correlation of associated changes, some 
of which might occur in cellular oncogenes and/or tumour suppressor genes, and the 
ultimate cancer have not been established unequivocally. 
10.5 CONCLUSION 
The immunolocalisation of FBI in cellular organelles within the brain tumour tissue 
showing morphological changes suggests that FBI may be implicated in the aetiology and 
exacerbation of the brain cancer condition. In addition, immunolocalisation of FBI in cells 
showing cellular pathology indicates that FBI may initiate biochemical and ultrastructural 
changes that trigger the carcinogenic process. Ultrastructural abnormalities observed in the 
nucleus and nucleolus might be morphological expressions of biochemical events initiated 
by FBI, which may eventually progress to carcinogenesis. Presence of immunogold-
labelled FBI the ER and mitochondria specifically suggest that FBI may be active in 
association with these cellular organelles as they contain high levels of enzyme systems. 
The associated ultrastructural abnormalities noted may be a consequence of FB I presence. 
This IHC and ICC study on the brain tumour tissue highlights the potential for exposure to 
FBI to be implicated in the initiation or exacerbation of the cancer condition, and requires 
further consideration. From the earlier serum HPLC results of this study where FBI was 
detected in the serum of both non-cancer and cancer subjects (Chapter 9), it was clear that 
the general population are at risk to the biochemical effects of exposure to this mycotoxin 
(Chapter 9). However, assumptions that FB I presence was a potential inducer of brain 
cancer could not be made and therefore it had to be localized within the tissue to put forth 
the hypothesis of a potential cause-effect relationship. This was successfully done within 
65% of the brain tumour samples analysed in this study. Fumonisin B I was also detected in 
two non-cancer brain specimens. The differences in response however may have been 
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attributed to the potential difference in the time scale of exposure or to the presence of FBI 
in the diet of the participant This was difficult to gauge in the hospital/urban environment, 
as exposure to this mycotoxin in the normal home environment/diet was unknown. 
The potential role of sphingolipids as mediators of fumonisin toxicity is multifaceted, and 
it is clear that many mechanisms come into play. Fumonisin B I effects within the brain and 
its association with cancer promotion may be related to loss of endothelial cell integrity, 
and subsequent leakage, increased mitogenesis, loss of cellular membrane integrity as a 
results of disruption of sphingolipid metabolism, increases in intracellular sphingoid bases, 
and FB I induced alterations in apoptotic pathways. A thorough analysis of the cellular 
distribution of potential FBI susceptible systems is required in search of FBI-target cell types 
within the human brain. The differential cellular localisation of xenobiotic metabolising 
enzymes in the brain may be an important factor in cell-specific toxicity. 
Although these findings support the hypothesis that FB I may be a potential factor in the 
aetiology of brain cancer, a larger sample size of both normal and tumour specimens need 
to be analysed before a direct causative link can be established . In order to establish 
whether the tissue Sa and So levels were elevated, quantitative evaluation of the levels of 
Sa and So within the human brain tissue also needs to be considered in relation to FBI 
presence, and whether their levels may be implicated in the initiation, promotion or 
progression of the cancer condition 
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Figures 10.1 a-d: Gallery showing processing of images for analysis where: 
(a) is the light microscope image, 
(b) is the conversion to grey image, 
(c) is the binary image showing segmentation of immuno-reactive regions, and 
(d) is the binary image after deletion on the Kontron 300 image analysis system. 
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Figure 10.1 e: Computed light micrograph to show the areas measured. A mask image 
overlay (different colours) surrounds the cell with the chromogen. The mask 
image serves as the region validation check. Each coil our in the overlay depicts 
varying intensity values. Intensity values are expressed on a grey scale. 
Figure 10.2: Light micrograph of the choroid plexus showing a mass of capillaries 
projecting into the ventricle (V) of the normal brain (H&E, Magn. X 100). 
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Figure 10.3a: Light micrograph of the cerebellar cortex of the nonnal brain showing a deeply 
convoluted fold. The outer molecular layer (ML) contains relatively few neurons 
and large numbers of unmyelinated fibres, and the inner granular cell layer (GL) 
is extremely cellular. Between the two is a layer of huge neurons called Purkinje 
cells (P) (H &E, Magn. X ] 00). 
b 
Figure 10.3b: Light micrograph of the Purkinje cells (P) that have very large cell bodies, and 
relatively fine axon extending down through the granular cell layer (H&E, Magn. 
X 1 000). 
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Figure 10.4: Light micrograph of a transitional meningioma consisting of diffuse sheets of 
spindle cells. Two rudimentary whorls (W) are shown with the cells arranged 
circumferentially around a central vascular space (H&E, Magn. X 400). 
Figure 10.5: Light micrograph of an anaplastic astrocytoma showing glioblastomatous 
transformation. One part ofthe tumour is a poorly differentiated fibrillary 
astrocytoma (A). The blood vessel in the centre is showing endothelial cell 
proliferation (E). There is also a band of necrosis (N) (H&E, Magn. X 400). 
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Figure 10.6: Light micrograph of a medulloblastoma from the posterior fossa with ovoid 
(0) or elongated cells. The stroma is sparse and consists largely of small 
blood vessels (BV)(H&E, Magn. X 240). 
Figure 10.7: Light micrograph of an adenoma of the choroid plexus consisting of numerous 
papillae (P), the surface of which is covered with a single layer of columnar 
epithelial cells (H&E, Magn. X 100). 
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Figure 10.8: Light micrograph of the renal medulla of a FBI-treated rat kidney used as a 
negative control in the IHC method, where the primary antibody was omitted. 
Absence of immunoreactivity indicates the antibody specificity (Magn. 
X 100). 
Figure 10.9: Light micrograph of a treated rat kidney where the secondary antibody was 
omitted during the IHC method application. Absence of immunoreactivity 
indicates the antibody specificity (Magn. X 400). 
340 
Figure 10.10: Light micrograph of FBI-treated Fischer 344 rat kidney tissue showing 
luminal distribution of FBI within distal convoluted tubules and within the 
lumen of the proximal convoluted tubules (peT) (Magn. X 200). 
Figure 10.11: Light micrograph of the non-cancer cerebellar cortex showing absence of 
non-immunological FBI staining (Magn. X 100). 
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Figure 10.12: Light micrograph of the method control where the primary antibody was 
omitted showing absence of immunoreactivity in the tumour tissue (Magn. 
X 40). 
Figure ]O.l3a: Light micrograph of a meningotheJial meningioma showing red AEC 
chromogen immunoprecipitation in tumour cells within the tissue 
(Magn. X 100). 
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Figure 10.13b: Light micrograph of the meningothelial meningioma showing FBI 
immunoreactivity indicated by the red AEC chromogen (Magn. X 400). 
Figure 10.13c: Light micrograph of a meningioma showing varying intensities of the AEC 
chromogen staining within neoplastic cells with enlarged nuclei (Magn. 
X 1000). 
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Figure 10.14: Light micrograph of a brain tumour specimen with FBI 
immunoprecipitation in a few cells (red AEC chromogen) (Magn. X 1000). 
Figure 10.15: Electron micrograph of a meningioma showing variation of cell size and 
pyknotic enlarged nuclei (Nu) (Magn. X 2 000). 
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Figure 10.16: Electron micrograph of a tumour specimen with pleomorphic nuclei (Nu), 
scattered desmosomes (D) and evidence of keratinisation (K) in the cytoplasm 
(Magn. X 2 000). 
Figure 10.17: Electron micrograph showing a nucleus (Nu) within a tumour specimen with 
a crenated border and FB, immunolocalised on the nuclear membrane and in 
the cytoplasm (gold probes in circles) (Magn X 25 000). 
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Figures 1 0.18a and b: Electron micrographs of brain tumour specimens showing nuclei (Nu) 
with FBI immunolocalised on the nuclear envelop and within the 
nucleoplasm (a) (Magn. X 12 000), on the nuclear membrane and in the 
tumour cell cytoplasm in association with dilated ER (b). Note the gold 
probes are circled for identification. (Magn. X 25 000). 
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Figure 10.19: Electron micrograph of a meduHoblastoma showing a pyknotic nucleus with 
gold-labelled FBI (gold probes circled) found in association with 
heterochromatin condensation along the periphery of the nucleus and with 
granules interspersed within the euchromatin (Magn. X 20 000). 
Figure 10.20: Electron micrograph of brain tumour tissue showing FBI immunolocalised 
within a mitochondrion (M) that is closely associated with ER and the 
nucleus. Note the gold probes are circled. (Magn. X 40 000). 
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Figure 10.21: Electron micrograph showing immunolabelled FBI (gold probes circled) within 
myelin figures (My), mitochondria (M), cytoplasm and in disrupted ER. 
(Magn. X 40 000). 
Figure 10.22: Electron micrograph showing FBI immunolabelled (gold probes circled) 
within elongated mitochondria (M) and swollen ER (Magn. X 25 000). 
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Figure 10.23: Electron micrograph showing immunolabelled FBI within swollen disrupted 
ER (Magn. X 60 000). 
Figure 10.24: Electron micrograph showing immunolabelled FBI within strands of broken 
ER and the cytoplasm (Cyt) of a brain tumour cell (Magn. X 60 000). 
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Figure 10.25: Electron micrograph showing immunolabelled FB, in association with 




Mycotoxicology is a vigorous and eclectic science that has recruited scientists from a wide 
variety of disciplines. As part of a comprehensive effort to curtail the adverse health effect 
posed by mycotoxins, substantial international research efforts have been conducted to 
determine the mechanisms of action of Fusarium mycotoxins. The literature review of this 
study highlighted that although diverse research studies have been directed into the effects 
of fumonisins on isolated and select cells in the human eNS, no direct links have been 
established between fumonisin exposure and the incidence of cancer of the brain. This 
study aimed to address this gap in knowledge within both the in vitro and in vivo 
components. 
In vitro models in cancer research provide avenues for elucidation of cellular events 
involved in multistage carcinogenesis In this study, the N2a neuroblastoma cell line was 
used to assess chemical toxicity that dealt with mechanistic, cellular and biochemical 
alterations associated with exposure to certain Fusarium mycotoxins and sphingoid bases 
in vitro. Investigations into their interactions with the N2a cells yielded information that 
would help identify how neuronal cell types might suffer damage as a result of exposure to 
these compounds in vivo. Modern toxicology subscribes to the theory that certain 
biochemical lesions produced by a compound initiate biological effects or toxic endpoints. 
The general objective of the in vitro cell studies was for elucidation of whether the 
mycotoxins or their active metabolites reacted with critical cellular molecules, the mode of 
action of these compounds, and/or for a potential sequence of events initiated by 
interaction of the mycotoxin or sphingoid base with cellular constituents. These 
interactions were expected to result in impairment of vital biochemical processes involving 
these molecules, possibly structurally and functionally altered molecular receptors, and 
consequent biochemical lesions. 
In this study, the characteristics of the mycotoxin-chemical toxicity prediction problem 
were addressed when the potential for selected Fusarium mycotoxins to induce cytotoxicity, 
apoptosis, growth arrest or necrosis in the N2a mouse neuroblastoma cell line were 
investigated. For the proper elucidation of the cytotoxicity of Fusarium toxins, it was 
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important to establish whether the observed cellular effects were due to direct interaction 
of the toxin with the cultured N2a neuroblastoma cells, or whether the toxin interacted 
with other cellular targets which in turn impaired cell function . Structural and ultrastructural 
changes that occurred as a result of mycotoxin exposure in the N2a cells were investigated 
using immunochemical techn iques in combination with LM and EM. The in vitro effects of 
FBI on sphingolipid metabolism in the N2cx cell culture model were also determined by 
quantitative HPLC analyses of treated N2a cells and CCM for Sa and So levels. 
Cytotoxicity is a complex event in vitro where its expression may be manifest in a wide 
spectrum of effects, from simple cell death to complex metabolic aberrations . Viability and 
cytotoxicity assays have principally been used to enumerate the proportion of live and dead 
cells in a population. In this study, cell survival, proliferation, and metabolic activity of the 
N2a cells were determined using the MTT bioassay. Fumonisin B I, FA, MON, DON, T2 
and ZEA, as well as the sphingoid bases Sa and So, induced varying levels of cytotoxicity 
or mitogenicity in the N2a neuroblastoma cell line following the 48-hour exposure period. 
As dead cells were unable to metabolise the MTT salt, this factor also facilitated 
determination of the levels of cell mortality following exposure to these compounds. The 
experimental evidence indicated that chemical congeners, which seemed to have negligible 
differences in their molecular structures (e.g., DON and T2 ; and FB 1, Sa and So), often 
exhibited large differences in bioactivity and cellular responses . The sphingoid bases were 
clearly more cytotoxic to this cell line than any of the mycotoxins tested at equivalent 
concentrations. The MTT assay was useful for quantitative analyses of factor-induced 
cytotoxicity within a 24-48 hour period of cell culture. 
When a cell is exposed to physical stress, biological injury, or deprived of necessary 
substances, it activates a series of stress responses. With minimal insult, the cell may 
recover, but with greater insults cell death or apoptosis results, the cell dies and is recycled 
to its neighbours. If the insult overwhelms a large number of cells then necrosis ensues. In 
this study, the ApoGlowTM assay was used to determine the effects of FBI, FA and 
(FB\+FA) on the N2a neuroblastoma cell line, and the Jurkat leukaemic suspension cell 
line. The ApoGlowTM assay was considered expensive, as aside from its high cost, it 
required specialised equipment for the analyses of data. However, with these confounding 
variables aside, depending on the cell line analysed and the concentrations of mycotoxin 
exposure, the ApoGlowTM assay revealed whether the mycotoxins acted antagonistically, in 
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synergism, or induced some level of cytotoxicity by disruption of cellular metabolism. The 
assay enabled the determination of whether apoptosis, necrosis, growth arrest, or 
proliferation occurred when Jurkat and N2a cells were exposed to specific concentrations 
ofFB[ , FA and their combination. The results on the Jurkat cell line indicated the potential 
effects of these mycotoxins on white blood cells. The effects noted on the N2a cells also 
provided insight as to how neuronal cells may respond in vivo if exposed to these 
mycotoxins . However, no characteristic or distinct trends were noted in the responses of 
the N2a and the Iurkat cell lines. This assay indicated that the biochemical events initiated 
would ultimately lead to cytological manifestations of toxicity. These changes were 
considered to best be assessed employing microscopical techniques. 
In subsequent studies, FM complemented with FCM facilitated quantitative correlative 
analyses between structural and intracellular biochemical changes that occurred in the N2a 
cells as a consequence of exposure to mycotoxin or sphingoid bases. The six mycotoxins, 
and Sa and So, induced varying levels of apoptosis and necrosis in the N2a cells following 
the 48-hour exposure period . Use of AcO and EtBr, revealed that N2a treated cells were 
characterized by loss of cell membrane integrity. Significant differences in the staining 
intensities were evident by comparison of the FBI, T2 and sphingoid base treated N2a cells 
with control cells. Staining N2a cells with Rh 123 and PI, revealed that visual separation of 
necrotic and late apoptotic N2a cells was difficult to distinguish using FM. The 
ZEA-treated N2a cells showed features consistent with the late apoptotic stage, with 
cytoplasmic condensation or cell shrinkage, as well as the relatively intact cell membrane 
noted in comparison to DON-treated N2a cells . The DON-treated N2a cells were swollen 
and displayed compromised plasma membrane integrity indicating possible necrosis . Cells 
treated with DON also displayed features characteristic of apoptosis, such as membrane 
blebbing. Cells with decreased Rh 123 fluorescence and that were PI positive included 
necrotic celis, indicated by cellular swelling, and loss of plasma membrane integrity. 
Variations in N2a cells mitochondrial membrane potential were assessed using IC-I. In 
MON-exposed N2a cells decreased cytotoxicity was evident in comparison to 
F A-treated cells . In FB I-treated N2a cells, large intercellular spaces were indicative of the 
proportion of cell death induced by FBI exposure. Quantitative analyses were carried out 
using Rh 123IPI for FCM analyses . 
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In most cases, an increase in mycotoxin concentration from 50 to 200~M was paralleled by 
a decrease in J-aggregate formation, suggesting a decrease in the ~\jJm . Staining with 
Rh 123IPI indicated whether N2a cells were late apoptotic or necrotic reflected by the 
levels of PI uptake. With the N2a cells exposed to T2 and DON, staining with Rh1231PI, 
revealed that the late apoptotic and necrotic N2a cells comprised greater than 80% of the 
population. Staining with JC-l however indicated a potential concentration-dependent 
decrease in viability from 63 to 57% for cells exposed to T2 . The viabilities of the N2a 
cells exposed to DON also varied considerably when the methods were compared. No dose 
dependent mechanism of cell death was established using either method, as fluctuations 
were wide. Using Rh 123IPI cell viabilities were consistently below 5% at all three levels of 
exposure. 
The FM and JC-l FCM results correlated well with the MTT assay results. Both the FM 
and FCM results show that the mycotoxins and sphingoid bases between 50 and 200~M 
induced varying levels of apoptosis, necrosis, and cytotoxicity on the N2a cells. The 
Rh123IPI method gave consistently higher levels of compromised cells than the JC-l 
method of FCM analyses, and was therefore considered less reliable than JC-l staining for 
FCM. Accurate identification and quantification of the mode of cell death occurring in a 
particular situation is a necessary pre-requisite to understanding the biological processes 
taking place. This was successfully demonstrated using both FCM and FM in the 
qualitative and quantitative assessment of the cellular changes following in vitro exposure 
to the selected compounds. As the detection of many mycotoxins by chemical methods is 
not adequate at present, the feasibility of testing all known mycotoxins chemically is not 
practical. This tissue culture method in combination with FCM and FM is a potential tool 
that would be useful in detection of cytotoxicity induced by extracts on whole cells, and the 
ability of mycotoxin standards to kill particular cell types, provided unbiased interpretation 
of data was facilitated. Despite the fact that no single method can provide unequivocal 
quantitative measure of apoptosis in all situations, flow cytometric techniques represent 
useful tools for biological and clinical studies requiring quantitative information about cell 
death. 
Immunohistochemical and ICC microscopic analyses elucidated the variability that exists 
with regards to consequences of exposure to a mycotoxin and subsequent cellular 
sensitivity. The results ofFM, FCM, MTT assays, IHC, and ICC correlated well with each 
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other. The immunolocalisation of T2, ZEA and FBI within cellular organelles that showed 
structural and ultrastructural pathology provided good correlation between potential cause and 
effect of these mycotoxins. At the LM level, treated cells displayed features of progressive 
damage leading from gradual retraction of processes, to loss of cytoplasmic volume and 
complete cell rounding. Some N2a neuroblastoma cells were reduced in size due to cell 
shrinkage and displayed cytoplasmic condensation. A positive correlation existed between 
cells that displayed increased intensity of chromogen adhesion, and cells that appeared 
more compromised by toxin exposure. 
At the EM level, microsegregation, and peripheral condensation of the nucleoli were 
typical features found in association with gold-labelled FBI immunolocalised within 
nucleoli, the nucleoplasm, discontinuous nuclear membranes, and in swollen cellular 
processes of FB I-treated N2a cells. Alterations of mitochondrial morphology included 
markedly swollen mitochondria with circular arrangement of the cristae, disintegration of 
the internal architecture of mitochondria, and distorted cristae, clearing of the mitochondrial 
matrix, as well as distortion or disruption of the outer mitochondrial membrane. Gold-labelled 
FBI within elongated and distorted mitochondria, as well as on cristae of mitochondria of 
the treated cells, indicate direct involvement of FBI with these organelles ultrastructural 
pathology. The ER profiles of FBI-treated N2a cells were short and discontinuous, with 
features of dilatation or swelling with occasional vesiculation of cisternae of the ER, in 
association with immunolabelled FBI. Gold-labelled FBI was localised within areas of 
cytoplasmic lysis as well as in the surrounding cytoplasm. The immunolocalisation of toxin 
within cellular organelles that displayed ultrastructural pathology suggested a potential 
correlation between cause and effect in this neuroblastoma cell line. 
Treatment of the N2a cells with ZEA accelerated cell growth at foci, induced giant cell 
formation, nuclear condensation, peripheral location of nuclei, membrane blebbing, and 
loss of cell membrane integrity. The cellular target of ZEA appeared cytoplasmic, although 
nuclear staining was also evident. Extensive cytoplasmic lysis, membrane damage and 
induction of giant cell formation were features of T2-treated N2a cells . As the IHC 
staining for T2 seemed predominantly cytoplasmic, it may have altered mitochondrial 
function in the N2a cells. The N2a cells treated with 100 and 200~M T2 however showed 
incorporation of toxin into nuclei. The interaction of mycotoxins with cellular 
macromolecules was viewed as the event initiating the series of observed phenomena. 
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Lesions occurring in DNA and RNA are of particular significance because they destroy the 
structural integrity of these informational molecules, and interrupt their biosynthesis and 
that of proteins and other cellular constituents essential to the viability of the cell . 
Biochemical toxicity can be attributed to multi-factorial interactions between biological 
factors and aspects of chemical structure that partition individual chemicals among 
mechanistic pathways that govern their activity. Different levels of susceptibility indicate 
that mycotoxins and sphingoid bases traversed cell membranes and interacted with cellular 
organelles. The immunolocalisation of FBI, ZEA and T2 in areas of cellular degeneration, 
in the nuclei, nucleoli, and mitochondria, ER and in areas of cytoplasmic lysis were 
considered indicative of sites of toxin interaction and subsequent interference with cellular 
metabolism. The capacity of a cell to incorporate these mycotoxins and effect cytological 
changes as a result of this exposure represents a major factor in the initiation of malignant 
transformation. These in vitro studies highlight the potential toxicity of these mycotoxins on 
neuronal cells, and draws attention to the cytotoxic effects that may be induced in vivo and 
contribute to, or exacerbate the condition of malignant transformation. On the basis of 
information obtained in these in vitro studies, a defined sequence of biochemical events 
leading to morphological manifestations of toxicity or carcinogenicity could not be 
constructed. However, results of numerous investigations have revealed general patterns of 
reactions that are thought to be associated with the toxicity response by virtue of the time 
course and consistency of their occurrence, and their potential importance in cellular 
metabolic phenomena. 
With the in vitro effects of FB I on the N2a neuroblastoma cell line documented thus far, it 
was expected that there would be a modification of sphingolipid metabolism on exposure 
to FBI . Quantitative HPLC analyses revealed that exposure to FBI caused an increase in 
intracellular free Sa and depletion of complex sphingolipids in the N2a cell line. 
Chromatographic analyses of CCM that the N2a cells were cultured in for 72 hours with 
50~ FBI and 100 lJ.M FBI indicate that the N2a cells took up approximately 67% and 
76% of the mycotoxin, respectively. 
Exposure of the N2a neuroblastoma cell line to FBI increases intracellular free Sa and 
depletion of complex sphingolipids. Determination of levels of total Sa and So from 
complex sphingolipids in the N2a cells, were facilitated by acid hydrolysis of the cultured 
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cells. Quantitative results revealed that there was a reduction in the concentrations of Sa 
from a level of 0.6±0.12IlM in control cells, to 02±0.09IlM in cells exposed to 50~lM FBI 
and to 0.2±0.1IlM in cells exposed to 1001lM FBI over the 72 hours incubation period. In 
terms of So, there was a reduction from 49±1.0IlM in control cells to 1.0±lAIlM and 
1.8±0.5IlM in cells exposed to 50llM FBI and lOOIlM FBI, respectively . These results 
indicate that there was as reduction in the cellular levels of complex sphingolipids 
Determination of the levels of free Sa and So in the N2a cells were facilitated by base 
hydrolyses. There was a distinct increase in the free Sa:So ratio from 0.52±0.2 in control 
cells, to 1.14±0.2 in cells exposed to 5 o 11M FBI. There was a further increase in the Sa:So 
ratio to 1A±0.3 in cells exposed to 1 00 11M FBI. Finally, analysis of the CCM in which the 
cells were cultured over the 72hour incubation period revealed that the Sa:So ratio in the 
CCM increased from 1. 7±0.3 for controls cells to 2.0±0.2 and 2.50±OA for cells exposed to 
50llM FBI and 100llM FBI respectively Correlation coefficients, R , for the Sa:So ratios to 
FBI in the CCM was 0.75, and for free Sa:So to FBI in cells was 0.85. The free Sa:So ratio 
in cells appear to be a better biomarker than the Sa:So in the CCM. 
The conceptual framework, and data presented supports the use of the Sa:So ratio as a 
biomarker for a dose response of FBI on sphingolipid metabolism in N2a cells. This 
framework is reasonably consistent with observed Sa:So ratios and FBI concentrations in 
the examined cells and culture media, as well as the current literature of FBI effects on 
sphingolipid biosynthesis in cultured cells. 
In the clinical component of this study, several analytical methods for FBI, Sa and So 
retrieval and quantitation from human sera were assessed. Research on mycotoxins in 
biological fluids contributes to clarity of the mechanism of health impairment attributable 
to these compounds and to a possible dose-response relationship . The HPLC analyses of 
sera described facilitated both qualitative and quantitative assessment of FBI, Sa and So 
levels in spiked sera. Extensive optimisation procedures led to reproducible results with 
high analyte recoveries. Optimal retrieval was achieved with the use of smaller volumes of 
solvents, increased vortexing times, and triple extraction of protein pellets with methanol 
for Sa and So. The recoveries of the individual sphingoid bases were considered a function 
of the volumes and affinities of the solvents used. With FBI, the mean recovery from 
spiked human serum samples obtained following optimisation was 95.8% (n=15). 
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Optimisation of the method also improved detection limits of FBI to ~5ng . mrl at a signal 
to noise ratio of 51.The methods were then considered adequately optimised for use in 
sera analyses of non-cancer and cancer patients, to establish whether correlations exists 
between FBI exposure, Sa:So ratios and brain cancer. 
Matched measurements of Sa:So ratios and FBI levels in human serum samples were 
determined for brain cancer patients and non-cancer volunteers from KZN. The approach 
used was to isolate and quantify serum levels of FBI , Sa and So from non-cancer (n=21) 
and brain cancer (n=50) subjects. Considerable overlap in the Sa:So ratios occurred 
between subjects in both groups (n=71). Fumonisin BI was detected in the serum of both 
non-cancer and brain cancer subjects . However, no correlation (R = 0 .26) existed between 
serum FB I levels and Sa: So ratios in non-cancer, nor the brain cancer subjects 
(R = - 0.23). This implies absence of a causal relationship between exposure to this 
exogenous sphingolipid inhibitor and disruption of sphingolipid metabolism in this study 
cohort. 
Gender-specific statistical analyses revealed that there was no significant difference 
between the non-cancer male and female serum Sa: So ratios in this study cohort (p=0.63). 
Serum FBI levels in the female brain cancer subjects, also did not differ significantly to 
that of non-cancer females (p=0.73), nor was the mean serum Sa: So ratio in the female 
cancer patients (2.09±1.74) significantly different (p=0.43) from female subjects in the 
non-cancer group (1.63±0.94). Furthermore, analysis of the sera Sa: So ratios of the cancer 
and non-cancer males revealed that these levels did not differ significantly either (p=0.56). 
Limiting variables in this study included the sample size, limited volumes of blood and the 
inability to age and sex match all sera samples obtained from the brain cancer subjects. 
In the field of mycotoxins, the biomarker approach represents a promising route for 
evaluation of risk associated with the ingestion of these toxic substances. The data 
presented in this study however contests the primary use of the Sa : So ratio as a biomarker 
for a dose response of FBI induced inhibition on sphingolipid metabolism, or as a 
biomarker for brain cancer in human subjects . The potential exists that FBI may be a 
contributing factor in the aetiology of brain cancer by way of its presence in sera. Even in 
the absence of overt diseases, immuno-modulation associated with mycotoxin exposure 
have important ramifications and on the health and quality of life of those affected. 
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The final clinical part of this study dealt with screening human brain tumour and 
non-tumour tissues using IHC methods to establish whether FBI is associated with the 
cellular pathology of human brain cancer. Seventy-six brain tumour tissue specimens were 
analysed for FBI presence using IHe. Of these, 38 specimens were matched with serum 
analyses for FBI , Sa, So, and the Sa: So ratios. Twenty-three of the 38 samples showed 
presence of FB I at the LM level. The matched FB I sera analyses of the 23 FB I positive 
tissue specimens indicate that although not significantly different (p=O.l1); the cancer 
group with FBJ within the tumour tissue had higher levels of FBI in the circulation than the 
cancer group without FBI immunolocalised within tissue. Fumonisin BI was localized 
within 65% of the tumour samples analysed, and was also detected in two non-cancer brain 
tissue specimens. Certainly differences in individual absorption and distribution, 
metabolism and repair all have the potential to influence individual sensitivity to a 
particular agent. In turn, these specific differences may account for the wide variation in 
incidence of cancer between and within groups of people. 
Experimental studies do not always provide hard experimental data that prove specific 
cancer-causative factors. Rather they usually provide specific associative hypotheses or 
'risk factors' for further study. The IHC and ICC analyses of the brain tumour tissue 
highlights the potential for exposure to FBI to be implicated in the initiation, promotion or 
exacerbation of the brain cancer condition, and requires further investigation. 
Immunolocalisation of FBI in brain tumour tissue showing morphological changes 
indicates that FBI may be associated with initiation of biochemical and ultrastructural 
changes that trigger the carcinogenic process. Ultrastructural abnormalities observed in the 
nucleus and nucleolus might be morphological expressions of biochemical events initiated 
by FBI, which may eventually progress to carcinogenesis. Presence of gold-labelled FBI in 
the ER and mitochondria specifically suggests that FBI may be active in association with 
these cellular organelles as they contain high levels of enzyme systems. 
Fumonisin BI exposure may induce alterations of sphingolipid metabolism and myelin 
synthesis in the CNS. These alterations may cause along with direct disruption of brain 
enzyme activity involved in sphingolipid synthesis, damage to myelinating cells. A 
thorough analysis of the cellular distri bution of potential FB I susceptible systems is required 
in search for target cell types in the human brain. 
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In order to establish a direct causative link between FBI presence and brain cancer, a larger 
sample size of both normal and brain tumour specimens are required. As sphingoid bases 
are intrinsically cytotoxic, quantitative analyses of the tissue Sa and So levels need to be 
correlated to tissue FB 1 levels. The elucidation of the biochemical events associated with 
carcinoma induction by fumonisins would provide insight into the mechanism underlying 
the carcinogenic process. Considerable experimental data is required in order to relate the 
biochemical effects of FBI directly to the subcellular and cellular events ultimately 
manifest in toxicity (necrosis) or in tumour induction within the brain. 
In this study, a "natural" experiment was exploited. The results are reflected in disease 
incidence statistics and the challenge was to unravel the pertinent variables. S imilariy, just 
as many experimental designs may be classed as irrelevant to the human situation, so too 
many manifestational epidemiological associations are unrelated to direct cause. 
Evaluation on the causal nature of an association is best achieved by means of direct 
experimentation. Where direct evidence is lacking, evaluation is neither easy nor objective. 
In this way a variety of corroborative evidence is accumulated which must be evaluated 
with caution. However laudable caution may be, there comes a point in the accumulation of 
evidence when it is more prudent to assume that the association is causal until proven 
otherwise (van Rensburg et aI., 1974). 
Although the results of IHC analyses reflect FBI exposure at the individual level, the 
impact and actual risk of such an exposure is not yet known, as exposure to a compound at 
a specific time point does not reflect the outcome of cancer in a specific population and 
vice versa. The data accumulated in this study does not warrant that FBI be classified as a 
brain carcinogen in vivo. However this data may be used as part of the exposure assessment 
in establishing risk assessment models, although the correlation of associated changes, 
some of which might occur in cellular oncogenes and/or tumour suppressor genes, and the 
ultimate cancer has not been established unequivocally. 
Currently, the available information on human health effects associated with fumonisins is 
inconclusive. Further studies on the pathophysiology of fumonisin toxicoses are essential 
in diagnosis of the disease, establishment of safety parameters and development of control 
and prevention procedures. Unless systems other than sphingolipid metabolism are 
discovered affected by fumonisins, the inhibition of CER synthase would be considered the 
initial step in the toxicity and carcinogenicity of these mycotoxins. This represents only the 
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starting point for understanding the pathology of these compounds. More must be learned 
about the cellular consequences of elevations in Sa and various Sa metabolites, and the 
reductions in key complex sphingolipids caused by fumonisins . Such investigations should 
provide insight into, not only into the biological role of sphingolipids, but also the 
mechanism of disease initiation by fumonisins. 
Although methods used in this study, such as FM, FCM, mc, ICC and HPLC have 
contributed to the elucidation of the mode of action of FB I and other mycotoxins studies, 
some of the most exciting prospects for markers of biological effects or pre-clinical disease 
arise from tools developed in the field of molecular biology. The major driving force in the 
development of neoplasia is the interaction of carcinogenic chemicals with the cellular 
genome of the target cells. The increasing mechanistic understanding of genetic alterations 
that underlie the progression from initiation to tumour formation has permitted the 
development of sensitive tests for tumour diagnosis. Studies at the molecular level will 
complement these studies and provide useful information for the design of remedial 
measures, and make for better understanding of the mechanism of action of FB I and other 
environmental toxins . The continuing development of molecular epidemiological methods 
to identify specific mutations in human tumours may at least narrow the list of potential 
aetiological factors for various human cancers. There is a need to analyse cells and tissues 
(normal and cancerous) for more than a few sphingoid bases and mycotoxins, if one is to 
deduce reasonable unambiguous interpretation of experiments on malignant 
transformation, necrosis, apoptosis or cell cycle arrest. 
The history of medicine has clearly recognized that preventative strategies offer the best 
means of eliminating mortality and morbidity from infections and diseases. 
Environmentally related diseases are a reality of every day life and in order that people 
may be rendered more aware of current problems, it is essential that environmental 
toxicologists remain dedicated to the examination and evaluation of the potential for 
environmentally induced diseases. The need for prevention of exposure to mycotoxins is 
certainly relevant in SA where many communities lack modern health care facilities . In 
SA, the importance of mycotoxins in public health will increase as the available food 
supplies decreases due to population growth. Opportunities for prevention of fumonisin 
induced diseases include reducing exposure and interfering with toxicological effects 
through nutritional intervention. In order to educate people it is necessary to determine the 
exact association between exposure and disease, establishing reliable and reproducible 
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indicators of fumonisin exposure and establishing a scientific basis for regulatory 
guidelines to protect the population from health hazards that are associated with exposure. 
Much has been written about coincidence - and many new age philosophers would have 
one believe that it has mystical meaning. Those more scientifically inclined put 
coincidence down to statistics. Although FBI was immunolocalised in the brain tumour 
tissues, the postulates required for a proof of a causal relationship in a human brain cancer 
have not been met. Fumonisins however are a human health hazard and continuous dietary 
exposure to small amounts could be detrimental. It still has to be shown that risk of brain 
cancer in a population rises in proportion with the degree of previous exposure to this 
mycotoxin . This requires quantitative intra- and inter-regional comparisons of exposure 
and brain cancer risk. 
While the condition of all forms of life is of concern, the ultimate effect of environmental 
degradation is on human health and in this regard; research is undertaken with the intent to 
serve both the scientific and medical communities by contributing to strategies of disease 
prevention. Focus is placed on the elucidation of potential carcinogenic stimuli to explain 
the initiation, promotion, and frequency of cancer. For practicing physicians, 
environmental related diseases are a reality of everyday life and in order that they might be 
rendered more aware of current problems, dedication to the examination and evaluation of 
environmental induced disease is essential 
More toxicological research is required to fully define the levels of fumonisins required to 
affect human health, chemical research to find more rapid and accurate analytical methods, 
and biochemical research to more fully elucidate the apparent mechanisms of toxicity of 
fumonisins in vivo. This generation of scientists involved in carcinogenesis research will 
likely see the ultimate rewards : substantial reduction of cancer incidence by prevention of 
exposure strategies, detection and eradication of early lesions before they become life 
threatening, and control of more advanced disease from rational treatment are realistic 
achievements (Yuspa, 2000). 
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Figure A1.1: Frequency of histologically diagnosed brain and central nervous system cancer in South Africa (1993-1995) 
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APPENDIX 3 
Table A3: ADP: ATP ratios of Jurkat cells treated with FBI, FA and (FBl+FA) 
over 22.5 hours. 



















I Control FA FB+FA 
0.27 0.59 0.26 0.64 
0.264 0.45 0.61 0.58 
0.301 0.50 0.361 0.49 
0.25 0.592 0.298 0.54 







ADP: A TP ratios of the N2 a. neuroblastoma cells treated with FBI, FA 
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0.446 0.341 0.5106 
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APPENDIX S 
Preparation of O.Sl\tI Tris stock solution 
Dissolved 60.6g Tris-[hydroxymethyIJ-aminomethane (molecular weight 121.12 in 800 ml 
distilled water. Adjusted pH to 7.2 with concentrated HCl (40 ml) and then adjusted final 
volume to 1000 ml. 
Preparation of O.OSM (SO mM) Tris-HCI buffer 
Diluted 0.5 M Tris stock solution 1: 10 (v/v) with 0.85% physiological saline (0 .15M NaCI) 
(i.e. 8.764 g NaCl in 1000 ml water). Then made up : 
1. 0.02% BSA in 0.05 M Tris (500 ml)(i .e., O.lg BSA in 500ml 0.05M Tris) . Adjusted 
pH to 7.2 with concentrated HCI. 
2 . 1% BSA in 0.05 M Tris (20 ml)(i.e., 0.2 g BSA in 20 ml, 0.05 M Tris). Adjusted 
pH to 8.2 with 1M NaOH. 
APPENDIX 6 
Appendix 6.1 
Method of preparation of Uranyl acetate 
A saturated solution of50:50 EtOH:water with uranyl acetate (421.15 glml) was prepared 
in a 5 ml tube. The mixture was allowed to settle for 4 hours, then centrifuged for 15 
minutes to pellet any particles in the suspension immediately before use. 
Appendix 6.2 
Method of preparation of Lead Citrate 
Materials 
2.66 g Lead nitrate 
3.52 g Sodium citrate 
60 ml water 
16 ml IN Sodium hydroxide 
Method 
The lead nitrate was dissolved in 60 ml water. Sodium citrate was added to the solution and 
a precipitate formed. The mixture was left to stand at RT for 30 min. After 30 min., the 16 
ml 1 N Sodium hydroxide was added and the solution turned clear. The stain was then 
filtered and stored at 4°C until use. 
APPENDIX 7 
Appendix 7.1 
Table A7: Recoveries of Fumonisin Bl from spiked sera samples. 
Specimen 0.5 ml serum FBI recovered per ml serum 0/0 FBI recovered 
(replicates) spiked with (ng/ml) 
1 393.47 98.37 




4 472.17 118 
n=4 413.54±41.06 103.37±10.25 
1 500.49 83.41 




5 548.48 91.413 
6 526.02 87 .67 
n=5 552.12±57.30 92.02±9.55 
1 749.79 93 .72 




4 817.32 102 
5 758 .38 94.79 
6 688 .27 86 .03 
n=6 735.52±52.48 91.89±6.53 
Appendix 7.2 
Preparation of Alkaline water 
O.lml 2M NH40H was diluted in 250ml deionised water, pH 8.5-9.2. The solution was 
prepared fresh daily. 
APPENDIX 8 
Appendix 8.1 
Aqueous methanolic Hel (1M Hel) for acid hydrolysis of complex sphingolipids was 
prepared immediately before use by mixing 8.6ml concentrated Hel with 9.4ml H20 , and 
bringing it to a lOami volume with MeOH 
Saturated methanolic KOH was prepared by dissolving 30g KOH in lOami MeOH, and 
filtering through Whatman No 2 paper. 
Appendix 8.2 
Table A8.1: Recoveries of Fumonisin Bl from culture media following the 72 hours 
exposure to N2a cells. 
FBI recovered from the 0/0 FBI recovered from % FBI taken up by the 
CCM CCM N2a. cells 
Treatment/replicates ().!M) 
50~M FBI 
1 21.7 43.3 56.7 
2 19.2 38.3 61.7 
3 16.2 32.4 67.6 
4 11.8 23.6 76.4 
5 12.8 25.6 74.5 
Mean±SD 16.3±4.2 32.6±8.3 67.4±8 .3 
100llM FBI 
1 23.9 23 .9 76.1 
2 24.1 24.1 75.9 
3 23.0 23.0 77 .00 
4 21.9 21.9 78 .1 
5 22.9 22.9 77.1 
6 26.6 26.6 73.4 
Mean±SD 23.76±1.61 23.76±1.61 76.24±1 .61 
Appendix 8.3 
Table A8.2: Total sphinganine and sphingosine levels in the N2a cell line following 
treatment for 72 hours: acid hydrolysis of cells. 
Treatment So (~M) Sa (J.1M) Sa: So ratio 
Control 
1 4.6 0.52 0.11 
2 6.02 0.62 0.10 
3 4.00 0.76 0.19 
Mean±SD 4.89±1.03 0.64±0.12 0.13±0.05 
50f.!M FBI 
1 2.56 0.26 0.10 
2 0.19 0.11 0.59 
3 0.24 0.1 0.39 
Mean±SD 0.99±1.35 0.15±0.09 0.16±0.25 
100f.!M FBI 
1 1.55 0.20 0.13 
2 2.32 0.32 0.14 
3 1.39 0.199 0.145 
Mean±SD 1.75±0.5 0.24±0.07 0.138±0.01 
Appendix 8.4 
Table A8.3: Free sphingosine and sphinganine levels in N2a cells after treatment 
with Fumonisin Bl for 72 hours: base hydrolysed extracts of the N2a 
cell line. 
Treatment So (nM) Sa (nM) Sa:So Ratio 
Control 
1 30.33 16.71 0.55 
2 36.60 11.51 0.31 
3 42.24 29.28 0.69 
Mean±SD 36.39±5.96 19.17±9.14 0.52±0.19 
50 J!M FBI 
1 53 .30 54.03 1.01 
2 60.28 63.61 1.06 
3 47.13 64.13 1.36 
Mean±SD 53 .57+6.58 60.59+5.68 1.14+0.19 
lOOJ!M FBI 
1 47.21 53.22 1.13 
2 43.93 78.02 1.78 
3 49.68 64 .05 1.29 
Mean±SD 46.94±2.88 65.10+12A3 lAO±0.33 
Appendix 8.S 
Table A8.4: Sphinganine and sphingosine analyses of the culture media following 
exposure of N2a cells to SO and lOO,..,M fumonisin Bl over 72 hours. 
Treatment/replicates So (nM) Sa(nM) Sa:So ratio 
Control 
1 24.8 38.2 1.54 
2 25A 45 .8 1.80 
3 48 63 .9 1.33 
4 21.9 40.6 1.85 
5 18 .5 39.2 2.12 
Mean±SD 27.72±11.66 45 .54±10.67 1.73±0.30 
50~M FBI 
1 18.9 42 2.22 
2 22.9 42 .9 1.87 
3 33 65 .7 1.99 
4 29.9 56A 1.89 
5 27 .2 51.6 1.897 
Mean±SD 26.38±5.59 51.72±9.87 1.97±0.15 
100~M FBI 
1 27.3 56.1 2.055 
2 27.5 62A 2.27 
3 25 .2 59 2.34 
4 23 .2 65 .3 2.82 
5 29.9 89.7 3 
Mean±SD 26.62±2.54 66.5±13A3 2.50±OAO 
APPENDIX 9 
Appendix 9.1 
Key used for all relevant tables in this appendix 
A I W M F - ND 
African Indian White Male Female Serum insufficient for Not Detectable 
analyses 
Table A9.1: Determination of the serum concentrations of sphinganine, sphingosine 
and fumonisin Bl in the serum of 21 non-cancer subjects. 
Age Race Sex FB,(nM) So (nM) Sa (nM) Sa:So ratio 
18 A F 20.1 18 NO NO 
19 I F 22.3 - - -
19 I F 24 .1 57.7 80 1.4 
19 W F 24.4 - - -
19 I F 46 .3 35 .2 79 2.2 
19 I F 60.7 29 .9 81 2 .7 
20 A F 66 50.9 88 1.7 
19 W F 69.8 83 .9 92 1.1 
19 I F 74.2 22 .8 76 3.3 
19 I F 106 26.1 40 1.5 
19 A F 118 73 .2 88 1.2 
18 I F 296 86.8 95 1.1 
FEMALES 
18.9±O.5 77.3±76.1 48.5±25.9 71.9±29.6 1.6±O.9 
18 I M 22 .5 129 91 0.71 
18 A M 26 119 102 0.86 
19 I M 41.2 47.9 84 1.75 
20 A M 50.3 88 .2 99 1.12 
19 I M 91.6 47 .2 79 1.67 
19 I M 95.2 343 801 2.33 
18 I M 106 - - -
18 I M 122 - - -
19 I M 127 - - -
MALES 
18.7±O.71 75.8±41.0 129.1±1l0.3 209.3±289.99 1.41±O.65 
ALL SUBJECTS 
18.81±O.60 76.65±62.11 78.68±77.99 123.44±182.42 1.55±O.82 
AI)' .. 
Appendix 9.2 
Table A9.2: Determination of the concentrations of sphinganine, sphingosine and 
fumonisin Bl in the serum of 16 non-cancer subjects. 
Age Race Sex FB,(nM) So (nM) Sa (nM) Sa:So 
18 A F 20.1 18 ND ND 
18 A M 26 119 102 0.86 
18 I F 296 86.8 95 109 
18 I M 22.5 129 91 0.71 
19 A F 118 73.2 88 1.20 
19 I F 24.1 57.7 80 1.39 
19 I F 60.7 29.9 81 2.71 
19 I F 46.3 35 .2 79 2.24 
19 I F 74.2 22.8 76 3.33 
19 I F 106 26.1 40 153 
19 I M 41.2 47 .9 84 175 
19 I M 916 47.2 79 1.67 
19 W F 69.8 83.9 92 11 
19 I M 95.2 343 801 2.34 
20 A F 66 50.9 88 1.73 
20 A M 50.3 88.2 99 1.12 
18.9±O.6 75.5±66.3 78.7±77.99 131.67±185.72 1.65±O.73 
APPENDIX 10 
Appendix 10.1 
Table AI0.l: List of non-cancer brain specimens obtained at autopsies at King 
Edward YIn hospital mortuary. 
Non-Cancer Age Race 
Subjects 
1 65 A 
2 65 A 
3 45 A 
4 64 A 
5 9 A 
6 25 A 
7 35 A 
8 35 A 
9 28 A 
10 49 A 
11 Unknown A 
12 Unknown A 
13 Unknown A 
14 Unknown A 
IS 36 A 












glutaraldehyde (25% stock) 



















Method to make Karnovsky's fixative (50 ml, pH 7.2) 
Cause of death 
Motor vehicle accident (MV A) 




Gun shot wound in chest 
Stabbed in chest 
Gunshot wound in abdomen 






Hepatitis / TB 
Cardiac failure 
The paraformaldehyde was dissolved in tepid water (i.e., water that was not allowed to 
boil) Then 1-3 drops of 1M NaOH were added until the fluid started to clear. Undiluted 
glutaraldehyde and the 0.2M sodium cacodylate buffer were then added. Finally, calcium 
chloride was added. The fixative was then filtered and the pH adjusted to pH 7.2. The 
solution was allowed to fix for 1hr at 4°C, and then used as required. 
Appendix 10.3 
Table AI0.2: Definition of terminology used in image analysis. 
1 FLD COln\lT Number of measured regions 
2 FLDAREA Area of all regions 
3 FLDAREAP(%) Percentage area of all regions in measurement frames 
4 FRAME AREA (11m2) Area of measurement frame 
5 FRAME AREA 1 (pixels") Unsealed area of the measurement frame 
6 FLDMEAND Mean grey value of all regions 
7 FLDSTDD Grey value standard deviation in all regions 
8 FLDMIND Minimum grey value in all regions 
9 FLDMAXD Maximum grey value in all regions 
Table AI0.3: Steps formulated in the macro drawn up for image analysis of the 
brain tumour tissue sections. 
l. imgdelete 1 
2. Gclear ° 
3. Tvlive 
4 . Tvinput 1 
5. MS marker 1,100.00,0.00,37,46,9,3 ,2 
6. Gmerge1 ,255 
7. ImgRGB2grey 1,2 
8. Normalise 2,3 ,5 
9. Dislev 3,4,10,129,1 
10. Binscrap 4,5,0,100,0 
11 . Mssetgeom 
12. Msframe 
13. MSsetfeat "FIELDFEAT' 
14. MSsetfeat "DRAWFEAT' 
15. Msmeasmask 5,1,"database", 0,2,10 
16. Msdrawmask 5,1 
17. Imgdisplay 1 
18. Gmerge 1,255 
Appendix 10.4 
Table AIO.4: Image analysis of brain tumour specimens. 
FLDAREA FLDAREAP FRAME AREA FRAME ARE A 1 FLDMEAND FLDSTDD FLDMIND FLDMAXD 
No 111m2 1% 111m2 Ipixd Igrey Igrey Igrey Igrey 
1 5544.74 6.66 83202.63 369725 104.08 21.21 75 176 
2 3672.4 5.97 61534.57 412850 211.54 42 .16 81 254 
3 7317.83 7.35 99550.15 442368 97.55 23 .03 1 170 
4 10426.29 10.47 99550.15 442368 116.54 25.28 10 203 
5 5276.04 7.45 70780.46 314525 138.31 30.95 71 234 
6 7527 .79 7.56 99550.15 442368 111.74 26 .94 1 196 
7 819.59 l.74 47173.17 209622 162.18 20.36 89 237 
8 6333.28 6.75 93882.54 417183 120.67 28.05 2 229 
9 5939.24 6.45 92108.78 409301 120.31 27 .88 2 225 
10 1522.84 2.04 74618.06 331578 178.96 38.2 51 254 
11 500l.95 5.66 88297.29 392364 129.09 24.7 3 244 
12 1287.67 6.07 21210.17 94251 120.56 33.15 1 254 
13 4l79.2 4.2 99550.15 442368 96 .84 41.55 1 251 
14 1809.99 1.87 96973 .91 430920 118.73 42.57 1 254 
15 5488.71 5.66 96973.91 430920 122.28 40.67 1 254 
16 535l.21 5.67 94297.06 419025 157.86 51.91 1 254 
17 2586.15 4.13 62573.28 278055 157.9 54.06 5 254 
18 3578.57 3.59 99550.15 442368 134.72 50.55 1 254 
19 2909.76 3.25 89426.09 397380 164 .98 52.67 47 254 
20 1473.78 1.54 95883 .59 426075 154.39 34.36 60 244 
21 5227.66 5.45 95883 .59 426075 164.01 36.05 54 254 
22 5192.78 5.42 95883.59 426075 163 .99 36.07 54 254 
4475.794091 5.23% 84475.15636 381716.5455 138.5104545 35.56227273 27.81818182 236.5 
2383.034465 2.248770564 20479.62867 88384.36932 29.32650491 10.52198421 32.74379093 26.4858 
